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Resumo 
 
Um número crescente de formulações, contendo moléculas conhecidas ou 
sintetizadas de novo, tem vindo a ser utilizado na terapia génica. A eficiência dos 
sistemas não-virais na entrega de ácidos nucleicos tem mostrado elevada 
dependência das suas características estruturais intrínsecas, que, por sua vez, 
condicionam as interações que estabelecem com as membranas celulares e as 
alterações conformacionais que sofrem no ambiente intracelular. Essas 
características têm, por isso, sido modeladas empiricamente com vista a aumentar a 
capacidade dos vetores para protegerem os ácidos nucleicos, ultrapassarem as 
barreiras biológicas e garantirem a libertação das moléculas transportadas nos 
devidos compartimentos intracelulares (citoplasma, núcleo ou mitocôndrias). É neste 
contexto que se insere o presente trabalho, tendo como objetivo estabelecer critérios 
e diretrizes que possam contribuir para uma preparação racional de novos vetores ou 
reformulação dos já existentes, poupando tempo, custos e recursos humanos. Com 
este propósito, compostos convencionais e sintetizados de novo, pertencentes a 
diferentes famílias químicas (tensioativos gemini, péptidos permeantes e polímeros 
termossensíveis) foram testados, em combinação ou não com lípidos auxiliares, como 
sistemas não-virais para a entrega de ácidos nucleicos, procurando, em paralelo, 
identificar as características estruturais de cada formulação responsáveis pelo 
sucesso ou insucesso da mesma na transfeção. 
Pequenas variações na estrutura de tensioativos gemini, tais como um aumento do 
comprimento das cadeias hidrocarbonadas e do espaçador, mostraram ter impacto 
direto na formação de arranjos supramoleculares, per se ou após complexação com 
DNA, com consequente repercussão na eficiência de transfeção e na citotoxicidade 
dos complexos. Por outro lado, o tipo de ligação (amina, amida ou éster) estabelecido 
entre os grupos polares e o espaçador de tensioativos gemini derivados de serina, 
condicionando a sua biodegradabilidade e as suas características estruturais, com 
impacto na complexação e proteção do DNA, bem como na extensão da sua libertação 
intracelular, revelou-se determinante para a eficácia de transfeção. Interações fracas 
entre os complexos e a membrana celular, resultando numa expectável 
desestabilização tardia dos complexos, com libertação do DNA na proximidade do seu 
alvo intracelular, revelaram contribuir igualmente para elevados níveis de transfeção. 
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No entanto, a eficiência da entrega de DNA na mitocôndria mostrou uma boa 
correlação com a capacidade dos complexos com tensioativos gemini para uma 
extensa interação com modelos membranares de composição semelhante à das 
membranas mitocondriais.  
Por outro lado, a interação de sistemas de entrega de material genético com 
membranas, levando à segregação de domínios lipídicos e à formação de fases não-
lamelares em membranas modelo e celulares, mostrou ser responsável pela aptidão 
do péptido permeante e cariofílico S4(13)-PV para transpor a membrana celular e 
entregar eficientemente ácidos nucleicos à célula. Além disso, a modificação 
estrutural deste péptido, por adição de uma cadeia de histidinas, originou complexos 
com eficiente capacidade endossomolítica, melhorando a entrega de DNA plasmídico 
e de siRNA.  
Finalmente, a habilidade de co-polímeros para mediarem eficientemente o 
silenciamento de genes mostrou beneficiar com um ajuste das proporções relativas 
dos respetivos blocos termossensíveis e catiónicos, repercutindo-se no equilíbrio 
entre interações eletrostáticas repulsivas e interações hidrofóbicas. A ocorrência de 
uma transição de fase dependente da temperatura revelou-se importante para que os 
polímeros condensassem os ácidos nucleicos em solução à temperatura ambiente e, 
após contacto com as células a 37 °C, os expelissem por dissociação dos complexos.  
Em suma, utilizando diferentes tipos de vetores, foi possível demonstrar a relevância 
da sua estrutura em cada etapa do processo de transfeção, desde a complexação dos 
ácidos nucleicos à sua libertação intracelular, evidenciando como uma modelação 
minuciosa das suas características estruturais os pode tornar capazes de vencer as 
diversas barreiras celulares. Este trabalho presta, assim, um contributo para uma 
melhor compreensão dos mecanismos através dos quais a composição, as 
propriedades físico-químicas e a arquitetura final de uma variedade de vetores não-
virais influenciam a sua eficiência de transfeção, o que representa um avanço para o 
desenho racional de novos sistemas de entrega de ácidos nucleicos.  
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Abstract 
 
Increasing efforts have been made to synthesize new molecules and to prepare new 
formulations with pre-existing molecules aiming at their application in gene delivery. 
Growing evidence shows that efficient nonviral nucleic acid delivery depends on 
intrinsic structural characteristics of the delivery systems, as well as on their ability 
to interact with cellular membranes and undergo conformational changes in the 
intracellular environment. These properties are interdependent and have been 
modulated by a “trial and error” approach towards the establishment of an optimized 
set of architectural characteristics that provide nanocarriers with the capacity to 
complex and protect nucleic acids, to overcome the biological barriers imposed to 
nucleic acid delivery and to ensure cargo release at or close the adequate intracellular 
target (cytoplasm, nucleus or mitochondria). It is in this context that the present work 
was developed with the ultimate goal of contributing for establishing criteria and 
guidelines for the preparation of new vectors or the reformulation of conventional 
ones, as a hypothesis driven procedure, sparing time, costs and human resources. 
With this purpose in mind, conventional and novel compounds from different 
chemical families, namely gemini surfactants, cell-penetrating peptides and 
thermoresponsive polymers, with or without helper lipids, were tested as nonviral 
nucleic acid delivery systems, in an attempt to identify the structural peculiarities of 
each formulation responsible for its success or failure in mediating transfection. 
Small variations in the structure of gemini surfactants, such as the progressive 
increase of tail and spacer length, showed to be able to generate different 
supramolecular arrangements of gemini surfactants and their complexes with DNA, 
thus being important for the modulation of transfection efficiency and cytotoxicity of 
the complexes. Furthermore, the type of linkage (amine, amide or ester) established 
between the headgroups and spacer of serine-derived gemini surfactants produced 
surfactants varying in spacer length, flexibility, and biodegradability, which showed 
to be implicated in the structural arrangement of their complexes with DNA, their 
ability to release the cargo, and their transfection efficiency. These small structural 
alterations modulated the strength of surfactant-DNA interactions, with impact on the 
extent of DNA complexation and protection, and on the intracellular release of DNA. 
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High transfection efficiency was associated with low extent of complex-membrane 
interactions, which resulted in late destabilization of the complexes and DNA release 
near its intracellular target. However, the efficiency of gemini surfactant-based 
complexes to deliver DNA to mitochondria showed to be dependent on enhanced 
interactions with membranes of composition mimicking that of mitochondrial 
membranes.  
On the other hand, nanocarrier interaction with membranes leading to lipid domain 
segregation and formation of nonlamellar phases in model lipid bilayers and in cell 
membranes showed to be responsible for the ability of the karyophilic cell-
penetrating peptide S4(13)-PV to transpose the cell membrane and efficiently deliver 
nucleic acids into the cell. Additionally, structural modification of this peptide by the 
addition of a histidine tail provided the corresponding nucleic acid complexes with 
effective endosomolytic ability, improving plasmid DNA and siRNA delivery.  
Finally, change of the relative proportions of thermoresponsive and cationic blocks 
constituting co-polymers, which resulted in the modification of the delicate interplay 
between repulsive electrostatic forces and hydrophobic interactions, guided their 
ability to efficiently mediate gene silencing. The occurrence of a temperature-
dependent phase transition allowed for the polymers to condense the nucleic acids in 
solution and, upon heating, the collapse of the polymer structure expelled them from 
the aggregates, the complexes being thus dissociated.   
This work provides deep insights into the mechanisms through which the 
composition, the physicochemical properties, and the final architecture of a variety of 
nonviral delivery systems, whose structure is susceptible of systematic modulation, 
influence their efficiency in mediating transfection. Using different types of nucleic 
acid delivery systems, we were able to show the relevance of their structure to each 
step of transfection, from complexation of nucleic acids to their intracellular release. 
This work shows that the modulation of structural features of the molecules used for 
nucleic acid delivery allows a fine tuning of the overall ability of the vectors to 
overcome the barriers imposed by the cells, thus representing a step forward towards 
the rational design of new nucleic acid delivery systems. 
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Synopsis 
 
This work was motivated by the growing interest in unraveling the structural 
properties that endow a compound with the capacity to complex nucleic acids, to 
mediate their delivery into the cell and promote their activity. The ultimate goal of 
this research is to contribute to the rational design of new and efficient gene delivery 
systems obviating extensive in vitro and in vivo screening of new molecules, almost 
exclusively conducted by trial and error.  
The work developed in the present Thesis aims at contributing to consolidate 
knowledge in this field, evaluating three types of nucleic acid delivery systems – 
based on gemini surfactants, cell-penetrating peptides (CPPs) and thermoresponsive 
polymers –, in terms of their physico-chemical properties, interactions with 
membranes and ability to mediate intracellular gene delivery. In this regard, Chapter 
1 (Introduction) consists of a comprehensive approach of the gene therapy goals, 
strategies, and types of the most currently used nucleic acid delivery systems. From 
the variety of compounds with potential for application in nucleic acid delivery, 
special attention will be paid to gemini surfactants, cell-penetrating peptides and 
stimulus-responsive polymers. The reason for the selection of these categories of 
gene carriers stems from the fact that they are amenable to structural manipulation, 
thus having been used to develop the experimental work, thanks to a joint 
collaboration with researchers from national and foreign laboratories where the 
synthesis of these compounds was performed. In the Introduction chapter, emphasis 
will be given to the structural characteristics that, for each class of compounds, are 
more relevant for their ability to act as gene delivery systems, either by forming 
covalently linked conjugates with the nucleic acids or originating complexes through 
electrostatic interactions. Studies focusing on interactions of nucleic acid complexes 
with synthetic models or cellular membranes will also be referred to underline the 
importance of conformational changes of the nucleic acid delivery system and of the 
structural lipid rearrangements in membranes for the success of the delivery 
approach. From the virtually infinite number of possible structural variations in 
gemini surfactant, CPP and polymer molecules, those that showed to improve their 
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ability to mediate gene delivery, by promoting interactions with the cell surface and 
facilitating complex internalization or overcoming natural barriers imposed in one or 
more of the multiple steps involved in the intricate intracellular trafficking leading to 
gene expression or silencing, will be addressed. 
The hypothesis that was on the basis of the present work as well as the general aims 
of this Thesis, including the intermediate milestones that were pursued and that 
contributed to reach the ultimate goals, will be presented in Chapter 2. 
Chapter 3 will give an overview of the theoretical basis underlying each methodology 
used in the Chapters 4 to 9, which consist of the reproduction of scientific articles 
already published (Chapters 4, 7, 8 and 9) or under revision (Chapter 5 and 6) in 
peer-reviewed international scientific journals. The methodologies briefly described 
in the articles that originated Chapters 4 to 9 will be described in detail in Chapter 3 
in order to facilitate the replication of each experiment by other researchers.  
Chapters 4 to 6 approach the use of gemini surfactants as gene delivery systems 
targeting nuclear and mitochondrial gene expression.  
Chapter 4 addresses conventional bis-quaternary gemini surfactants from the 
alkanediyl-α,ω-bis(alkyldimethylammonium bromide) family, containing different 
spacer and hydrocarbon chain lengths, which were systematically studied regarding 
their ability to mediate gene delivery. The results are discussed in terms of the 
importance of an optimal tail and spacer length for efficient complexation and release 
of the cargo and of the relevance of complex-membrane interactions for their ability 
to enter the cells. The existence of a linker (spacer) between the two headgroups of 
gemini surfactants, maintaining them closer than the optimal distance defined by the 
entropic/enthalpic balance of surfactant molecules in solution, provides these 
systems with special aggregation properties, which were shown to contribute to their 
potential for gene delivery. 
Modifications of gemini surfactants with natural structural motifs, such as sugars, 
lipids or aminoacids, which are recognized by organisms as blocks for their intrinsic 
anabolic pathways rather than unfamiliar and potentially harmful elements that 
should be eliminated, have the capacity to reduce the toxicity of those compounds. In 
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this context, the ability of members from a serine-derived gemini surfactant family to 
mediate transfection will be addressed in Chapter 5. Amide and ester linkages, 
introduced between the surfactants’ headgroups and spacer, showed to produce 
gemini surfactants with biodegradability potential, contributing to decrease the 
toxicity of the delivery system, as well as to favor the release of cargo inside the cells, 
upon eventual digestion of the compounds by intracellular enzymes.  
Alternative targets for transfection are provided by other organelles containing the 
machinery to produce their own proteins. In animal cells, mitochondria are the only 
organelles to meet this requirement. Cell energy production became the 
quintessential role of mitochondria. Optimization of eukaryotic cell resource, by 
concentration of a great part of the energy producing enzymes in mitochondria, 
resulted in the generation of toxic oxygen reaction species at high concentration in 
these organelles. Therefore, and adding to this the fact that mitochondrial DNA is not 
protected by histone-condensation, oxidation of mitochondrial DNA is much more 
likely to occur than oxidation of nuclear DNA. The identification of a large number of 
point mutations in mitochondrial DNA related with several diseases, mostly affecting 
high energy-consuming organs, has driven the interest towards the development of 
transfection agents able to specifically target mitochondria. The recent design of a 
plasmid DNA construct that codes for GFP protein, which is specifically expressed by 
the mitochodrial machinery, propelled the study performed in the present work 
regarding the potential of gemini surfactants as mitochondria-targeting gene delivery 
systems. In this regard, in Chapter 6, members of both families of gemini surfactants 
previously used to deliver DNA into the nucleus were shown to be able to deliver 
mtpDNA into mitochondria. The extent of gemini surfactant-DNA complex 
interactions with model membranes of specific lipid compositions, mimicking those 
of different cellular structures faced by complexes along their intracellular trafficking 
towards mitochondria, showed a strict correlation with their ability to mediate 
efficient mitochondrial gene expression. 
Cell-penetrating peptides are the focus of Chapters 7 and 8. In Chapter 7, the 
S4(13)-PV cell-penetrating peptide and its derivative with scrambled sequence are 
compared in terms of their ability to interact with model and cell membranes. The 
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results are discussed regarding membrane lipid phase transitions induced by the 
presence of peptides, and their commitment in the molecular mechanisms underlying 
the success of peptide membrane translocation and, consequently, their capacity to 
be used as gene delivery systems. Chapter 8 regards the use of S4(13)-PV and its 
derivatives (scrambled, reverse NLS and a derivative containing an additional 
histidine tail) as DNA and siRNA delivery systems. The histidine tail was added to 
improve endosomal escape of the complexes internalized by endocytosis, taking 
advantage of the buffering ability provided by the imidazole groups in this aminoacid 
residue. Survivin, which is overexpressed in the majority of cancers and is 
responsible for switching off apoptosis, being hence involved in the survival and 
recurrence of several types of cancer, showed to be efficiently silenced by a siRNA 
complexed to histidine tail-containing S4(13)-PV peptide. The transfection efficiency 
of the different peptides is here compared and data are interpreted in terms of their 
structural peculiarities. 
Finally, Chapter 9 explores the use of thermoresponsive co-polymers, containing 
different ratios of a thermoresponsive block and of a cationic block, to mediate gene 
silencing. The silencing efficiency of the polymers is compared and differences are 
interpreted in terms of their ability to complex and release DNA, the success of the 
latter event being driven by the phase transition temperature (cloud point) of these 
polymers near the physiological temperature. 
General conclusions and future perspectives are presented in Chapter 10, 
summarizing the most important results obtained in the course of this work and 
providing an overview of new studies envisaged as potentially contributing to gain 
further insight into this interesting research field. 
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General Introduction 
 
1.1 GENE THERAPY 
Gene therapy emerged as a new therapeutic modality to treat genetic diseases, both 
inherited and acquired. The diseases that can be targeted with this type of therapy are 
characterized by anomalous expression of one gene (monogenic disorders), such as 
severe combined immunodeficiency (SCID), cystic fibrosis and hemophilia, or several 
genes (polygenic disorders), which include cancer and cardiovascular diseases, 
(Opalinska & Gewirtz 2002; Verma & Somia 1997). The basic concept of gene therapy 
consists of inserting genes into target cells in order to prevent, halt or reverse a 
pathological process (Verma & Weitzman 2005; Somia & Verma 2000; Mountain 2000; 
Glover et al. 2005). The most used gene therapy strategies consist of the replacement 
of a nonfunctional gene with its normal version, the introduction of a gene that is 
dysfunctional or absent as a consequence of a disease, or the addition of a therapeutic 
gene. The simultaneous deletion of a damaged gene and introduction of its functional 
form implicate the controlled recombination of DNA fragments. To overcome this 
difficulty, a plasmid DNA (pDNA) containing a functional or a therapeutic gene is 
usually introduced into the target cells, in order to correct a genetic deficiency. 
As opposed to the abovementioned approaches, gene knockdown, which takes 
advantage of the recently discovered RNA interference (RNAi) technology, uses RNA 
molecules, which can be siRNAs or miRNAs, to impair the translation of messenger 
RNA into proteins that are overexpressed as a consequence of a disease (Opalinska & 
Gewirtz 2002; Hannon 2002). These small non-coding RNA molecules exhibit 
regulatory functions, acting as a fine tuning of the mRNA available for protein 
synthesis. In this regard, siRNAs target specific mRNA sequences, to which they bind 
with specific complementarity, leading to their cleavage. On the other hand, miRNAs 
do not require perfect complementarity with their target sequence (Whitehead et al. 
2009). Depending on the degree of complementarity between the miRNA and the 
target mRNA, translation can be blocked (imperfect complementarity) or the mRNA 
strand can be degraded (perfect complementarity) (Hannon 2002; de Fougerolles et al. 
2007; He & Hannon 2004; Cullen 2004). The application of small non-coding RNAs in 
gene silencing takes advantage of the cellular machinery endogenously used for 
processing these molecules, namely the RNAse III enzyme Dicer and the RNA-induced 
silencing complex (RISC), leading to the inactivation of the target mRNA.  
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1.2 NUCLEIC ACID DELIVERY SYSTEMS 
The major drawback of gene therapy is the inability of nucleic acids to travel in 
biological fluids without being degraded and to enter the cells unaided. Investigation 
regarding nucleic acid delivery systems has been carried out for decades, aiming at 
providing a vector able to protect, to carry and deliver the nucleic acids into the cells, 
releasing them in or close to their target organelle. Several strategies were explored 
along the years, with the purpose of delivering nucleic acids into cells, both efficiently 
and safely. These strategies include viral and nonviral delivery approaches. 
Viral vectors, which are highly efficient, are based on viral particles whose gene 
responsible for the virulence is replaced with a therapeutic gene. The disadvantages of 
these systems regard safety. On the one hand, viral particles, such as adenovirus, have 
the ability to trigger immunological responses, which prevents repeated 
administration and limits the therapeutic efficacy of the treatment (Mountain 2000). In 
fact, adenoviruses used to treat partial ornithine transcarbamylase (OTC) deficiency 
patients, promoted a strong immune response, resulting in patient death (Lehrman 
1999; Somia & Verma 2000). On the other hand, some types of viruses used to prepare 
viral delivery systems, such as retrovirus, have the ability to insert their genetic cargo 
on the host’s genome. The use of retroviral vectors led to tragic results in clinical trials 
featuring the treatment of patients with X-linked SCID, who developed leukemia 
(Hacein-bey-abina & Schmidt 2003; Check 2005). Despite the tragic events, an 
important proof-of-concept of gene therapy emerged from the clinical trials addressing 
SCID, with the successful treatment of this disease (Fischer et al. 2002). 
Nonviral delivery of nucleic acids can be accomplished by physical and chemical 
methods. Physical methods to introduce nucleic acids into cells include bombarding 
the cells with metal particles covered with nucleic acids (gene gun) or inducing cell 
membrane permeability through electroporation. Both these approaches damage the 
cells and are, hence, highly cytotoxic (Li & Huang 2000; Mellott et al. 2013). To avoid 
the toxic effects of viral vectors and nonviral physical methods, a need for suitable 
alternatives propelled the study of chemical nonviral nucleic acid delivery systems. In 
this regard, several types of molecules have been explored over the years in the search 
of safe and efficient delivery systems.  
In contrast to viral vectors, chemical nucleic acid delivery systems lack the endogenous 
ability to “infect” the cells, a feature that viruses have developed along millions of years 
of co-evolution with their host cells. Several biological barriers stand in the way of 
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efficient gene delivery mediated by nonviral vectors. The immune system and 
extracellular nucleases constitute obstacles to the delivery of nucleic acids, before 
those reach the target cells. At cellular level, the cytoplasmic membrane, endosomal 
entrapment and lysosomal degradation are other barriers that must be overcome. 
Therefore, an efficient nucleic acid delivery system should be able to reach the target 
cells, preventing nucleic acid degradation by nucleases and circumventing the immune 
defense, to cross the plasma membrane, thereby mediating nucleic acid internalization, 
to escape the endolysosomal pathway, avoiding lysosomal degradation, and to allow 
dissociation of the nucleic acids from the carrier near the intracellular target (Figure 
1.1). Furthermore, pDNA delivery systems should be able to facilitate nucleic acid 
translocation to the nucleus or to mitochondria for gene expression to occur (Simões 
et al. 2005; Heitz et al. 2009). 
 
 
Figure 1.1 Physiological barriers to transfection. In order to efficiently accomplish its task, a successful 
nucleic acid delivery system should be stealthy to avoid immune reaction, reach the target tissue/organ 
while avoiding enzymatic degradation and diffuse through the extracellular matrix (A). Upon reaching 
the target cell, the delivery system should be internalized (B), either by endocytosis or through direct 
membrane translocation. Once inside the target cell, the delivery system should mediate endosomal 
escape to avoid lysosomal degradation (C). The nucleic acids should be released from the delivery 
system at or close to their intracellular target (D), either in the cytoplasm, in the case of siRNAs and 
miRNAs, or in the nucleus (E) or mitochondria (F), in the case of pDNA. 
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Chemical nucleic acid delivery systems should provide means to overcome the 
abovementioned obstacles so that nucleic acids can exhibit their therapeutic effect, 
either in the cytosol, in the nucleus or in mitochondria. In this regard, several classes of 
molecules have been studied that fulfill the requirements to efficiently carry and 
deliver nucleic acids into the target cells at or close to their action site. These classes of 
molecules include lipids, cell-penetrating peptides (CPPs), polymers and surfactants. 
The pioneer work of Felgner and coworkers (Felgner et al. 1987), who have 
synthesized a cationic lipid (DOTMA) that forms liposomes able to spontaneously 
interact with DNA and facilitate the delivery of functional DNA to CV-1 cells (green 
monkey kidney fibroblasts) and COS-7 cells (SV40-transformed CV-1 cells) in culture, 
paved the way to an extensive evaluation of other molecules to mediate nucleic acid 
delivery, such as those reported in the present work and described in detail in the next 
sections. 
In general, efficient nucleic acid delivery systems originate from cationic molecules, 
able to interact electrostatically with the negative charges of the nucleic acids, leading 
to their complexation, and with the cell surface, which is rich in negatively charged 
glycosaminoglycans (GAG) and proteoglycans (PG), favoring the internalization of the 
delivery system. In most cases, cell uptake occurs through endocytosis rather than by 
direct membrane translocation, although the latter pathway has also been observed. 
Furthermore, the nucleic acid delivery system should have structural properties that 
assure conformational changes facilitating cargo release under the environmental 
conditions offered by the intracellular milieu (e.g. regarding temperature and pH). 
Cancer therapy may take advantage of such delivery system structural alterations into 
the tumor microenvironment, which has been described as hyperthermic and acidic.  
Due to accumulated information on gene carriers resulting from biological and 
biophysical studies, the next sections will describe in detail the classes of nonviral gene 
delivery systems used in the present work, namely gemini surfactants, cell-penetrating 
peptides and thermoresponsive polymers. 
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1.2.1 GEMINI SURFACTANTS 
Dicationic detergents were first synthesized in 1971 when Bunton and coworkers 
attempted to produce molecules able to catalyze nucleophilic substitutions of 
hydroxide ions with chloro- and fluoro-2,4-dinitrobenzene and hydroxide and fluoride 
ions with p-nitrophenyl diphenyl phosphate (Bunton et al. 1971). These new 
detergents were found to be more catalytically active than monomeric detergents, 
which was explained taking into account the critical micelle concentration (the 
concentration of surfactant above which micelles spontaneously form, cmc), dicationic 
detergents presenting cmcs two orders of magnitude lower than that of the monomeric 
detergent (CTAB) with the same hydrocarbon chain length. Since catalytic activity 
depended on the proximity of the reaction molecules, favored by their incorporation in 
micelles, detergents that form micelles at the lowest concentrations were the most 
efficient catalysts (Bunton et al. 1971). These detergents, composed of two sets of a 
polar headgroup and a hydrocarbon chain, linked together by a spacer at or close to 
the polar groups, were overlooked for some time until they were rediscovered in 1991, 
when the name “gemini surfactants” was coined to describe these twin molecules 
(Menger & Littau 1991).  
The group of Menger summarized the relevant structural features that define a gemini 
surfactant: i) at least two hydrophobic chains (herein named tails) and two polar 
groups, which can be positively charged (ammonium), negatively charged (phosphate, 
sulphate or carboxylate) or nonionic (polyether or sugar) and ii) a spacer that can be 
short (2 methylene groups) or long (up to 12 methylene groups), rigid (stilbene) or 
flexible (aliphatic or aromatic). Later, the authors recognized that, although originally 
the name “gemini surfactant” described symmetrical molecules, other asymmetrical 
surfactants (e.g. n-s-m, instead of m-s-m, where n or m refers to the number of tails’ 
carbon atoms and s, the number of spacer’s carbon atoms) and surfactants containing 
three or more polar groups or tails had also been included in the “gemini” class 
(Menger & Keiper 2000). 
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1.2.1.1 Structural properties of gemini surfactants in aqueous solution 
The word “surfactant” originates from the contraction of “surface-active agent”, which 
is a molecule able to reduce the water surface tension. Gemini surfactants present 
surface activity three orders of magnitude higher than that of monomeric surfactants. 
At an air/water interface, gemini surfactants are able to adopt a number of 
conformations, which are not allowed to monomeric surfactants (Figure 1.2). In fact, 
gemini surfactants could assume a linear conformation (trans conformation), placing 
one hydrophobic tail into the air and forcing the other one into the water or laying flat 
on the surface, or they could adopt an “horseshoe” conformation (cis conformation) in 
which both chains point to the air, while in monomeric surfactants the polar 
headgroup interacts with the air/water interface, and the single hydrocarbon chain 
points to the air (Menger & Littau 1993). 
 
 
Figure 1.2 Possible orientations of gemini surfactants (A-C) and of a monomeric surfactant (D) at an 
air/water interface. Possible conformations adopted by gemini surfactants include: A) linear 
conformation perpendicular to the interface, B) “horseshoe” conformation (cis conformation) and C) 
linear conformation parallel to the interface. 
 
The different conformations adopted by the gemini surfactants depend on the affinity 
of each portion of the molecule to water and on the steric hindrance between the two 
alkyl tails of the gemini surfactant. The spacer and tails, being hydrophobic, will avoid 
the water, while the headgroups will favor contact with the water. Trans conformation 
is unfavorable due to the large hydrophobic portion of surfactant in contact with 
water. However, for surfactants containing short spacers (s≤4), the cis conformation 
represents an overlap of the two tails. Therefore, the two alkyl tails of a dimeric 
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surfactant in aqueous solution are expected to adopt trans conformation for molecules 
containing short spacers and cis conformation as the spacer length increases 
(Grosmaire et al. 2002).  
Gemini-induced reduction of water surface tension is more than twice that induced by 
single chain-surfactants and, hence, cannot be attributed solely to the presence of two 
sets of hydrophilic headgroup plus hydrophobic tail. This effect depends on the 
distance at which the headgroups are kept, due to the spacer length and rigidity. Thus, 
the 12–2–12 gemini surfactant was found to pack much more tightly at the air/water 
interface than 12–3–12 and 12–4–12 gemini surfactants due to increased chain–chain 
interactions, which disfavor the desorption of molecules from the surface to the bulk 
solution (Groth et al. 2004). 
With the increase of the surfactant concentration, the air/water interface cannot 
accommodate all the surfactant molecules, which start to accumulate in solution. The 
micellization process occurs in order to minimize the free energy of a water/surfactant 
system and consists of the formation of supramolecular structures, which decrease the 
contact between the hydrophobic hydrocarbon chains of the surfactant and water 
molecules. In these structures, the hydrophilic headgroups are in contact with the 
water and are kept away from each other due to electrostatic repulsions. 
The existence of a spacer with different lengths linking the two headgroups of the 
surfactant molecule results in an unusual behavior in aqueous solution. Thus, the cmc 
of gemini surfactants reflects a compromise regarding the conformation of the spacer, 
which depends both on its length and flexibility, and on the degree of repulsion 
between the two similarly charged headgroups. As Table 1.1 illustrates, for 12-s-12 
and 16-s-16 gemini surfactants with increasing spacer length, the cmc reaches a 
maximum for those containing a spacer of 4 and 6 carbon atoms, respectively, and 
decreases for those displaying longer spacers. 
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Table 1.1 Cmc of gemini surfactants of the alkanediyl-α,ω-bis(dimethylalkylammonium bromide) family 
measured at 25 °C (mM)*. 
 
m-s-m 8-s-8a 10-s-10 12-s-12c 14-s-14 16-s-16g 18:1-s-18:1i 
m-2-m   0.84 0.137d 0.021 0.0269 
m-3-m 57.0 6.10b 0.87 0.091e 0.026 0.0234 
m-4-m   1.17  0.027  
m-5-m   1.09 0.15f 0.038j  
m-6-m 73.0  1.03  0.043 0.018 
m-8-m   0.83  0.033  
m-10-m   0.63    
m-12-m   0.37h    
m-16-m   0.12h    
* Values of cmc were gathered from: a (Frindi & Michels 1994), b (Wettig & Verrall 2001), c (Grosmaire et 
al. 2002), d (Manet et al. 2010), cmc was determined at 30 °C, e (Uhríková et al. 2005), f (Kabir-ud-Din et 
al. 2010), g (Zana et al. 1991), h (Khan et al. 2010) and i (Li et al. 2005). 
 
A favorable effect of the increase of the hydrophobic spacer length on the micellization 
process, which is driven both by enthalpic and entropic forces, would be expected. 
However, similarly to the behavior at the air/water interface, spacers shorter than the 
equilibrium distance between the charged headgroups (s≤4-6) will force these two 
groups to be closer than they would be if they belonged to individual molecules. 
Therefore, these spacers are maintained fully extended to minimize the repulsion 
between the headgroups, establishing an unfavorable contact with the water. In this 
regard, it was proposed that the increase of the cmc with the increase of the spacer 
length up to 4-6 carbon atoms reflects a balance between the hydrophobic effect, 
which increases with the increase of the hydrophobic spacer length, and the repulsive 
electrostatic forces between the cationic headgroups, which compel the spacer to be 
maximally stretched up to an equilibrium distance, therefore constraining the spacer 
to be extensively in contact with the surrounding aqueous medium (Menger & Keiper 
2000; Weihs et al. 2005; Perez et al. 2007). 
On the other hand, spacers longer than the equilibrium distance will not be fully 
extended and will minimize their contact with the water (Karaborni et al. 1994). If the 
spacer is long and flexible enough, this can occur through coiling of the spacer into the 
hydrophobic region of the structure (Almeida et al. 2011; Zana et al. 1991). The 
increase of the length of the hydrocarbon spacer, above that corresponding to 4-6 
methylenes, contributes to the overall hydrophobicity of the gemini surfactant, 
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reducing progressively the monomer solubility and, consequently, promoting self-
assembly at concentrations progressively lower (Menger & Keiper 2000). 
Gemini surfactants derived from aminoacids also present values of cmc one or two 
orders of magnitude lower than those of the corresponding single chain analogues, as 
exemplified by those based on arginine and serine (Table 1.2) (Weihs et al. 2005; 
Perez et al. 2007; Silva et al. 2012; Silva et al. 2013). Although there is no available data 
for these surfactants to define the spacer length that corresponds to the equilibrium 
distance between the headgroups, it is remarkable that the increase of the spacer from 
2 to 5 methylene groups in (12Ser)2CONm gemini surfactants also promotes an 
unexpected increase in cmc values, which can be explained by the phenomenon 
referred above for the classical gemini surfactants. 
 
Table 1.2 Critical aggregation concentration (cac)* of serine- and arginine-derived gemini surfactants 
measured at 25 °C (mM)*. 
   m=2 m=3 m=5 m=6 m=9 m=10 m=12 
Serine-based 
monomeric 
14Ser 1.16a        
12Ser 1.87a        
Serine-based 
dimeric 
(16Ser)2N5    0.015c     
(14Ser)2N5    0.042c     
(12Ser)2Nm    0.32c   0.067c 0.082c 
(12Ser)2CONm  0.27b  0.40b     
(12Ser)2COOm  0.37b  0.26b     
Arginine-based 
monomeric 
LAM# 6.0d        
CAM# 16.0d        
Arginine-based 
dimeric 
Cm(LA)2#   0.56d  0.40d 0.18d   
Cm(CA)2#   2.0d  1.6d 1.1d   
*Critical aggregation concentration (cac) is used herein instead of critical micellar concentration (cmc) 
due to the broader meaning of cac, which includes other types of supramolecular arrangements, such as 
vesicles, besides micelles. 
#nSer,Nα-alkyl-L-serine, (nSer)2Nm, Nα,Nα-bis(Nα-alkylserine)α,ω-alkylendiamines, (12Ser)2CONm, 
Nα,Nα-bis(Nα-dodecylserine)α,ω-alkylendiamides, (12Ser)2COOm Nα,Nα-bis(Nα-dodecylserine)α,ω-
alkylendiesteres,LAM, Nα-lauroyl-L-arginine methyl ester, CAM, Nα-caproyl-L-arginine methyl 
ester,Cm(LA)2, Nα,Nα-bis(Nα-lauroylarginine) α,ω-alkylendiamides, Cm(CA)2, Nα,Nα-bis(Nα-
caproylarginine) α,ω-alkylendiamides. 
a from (Silva et al. 2009), b from Silva et al. 2013, c from Silva et al. 2012, dfrom (Perez et al. 2002). 
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On the other hand, the increase in the length of the tails up to 16 carbon atoms 
produces an effect on cmc similar to that observed for monomeric surfactants, i.e. the 
increase of the alkyl chain length results in a decrease of the cmc (Zana et al. 1991; 
Silva et al. 2012; Perez et al. 2002) 
The type of supramolecular aggregates (micelles, bilayers and inverted hexagonal 
phases) formed by surfactants can be inferred, similarly to those formed by other 
amphiphiles, from the molecular geometry of the molecules, which in the case of 
gemini surfactants depends on the conformation adopted and, hence, on the spacer 
length, as previously mentioned.  
According to the most popular model to explain amphiphile mesomorphism, a critical 
packing parameter (P) can be defined, which depends on the shape of amphiphilic 
molecules and allows to predict the mesomorphic phase preferentially adopted by 
those molecules when dispersed in water. That parameter takes into account the 
volume of the hydrophobic chains (vc), the cross sectional area of the headgroups (a) 
and the length of the hydrophobic chains (lc), and is given by the equation: 
𝑃 =
𝑣𝑐
𝑎 × 𝑙𝑐
 
Thus, amphiphiles which maintain a uniform cross-sectional area along their length 
(cylindrical shape) tend to form planar mesomorphs, such as bilayers; molecules with 
larger headgroup than tail areas (conical shape) tend to form micelles or cylindrical 
micelles, arranged in hexagonal structures, with the hydrophilic headgroups facing the 
aqueous environment and the hydrophobic tails concealed inside the supramolecular 
structure, away from the water (HI structures), and those which have smaller 
headgroup than tail areas (inverted conical shape) form inverted hexagonal structures 
(HII phases) (Figure 1.3).  
The approach to understanding the nonlamellar behavior of amphiphiles based on 
their molecular shape is simple and allows to predicting the “preferred” aggregates 
formed by amphiphilic molecules, when dispersed in an aqueous medium. However, 
this model does not adequately consider the contribution of headgroup and/or chain 
repulsion for the interaction free energy, nor the flexibility of the amphiphilic 
molecules, which can provide them with more than one molecular shape. For instance, 
pH changes may influence the net charge of polar groups and, consequently, the cross-
sectional area per headgroup, which leads to alteration of the geometric shape of the 
molecules as a whole. 
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Figure 1.3 Molecular shape of amphiphiles (inverted cone, cylinder, cone) (left) and supramolecular 
structures adopted (right) according to the critical packing parameter (P), calculated as the ratio 
between the volume of the hydrophobic chains (vc) and the product of the cross sectional area of the 
headgroups (a) multiplied by the length of the hydrophobic chains (lc) (modified from Balazs & Godbey 
2011). 
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An alternative model was proposed in which the propensity to form nonlamellar 
structures is evaluated in terms of a balance between opposing tendencies towards the 
minimization of the monolayer curvature free energy and the free energy associated 
with hydrocarbon chain packing. In this regard, the predisposition to form nonlamellar 
structures depends on the intrinsic radius of curvature, R0, which derives from the 
asymmetric nature of the amphiphile molecules and endows the supramolecular 
structures to curl when relaxed. This curling, which is a consequence of the side-by-
side packing of molecules whose cross sectional area varies systematically along the 
length of the molecules, defines the spontaneous curvature (C0=1/R0) of an amphiphile 
layer and its mesomorphic tendency. This model accommodates the essentials of the 
“shape” concept, since amphiphiles whose shape is defined by an uniform cross section 
along their length (cylindrical shape) have zero spontaneous curvature and form 
stable bilayers, whereas amphiphiles with inverted conic shape form layers with a 
positive intrinsic curvature, originating stable micelles or HI phases, and those with 
conic shape generate layers with a negative intrinsic curvature, predisposing to the 
formation of HII phases (Gunter 2004; Lewis & Mannock, David & McElhaney 1997). 
As previously referred, depending on the length, the spacer of gemini surfactants 
imposes different conformations to molecules, which are characterized by different 
values of the critical packing parameter, this being reflected in the generation of 
micelles with different morphologies. In fact, surfactants with short spacers (s=2, 3 or 
4) have been shown to originate elongated micelles, which “grow” in a single 
dimension with the increase of the surfactant concentration. This effect is more 
pronounced for surfactants with the shortest spacer, probably due to the increased 
geometrical constraints in the formation of aggregates (Groth et al. 2004). 
In the context of the mesomorphism, gemini surfactants have been shown to present a 
phase behavior similar to that of their corresponding monomeric surfactants. 
However, the potential for gemini structure modulation is enormous and the length 
and chemical nature of the spacer can be modified in order to modulate their 
thermotropic and lyotropic behaviors (In & Zana 2007).  
The study of the concentration dependence of the mesomorphic behavior (lyotropism) 
of gemini surfactants showed a complex sequence of phases adopted by the 
surfactants in solution, including spherical micelles, worm-like micelles, ribbons, 
multi-bilayers, multi-bilayer ribbons, lamellar and inverted hexagonal phases (Oda et 
al. 1999; Alami et al. 1993). This sequence may not always be followed and coexistence 
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of several phases is common. The average length of the “worms” is defined by two 
opposing forces: the electrostatic repulsions between the polar headgroups, which 
favors scission of the worms, and the “end-cap energy” that favors micelle growth by 
minimizing the number of high energy termini. Thus, it was observed that, at high 
concentrations of 12-2-12 gemini surfactants, the “end-cap energy” becomes dominant 
over the electrostatic repulsion and long worm-like micelles are formed (Menger & 
Keiper 2000). Micelle shape has shown to depend on the length and hydrophilicity of 
the spacers. Hence, short hydrophobic spacers originate nonspherical micelles 
(“threads”) and long hydrophobic spacers lead to rod-like micelles, while hydrophilic 
spacers originate (more or less) spherical micelles. Figure 1.4 illustrates the phases 
adopted by n-2-m surfactants in an aqueous medium and denotes the occurrence of 
phase transitions induced by temperature increase. For example, the symmetrical 
surfactants 14-2-14, 16-2-16, 18-2-18 show a temperature-induced transition from 
tubular lamellar phases to isotropic entangled worm-like micelles (Oda et al. 1997). 
Not only the spacer length but also the type of linkage between the headgroups and the 
spacer contribute to the type of supramolecular aggregates formed by gemini 
surfactants. Serine-derived gemini surfactants containing short spacers linked to the 
heagroups through an amide or ester bond were shown to aggregate into micelles, 
whereas those containing a long spacer (12 carbon atoms-long) formed giant vesicles 
even at low concentration. However, the amine derivative with 12 carbon atoms-long 
spacer also formed micelles. This is justified by the fact that the positive charges of the 
headgroups of surfactants from the amide and ester series, in contrast to those of 
surfactants of the amine series, are actually at a distance greater than that 
corresponding to the spacer length (12 carbon atoms-long alkyl chain), since the chiral 
carbon atom and the α-carboxylate group of each headgroup also contribute to this 
distance. This translates into a critical packing parameter of the amide and ester 
derivatives close to 1, favoring the formation of bilayers, while that of the amine 
derivative is about 0.3-0.5, favoring micelle formation. 
In contrast to gemini surfactants, monomeric surfactants present fewer types of 
phases with no tendency to form elongated or stacked structures (Oda et al. 1999). 
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Figure 1.4 Phases observed in aqueous solutions of n-2-m surfactants as a function of n and m, at 
concentrations between 0.1 and 10% w/w (ca. 1.6–160 mM). Transition temperatures are indicated 
whenever a phase transition was observed upon heating (modified from Oda et al. 1997). 
 
1.2.1.2 Structural modulation of gemini surfactants featuring their biological/ 
pharmacological application 
In theory, any two surfactants can be linked by a spacer group. Since the early studies 
reporting the higher surface activity and lower cmc of gemini surfactants as compared 
to their monomeric counterparts, and their particular micelization behavior 
(formation of elongated, entangled micelles, rather than spherical micelles), allied to 
low toxicity (in general lower than that of monomeric surfactants with similar 
headgroups and hydrocarbon chains), several families of gemini surfactants were 
developed, aiming at their application in environmental, industrial and 
pharmacological fields. In fact, gemini surfactants revealed the capacity to act as 
emulsifiers, antifoaming agents, detergents, dispersants, wetting agents and thickeners 
(reviewed in Menger & Keiper 2000). Furthermore, some gemini surfactants, 
especially those containing short spacers (Hoque et al. 2012), have been shown to 
exhibit high antimicrobial efficiency, namely against pathogenic bacteria (Pérez et al. 
1996). 
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The interest in gemini surfactants regarding their therapeutic use is related with the 
lower concentration of these surfactants that is expected to be needed to reach the cmc 
as compared to that of their monomeric counterparts. For example, in a gene delivery 
system, the gemini surfactant capacity to form supramolecular aggregates at low 
concentrations has a positive impact on cytotoxicity, the gemini surfactant-containing 
systems being less toxic than those containing the corresponding monomeric 
surfactants at higher concentrations (Karlsson et al. 2002). 
Gemini surfactants were shown to be versatile vectors for nonviral gene delivery 
(Yang et al. 2010). This stems from the fact that there are many possibilities, through 
chemical modification of the alkyl tails and the spacer group of these compounds, to 
modulate their physicochemical behavior towards the enhancement of the efficiency of 
gene transfer. For example, modification of the length, degree of unsaturation and 
substitution of different functional groups in the spacer and alkyl chains can provide 
opportunities to tailor their chemical structure for specific needs (Zana et al. 1991; 
Zana & Lévy 1997). On the other hand, the variety of supramolecular structures 
adopted by gemini surfactants, depending on their concentration, which can also 
change upon meeting different environments in the cell (e.g. provided by membrane 
structures, pH and redox conditions), endows each gemini surfactant molecule with 
high structural versatility.   
Gemini surfactants derived from sugars (van Doren et al. 2000; Menger & Mbadugha 
2001; Bell et al. 2003; Johnsson et al. 2003; Wasungu et al. 2006a; Wasungu et al. 
2006b; Klijn et al. 2006; Klijn et al. 2007; Liu et al. 2013), oligocations, such as ornitine 
and spermine (Dauty et al. 2001; Ronsin et al. 2001), lipids, such as cholesterol (Bajaj 
et al. 2007; Bajaj et al. 2008a; Kim et al. 2011; Misra et al. 2013) and cardiolipin 
(Bhattacharya & De 1999; Bajaj et al. 2008b), and aminoacids (McGregor et al. 2001; 
Brito et al. 2006; Fan et al. 2008; Yang et al. 2010; Luckzynski et al. 2012; Singh et al. 
2012; Silva et al. 2012; Silva et al. 2013; Pérez et al. 2014) have been synthesized, 
characterized in terms of their mesomorphic behavior in solution and evaluated in 
terms of transfection efficiency. Carbohydrate- and aminoacid-based gemini 
surfactants represent classes of surfactants with superior properties of 
biocompatibility and biodegradability, due to their similarity with natural amphiphilic 
molecules. 
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The structure, synthesis, physicochemical characteristics (surface adsorption, 
aggregation and phase behavior) and biological properties (toxicity, antimicrobial 
activity and biodegradation) of aminoacid-derived gemini surfactants, as well as their 
potential applications, such as drug and gene delivery, have been recently reviewed by 
Perez 2014, and a summary of the most important properties and applications are 
presented in Table 1.3. 
The structural characteristics of gemini surfactants and their supramolecular 
assemblies, as related to the several steps of the transfection process, will be 
addressed in the next sections. 
 
Table 1.3 Physicochemical and biological properties of aminoacid-derived gemini surfactants and their 
potential applications. 
 
Aminoacid 
Physicochemical 
Properties 
Biological 
Properties 
Potential 
Applications 
References 
Alanine 
The alanine residue was 
introduced in the alkyl chains, 
rather than as the headgroup. 
Anti-adhesive Antifungal agent 
(Luckzynski 
et al. 2012) 
Aginine 
Thermotrpic phase transition 
from elongated micelles  to 
hexagonal liquid crystal phase 
(surfactants containing s=3 or 
6) or to lamellar phase 
(surfactant containing s=9) 
Cytotoxic for gram negative 
and gram positive bacteria; 
hemolytic capacity increasing 
with the spacer and the alkyl 
chain lengths. 
Antimicrobial 
agent 
(Pérez et al. 
1996) 
Cystein 
(Cystine) 
Tightly packed at the 
air/water interface and in 
supramolecular aggregates 
- 
Encapsulation 
and release of 
hydrophilic 
drugs 
(Fan et al. 
2008) 
Lysine 
Two units of a di- or tri-
peptide, linked through their 
α or ε group to an alkyl chain, 
forming both the headgroups 
and the spacer. 
Long (C18) alkyl chains and 
Lys residues linked through 
their ε group originate 
surfactants that efficiently 
mediate transfection in mouse 
muscle cells; 
The presence of the aminoacid 
residues improved DNA 
delivery and release 
Transfection 
agent; 
scleroderma, 
atopic dermatitis 
and wound 
healing 
(McGregor 
et al. 2001; 
Singh et al. 
2012) 
 
Serine 
Formation of elongated 
micelles (s=2 or 5) or vesicles 
(s=12) in aqueous solution 
above their respective cac. 
Non-toxic for eukaryotic cells 
(low cytotoxicity for HeLa 
cells) 
Transfection 
agent* 
(Silva et al. 
2012 and 
2013) 
*This aspect is explored in the present work (Chapters 5 and 6). 
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Cytotoxicity 
As mentioned above, the concentration of gemini surfactants needed for a given 
application, such as gene delivery, is significantly lower than that of their monomeric 
counterparts required for the same purpose. This has an obvious impact on 
cytotoxicity. In addition, at the same concentration, gemini surfactants have been 
found to be generally less cytotoxic than their monomeric counterparts. In this regard, 
lipid-, aminoacid- and sugar-based gemini surfactants were found to be more 
biocompatible and more biodegradable than monomeric surfactants or conventional 
gemini surfactants (Pérez et al. 2014; Wasungu et al. 2006b; Perez et al. 2002; Kim et 
al. 2011; Misra et al. 2013). This is mainly due to the existence of linkages in the 
molecules of these surfactants, which can be cleaved inside the cells, resulting in 
moieties (lipids, aminoacids or sugars) that are easily metabolized. 
However, gemini surfactants incorporated in membranes may disturb their structure 
and dynamics, causing adverse effects to the cells. The reported influence of alkyl chain 
length of serine-derived gemini surfactants on cell viability is a clear demonstration of 
the impact of surfactant membrane insertion on cytotoxicity (Silva et al. 2013). Thus, 
the increasing hydrophobicity of surfactants containing progressively longer 
hydrocarbon chains (n=12, 14, and 16 carbon atoms), which should be accompanied 
by increasing propensity to incorporate into lipid bilayers of cell membranes, and, 
eventually, increasing disturbance of membrane-mediated physiological processes, 
should be on the basis of the resulting progressively higher toxicity. However, the 
surfactant with 18 carbon atoms-long chains induced less cytotoxicity than that with 
16 carbon atoms-long chains, probably indicating that this chain length resembles that 
of the fatty acyl chains of membrane lipids, and therefore is less disturbing to the 
physical properties of the membrane. Serine-derived surfactants containing alkyl 
chains with the same length (n=12) and amine, amide or ester linkages to the spacer 
also showed differences in cytotoxicity, the ester and amide derivatives revealing 
higher cytotoxicity than the amine derivative. Furthermore, the latter presented a 
dose/response curve with a steep slope, indicating a potent single effect presumably 
involving interference with a vital metabolic function. On the contrary, the shape of the 
sigmoidal dose/response curves of the amide and ester derivatives was interpreted in 
terms of a low specificity of the toxic effects, probably involving a large spectrum of 
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variables. Chemical susceptibility of surfactants from the amide and ester families to 
pH or enzymatic degradation may explain their high cytotoxicity, since the cells would 
be exposed to monomeric serine-derived surfactants in a concentration twice that of 
the gemini surfactant (Silva et al. 2013).  
 
DNA complexation 
The interactions between cationic surfactants and polyions with opposite charges, 
such as DNA, leading to the formation of polymer–surfactant aggregates, have been 
analyzed as a basis for the design of transfection agents or gene delivery systems. The 
polyelectrolyte chain binds to surfactant molecules through electrostatic attractive 
interactions, and the hydrophobic moieties of the surfactant molecules stabilize the 
aggregates due to the hydrophobic effect in aqueous solution (Uhríková et al. 2005). 
This concept is particularly relevant to drive the search of gemini surfactant-based 
systems for gene delivery. In fact, the strength of the interactions established between 
gemini surfactants and DNA may determine the ability of the delivery system to 
condense and release DNA into the cell. 
The structural arrangement displayed by complexes composed of gemini surfactants 
and DNA depends on the supramolecular aggregates gemini surfactants form on their 
own, when dispersed in water in the absence of DNA. Based on experiments of atomic 
force microscopy (AFM), Wang and coworkers (Wang et al. 2007) suggested that the 
addition of DNA to surfactants in the form of micelles originated compacted globular 
complexes, with strings of DNA connecting several globules, similarly to the “spaghetti 
and meatballs” model proposed for cationic liposome-DNA complexes (Sternberg et al. 
1994). On the other hand, when gemini surfactants aggregated to form vesicles, DNA 
molecules distributed around the vesicles, which then rearranged themselves to form 
an inverted hexagonal lattice containing DNA. The higher transfection efficiency 
mediated by surfactants that form vesicles as compared to those forming micelles was 
assigned to the ability of the former to generate HII structures upon DNA complexation 
(Wang et al. 2007).  
The structure of the complexes also showed to depend on the cationic gemini 
surfactant/DNA charge ratio. In this regard, the titration of gemini surfactants with 
DNA showed that, at low DNA/surfactant charge ratio (0.2), the micelle-forming 
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18:1-6-18:1 gemini surfactant gave rise to toroidal isolated complexes, which were 
converted to cylindrical structures upon further addition of DNA (DNA/surfactant of 
0.3-0.4), the DNA in excess acting as a bridge between the isolated complexes. In the 
case of a surfactant with shorter spacer, 18:1-2-18:1 surfactant, vesicles surrounded 
by DNA were formed at low (-/+) charge ratio (0.05), and larger “fiber-like” aggregates 
occurred at high (-/+) charge ratios (0.3-0.4), possibly reflecting a conversion to an 
inverted hexagonal phase (Wang et al. 2007). 
The compaction of DNA by cationic gemini surfactants might involve an initial 
interaction of a small cluster of surfactant molecules with DNA and the combined effect 
of electrostatic and hydrophobic interactions should promote the contribution of more 
surfactant molecules, thus enhancing the compaction. This process results in an 
enthalpy gain, similarly to self-association, thus being favored by a low cmc (Kirby et 
al. 2003). The low cmc values presented by these surfactants was proposed to increase 
the stability of the surfactant/DNA complexes, due to micelle aggregation that would 
keep the complexes together during the delivery process, and therefore improve their 
transfection ability (Badea et al. 2005). The same forces driving the surfactant 
micellization process are also responsible for their aggregation with the negatively 
charged nucleic acids. Therefore, it is not surprising that a low cmc favors the 
supramolecular assemblies involving both these types of molecules. 
The most efficient DNA compaction was found for gemini surfactants with short 
spacers (s=2, 3) (Karlsson et al. 2002). Micelles of these surfactants were shown to 
disassemble in the presence of DNA, which interacts with gemini surfactant 
monomers, creating disperse micelle-like aggregates of surfactant and DNA (Jiang et al. 
2004). In this context, a molecular compaction model was suggested for DNA 
condensation promoted by an imidazolium-based gemini surfactant (Zhou et al. 2013). 
The progressive increase of the surfactant/DNA (+/-) charge ratio would result in the 
conversion of twisted, collapsed DNA molecules into stacked toroidal nanoparticles 
and, subsequently, into spherical nanoparticles with smaller sizes (Figure 1.5) (Zhou 
et al. 2013).  
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Figure 1.5 Schematic representation of the DNA condensation process with the addition of increasing 
amounts of imidazolium-derived gemini surfactant [12-4-12im]Br2, from the free DNA with loose 
conformation (A), to condensed DNA with toroidal structure (B), and then to condensed DNA with 
spheroidal structure (C) (modified from Zhou et al. 2013) 
 
Apparently, the ability to mediate gene delivery varies inversely with the spacer 
length, which correlates with the area occupied by the surfactant headgroup. A short 
spacer maintains the cationic headgroups at a distance closer to that corresponding to 
the distance between the phosphate groups of DNA, therefore enhancing the 
complexation. A distance of 4.9 Å, corresponding to three methylene groups, between 
gemini surfactant ammonium headgroups showed to be optimal for the interaction 
with the DNA phosphate groups (Wettig et al. 2007). 
Additionally, the length of the alkyl chains and the type of connection between the 
elements of the gemini surfactants have been shown to influence their ability to 
complex DNA and, consequently, their transfection efficiency. In this regard, studies 
performed with gemini surfactants containing two lysines as headgroups, linked 
together through a disulfide bond, and connected, either through the α-amine group or 
through the ε-side chain, to alkyl chains of different length, showed that transfection 
efficiency improved with the increase in length of the surfactant hydrocarbon chains 
(the maximum complexation and transfection efficiency being achieved with the 
gemini surfactants containing oleoyl chains), and depended on lysine residue 
connection. Thus, gemini surfactants in which the lysine residues were linked through 
their ε-side chains promote higher transfection efficiency than those in which lysine 
residues were linked through their α-amine group (McGregor et al. 2001). 
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Cellular internalization 
Cells internalize DNA complexes from their surroundings using a variety of 
mechanisms, including direct membrane translocation, which, while being 
independent of energy and of the presence of specific proteins, depends on the ability 
of the components of the delivery system to interact and destabilize membranes with 
specific composition.   
In this regard, DSC and fluorescence polarization studies showed that surfactants with 
short alkyl chains induce a decrease of the overall order of a DPPC lipid bilayer, 
whereas surfactants with long alkyl chains (C16 and C18) promote an increase of lipid 
packing and induce the formation of new and more ordered structures, as assessed by 
the appearance of a new endothermic peak at temperatures above that corresponding 
to the gel to fluid phase transition of DPPC (Almeida et al. 2010). An increase in the 
spacer length was found to decrease the membrane lipid packing, especially in the 
region closer to the hydrophobic/hydrophilic interface, as assessed by the 
fluorescence probes 2-AS, 6-AS, 12-As and 16-AP, which report the gradient of lipid 
order across the bilayer. The presence of a long hydrophobic spacer is expected to 
interact and disturb the arrangement of a large number of DPPC molecules per 
surfactant molecule, therefore contributing to a disordering effect of the membrane at 
the interfacial region. The insertion of surfactant molecules with very long spacers 
(C10) in the lipid bilayer minimizes this effect since the two tails of this surfactant are 
likely to be inserted away from each other, thus allowing lipid positioning between the 
tails of the surfactant molecule, which helps to conceal the long hydrophobic spacer 
from the water, representing a stable arrangement of the surfactant molecules 
(Almeida et al. 2010; Almeida et al. 2011). 
As an alternative to direct membrane translocation, there is a variety of energy- and 
protein-dependent endocytic pathways (schematized in Figure 1.6) that may ensure 
the internalization of gene delivery systems. These pathways lead to different 
intracellular trafficking routes, which include the endolysosomal route in the case of 
clathrin-mediated endocytosis, and, in some circumstances, may avoid this 
degradative pathway, such as in the case of caveolae- or raft-mediated endocytosis. In 
order to achieve efficient gene delivery, complexes internalized by endocytosis have to 
mediate DNA escape from the endolysosomal pathway and release their cargo in the 
proximities of their intracellular target to avoid nuclease degradation. 
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Figure 1.6 Intracellular trafficking following macropinocytosis, clathrin-mediated endocytosis and 
caveolae-mediated endocytosis. A) Macropinocytosis leads to the formation of a macropinosome, which 
is thought to eventually fuse with lysosomes or recycle its content to the cell surface. B) Clathrin-
mediated endocytosis leads to the formation of an early endosome, which is acidified and fuses with 
pre-lysosomal vesicles containing enzymes (in red) to give rise to a late endosome and finally a 
lysosome, where the acidic and hydrolytic enzyme-rich environment leads to nanocarrier and drug 
degradation. C) Caveolae-mediated endocytosis of a nanocarrier gives rise to a caveolar vesicle, being 
delivered to caveosomes, which offer a neutral environment, devoid of the acid hydrolases existing in 
lysosomes, to the endocytosed material (reproduced with permission from Hillaireau & Couvreur, 
2009). 
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Endosomal escape 
An important feature that has been explored in several types of molecules used in gene 
delivery is their ability to undergo conformational changes upon interaction with the 
endosomal membrane, in order to promote cytoplasmic release of the carried nucleic 
acids. In this regard, lipids, surfactants, peptides and polymers with sensitivity to 
temperature, pH or redox environment have been employed in formulations of gene 
delivery systems. 
DNA complexes of the gemini surfactant 1,9-bis(dodecyl)-1,1,9,9-tetramethyl-5-imino-
1,9-nonanediammonium dibromide (12-7NH-12) and of its derivative with a glycyl-
lysine dipeptide substituted spacer, both prepared with DOPE, constitute a good 
example to underline the relevance of endosomal escape aiming at efficient 
transfection. These complexes were shown to be internalized by clathrin-mediated 
endocytosis. However, the complexes containing the unsubstituted surfactant 
underwent lysosomal degradation, whereas those containing the aminoacid 
substitution were able to escape from the endolysosomal route due to their high 
buffering capacity, inducing an ATPase-driven proton accumulation in endosomes to 
retain their acidic pH, followed by passive chloride ion influx. The consequent high 
ionic concentration caused inflow of fluid and, thus, osmotic stress (“proton sponge” 
effect). On the other hand, the complexes increased in size in response to medium 
acidification, due to unfolding (relaxation) of the surfactant. These two factors 
contributed to disrupt the endosome and to loosen the interaction between the DNA 
and the surfactant, promoting DNA release to the cytosol (Singh et al. 2012). 
The dependence of DNA complex supramolecular arrangements on pH has been 
studied with a formulation based on a sugar-containing gemini surfactant, in which the 
headgroups consist of pentoses. In vitro assays showed that a gradual acidification of 
the medium to simulate the endosomal lumen led to the appearance of different 
mesomorphic phases adopted by the complexes, namely lamellar phase, condensed 
lamellar phase and inverted hexagonal phase (HII), as assessed by SAXS and cryo-TEM. 
As a result of this morphological change, it was proposed that the complexes would be 
able to fuse with the endosomal membrane, causing destabilization of this intracellular 
structure and favoring the release of DNA into the cytoplasm (Bell et al. 2003). 
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DNA complex sensitivity to the redox environment was assayed in gemini surfactants 
with decamino and lauramino chains, which exhibited disulfide bonds to bridge two 
monomeric subunits derived from cysteine, forming cystine-derived gemini 
surfactants (Fan et al. 2008). Studies of dynamic light scattering and TEM showed that 
these surfactants aggregated into small vesicles and micelles. However, upon 
reduction of the disulfide bonds, no supramolecular structures were detected, due to 
the higher cmc of the monomeric components as compared to the gemini surfactants. 
The supramolecular aggregates reappeared after the oxidation of thiol groups have 
restored the disulfide bond, indicating a reversible disassembly and rebuilding of 
aggregates. This behavior suggested the possibility of using these surfactants to 
encapsulate biologically active molecules. The water soluble dye riboflavin showed to 
be encapsulated only in oxidative conditions, that is, when a disulfide bond connected 
the monomeric subunits of the surfactants, allowing the formation of supramolecular 
aggregates (Fan et al. 2008).   
Similarly to transfection mediated by cationic lipids, that mediated by cationic gemini 
surfactants also showed to be favored by the addition of DOPE, as a helper lipid, to the 
delivery system (Camilleri et al. 2000). Helper lipids or co-lipids are uncharged lipids 
that have been used to enhance transfection mediated by cationic vectors, cholesterol 
and DOPE being the most widely employed. Cholesterol has been used as a helper lipid 
due to its ability to modify hydrocarbon chain packing, resulting in more stable 
complexes and, therefore, with potential for large traveling periods in blood 
circulation (Koynova & Tchenkov 2010). DOPE, characterized by a high propensity to 
form inverted hexagonal phases, has been suggested to play a role in facilitating the 
disassembling of lipid-based DNA formulations and DNA escape from the endosmes 
(Hoekstra et al. 2007 Duzgunes et al. 2007). 
As expected, DOPE is not a “universal enhancer” of transfection efficiency, since its 
action takes place at the endosomal membrane level and, on the one hand, not all 
complexes are internalized through the endolysosomal route, and, on the other hand, 
DOPE-induced destabilization of the endosomal membrane depends on the presence of 
other components in the complex. In fact, the addition of DOPE to DNA complexes 
containing bis-quaternary ammonium surfactants with short (C2 and C3) and 
intermediate (C6) spacers and long tails (C18:0 and C18:1) did not enhance their 
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ability to mediate transfection, probably because these complexes were not 
internalized by endocytic mechanisms (Rosenzweig et al. 2001).  
On the other hand, phase transitions from lamellar to normal hexagonal structures (HI) 
have also been found to occur in complexes able to efficiently mediate transfection, 
such as those containing pH-sensitive sugar-based gemini surfactants (Wasungu et al. 
2006b), which underwent a bilayer-to-HI phase transition at mildly acidic pH 
(Wasungu et al. 2006a).  
 
Nucleic acid release 
Nucleic acid release depends on the lability of the interaction between the carrier 
molecules and the polynucleotide chains. Only an efficient nucleic acid release in an 
appropriate intracellular location will originate high levels of transfection. Complexes 
containing gemini surfactants modified from the 12-7H-12 parent molecule, by 
introducing an aminoacid (glycine or lysine) or a dipeptide (glycyl-lysine or lysine-
lysine) in the spacer, presented increased flexibility and lability, conferred by van der 
Waals and hydrogen bonding interactions (Yang et al. 2010). These complexes were 
shown to be endocytosed without significant destabilization upon interaction with the 
plasma membrane. Furthermore, the substituted gemini surfactants protected DNA 
from degradation inside the endosomes during the time necessary to occur endosomal 
membrane destabilization. In contrast, complexes containing the unsubstituted gemini 
surfactant were promptly destabilized upon interaction with the cytoplasmic 
membrane, leading to a premature release of the DNA into the cytoplasm or inside the 
caveosome, and consequent degradation (Singh et al. 2012). 
 
1.2.1.3 Summary 
Gemini surfactants emerged as new molecules presenting characteristics that allow to 
obtaining supramolecular assemblies and DNA compaction at very low concentration. 
In a toxicological context, this has a great impact on pharmacological applications, due 
to the possibility of minimizing cell, organism and environmental toxicity. On the other 
hand, gemini surfactants offer the possibility for structure modulation, allowing the 
introduction of biocompatible and biodegradable elements that would further 
decrease the toxicity, or improve the clearance rate from the organism. 
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In the perspective of gene delivery, gemini surfactant structure modulation may 
regulate surfactant affinity towards DNA, reflected in complexation efficiency and DNA 
protection, thus allowing a fine tuning of the nucleic acid release. The intracellular 
release of the cargo may be tuned, among other ways, by the introduction of labile 
linkages between specific groups of the gemini surfactant molecules. The mechanisms 
by which gemini surfactant-based complexes are taken up by cells, and, consequently, 
their intracellular traffic and fate, can also be modulated by the use of surfactants with 
different structural features. Surfactant ability to interact selectively with certain 
membrane regions (e.g. raft and non-raft regions), due to structural peculiarities of 
their own molecules or of the aggregates they form, may determine the mechanisms by 
which surfactant-based complexes transpose the plasma membrane, and hence the 
pathway of their cellular internalization. In summary, a gene therapy-addressed 
manipulation of gemini surfactant structure is now taking the first steps towards the 
development of new, more efficient and less toxic systems for gene delivery.  
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1.2.2 CELL-PENETRATING PEPTIDES 
Cell-penetrating peptides (CPPs) present a variety of amino acid sequences, usually 
enriched in basic residues and with the ability to be arranged in amphipathic 
secondary structures, such as α-helixes and β-sheets, which contribute to their cell-
penetrating properties. The ability to enter into the cells and to carry molecules across 
the cytoplasmic membrane makes CPPs interesting vehicles for drug delivery. In this 
context, considerable effort has been expended in developing new and more efficient 
CPPs to deliver bioactive molecules with low capacity to permeate membranes, such as 
nucleic acids. 
Two strategies have been used in CPP-mediated nucleic acid delivery. CPPs were 
covalently conjugated with their cargo, mostly consisting of DNA mimic molecules or 
steric block oligonucleotides, such as peptide nucleic acids (PNA) (Koppelhus et al. 
2002) and phosphorodiamidated morpholino-oligomer (PMO) (Abes et al. 2006a). 
Although the covalent approach is advantageous for delivering uncharged molecules, 
such as nucleic acid analogs, its use for the delivery of plasmid DNA or oligonucleotides 
(ONs) has proved to be more challenging, involving high costs and technical 
difficulties. Furthermore, although the size and stoichiometry of the CPP conjugates 
are relatively constant and predictable, their efficiency in releasing the cargo and the 
activity of carried molecules are sometimes hardly anticipated (Meade & Dowdy 
2008). In contrast, the non-covalent approach is simpler and has been shown to 
originate complexes with net positive charge that provide nucleic acids with 
protection against nuclease-mediated degradation, favoring the release of the nucleic 
acids once inside the cell (Heitz et al. 2009; Morris et al. 1997). Thus, most studies 
regarding CPP use as nucleic acid delivery systems report the formation of non-
covalent complexes based on electrostatic interactions between the cationic CPPs and 
the negatively charged nucleic acids. Peptides that can form non-convalent complexes 
are usually short amphipathic peptides consisting of two domains, one hydrophilic 
(polar) and the other hydrophobic (non-polar).  
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1.2.2.1 Structure versatility of CPPs  
The high structural versatility of CPPs is an attractive property of this kind of vectors. 
The diversity of amino acid side chains, which includes charged and non-charged, 
polar and hydrophobic groups, allows the design of a variety of peptide sequences 
resulting in different secondary structures, thus influencing the final molecule 
conformation and the mode by which it interacts with other biomolecules and with 
supramolecular structures, such as biological membranes. Furthermore, the 
conjugation of CPPs with other small molecules, namely fatty acids, nucleic acid 
derivatives, and phosphoryl groups, confers different biological properties to the 
original peptide. Modifications have been introduced in the first generation CPPs in 
order to favor their complexation with nucleic acids and improve their biological 
activity, by promoting their interaction with the cell membrane, their internalization 
and their targeting to specific cell organelles. On the other hand, since most CPPs, 
particularly when associated with a cargo, are internalized through endocytosis, and 
this pathway has the potential of entrapping CPP complexes in endosomes, leading to 
lysosomal degradation of the cargo, chemical and structural modifications of classical 
CPPs have also been performed in order to provide CPPs with endosomolytic 
properties, favoring nucleic acid endosomal escape. With this purpose, several 
strategies have been developed, such as the addition of histidine residues. A typical 
example of the contribution of this modification to increase transfection efficiency is 
given by Tat peptide. The covalent fusion of histidine residues to Tat peptide, either at 
the N- or the C-terminal, originated CPPs with different transfection efficiencies, the 
most promising being that with 10 histidine residues attached to Tat peptide (Tat-
10His), which mediated gene delivery 7,000-fold more efficiently than the original Tat 
peptide. The increase in transfection efficiency was explained as being a consequence 
of the “proton sponge” effect, which would be promoted by the imidazole groups of 
histidine residues, leading to enhanced endosomal release of nucleic acids. On the 
other hand, it was observed that the incorporation of 2 cystein residues into the Tat –
derived peptide 5His-Tat-5His, producing Cys-5His-Tat-5His-Cys, resulted in an even 
higher efficacy in transfection, which was attributed to the increased stabilization of 
the peptide/DNA complexes, possibly due to the formation of disulfide bonds between 
cystein residues (Lo & Wang 2008).  
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Penetratin, used as a carrier for siRNA, resulting in efficient cellular uptake and 
knockdown, both in vitro and in vivo (Cheng et al. 2011), has been also modified, giving 
rise to a new peptide designated EB1, by replacing two basic amino acids with 
histidines and adding 6 amino acids (LIRLWS) to its N-terminal. The improved gene 
silencing ability of this peptide with respect to penetratin was attributed to the 
endosomolytic properties, provided by the histidine residues (Lundberg et al. 2007). 
This new peptide was further modified, by addition of a single C-terminal cysteine 
(Cys) to improve the ability of EB-1 to deliver plasmid DNA. Consequently, a peptide 
dimmer was formed, through a disulfide bond, its affinity to DNA being enhanced as 
compared to that of the monomers. Furthermore, when the covalent bond was reduced 
in the cytoplasm of the cell, the cargo was efficiently released and reached its target, 
resulting in pDNA expression in 50% of the cells (Åmand et al. 2012). 
CPPs derived from the dermaseptin peptide are also an example of peptides whose 
structure has been modulated through the introduction of different modifications in 
the original peptide, and whose biophysical properties and biological activity as gene 
carriers have been extensively studied in order to establish structure-activity 
relationships. In this regard, the CPP S4(13), constituted by the first 13 aminoacids of 
the dermaseptin S4 peptide, was modified by the covalent attachment of the nuclear 
localization sequence (NLS) of the SV40 large T-antigen (PV) to its N-terminal, which 
enhanced the ability of this peptide (PV-S4(13)) to accumulate in the nucleus in an 
ATP-dependent manner. In contrast, the PV-S4(13) analogue containing the NLS in a 
reverse order (rPV-S4(13)), although presenting the same cell permeating ability as 
PV-S4(13) and S4(13), did not show karyophilic character. These findings propelled 
the study of S4(13) and its derivatives as carriers of nucleic acids to different 
intracellular compartments of cultured cells.  
Another variation of S4(13) peptide was produced by introducing the NLS of the SV40 
large T-antigen to its C-terminal (S4(13)-PV). S4(13)-PV peptide electrostatically 
associated to plasmid DNA showed to efficiently mediate transfection, particularly at 
high peptide/DNA charge ratios (5/1 and higher) (Trabulo et al. 2008). Importantly, 
complexes prepared with a scrambled analogue, obtained by randomization of the 
original sequence of amino acids, mediated transfection with significantly lower 
efficiency than those prepared with S4(13)-PV or S4(13)-PVr peptides, which 
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demonstrates the importance of the amino acid sequence of CPPs derived from the 
dermaseptin S4 peptide (amino acids 1–13) to the transfection process. 
In comparison with other well-known CPPs, such as Tat, dermaseptin-derived peptides 
have the advantage of lacking intracellular functions, being hence less prone to 
interfere with normal metabolic pathways (Hariton-Gazal et al. 2002). Table 1.4 
presents the sequences of S4(13) and its derived synthetic peptides, as well as the 
corresponding modifications introduced in order to potentiate their performance. 
 
Table 1.4 S4(13) and related peptides, amino acid sequence and type of modification introduced. 
 
Peptide Amino acid Sequence Type of modification References 
S4(13) 1ALWKTLLKKVLKA13 
Peptide fragment with residues 1-13 
of Dermaseptin S4 
(Hariton-Gazal et 
al. 2002) 
PV-S4(13) PKKKRKV1ALWKTLLKKVLKA13 
N-terminal addition of NLS derived 
from SV40 large T-antigen (PV) to 
enhance nuclear import of the 
peptide 
(Hariton-Gazal et 
al. 2002) 
rPV-S4(13) VKRKKKP1ALWKTLLKKVLKA13 
N-terminal addition of PV in reverse 
order to study the role of the PV 
amino acid sequence in the  nuclear 
import of the peptide 
(Hariton-Gazal et 
al. 2002) 
S4(13)-PV 1ALWKTLLKKVLKA13PKKKRKVC 
C-terminal addition of PV to enhance 
nuclear import of the peptide 
(Mano et al. 
2006) 
S4(13)-PVr 1ALWKTLLKKVLKA13VKRKKKPC 
C-terminal addition of PV in reverse 
order to elucidate how NLS sequence 
influences the cellular uptake of 
S4(13)-PV peptide. 
(Mano et al. 
2006) 
scrambled 1KTLKVAKWLKKAKPLRKLVKC21 
Random amino acid sequence 
derived from S4(13)-PV peptide to 
elucidate how peptide primary 
structure influences the cellular 
uptake of S4(13)-PV peptide. 
(Mano et al. 
2006) 
H5-S4(13)-PV 
HHHHH1ALWKTLLKKVLKA13PKKKR
KVC 
Addition of a five histidine tail to the 
N-terminal of the S4(13)-PV to 
facilitate endosomal release* 
(Cardoso et al. 
2013) 
* This aspect is explored in the present work (Chapter 8). 
 
1.2.2.2 Structural properties of CPPs and their impact on CPP-cell interactions and 
cellular uptake 
Interaction of CPPs with the cell surface constitutes a key step for their internalization 
and, consequently, for their success in nucleic acid delivery. Electrostatic interactions 
with the extracellular matrix revealed to be a prerequisite for the uptake of the 
majority of cationic peptides, including Tat and Tat fusion proteins and polyarginines 
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(Tyagi et al. 2001). The involvement of proteoglycans (PG) and glycosaminoglycans 
(GAG) in S4(13)-PV cell internalization was also demonstrated (Mano et al. 2005). In 
this case, a strong inhibition of peptide internalization was observed in the presence of 
low heparin concentrations and, in genetically modified cells deficient in PG, it was 
observed that these membrane components potentiated peptide internalization, 
although their presence at the cell surface was not absolutely required. In addition, at 
high peptide concentrations (1 μM), dynamin, which is involved in clathrin- and 
caveolae-mediated endocytosis and phagocytosis, showed not to be essential for 
peptide uptake, whereas at low peptide concentrations (0.2 and 0.4 μM) 
chlorpromazine, a specific inhibitor of clathrin-mediated endocytosis, reduced peptide 
uptake. Therefore, two distinct mechanisms were proposed for the cellular uptake of 
S4(13)-PV peptide, whose dominance depended on peptide concentration, namely a 
GAG- and endocytosis-dependent mechanism at low peptide concentration, and a GAG- 
and endocytosis-independent mechanism at high peptide concentration (Mano et al. 
2005). 
Similarly to S4(13)-PV, MPG was shown to enter cells even in the absence of GAG, 
although at a lower rate than in their presence. Electrostatic interactions between MPG 
and GAG showed to induce significant GAG clustering. The similar propensity of MPG, 
which exhibits a β-sheet structure, and MPGα, a MPG derivative that forms an α-helix, 
to interact with GAG and induce GAG clustering suggested that the type of secondary 
structure is not relevant for the initial interactions between the peptide and the 
extracellular matrix (Gerbal-Chaloin et al. 2007). 
An ultrastructural approach to peptide-membrane interactions and cellular uptake 
was performed with the S4(13)-PV peptide and its derivatives with a reverse NLS and 
a scrambled sequence, using transmission electron microscopy (TEM). The S4(13)-PV 
and S4(13)-PVr peptides showed to form nanoparticle-like regular spherical 
structures (sizes ranging 80 to 100 nm for S4(13)-PV and 140 nm for the reverse NLS 
peptide) at the surface of the cells, before transposing the cell membrane. On the other 
hand, the scrambled peptide formed larger irregular aggregates and permeated the 
cells less efficiently than the other two peptides, suggesting that the peptide primary 
structure impacts on CPP-cell surface interactions, with repercussion on their 
internalization. The generation of nanometer-sized particles has also been shown with 
other peptides, such as Pep-1 (Muñoz-Morris et al. 2007), MPG and CADY (Crombez et 
al. 2008). Nanoparticles of S4(13)-PV peptide generated upon interaction with cell 
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membranes were not found in the absence of cells, that is S4(13)-PV did not form 
nanoparticles when added to a culture medium containing or not serum, or in the 
presence of anionic GAGs, like heparin, chondroitin sulfate and hyaluronan. Therefore, 
the clustering of S4(13)-PV peptides seems to depend on a specific environment or on 
the direct interaction of the peptide with the cell surface (Padari et al. 2010). 
Moreover, electron microscopy studies showed that the association of S4(13)-PV and 
S4(13)-PVr particles to the plasma membrane of HeLa cells promoted membrane 
fading, denoting an interference with the packing of bilayer lipids, which is consistent 
with results demonstrating that S4(13)-PV becomes buried in the lipid bilayer upon 
interaction with negatively charged vesicles. In contrast, scrambled peptide cellular 
association did not perturb plasma membrane integrity, even at high concentrations. It 
was proposed that both the modulation of the plasma membrane properties and the 
different particle assemblies might be responsible for the differences observed in the 
efficiency of uptake of the S4(13)-PV, reverse NLS and scrambled peptides (Padari et 
al. 2010).  
Nanocarrier interactions with membrane lipids have shown to constitute a key 
element for the success of nucleic acid delivery. In this context, the study of CPP–lipid 
interactions using membrane models has revealed to be of crucial importance for 
unraveling how CPPs affect the physical properties of the lipid bilayer, and how 
membrane physical alterations determine the competence of CPPs to translocate the 
cell membrane and to deliver its cargo into the cell. 
It was shown that penetratin affected the temperature, enthalpy and cooperativity of 
the main phase transition of the anionic lipid DMPG, while RL16 produced a strong 
perturbation in the lipid chain packing of bilayers composed of the zwitterionic lipid 
DMPC. Penetratin is unstructured in solution and also in the presence of zwitterionic 
lipid membranes and adopts an α-helix secondary structure upon interaction with 
anionic membranes. The electrostatic interactions between the cationic residues of 
penetratin and the negatively charged headgroups of the lipids trigger peptide 
structural changes, which create hydrophobic patches in the peptide allowing its 
partial insertion into the lipid acyl chain region. Translocation of penetratin appears to 
involve the formation of nonlamellar lipid structures, such as inverted micelles. On the 
other hand, RL16 presents an α-helix secondary structure both in solution and in the 
presence of lipid membranes. Upon interaction with zwitterionic membranes, RL16 
inserts deeply in the lipid fatty acyl chain region, decreasing lipid order. However, in 
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DMPG bilayers, RL16 does not insert into the acyl chain region but rather remains 
anchored at the headgroup region where it establishes electrostatic interactions. In 
these membranes, RL16 molecules seem to act according to a detergent-like carpet 
mechanism, assembling at the bilayer surface and disintegrating the membrane in a 
detergent-like manner above a threshold peptide concentration. Although being both 
highly cationic, penetratin and RL16 differ in their amphipaticity. The interactions of 
these CPPs with anionic membranes are guided by the spatial charge distribution in 
the peptide sequence, involving hydrophobic interactions between the peptide 
sequence and the lipid bilayer core, and electrostatic interactions between the peptide 
charged residues and the lipid headgroups. The balance between those types of 
interactions determines whether CPP inserts into the lipid bilayer or lays on the 
membrane surface, hence influencing the internalization process (Alves et al. 2008). 
Figure 1.7 schematizes the models of peptide-membrane interactions proposed for 
cationic peptides which adopt α-helix secondary structure, either amphipatic or non-
amphipatic. 
 
 
 
Figure 1.7 Model for peptide-membrane interactions. A) Peptide amphipathicity and net positive 
charge guide the perturbations induced by the peptides on membrane physical properties. Peptide 
surface regions are represented in dark when enriched in charged residues, and in white when 
hydrophobic residues predominate. B) Amphipathic peptide-membrane interaction results in positive 
membrane curvature; C) Detergent-like activity induces the formation of toroidal pores; D) Positively 
charged peptide-membrane interaction induces a negative curvature in the membrane outer monolayer. 
E) Membrane bridging and vesicle aggregation; F) Membrane tubulation results from curvature-induced 
invaginations (from Lamazière et al. 2007, no permission required). 
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Although a negative surface charge is common for most eukaryotic cells, due to the 
presence of proteoglycans, the membrane lipid composition varies with the type of 
cell, its differentiation and health or disease conditions. Therefore, the interactions of 
cell-penetrating peptides with lipids containing acyl chains with different length or 
different degree of unsaturation should also be taken into consideration. In fact, RL16 
showed to interact preferentially with lipids containing short (DMPC) rather than long 
(DSPC) alkyl chains, and with saturated (DMPC) rather than unsaturated (POPC) lipids. 
Thus, the thickness and packing of the lipid bilayer can influence the specific 
membrane domains with which the peptide interacts and the extent of this interaction 
(Joanne et al. 2009).  
In an attempt to better understand the molecular mechanism responsible for the 
translocation of the S4(13)-PV peptide across biological membranes, a detailed 
characterization of the interaction of this peptide with model membranes was 
performed using a biophysical approach (Mano et al. 2006). Thus, fluorescence studies 
based on the intrinsic fluorescence of S4(13)-PV (resulting from a single Try residue 
located at the N-terminus) showed the occurrence of a shift of the maximum emission 
wavelength to shorter wavelength values (blue-shift), in the presence of anionic 
membranes, suggesting a deep insertion of the peptide into those membranes. 
Interestingly, the magnitude of the blue shift, reflecting the incorporation of S4(13)-PV 
into the hydrophobic core of the membrane, was significantly higher than that 
reported for penetratin, transportan and Pep-1. Furthermore, circular dichroism 
studies showed that the helical content of S4(13)-PV increased with the negative 
charge density of the lipid bilayers and with the lipid/peptide ratio, a behavior that 
was also observed with penetratin and RL16 (Mano et al. 2006). On the other hand, the 
ability of S4(13)-PV and S4(13)-PVr peptides to be partially arranged in an 
amphipathic α-helix upon peptide-membrane interaction was not shared by the 
scrambled peptide. The formation of this secondary structure might be related with 
the capacity of S4(13)-PV and S4(13)-PVr peptides to insert into the lipid bilayer and 
translocate across biological membranes, which was not exhibited by the scrambled 
peptide. Furthermore, scrambled peptide cellular internalization through endocytosis 
was evidenced by the punctuated cytoplasmic pattern observed by confocal 
microscopy. On the contrary, the S4(13)-PV and S4(13)-PVr peptides exhibited mainly 
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a diffuse subcellular localization, suggesting an endocytosis-independent translocation 
process, also observed for penetratin and nonarginine (R9) (Lamazière et al. 2007), 
which might be initiated by the binding of the peptide to the membrane as a 
consequence of the electrostatic interactions established between the peptide and the 
charged cell surface PG (Mano et al. 2006; Mano et al. 2007). These data suggest that 
membrane-induced conformational changes strongly influence the mechanism by 
which the cellular uptake of the peptides occurs. The transient membrane 
destabilization induced by the amphipathic α-helix formed by S4(13)-PV peptide upon 
interaction with the membrane would result in its translocation to the intracellular 
milieu. In this regard, the sequence, length and conformation of the CPP were reported 
to play a more important role in peptide membrane penetration than the accumulation 
of positive charges (Mueller et al. 2008). 
Table 1.5 summarizes the peptides used for cargo delivery reported in this section 
and their sequences, with emphasis on the structural modifications introduced to 
second generation peptides. 
 
Table 1.5 Cell-penetrating peptides commonly used for cargo delivery. 
 
Peptide Sequence Modification Reference 
Tat(49-57) 49RKKRRQRRR57 
Peptide with residues 49-57 of HIV-1 
TAT 
(Wender et al. 
2000) 
R9 1RRRRRRRRR9 - 
(Mitchell et al. 
2000; Wender 
et al. 2000) 
MPG 
1GALFLGFLGAAGSTMGAWSQPKKKRKV27-
cysteamide 
Peptide containing NLS of SV40 large 
T-antigen 
(Deshayes et al. 
2004) 
MPGα 
1GALFLAFLAAALSLMGLWSQPKKKRKV27-
cysteamide 
Substitution of Gly6and Gly9 by alanines 
and Gly12, Thr14 and Ala17 by leucines to 
increase peptide helical content 
(Deshayes et al. 
2004) 
Penetratin 
(Pen) 
43RQIKIWFQNRRMKWKK58 
Peptide fragment with residues 43-58 
of AntpHD 
(Derossi et al. 
1994) 
Transportan 
(TP) 
1GWTLNSAGYLLGKINLKALAALAKKIL27 
Substitution of Pro13 Lys in Galparan 
to allow the attachment of cargo 
molecules to the Lys residue 
(Pooga et al. 
1998) 
Pep-1 
1KETWWETWWTEWSQPKKKRKV21-
cysteamide 
Substitution of the HIV-1 gp41-derived 
hydrophobic domain by a hydrophobic 
tryptophan-rich motif to improve the 
delivery of peptides and proteins 
(Morris et al. 
2001) 
EB1 LIRLWS43HLIHIWFQNRRLKWKK58K 
Substitution of Arg43 His; Gln44Leu; 
Lys46 His; Met54Leu and addition of 
6 amino acids to the N-terminal and a 
Lys residue to the C-terminal of 
penetratin to enable peptide penetration 
into the endosomal membrane 
(Lundberg et 
al. 2007) 
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Table 1.5 (cont.) Cell-penetrating peptides commonly used for cargo delivery. 
 
EB1-Cys LIRLWS43HLIHIWFQNRRLKWKKK58C 
Addition of C-terminal cysteine to 
EB1to allow peptide dimerization by 
disulfide bond formation in order to 
enhance peptide/nucleic acid complex 
stability and intracellular cargo release 
(Åmand et al. 
2012) 
RL16 1RRLRRLLRRLLRRLRR16 - 
(Alves et al. 
2008) 
S4(13) 1ALWKTLLKKVLKA13 
Peptide fragment with residues 1-13 of 
Dermaseptin S4 
(Hariton-Gazal 
et al. 2002) 
 
1.2.2.3 Summary 
The interest in using CPPs to improve non-invasive cellular delivery of therapeutic 
macromolecules, including nucleic acids, resulted from the recognition of their 
remarkable ability to transpose cell membranes. Multiple factors may affect the 
efficiency of CPP internalization, including structural features of the CPP and its 
associated cargo, the target cell type and specificities of CPP-membrane lipid 
interactions. However, other obstacles besides transposition of cellular membranes 
hamper to a successful cargo delivery. Changes in the peptide amino acid sequence, 
fusion of additional sequences with different properties and/or association with 
lipophilic moieties have been performed to optimize CPP ability to deliver biologically 
active molecules. Most commonly, such modifications are intended to contribute to the 
stabilization of CPP/nucleic acid complex, the improvement of CPP cellular association 
and/or uptake, and the release of cargo entrapped in endosomes, ultimately to favor 
cargo accumulation in the target cellular compartment (nucleus, mitochondria or 
cytoplasm). 
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1.2.3 POLYMERS 
Polymers are large molecules consisting of small chemical repeating units (monomers) 
covalently linked together. The capacity of synthetic cationic polymers to interact with 
nucleic acids through electrostatic interactions, forming complexes (polyplexes) that 
exhibit enhanced bonding to the cell surface and efficient internalization into 
endosomal vesicles has been explored for gene delivery applications. Several strategies 
have been used to improve the various steps of transfection mediated by polyplexes, 
from cellular internalization to the nuclear import. Cell internalization of polymer-
based gene delivery systems was enhanced through the use of ligands that promote 
the cellular uptake, such as endogenous ligands (e.g. transferrin, folate), 
carbohydrates, antibodies and cell-penetrating peptides (e.g. Tat, penetratin). In order 
to favor nucleic acid escape from endosomes, several strategies were adopted to 
reinforce the “proton sponge” effect, characteristic of polymers containing a large 
number of protonable amine groups, such as polyethylenimine (PEI) (Won et al. 2009). 
These include the addition of a pH-sensitive peptide (which undergoes a 
conformational change from a random coil to α-helix at low pH) to the polymer 
formulation, and the use of pH-sensitive polymers, designed to have the same 
functional groups that are presumably responsible for the membrane-disrupting 
properties of pH-sensitive peptides (carboxyl groups which are protonated at acidic 
pH and alkyl groups that interact with the endosomal membrane to collectively 
enhance cargo escape from endosomes) (Wong et al. 2007). Another aspect that must 
be taken into consideration is the internal cell structure provided by the cytoskeleton, 
which gives rise to a viscous environment that counteracts the diffusion of large 
molecules such as naked DNA and large polyplexes. In order to obviate this obstacle to 
polymer-mediated transport of nucleic acid towards the nucleus, natural endogenous 
cytosolic factors, such as NLS and carbohydrates to bind to intracellular carbohydrate-
binding receptors that mediate intracellular trafficking, have been used (Wong et al. 
2007). To favor nucleic acid dissociation from the delivery system, disulfide bonds, 
which can be reduced by glutathione in the intracellular medium, and hydrolytically-
sensitive ester bonds, which can act as labile crosslinkers for highly branched 
structures, have been incorporated into the polymers. In addition, thermoresponsive 
polymers, able to undergo temperature-dependent structural rearrangements with 
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repercussion on polyplex behavior in terms of nucleic acid condensation and release, 
have also been extensively explored for gene delivery (Wong et al. 2007). In the next 
section special attention will be drawn to this type of polymers since they were object 
of our studies in Chapter 9. 
 
1.2.3.1 Temperature-responsive polymers 
Some polymers have been designed to respond to exterior stimuli, such as 
temperature, pH, redox potential, light, ionic strength, electric and magnetic fields or 
the presence of enzymes or specific ligands (Alexander 2006). Thermoresponsive 
polymers, which undergo conformational changes as a response to small temperature 
variations, have been used in gene delivery, due to the possibility they offer to regulate 
the degree of DNA condensation in response to small temperature variations and, thus, 
to modulate the rate and site of cargo release (Alexander 2006). Thermoresponsive 
polymers also constitute a selective means of drug transport to tumor tissues, where 
the release can occur spontaneously due to tumor hyperthermic environment or be 
forced through the application of localized heating. This class of polymers undergoes a 
reversible coil-to-globule phase transition in response to temperature (Figure 1.8A). 
The transition temperature, above which the globule phase exists, is designated “lower 
critical solution temperature (LCST)” or “cloud point”. This transition, which is 
accompanied by a sharp change in the polymer hydration state, is entropically driven. 
When a polymer is placed in water, the enthalpy favors dissolution/solvation due to 
the formation of a large number of hydrogen bonds between the solvent and the 
solute. However, the resulting organization of water molecules around the solute 
results in a loss of entropy. At low temperatures, the enthalpic contribution dominates 
resulting in dissolution. As the temperature increases, the hydrogen bonds weaken, 
resulting in a reduced enthalpic contribution and an increasing unfavorable entropic 
contribution. Once the temperature is raised above the LCST, the entropic contribution 
dominates and phase separation is favored over dissolution. Since the 
thermoresponsive behavior depends on the solvent interaction with the polymer and 
the hydrophilic/hydrophobic balance within the polymer molecule, it is not surprising 
that additives to the polymer/solvent system, besides polymer concentration and 
molecular weight, can influence the temperature at which the phase transition occurs. 
Such additives include salts, surfactants and co-solvents (Schmaljohann 2006). 
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The polymer poly(N-isopropylacrilamide), known as PNIPAAM, is one of the most 
widely studied thermoresponsive polymers, which exhibits a phase transition in water 
at 32 °C (LCST). However, this critical temperature can be increased or decreased by 
copolymerization with hydrophilic or hydrophobic monomers, respectively (Schild 
1992; Talelli & Hennink 2011). Polymers of PNIPAAM are able to carry different 
molecules, such as drugs or nucleic acids.  
Copolymerization of PNIPAAM with hydrophobic or hydrophilic blocks can originate 
micelles, with PNIPAAM located in the micellar shell or core, respectively (Figure 1.8B 
and C). At temperatures below the LCST, copolymers of PNIPAAM with hydrophobic 
blocks form micelles with a hydrated PNIPAAM shell. When heated above the LCST, 
micelles destabilize and aggregate due to the collapse of the micellar shell. These 
micelles when loaded with a drug should release it as a consequence of the phase 
transition. Since this phase transition occurs at a temperature below the body 
temperature (LCST<37 °C), PNIPAAM is not useful for in vivo applications, the micelles 
with a PNIPAAM shell being expected to aggregate upon injection. However, PNIPAAM 
copolymerized with hydrophilic monomers originated polymers with an LCST above 
37 °C (Talelli & Hennink 2011).  
Three PEI-PNIPAAM grafted co-polymers, varying in the PNIPAAM molecular weight 
and grafting density, were compared in terms of their thermoresponsive behavior. A 
temperature increase resulted in the collapse of the copolymers containing the highest 
PEI/PNIPAAM molar ratio, regardless of the length of the PNIPAAM grafts. The 
hydrophobicity of PNIPAAM grafts, resulting either from long chains or from large 
number of grafts, contributes to this phenomenon. PNIPAAM grafts can be envisaged 
as being oriented around the PEI domains below the LCST and collapsing upon heating 
to temperatures above the LCST. This model predicts larger hydrophobic domains 
above LCST and stronger association forces for the polymer with the highest grafting 
density. Alternatively, the copolymers in solution can be arranged with the PNIPAAM 
domains residing inside the structure, even below LCST, since their chains are more 
hydrophobic than PEI. In this case, the collapse of PNIPAAM domains above LCST 
would lead to large changes in apparent volume, especially for copolymers containing 
more PNIPAAM grafts. Most likely, large hydrophobic surface regions lead to a reduced 
colloidal stability (Griffiths et al. 2008). 
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Figure 1.8 Effect of temperature (below and above LCST) on the phase behavior of PNIPAAM and on the 
micellization of PNIPAAM copolymers. A) PNIPAAM undergoes a ‘coil-to-globule’ transition above the 
LCST, as a result of hydrophobic associations. B) PNIPAAM copolymers containing a permanently 
hydrophobic segment form core-shell micelles in aqueous solution at low temperatures, where the core 
is hydrophobic and the hydrated PNIPAAM constitutes the shell. As the temperature increases above the 
LCST, the PNIPAAM shell collapses, causing the destabilization of the micelles and triggering drug 
release. C) PNIPAAM copolymers containing hydrophilic segments are water soluble at temperatures 
below LCST. At higher temperatures, the segments self-assemble into micelles, as a result of the self-
association of the thermoresponsive moieties. Core-shell micelles, based on a PNIPAAM core and on a 
hydrophilic shell are thereby formed. In this case, drugs can be loaded (or released) in hyperthermic (or 
hypothermic) conditions (modified from Calejo et al. 2013a).  
 
Another charged block, (3-acrylamidopropyl)-trimethylammonium chloride 
(AMPTMA), which is a quaternized acrylamide-based monomer, was copolymerized 
with PNIPAAM and the resulting copolymers of different lengths were characterized in 
terms of their thermoresponsiveness (Figure 1.9) (Patrizi et al. 2009). Both the LCST 
and the cmc of the copolymers were found to increase with the increase in length of 
the cationic block AMPTMA, for the same NIPAAM length. The increase of AMPTMA 
length corresponds to a decrease in hydrophobicity of copolymer molecules, which 
stabilizes copolymer monomers in solution, by shielding the hydrophobic NIPAAM 
blocks. An opposite effect is observed with variation of the NIPAAM block length for 
the same AMPTMA length (Patrizi et al. 2009). More recently, PNIPAAM-b-PAMPTMA 
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block copolymers were shown to interact electrostatically with oppositely charged 
poly-electrolytes, namely DNA, forming polymer-DNA complexes, designated mixed 
micelles. In this regard, the extent of polymer-DNA interaction was found to depend 
not only on the temperature (high temperature promotes complexation), but also on 
the ionic strength of the medium (high salt reduces electrostatic interactions between 
the polymers and DNA), providing an additional mean of controlling DNA 
complexation (Tardani et al. 2011).  
 
  
Figure 1.9 Schematic representation of the copolymer PNIPAAMn-b-PAMPTMAm (reproduced with 
permission from Calejo et al. 2013b).  
 
1.2.3.2 Transfection mediated by thermoresponsive polymers 
The thermoresponsive homopolymer PNIPAAM has been used to carry and deliver 
oligodeoxynucleotides (ODN) into cells. The nucleic acid delivery systems were 
produced either by co-polymerization of the ODN with PNIPAAM (ODN-PNIPAAM) or 
by electrostatic association between the ODN and PNIPAAM (ODN + PNIPAAM). The 
ODN-PNIPAAM conjugate, but not the ODN + PNIPAAM complex, was able to protect 
ODN from nuclease degradation with high efficiency and to mediate successful 
transfection (Murata et al. 2003). However, covalent linkage between the nucleic acids 
and their carrier can be disadvantageous, namely if the release of the nucleic acids 
becomes compromised. 
Copolimerization of PNIPAAM with cationic monomers was used in order to obtain 
thermoresponsive polymers able to interact with nucleic acids electrostatically, 
protecting them from degradation and facilitating their intracellular release. PNIPAAM 
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copolymerized with protonated poly-2-(dimethylamino)ethyl methacrylate 
(PDMAEMA) groups was shown to form complexes with DNA with high stability at 
37 °C (those with low PNIPAAM content) or which precipitated at 37 °C (those rich in 
PNIPAAM). The most stable complexes proved to be the most effective in transfection, 
probably because they are able to delay the release of their cargo. Furthermore, 
maximum transfection was shown to depend on the co-polymer/DNA ratio, polyplexes 
prepared at 1/2 to 4/1 co-polymer/DNA ratios, which corresponded to polyplex Zeta 
potentials close to neutrality, being those showing the highest transfection efficiency 
(Hinrichs et al. 1999). 
Twaites and coworkers designed PEI-PNIPAAM and PNIPAAM-PDMAEMA-
hexylacrylate (HA) conjugates. The latter polymer joins together the thermoresponsive 
polymer PNIPAAM with the strongly hydrophilic DMAEMA and the hydrophobic HA. 
Each of the temperature-responsive polymers formed complexes with DNA under 
physiologically relevant conditions (Twaites et al. 2005). Moreover, these polymers 
were shown to transport DNA into mouse myoblasts and PEI-PNIPAAM was able to 
mediate DNA translocation to the cell nucleus. However, linear-PEI-PNIPAAM 
copolymer was unable to mediate gene expression, while the branched-PEI-PNIPAAM 
analogue efficiently transfected cells. Thermoresponsive polymer-DNA complexes 
were found to induce lower cytotoxicity than PEI homopolymer (Twaites et al. 2005). 
Lavigne and colleagues studied two PEI-PNIPAAM conjugate polymers with different 
LCSTs and presenting coil-to-globule transitions when complexed with plasmid DNA. 
This transition was shown to lead to conformational changes of the polyplexes, 
reflected in differences in electrophoretic mobility of polyplexes at temperatures 
below and above polymer LCST. More interestingly, complexes prepared above the 
LCST were shown to improve their transfection efficiency in an experimental design, 
which included a “cold-shock” below the LCST of the polymer during transfection to 
initiate a change in the polymer conformation. The authors suggested that the 
microstructural changes in the polymer-DNA complexes, induced upon the abrupt 
decrease of temperature, when these were inside the endosome, facilitated DNA 
release thus leading to a better transfection yield. Maximal transfection efficiency 
corresponded to twice that of the commercially available reagent JetPEITM, and the 
polyplexes showed to be less toxic than this reagent (Lavigne et al. 2007). 
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Cationic block copolymers based on PNIPAAM-b-PAMPTMA were also studied 
regarding their transfection efficiency. Copolymers with short charged blocks showed 
high potential for association with DNA at 37 °C, forming compact core-shell structures 
that were able to protect DNA from the external environment and led to expressive 
transfection efficiencies. However, the increase in the length of the charged PAMPTMA, 
for a constant length of PNIPAAM, led to an increased degree of charge repulsion 
between the polymer molecules, inhibiting to some extent the thermoresponsive 
association of PNIPAAM with DNA, with the resulting formation of polyplexes with an 
‘open’ structure (Figure 1.10). The low compactness of these polyplexes associated 
with their low capacity to destabilize lipid bilayers was considered to be the key factor 
for their low transfection efficiency. For long charged blocks, a very long PNIPAAM 
block was therefore found essential to ensure the formation of compact nanoparticles 
(Figure 1.10) that led to a successful gene delivery (Calejo et al. 2013b). 
 
 
Figure 1.10 Schematic illustration showing the temperature effect on the formation of PNIPAAM-b-
PAMPTMA/DNA polyplexes. The double-stranded molecule represents the nucleic acid payload, in this 
case the plasmid DNA in its supercoiled, condensed structure. At 25 °C, the polymer is in its extended, 
soluble form, allowing the establishment of electrostatic interactions between the positively charged 
PAMPTMA block and the negatively charged DNA. At 37 °C, the highest degree of aggregation takes place 
in the presence of the polymer with the shortest PAMPTMA(+) block (PNIPAAM48-b-PAMPTMA(+)6) and 
with the longest PNIPAAM block (PNIPAAM65-b-PAMPTMA(+)20) (reproduced with permission from 
Calejo et al. 2013b). 
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1.2.3.3 Summary 
Polymeric vectors constitute promising tools for in vivo delivery of genes and RNAi 
mediators, due to their controllable structures, safety, transfection efficacy and 
possibility of large-scale production. Transfection efficiency of thermoresponsive co-
polymers was comparable or higher than that of PEI homopolymer, which has been 
widely regarded as the most effective polymeric vector for in vitro gene delivery, 
although revealing high cytotoxicity. The design of block copolymers showing thermal 
transitions close to physiological temperature and the possibility for fine modulation 
of their ability to dissociate and release their cargo can revolutionize therapeutical 
technologies based on thermoresponsive polymers. In this regard, the synthesis and 
investigation of copolymers composed of PNIPAAM and biocompatible molecules open 
the window for the treatment of inflammatory reactions, which promote hyperthermia 
and are associated to a variety of diseases. 
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1.3 NUCLEIC ACID DELIVERY SYSTEMS TARGETING MITOCHONDRIA 
Being organelles that contain their own DNA, mitochondria have been regarded as 
potential targets for gene delivery. Following mitochondrial genome decoding in 1981, 
it became apparent that these organelles did not use the “universal genetic code”, 
which implied that mitochondrial transfer-RNAs (tRNA) recognized some codons as 
corresponding to certain aminoacids, different from those identified by cytosolic 
tRNAs (Anderson et al. 1981). In fact, four codons are different in mammalian nuclear 
and mitochondrial translational systems (Table 1.6) (Wallace 1999; Yoon et al. 2010). 
 
Table 1.6 Differential codon usage in the mammalian nuclear and mitochondrial translation systems. 
 
codon Mitochondria Nucleus 
AUA Met Ile 
AGA Stop Arg 
AGG Stop Arg 
UGA Trp Stop 
 
Although mitochondrial genome is very small and encodes only 13 protein subunits of 
the mitochondrial respiratory chain (Howell 1999), a number of mitochondrial 
diseases have been related with point mutations in the mitochondrial genome 
(DiMauro & Schon 2001; Yoon et al. 2010; Wallace 1999). These disorders include 
encephalomyopaties, such as mitochondrial encephalopathy with lactic acidosis and 
stroke-like episodes (MELAS), myoclonic epilepsy with ragged red fibers (MERRF), 
Kearns-Sayre syndrome (KSS), chronic progressive external ophthalmoplegia (CPEO) 
and neuropathy, ataxia, and retinitis pigmentosum/maternally inherited Leigh 
syndrome (NARP/MILS), maternally inherited cardiomyopathy (CM), and Leber's 
hereditary optic neuropathy (LHON), which typically present highly variable 
multisystem defects that involve abnormalities of skeletal muscle and/or central 
nervous system (Figure 1.11) (Howell 1999). 
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Figure 1.11 Morbidity map of the human mitochondrial genome. The map of the 16.6-kb mtDNA shows 
the location of the protein-coding genes for the seven subunits of complex I (ND), the three subunits of 
cytochrome c oxidase (COX), cytochrome b (Cyt b), and the two subunits of ATP synthase (ATPase 6 and 
8); the 12S and 16S ribosomal RNAs (rRNA); and the 22 transfer RNAs (tRNA), identified by one-letter 
codes for the corresponding amino acids. Diseases linked to mtDNA point mutations are indicated in 
balloons pointing to the DNA region where the mutations occur; FBSN, familial bilateral striatal 
necrosis; KSS, Kearns-Sayre syndrome; LHON, Leber hereditary optic neuropathy; MELAS, 
mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes; MERRF, myoclonic epilepsy 
with ragged-red fibers; MILS, maternally inherited Leigh syndrome; NARP, neuropathy, ataxia, retinitis 
pigmentosa; PEO, progressive external ophthalmoplegia. 
 
The number and variety of diseases associated with mitochondrial DNA mutations 
have been related to the low level of repair potential of mitochondrial DNA (Mason 
2003) and to the high mutation rate promoted by the large scale production of reactive 
oxygen species (ROS) in mitochondria. However, the mitochondrial genome is 
different from the nuclear DNA so that the severity of mitochondrial gene mutations 
can be strongly attenuated. In fact, the circular mitochondrial DNA exists in hundreds 
or thousands of copies in each mammalian cell and deleterious mutations of mtDNA 
often affect only a few copies, thus originating mitochondria harboring both normal 
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(wild-type) and mutant populations of mtDNA (heteroplasmy). In addition, for a 
disease phenotype to appear, a minimum critical number of mutant mtDNA molecules 
should be present (threshold effect) (DiMauro & Schon 2001). 
Mitochondria play well known and extensively studied roles in energy supply, ROS 
production and apoptosis, and appear as suitable targets for gene therapy of the 
abovementioned life limiting diseases. As with gene delivery targeting the cell nucleus, 
mitochondrial targeting is also limited by the inability of the nucleic acids to cross 
membrane barriers, including the double mitochondrial membrane. One advantage of 
mitochondrial targeting over nuclear targeting regards the uptake of DNA by that 
organelle, which is facilitated by the “natural competence” of mitochondria for DNA 
import (Koulintchenko et al. 2006), a process later identified as being mediated by 
voltage-dependent anion channels (VDAC) present in the inner mitochondrial 
membrane (Weber-Lotfi et al. 2009). In fact, ATP has been shown to enhance 
exogenous DNA uptake and to promote its integration in mitochondrial nucleoids. 
Large molecules of imported DNA with a proper sequence content might promote 
recombination with the resident mtDNA, but for small DNA molecules (smaller than 4 
kb), the sequence requirements disappear (Ibrahim et al. 2011). 
Lipophilic cations with delocalized charges have traditionally been identified as 
mitochondriotropic molecules, that is, with ability to reach mitochondria and 
accumulate in their matrix. However, lipophilic cations correspond only to one third of 
the molecular species whose mitochondrial tropism has been reported. In this regard, 
Horobin and coworkers performed a remarkable work in systematizing the properties 
presented by 100 molecules that have shown mitochondriotropism. In this study, four 
groups of molecules, which accumulated in or close to mitochondria, were defined: i) 
lipophilic cations (36%), ii) acids (potentially or actual anions), most of which were 
weak acids whose free acid species were lipophilic (39%), iii) hydrophilic cations 
(14%), and iv) electrically neutral compounds (10%). Thus, amphiphilicity was found 
not to be a required property of mitochondriotropic molecules (Horobin et al. 2007).  
Nucleic acids were shown to be efficiently delivered to isolated mitochondria in 
several conditions (Seibel et al. 1995; Weissig et al. 2001a). The colocalization of 
nucleic acids delivered by different carriers, such as dequalinium, lipids and polymers, 
with mitochondria, in their natural environment, i.e. in live cells, has been also 
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demonstrated (Yasuzaki et al. 2010; Lee et al. 2007; Lee et al. 2013; Weissig et al. 
2005) (Figure 1.12). DQAsomes, liposome-like aggregates formed by dequalinium, 
which is a dicationic amphiphile traditionally regarded as mitochondriotropic, were 
used to mediate gene delivery to mitochondria in live cells. This vector showed to be 
able to promote DNA uptake by the cells, to favor its escape from the endolysosomal 
route and to deliver it to the vicinity of mitochondria (D’Souza et al. 2003). Another 
line of work used MITO-Porter, a lipid-based system that enters the cells by promoting 
fusion with the cytoplasmic membrane. Colocalization of the MITO-Porter carrying 
DNA (labeled with a fluorescent probe) with mitochondria was observed, although a 
small amount of the vector also colocalized with the nucleus (Yasuzaki et al. 2010). PEI 
conjugated with the mitochondrial leading peptide (MLP) was also used to deliver DNA 
to mitochondria. Importantly, it was shown that these MLP-PEI/DNA complexes 
colocalized with mitochondria in living cells without promoting cytotoxicity (Lee et al. 
2007). In a subsequent study, PEI was copolymerized with Poly(D,L-lactic-co-glycolic 
acid) (PLGA) and used in the micelle form to carry both DNA and the antioxidant α-
tocopherol. The production of ROS promoted by the transfection event was shown to 
decrease in the experimental conditions under which the antioxidant was used. This 
antioxidative transfection system yielded a significant reduction in intracellular 
oxidative stress and mitochondrial membrane potential perturbation, leading to 
remarkably enhanced transfection in human cancer cell lines. However, since the 
authors used unmodified luciferase-coding plasmid in their transfection experiments, 
there is no guarantee that the produced protein has resulted from mitochondrial gene 
expression (Lee et al. 2013). 
In this regard, three protein-encoding plasmid DNA sequences were synthesized in 
order to be expressed in mitochondria. In 1996, Wheeler and coworkers designed an 
ornithine transcarbamylase (OTC) gene flanked by mitochondrial sequences in order 
to be cloned and transcribed in mitochondria. These authors avoided the codons which 
differ from the universal code, in order to further promote translation, allowing both 
the mitochondrial and the cytosolic (nucleus-associated) machinery to synthesize the 
protein (Wheeler et al. 1996). In a subsequent work, Chrzanowska-Lightowlers and 
collaborators modified the firefly luciferase gene, so that it could be expressed in 
mitochondria. In this work, advantage was taken of the non-universal mitochondrial 
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genetic code, in order to produce a reporter gene which would result in 
intramitochondrial protein synthesis (Chrzanowska-Lightowlers et al. 1999). More 
recently, Lyrawati and colleagues produced an “artificial mini-mitochondrial genome”, 
i.e. a plasmid DNA molecule, coding for a reporter green fluorescent protein (GFP) 
designed to be expressed exclusively in mitochondria. For this purpose, besides the 
use of a specific codon from the non-universal mitochondrial genetic code, the favored 
mitochondrial codons that are highly expressed in mitochondrial-encoded proteins 
were used to replace the corresponding codons used by the cytosolic machinery. The 
produced mitochondrial DNA was designated pmtGFP (Lyrawati et al. 2011). 
 
 
Figure 1.12 Strategies used for mitochondrial targeting. Isolated mitochondria were targeted using 
mitochondria leading peptide (MLP)-DNA conjugates (A) and DQasomes electrostatically associated 
with DNA (B). In both situations, the delivery systems were internalized by mitochondria. Mitochondria 
in live cells were targeted using DQasomes (C), MLP-PEI conjugates (D) and MitoPorter (E). In these 
three cases the DNA was electrostatically associated with the carriers and colocalization of DNA and 
mitochondria was observed in live cells (see text for details).  
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1.3.1 SUMMARY 
In summary, gene delivery targeting mitochondria has emerged as a promising 
approach to address life-limiting diseases with origin in mtDNA mutations. Several 
studies described successful attempts to deliver molecules to mitochondria in living 
cells. On the other hand, DNA has been shown to enter isolated mitochondria and to be 
transcribed and translated by these organelles, originating functional proteins. The 
next step of this process involves the conjugation of these two abilities, i.e., to find a 
delivery system able to mediate both efficient cellular internalization and 
mitochondrial uptake of the carried nucleic acids leading to enhanced gene expression. 
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1.4 CONCLUDING REMARKS 
The field of nonviral technology for drug delivery has benefited from the joint 
cooperation of chemists, biophysicists and cell biologists aiming at discovering novel 
molecules with ability to transfect cells and improving those already existing, by 
structural remodeling. The development of delivery systems has aimed at achieving 
high cargo transfer efficiency and avoiding cytotoxicity at the concentrations needed 
for a successful biological activity. Therefore, cell biological studies have been focused 
on selecting non-toxic molecules with high ability to transpose cellular membranes 
and promote intracellular cargo delivery. 
On the other hand, biophysical analysis has the purpose of establishing structure-
activity relationships, considering four different steps in the delivery process, namely 
the interaction and binding of the delivery molecules to the cell surface, eventually 
evoking conformational alterations, their translocation across cell membrane, their 
escape from endosomes, when the endocytic pathway is used for the cellular 
internalization of the delivery system, and their ability to release their cargo into the 
intracellular milieu. 
Although currently there is no recipe to create the ideal delivery system, a major 
concern regards the chemical and structural characteristics of the carrier molecules 
along with the nature of their interaction with the cargo and the cell membranes. Thus, 
research in the field of nonviral gene delivery benefits from an integrative protocol 
using biological and biophysical analysis. 
Electrostatic interactions between opposed charges (from cationic components of the 
delivery systems and the negatively charged cloud at the cell surface, conferred by 
glycosaminoglycans, GAGs), and hydrophobic interactions (established between 
amphipathic molecules composing the carrier and the lipid bilayer) guide the 
interactions between the delivery systems and cell membranes, and perturbation of 
the physical properties of the membrane lipid bilayer can also contribute to an 
additional gain in free energy for the translocation process. 
The heterogeneous and the highly dynamic nature of cell membranes make the 
assessment of delivery system-cell membrane interactions a complex process, with 
several factors involved, which increase the difficulty of studying it in detail at a 
molecular level. Therefore, membrane-mimicking lipid systems, which contain neither 
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proteins nor sugars, have been used to evaluate the influence of membrane structure 
and composition on carriers’ cellular uptake.  
A full characterization of the nucleic acid delivery systems originated from gemini 
surfactants, CPPs and stimuli-responsive polymers can contribute positively to the 
rational remodeling of those types of molecules. This approach can be fostered by the 
conjugation of biological and biophysical techniques, jointly contributing to the 
establishment of the principles able to warrant the design of increasingly competent 
nucleic acid delivery systems applicable to different therapeutic purposes. 
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Objectives 
 
The hypothesis that originated the work presented in this Thesis is that the chemical 
structure of nucleic acid delivery systems, the interactions they establish with 
membranes and the conformational alterations they undergo under different 
biological conditions are intrinsically related to their performance. Therefore, a deep 
understanding at a molecular-level of this relationship will provide a fundamental 
basis for developing new materials and strategies, in order to vastly improve the 
efficiency of non-viral gene delivery systems. 
In order to test our hypothesis, we proposed to carry out several tasks with the 
following aims: 
1. Development/improvement of non-toxic gene delivery systems based on 
cationic gemini surfactants from two families, conventional and serine-derived bis-
quaternary. 
2. Physical characterization of the gemini surfactant-based gene delivery systems 
developed and comparison of the properties presented by those able to efficiently 
mediate gene delivery with those lacking this ability. 
3. Evaluation of the ability of gemini surfactant-based gene delivery systems to 
promote mitochondrial gene expression. 
4. Assessment of the extent of the interactions between the gemini surfactant-
based complexes able to efficiently mediate mitochondrial gene expression and 
membrane models mimicking the lipid composition of different cell membranes. 
5. Characterization of the biophysical changes induced by the cell-penetrating 
peptide S4(13)-PV and its scrambled derivative in lipid membrane models and 
ultrastructural analysis of the arrangements adopted by the cell-penetrating peptides 
upon interaction with cellular membranes. 
6. Development of new formulations for plasmid DNA and siRNA delivery based on 
a cell-penetrating peptide derived from S4(13)-PV by addition of a histidine 
sequence, in order to improve its endosomolytic capacity. 
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7. Evaluation of the silencing ability of PNIPAAM-b-PAMPTMA(+) block 
copolymers with different thermoresponsive and cationic block lengths, and, 
consequently, different charge densities and cloud points. 
These objectives were defined as milestones to be achieved along the experimental 
plan envisaging to reach two challenging goals: i. to prepare innovative formulations 
based on cationic gemini surfactants, cell-penetrating peptides and thermoresponsive 
polymers, combining high performance in delivering nucleic acids into cells and 
mediating gene expression and silencing, without causing cytotoxicity, and ii. to 
unravel the structural characteristics of the generated nucleic acid delivery systems 
that, on the one hand, modulate their interaction with cellular membranes, cell 
uptake and intracellular trafficking, and, on the other hand, ensure their high 
transfection efficiency, with minimal adverse effects to cells. 
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3.1 MATERIALS 
3.1.1 GEMINI SURFACTANTS 
Conventional and serine-derived bis-quaternary gemini surfactants were synthesized, 
purified and physically characterized in Centro de Investigação em Química, 
Department of Chemistry and Biochemistry, University of Porto (Porto, Portugal) and 
kindly provided to us thanks to a collaboration with Prof. Eduardo Marques and Prof. 
Luísa do Vale from that Institution. 
 
3.1.2 CELL-PENETRATING PEPTIDES 
Peptides of the S4(13)-PV family, namely S4(13)-PV (wild type), S4(13)-PVscr 
(scrambled derivative of S4(13)-PV, with the same aminoacid composition and 
overall charge of the wild type peptide, but a distinct primary sequence), 
S4(13)-PVrev (reverse NLS derivative, whose aminoacid sequence only differs from 
that of the wild type peptide in the sequence of three aminoacids in the NLS) and 
H5-S4(13)-PV (histidine derivative, resulting from the addition of a 5-histidine tail to 
the amine terminus of the wild type peptide), were synthesized, purified and 
physically characterized in Centro de Investigação em Química, Department of 
Chemistry and Biochemistry, University of Porto (Porto, Portugal) and kindly 
provided to us thanks to a collaboration with Prof. Paula Gomes from that Institution. 
 
3.1.3 THERMORESPONSIVE POLYMERS 
PNIPAAM-b-PAMPTMA diblock copolymers were synthesized, purified and physically 
characterized in Department of Chemistry, University of Oslo (Oslo, Norway) and 
kindly provided to us thanks to a collaboration with Prof. Bo Nyström from that 
Institution. 
 
3.1.4 LIPIDS 
The lipids bis(monooleoylglycero)phosphate (18:1 BMP), cholesterol (chol), 1,2-
dimyristoyl-sn-glycero-3-phosphocholine (DMPC), 1,2-dioleoyl-sn-glycero-3-
phosphocholine (DOPC), 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE), 
1,2-dioleoyl-sn-glycero-3-phospho-(1′-rac-glycerol) (DOPG), 1,2-dioleoyl-3-
trimethylammonium-propane (DOTAP), 1,2-dipalmitoyl-sn-glycero-3-
phosphocholine (DPPC), 1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine (DPPE), 
1,2-dipalmitoyl-sn-glycero-3-phospho-(1′-rac-glycerol) (DPPG), 1-palmitoyl-2-oleoyl-
sn-glycero-3-phosphocholine (POPC), 1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-(1′-
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rac-glycerol) (POPG), 1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-L-serine (POPS), 
bovine brain sphingomieline (SM) and 1’,1’,2’,2’-tetraoleoyl cardiolipin (TOCL) were 
purchased from Avanti Polar Lipids (Alabaster, AL).  
 
3.1.5 FLUORESCENT PROBES 
The fluorescent probes 1,6-diphenyl-1,3,5-hexatriene (DPH), 3-(p-(6-phenyl)-1,3,5-
hexatrienyl)phenylpropionic acid (DPH-PA), 2-(9-anthroyloxy) stearic acid (2-AS), 6-
(9-anthroyloxy) stearic acid (6-AS), 12-(9-anthroyloxy) stearic acid (12-AS), 16-(9-
anthroyloxy) palmitic acid (16-AP), N-(7-nitrobenz-2-oxa-1, 3-diazol-4-yl)-
phosphatidylethanolamine (NBD-PE) and rhodamine-phosphatidylethanolamine 
(Rho-PE) were obtained from Molecular Probes Inc. (Eugene, OR). 
 
3.1.6 PRIMERS 
The primers for survivin and HPRT-1 genes were pre-designed by Qiagen (QuantiTect 
Primer, Qiagen).  
 
3.1.7 ANTIBODIES 
The antibody anti-survivin (goat) was purchased from Santa Cruz (Santa Cruz 
Biotechnology, Inc., Heidelberg, Germany), the antibody anti-α-tubulin (mouse) and 
the secondary antibodies were obtained from Sigma (St. Louis, MO, USA). 
 
3.1.8 PLASMID DNA 
Plasmid DNA encoding GFP (pEGFP-C1 plasmid DNA, here simply denominated 
pDNA) was obtained from Clontech, CA, USA, and plasmid DNA encoding 
mitochondrial GFP (mtpDNA) was synthesized and kindly provided by Prof. Diana 
Lyrawati, Brawijaya University (East Java, Indonesia). 
 
3.1.9 SIRNAS 
The anti-GFP siRNA (5′-GCAAGCUGACCCUGAAGUUCAU-3′) and Cy3-labeled 
nonspecific siRNA sequence were purchased from Ambion (Austin, TX, USA). The 
anti-survivin siRNA (5′-GGACCACCGCAUCUCUACAdTdT-3′) and the non-silencing 
siRNA used as control were obtained from Dharmacon (Lafayette, CO, USA). 
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3.2 METHODS 
3.2.1 PREPARATION OF NUCLEIC ACID DELIVERY SYSTEMS 
Nucleic acid delivery systems were prepared through non-covalent association of 
nucleic acids with several carrier molecules. This process is an easy method to 
generate complexes from negatively charged nucleic acids and cationic carriers, and 
has the advantage of neither compromising the biological activity of the carried 
nucleic acid nor requiring the generation and testing of new constructs for any given 
nucleic acid cargo. However, the reproducibility of the procedure and the control of 
the stoichiometry are not as rigorous as those obtained with covalently linked 
systems (Heitz et al., 2009). The procedure that originates the most efficient 
complexes depends on a variety of factors, including the nature of the carrier 
molecules, and, for ternary complexes, i.e., those containing helper lipids besides the 
cationic carrier molecule and nucleic acids, the order of component addition is 
equally relevant.  
 
3.2.1.1 Gemini surfactant-based complexes 
The influence of the method for preparation of nucleic acid complexes based on 
conventional bis-quaternary gemini surfactants on their transfection ability was 
evaluated. Plain complexes of surfactant/DNA or ternary complexes of 
surfactant/helper lipid/DNA were prepared using two different methods (A and B). 
Method A, reported in Cardoso et al., 2011, consisted of dissolving gemini surfactants 
or their mixture with DOPE and cholesterol in chloroform, at the desired molar ratios 
(3:2:1 and 3:4:2). Solutions were then dried under vacuum in a rotatory evaporator 
and the resulting lipid films were hydrated with deionised water to a final lipid 
concentration of 2 mM. Surfactant or surfactant plus lipid dispersions were then 
sonicated for 3 min, extruded 21 times through two stacked polycarbonate filters of 
50 nm pore diameter, using a Liposofast device (Avestin, Toronto, Canada), to 
produce small unilamellar vesicles (SUV) and, after a three-fold dilution with 
deionised water, they were filter-sterilized utilizing 0.22 μm pore-diameter filters 
(Schleicher & Schuell, BioScience, Germany). Plain complexes (surfactant/DNA) and 
ternary complexes (surfactant/DNA/lipid) were prepared by mixing 100 μL of a 
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HEPES-buffered saline solution (HBS; 100 mM NaCl, 20 mM HEPES, pH 7.4) 
containing 0.5 μg of pEGFP-C1 plasmid DNA encoding GFP (Clontech, CA, USA) with a 
volume of the previously prepared surfactant suspensions (without or with helper 
lipids), to obtain surfactant/DNA (+/-) charge ratios in the range of 2/1 to 8/1. The 
resulting mixtures were then incubated for 15 min at room temperature. 
Method B consisted of an adaptation of the method described by Badea and 
coworkers (Badea et al., 2005). Briefly, aqueous solutions (0.5 mM) of gemini 
surfactants were filtered through 0.22 μm pore-diameter filters (Schleicher & Schuell, 
BioScience, Germany) and a solution of DOPE and cholesterol (2:1 molar ratio) in 
chloroform was dried under vacuum in a rotatory evaporator, the resulting lipid film 
being hydrated with HBS (pH 9.0) to a final lipid concentration of 0.5 mM. The 
resulting multilamellar vesicles (MLV) of DOPE plus cholesterol were then sonicated 
for 3 min and filtered through 0.22 μm pore-diameter filters (Schleicher & Schuell, 
BioScience, Germany). Complexes were prepared by mixing 100 μL of HBS containing 
0.5 µg of pEGFP-C1 plasmid DNA encoding GFP with aliquots of the aqueous gemini 
surfactant solution, to obtain surfactant/DNA (+/-) charge ratios in the range of 2/1 
to 8/1. These preparations were incubated 15 min at room temperature. To produce 
the ternary complexes, a volume of DOPE:Chol liposomes was added to 
surfactant/DNA complexes to obtain surfactant/lipid molar ratios in the range of 1/1 
to 1/2, followed by 30 min incubation at room temperature. 
The two methods are depicted in Figure 3.1. Since method B was less time 
consuming and revealed to produce the most efficient complexes with the 
conventional gemini surfactants as compared to method A, the former was selected to 
be employed in the preparation of complexes based on conventional as well as serine-
derived gemini surfactants, containing either pDNA or mtpDNA. 
materials and methods 
 
77 
 
 
Figure 3.1 Schematic representation of the two methods used for complex preparation. Method A: 
gemini surfactant or gemini surfactant plus DOPE and cholesterol were dissolved in chloroform  and 
then mixed at the desired molar ratio and dried under vacuum in a rotatory evaporator. The dried lipid 
films were hydrated with deionised water and the resulting MLV were sonicated and extruded. 
Complexes were prepared by mixing 0.5 μg of pEGFP-C1 plasmid DNA encoding GFP with an aliquot of 
the previously prepared SUV dispersion, to obtain the desired surfactant/DNA (+/-) charge ratio. The 
mixture was further incubated for 15 min at room temperature. Method B: DOPE and cholesterol were 
dissolved in CHCl3 and then mixed at the desired molar ratio (2:1) and dried under vacuum in a 
rotatory evaporator. The dried lipid film was hydrated with HBS (pH 9.0) and the resulting MLV were 
then mildly sonicated in a sonication bath. Complexes were prepared by mixing 0.5 µg of pEGFP-C1 
plasmid DNA encoding GFP with aliquots of a gemini surfactant aqueous solution prepared at 0.5 mM, 
to obtain the desired surfactant/DNA (+/-) charge ratios, followed by incubation at room temperature 
for 15 min. To obtain the ternary complexes (surfactant/DNA/lipid), a volume of DOPE:Chol liposomes 
was added to this mixture at the desired surfactant/lipid molar ratio, followed by an incubation for 30 
min at room temperature. 
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3.2.1.2 Cell-penetrating peptide-based complexes 
Plain complexes of CPP/DNA or ternary complexes of CPP/DNA/DOTAP:DOPE were 
prepared in HBS. Plain complexes were produced by gently mixing pDNA (0.5 μg) or 
siRNA (25 pmol) with each of the CPPs, at the desired charge ratio, followed by 15 
min (pDNA complexes) or 30 min (siRNA complexes) of incubation at room 
temperature. Ternary pDNA complexes were obtained by gently mixing 
peptide/pDNA complexes, prepared at the desired charge ratio, with DOTAP:DOPE 
large unilamellar vesicles (LUV), prepared from MLVs (generated as previously 
referred). Mixtures were then incubated for 15 min, at room temperature. 
Complexes of siRNA containing both CPP and LUVs composed of DOTAP:DOPE were 
prepared following two different methodologies. One method involved the addition of 
CPP to the siRNAs (50 nM), in order to obtain the desired CPP/siRNA (+/-) charge 
ratios, followed by the addition of the cationic LUV (CPP/siRNA/DOTAP:DOPE 
complexes). In the other method, CPPs were mixed with the cationic LUV, before the 
addition of the siRNAs (CPP/DOTAP:DOPE/siRNA complexes). After the addition of 
each component, the mixtures were gently mixed and incubated for 30 min at room 
temperature to allow the formation of the complexes exhibiting the desired (+/-) 
charge ratios. 
 
3.2.1.3 Thermoresponsive polymer-based complexes 
Polymers were dissolved in cell culture medium without serum (OptiMEM) or 
containing 10% fetal bovine serum (FBS) (DMEM-LG) and gently mixed with siRNA 
targeting GFP (50 nM), at the desired polymer/siRNA (+/−) charge ratios, at room 
temperature. The mixtures were further incubated for 20 min at room temperature. 
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3.2.2 EVALUATION OF THE PHYSICO-CHEMICAL PROPERTIES OF NUCLEIC ACID COMPLEXES 
Physico-chemical properties of the complexes, such as hydrodynamic diameter, 
surface charge density and colloidal stability were evaluated because of their 
importance in determining the success in nucleic acid delivery.  
 
3.2.2.1 Mean diameter 
Evaluation of the hydrodynamic size distribution of surfactant-, peptide- and 
polymer-containing particles complexed with nucleic acids (DNA or siRNA) were 
performed by measuring the dynamic light scattering (DLS), through photon 
correlation spectroscopy (PCS). In PCS, the time-dependent fluctuations resulting 
from the Brownian motion of particles in suspension are determined by 
autocorrelation spectroscopy of scattered laser light. A photomultiplier detects the 
light intensity scattered at a given angle, which then passes to an autocorrelator, 
which determines the rate of diffusion or Brownian motion of the particles, and hence 
their size, through a time-dependent analysis (Figure 3.2). The relationship between 
the size of a particle and its speed due to Brownian motion is defined in the Stokes-
Einstein equation: 
𝐷 =
𝑅𝑇
𝑁𝐴
1
6𝜋ηa
 
where D is the diffusion coefficient of a spherical particle of radius a, R is the gas 
constant, NA is the Avogadro number, T is the absolute temperature and η is the 
viscosity of the medium. Particle size is determined as the diameter of a sphere that 
would diffuse at the same speed as the particle being measured. In the present work, 
the detection angle was fixed at 90° and the assay was performed using a Coulter N4 
Plus Instrument (Coulter Electronics, Miami, FL). The analysis was performed at 
room temperature, in HBS, and complexes were prepared, as recommended, 
immediately before analysis. 
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Figure 3.2 Schematic representation of the propagated waves from the light scattered by the particles 
dispersed in an aqueous medium (modified from Zeta Sizer Nano Series, User Manual, Ch. 13). 
 
3.2.2.2 Zeta potential 
The Zeta potential or electrokinetic potential of surfactant-, peptide- and polymer-
containing particles was measured using a Zetasizer Nano ZS, ZN 3500, with a 532 nm 
laser (Malvern Instruments, UK). Charged particles modify the distribution of ions in 
the surrounding medium, resulting in an increased concentration of counter-ions 
close to the surface. Therefore, an electrical double layer is formed around each 
particle, consisting of an inner region (Stern layer), where ions are strongly bound to 
the particle, and an outer, diffuse region where ions are more loosely attached. 
Counter-ions within this double layer form a stable entity with the particle they 
surround, creating a boundary (slipping plane). The difference of potential between 
this boundary and the bulk is known as the Zeta potential (Figure 3.3).  
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Figure 3.3 Schematic representation of the ion organization around the particle of interest (modified 
from Zeta Sizer Nano Series, User Manual, Ch. 1). 
 
Zeta potential is measured using a combination of electrophoresis and Laser Doppler 
Velocimetry. This method measures the velocity of a particle in a liquid when an 
electrical field is applied. Zeta potential can be determined from the velocity of the 
particle and the electrical field applied, taking into consideration the viscosity and the 
dielectric constant of the medium. 
Electrophoretic mobility is detected by the Doppler shift in frequency, ∆υ, using a 
heterodyne method, and calculated using the equation: 
∆υ=U(Ek) 
where U is the electrophoretic mobility, E is the applied electric field, and k is the 
scattering angle determined by the equation: 
𝑘 =  
4𝜋𝑛
𝜆
𝑠𝑖𝑛
𝜃
2
 
where λ is the wavelength of the helium–neon laser light in vacuum, n is the refractive 
index of the medium, and θ is the angle between the incident laser beam and the 
detector. From both equations, electrophoretic mobility can be calculated using the 
equation: 
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𝑈 =
∆𝜐𝜆
2𝑛𝐸𝑠𝑖𝑛
𝜃
2
 
The Smoluchowski approximation assumes that the double-layer thickness is small 
compared to the colloidal particle diameter, thus correlating electrophoretic mobility 
and Zeta potential: 
𝑈 =
𝜀𝑟𝜀0𝜁
𝜂
 
where ζ is the Zeta potential, εr is the dielectric constant of water, ε0 is the 
permittivity of the free space and η is the viscosity, this being a valid assumption for 
aqueous systems of defined electrical conductivity (Cardoso et al., 2009). 
The measurements were performed in the aqueous buffer HBS, at 25 °C (for 
surfactants, CPPs, polymers and respective DNA complexes) or 37 °C (for polymers 
and respective DNA complexes), using DTS 1060C folded capillary cells and the 
protocol for general purposes (electric current 3.0 mA, medium viscosity 0.89 cP, 
medium refractive index 1.33, sample viscosity 0.89 cP, particle refractive index 1.45 
and equilibration time 3 min). Values of dielectric constant of 78.5 and beam mode 
F(Ka) of 1.5 (Smoluchowsky) were used and Zeta potential was calculated for each 
scattering angle (8.6°, 17.1°, 25.6° and 34.2°). 
 
3.2.2.3 Colloidal stability 
Turbidity fluctuations of complex dispersions in HBS buffer (pH 7.4) were monitored 
as a function of time in a SPECTRAmax PLUS 384 spectrophotometer (Molecular 
Devices, Union City, CA) at a wavelength of 550 nm, in HBS buffer, pH 7.4 over a 
period of 48 h, in order to evaluate complex colloidal stability. 
 
3.2.3 STRUCTURAL PROPERTIES OF COMPLEXES AND THEIR INTERACTIONS WITH MEMBRANES 
The interactions between nanocarriers and membrane lipids may play a key role in 
the success of nucleic acid delivery. In this context, the use of lipid models has been 
revealed very helpful to address the effects of nanocarriers or corresponding nucleic 
acid complexes on the physical properties of cell membrane lipids, with repercussion 
on the transfection process. A biophysical approach is also useful to evaluate the 
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compactness of lipid-based complexes, which can be determinant for the protection 
and dissociation of carried molecules. 
 
3.2.3.1 Fluorescence polarization analysis 
Membrane fluidity can be determined from the spectroscopic parameter provided by 
fluorescence polarization or fluorescence anisotropy. Several fluorescent probes can 
be used to detect alterations in membrane physical properties at different depths of 
the lipid bilayer, such as 1,6-diphenyl-1,3,5-hexatriene (DPH) and its anionic and 
cationic analogs 3-[p-(6-phenyl)-1,3,5-hexatrienyl]phenylpropionic acid (DPH-PA) 
and 1-(4-trimethylaminophenyl)-6-phenyl-1,3,5-hexatriene (DPH-TMA), respectively. 
The high molar absorption coefficient of DPH (ε350nm ≈ 80,000 M-1 cm-1), as well as its 
high quantum yield in hydrophobic environments (0.8 in hexane, at 25 °C), negligible 
emission in aqueous media, and absorption and emission spectra at distinct 
wavelength ranges, are advantageous spectroscopic properties that invite the use of 
this probe in membrane studies (Shinitzky & Barenholz, 1974). The high 
hydrophobicity of DPH compel its insertion deep into the hydrocarbon core of the 
lipid bilayer (Andrich & Vanderkooi, 1976), whereas its charged derivatives are 
anchored at the lipid–water interface (Prendergast et al., 1981; Trotter & Storch, 
1988). Steady-state fluorescence anisotropy measurements are based on the 
principle of photoselectivity (Gennis, 1989). The exposure of a liposome suspension 
labeled with a fluorescent probe to light of a suitable wavelength (340–360 nm), 
polarized along the z-axis, results in the excitation of the probe molecules whose 
transition dipole moments are also oriented in the vertical direction. Light emission 
at an adequate wavelength is monitored when the emitted light is polarized in a 
parallel and in a perpendicular direction to the exciting radiation, providing the Iǁ and 
I⏊ components, respectively. The values of Iǁ and I⏊ are used to obtain the anisotropy 
(r) or fluorescence polarization (P) according to the equations: 
𝑟 =
𝐼𝐼𝐼−𝐺𝐼⏊
𝐼𝐼𝐼+2𝐺𝐼⏊
 and 𝑃 =
𝐼𝐼𝐼−𝐺𝐼⏊
𝐼𝐼𝐼+𝐺𝐼⏊
 
where G is the grating correction factor for the optical system, obtained from the 
equation: 
𝐺 =
𝐼⏊
𝐼𝐼𝐼
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The constraints to the rotational diffusion and reorientation of probe molecules 
indicated by the value of r or P, reflect the free volume existent in the region where 
the probe resides within the membrane. Therefore, r and P describe (indirectly) the 
freedom degree and level of mobility (range and rate of motion) of phospholipid 
hydrocarbon chains (Trabulo et al. 2012). 
For fluorescence polarization measurements, liposomes were prepared by mixing the 
lipids in chloroform at the desired molar ratio and hydrating the lipid films with Tris-
maleate (50 mM), KCl (10 mM), pH 7.4 buffer in order to obtain a concentration of 
200 μM in phospholipid. This preparation (MLV) was then sonicated in a low energy 
water sonifier for a few seconds to decrease light scattering. The probe DPH-PA, as 
well as the probes derived from stearic acid 2-(9-anthroyloxy) stearic acid (2-AS), 6-
(9-anthroyloxy) stearic acid (6-AS), 12-(9-anthroyloxy) stearic acid (12-AS) or 
palmitic acid 16-(9-anthroyloxy) palmitic acid (16-AP) were then incorporated in 
liposomes, by injecting a few microliters (5-10 µL) of the concentrated probe solution 
in dimethylformamide into liposome suspensions to obtain a lipid/probe molar ratio 
of 200/1. Thereafter, the liposome suspensions were incubated for 30 min in a water 
bath set 7–10 °C above the transition temperature of the phospholipids, in order to 
favor probe incorporation into the lipid bilayers, and let to stabilize overnight at 
room temperature, in the dark. Blank samples were prepared with equivalent 
volumes of the probe solvent to correct fluorescence measurements for the 
contribution of light scattering, although these corrections were often found to be 
negligible (blank fluorescence intensity lower than 5% of that of the respective 
sample). To study the effect of CPPs on membrane fluidity, these were allowed to 
incubate with liposomes labeled with different probes for 30 minutes in a water bath 
set 7–10 °C above the transition temperature of the phospholipids and the 
fluorescence polarization of the probes was evaluated in an appropriate temperature 
range. 
To evaluate hydrocarbon chain packing in gemini surfactant-based complexes, these 
were incubated with the fluorescent probes DPH or DPH-PA for 30 min and the 
fluorescence polarization of the probes was evaluated at 37 °C. The same 
formulations lacking DNA were used as controls. 
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The fluorescence polarization measurements were performed in a Perkin Elmer LS 
55B fluorescence spectrophotometer (Perkin Elmer, U.S.A), equipped with 
polarization filters and a thermostated cell holder. The excitation and emission 
wavelengths were set at 336 nm and at 450 nm, respectively for DPH-PA and at 365 
nm and 450 nm for the probes 2-AS, 6-AS, 12-AS and 16-AP, with 5 nm excitation and 
6 nm emission band pass. 
 
3.2.3.2 Differential scanning calorimetry (DSC) 
Differential scanning calorimetry (DSC) is a sensitive technique that provides useful 
information about effects of lipid interactions with strange molecules from the 
perspective of the structure and dynamics of lipid aggregates. For this purpose, two 
conditions should be observed, firstly lipids or lipid mixtures should undergo a phase 
transition (or transitions) within an accessible temperature range and, secondly, this 
temperature range should be distinct from those at which phase transitions for other 
elements of the mixture occur. Depending on the objective, that is determination of 
the effect of nucleic acids on the compactness of lipid-based complexes, or simulation 
of the interaction of carrier molecules with membranes, the samples are prepared 
differently. In the first case, the method of complex preparation should be reproduced 
and, in the second case, the carrier molecules should be added to preformed 
liposomes of a specific composition with biological relevance (Trabulo et al. 2012). 
For this purpose, large unilamellar vesicles (LUV), which provide a more realistic 
model of a membrane lipid bilayer, or multilamellar vesicles (MLV), which present 
much more cooperative transitions, can be used (Alves et al. 2008).  
The DSC profiles register the excess of heat capacity (Cp) of the system as a function 
of temperature. After defining the interpolated baseline (the line connecting the pre- 
and post-transition baselines) different characteristic temperatures can be 
determined (Figure 3.4). The temperature of the onset (Ton) and the temperature at 
the endothermic peak (Tm) are automatically defined in the thermotropic profiles. To 
define the range of the phase transition or lateral phase separation (Tf–Ton), the 
temperature of completion of the phase transition (Tc) can be determined by the 
intersection of a tangent to the descendent slope of the endothermic peak with the 
baseline. Additionally, the calorimetric enthalpy changes (ΔH) of the thermotropic 
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events are normalized to the exact phospholipid content in each pan, determined by 
quantification of the inorganic phosphate obtained after carefully opening the pans, 
dissolving their contents in chloroform/methanol (3:1) and digesting them with 
perchloric acid (70%) (Trabulo et al. 2012).  
 
 
Figure 3.4 Example of a DSC profile (heating scan) of DPPG bilayers. Characteristic temperatures are 
indicated: Ti, when DSC record first deviates from the base line; Ton, determined by extrapolating to the 
baseline a tangent to the ascending slope of the endothermic peak; Tm, the peak maximum; Tc, 
determined by extrapolating to the baseline a tangent to the descendent slope of the endothermic 
peak; and Tf, obtained when the curve reaches again the baseline. ∆T1/2 (peak width at half maximum 
height) is also indicated (modified from Trabulo et al. 2012). 
 
For determination of the effect of DNA molecules on the thermotropic behavior of 
gemini-based formulations, aqueous dispersions of gemini surfactants were 
incubated with plasmid DNA and, in the case of ternary complexes, a suspension of 
DOPE:Chol MLV was subsequently added. In parallel, equivalent formulations lacking 
DNA were also prepared. The preparations with gemini surfactants (2.5 to 3.0 wt%) 
were let to stabilize at room temperature for 15 min and for an extra period of 30 min 
when they also contained helper lipids. 
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To study the effect of CPP on the thermotropic behavior of membrane lipids, MLV 
suspensions (DPPC, DMPG, DPPG or a mixture of POPG/DPPE at 3/7 molar ratio, 75 
mM) were incubated with peptide (lipid/peptide molar ratios in the range of 20/1 to 
80/1) for 30 min in a water bath set 7-10 °C above the transition temperature of the 
lipids. 
Gemini-based formulations or MLV suspensions containing the CPPs were 
centrifuged at 148,000 g for 45 min at 4 °C to obtain a pellet, which was then carefully 
transferred into a 50 µL capacity aluminum pan, subsequently hermetically sealed 
with a crimper. A void pan was used as reference. 
All measurements were performed in a Perkin-Elmer Pyris 1 differential scanning 
calorimeter. Heating scans were performed over an appropriate temperature range, 
at a scan rate of 5 °C/min. To check the reproducibility of data, three heating scans 
were recorded for each sample. Data acquisition and analysis were performed using 
the software provided by Perkin Elmer. 
 
3.2.3.3 Video-enhanced light microscopy analysis (VELM) 
Video-enhanced light microscopy (VELM) results from the combination of optical 
microscopic techniques with advanced video and digital image-processing 
technology. In video-enhanced light microscopy, in particular video-enhanced 
contrast microscopy (VECM), a high-resolution high-light-level video camera receives 
its input from an unconventionally adjusted light microscope, usually employing 
Nomarski optics (differential interference contrast, DIC). Both analogue and digital 
contrast-enhancement procedures and background image subtraction are used to 
produce major gains of image quality. VECM involves a video-based monochrome 
imaging technique designed to visualize sub-resolution structures and to follow their 
dynamics in living systems in real time (Shotton, 1988).  
For high-contrast imaging, under DIC mode, of aqueous dispersions of gemini 
surfactants (2.5-3.0 wt%), of gemini surfactant/DNA complexes (56 mM in gemini 
surfactant), and of gemini surfactant/DNA/helper lipids (200 µM in gemini 
surfactant), samples were prepared by dispersion of the solid surfactant in high 
purity Milli-Q water (gemini surfactant sample) and by using method B, as described 
above (section 3.2.1.1) to obtain the complexes of gemini surfactant/DNA and gemini 
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surfactant/DNA/helper lipids. For the thermal study of the dispersions, carefully 
sealed slide/coverslip preparations were made and temperature was controlled using 
a Linkam THMS600 heating stage (±0.1 °C). VELM images were obtained with an 
Olympus BX51 light microscope, under DIC mode. Images were acquired with an 
Olympus C5060 video camera and software CellA. 
 
3.2.3.4 PicoGreen intercalation assay 
PicoGreen is a fluorescent intercalating probe whose fluorescence is dramatically 
enhanced upon binding to nucleic acids (DNA or siRNAs). The accessibility of the 
probe to the nucleic acids in the delivery system is hence reflected by an increase in 
fluorescence and reports indirectly the efficiency of the protection conferred by the 
vector to the carried molecules. A SPECTRAmax Gemini EM fluorimeter (Molecular 
Devices, Union City, CA) was used to measure PicoGreen fluorescence. Complexes 
containing 0.2 μg of plasmid DNA or 14 pmol of siRNA, prepared in a total volume of 
100 μL of HBS, were transferred to a 96-well (blackwalled) plate (Corning, NY, USA) 
followed by 15 min of incubation at 37 °C. Hundred microliters of PicoGreen 
(Molecular Probes, Eugene, OR), diluted according to the manufacturer's instructions 
(1:200 dilution in HBS buffer from a stock solution provided by Molecular Probes), 
were added to each sample. The fluorescence intensity of PicoGreen, directly 
proportional to the amount of accessible/free nucleic acid, was monitored at 25 °C 
(surfactant-, CPP- and polymer-based complexes) and at 37 °C (polymer-based 
complexes) for determining the extent of nucleic acid complexation. The excitation 
and emission wavelengths were set at 485 and 520 nm, respectively. For each 
formulation, the degree of nucleic acid protection conferred by the complexes was 
calculated by subtracting the values of residual fluorescence (PicoGreen in the 
absence of nucleic acid) from those obtained for each measurement, and expressed as 
a percentage of the control consisting of naked nucleic acid only, according to: 
𝑃𝑛𝑢𝑐𝑙𝑒𝑖𝑐  𝑎𝑐𝑖𝑑 = 1 −
𝐹 − 𝐹100
𝐹0 − 𝐹100
× 100 
where F is the fluorescence intensity measured after adding the PicoGreen solution to 
the complexes, F0 (corresponding to 0% of nucleic acid protection) was obtained by 
using free nucleic acid in the same amount as that associated with the complexes, F100 
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(corresponding to 100% of nucleic acid protection) is the residual fluorescence 
intensity of a negative control obtained by using a PicoGreen solution without nucleic 
acid, which mimics a situation of 0% of nucleic acid available to the PicoGreen 
solution.  
The potential destabilization of the complexes was assessed by monitoring the 
fluctuations of PicoGreen fluorescence intensity upon complex incubation for 15 min 
with SUV of DOPC or of a mixture of DOPE:DOPC:POPS (2:1:1 molar ratio), prepared 
from a suspension of MLV in HBS buffer by 19 times extrusion through two stacked 
polycarbonate filters of 50 nm pore diameter. Vesicle lipid-induced DNA deprotection 
was taken as the difference between the protection obtained for complexes in 
absence of the lipid vesicles and that obtained in their presence.  
 
3.2.3.5 Förster resonance energy transfer (FRET) 
Förster resonance energy transfer, a technique generally referred to by the acronym 
FRET, was used to monitor lipid mixing between two populations of vesicles induced 
by carrier molecules or mixing of lipids from a population of vesicles with the 
components of nucleic acid complexes (containing surfactants and helper lipids). This 
approach is based on the use of two fluorophores previously selected so that the 
emission band of one (the “energy donor”) overlaps (at least partially) the excitation 
band of the other (the “energy acceptor”). When the two probes are in close proximity 
(approximately 10 nm of distance), the energy from a photon absorbed by the 
“energy donor” can be transferred non-radiatively to the “energy acceptor”, which 
will then fluoresce as if it had been excited directly. Since the efficiency of 
fluorescence energy transfer between two given fluorophores is dependent upon 
their spatial separation, this technique provides a means to monitor the mixing of the 
lipids from vesicles labeled with adequated fluorophores (Struck et al., 1981). For this 
purpose, the fluorophores N-(7-nitro-2,1,3-benzoxadiazol-4-yl) (NBD), the “energy 
donor”, and rhodamine (Rho), the “energy acceptor”, are commonly used, being 
covalently coupled to the free amino group of phosphatidylethanolamine to provide 
lipid analogues, which should be incorporated into lipid bilayers at appropriate 
surface densities (ratio of fluorescent lipid to total lipid of 1 mol%). When labeled 
vesicles are added to non-labeled vesicles or other structures, at such conditions that 
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the mixing of components from both structures is induced, the surface density of the 
probes decreases and the distance between the “energy donor” and “energy acceptor” 
increases, resulting in a decreased efficiency of resonance energy transfer, which can 
be measured experimentally by an increase in the fluorescence of the “energy donor” 
or a decrease in the fluorescence of the “energy acceptor” (Figure 3.5). Alternatively, 
a population of vesicles can be labeled with the “energy donor” and the other with the 
“energy acceptor”. In this case, lipid mixing between the two vesicle populations 
promotes the proximity of the fluorescent probes with an increase in FRET. 
 
 
Figure 3.5 Representation of a component-mixing assay based on Förster resonance energy transfer 
(FRET). The average spatial separation of the donor (D) and acceptor (A) lipid probes increases upon 
mixture of labeled membranes with unlabeled membranes, resulting in decreased efficiency of 
proximity-dependent FRET. Decreased FRET efficiency is registered by increased donor fluorescence 
intensity and decreased acceptor fluorescence intensity (from www.probes.com/handbook/ 
boxes/0432.html). 
 
In the present work, FRET experiments were performed in order to assess the extent 
of the interaction between components of the cationic surfactant-based vectors and 
vesicles mimicking the lipid composition of different membranes and different 
membrane regions as follows: non-raft regions of the cytoplasmic membrane 
(POPC:DOPE at 2:1 molar ratio), lipid-rafts (SM:DMPC:Chol at 1:1:1 molar ratio), late 
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endosomal membrane (POPC:DOPE:SM:BMP at 5:2:1:2 molar ratio) and 
mitochondrial membrane (DOPC:DOPE:TOCL at 1:1:1 molar ratio). Lipid vesicles 
were labeled with 1% N-(7-nitrobenz-2-oxa-1, 3-diazol-4-yl)-
phosphatidylethanolamine (NBD-PE) and 1% rhodamine-phosphatidylethanolamine 
(Rho-PE) (Molecular Probes, Eugene, OR). Aliquots of chloroform solutions of both 
probes were added to the lipid mixtures in chloroform. This solvent was removed by 
evaporation in a rotatory evaporator and the dried lipid films were hydrated in HBS 
saline buffer (pH 7.4). The resulting MLV were then sonicated for 3 min and extruded 
15 times through two stacked polycarbonate filters of 100 nm pore diameter using a 
Liposofast device (Avestin, Toronto, Canada) to obtain LUV. Phospholipid content was 
determined by measuring the inorganic phosphate (Murphy & Riley 1962) released 
after hydrolysis of dried phospholipids, at 180 °C, in 70% HClO4 (Bottcher et al. 
1961). Component mixing assays were performed in a 96-well black-walled plate, 
using 400 µM of labeled lipid vesicles and 100 µM of the different surfactant-based 
complexes. Component mixing was measured at 37 °C, after an incubation period of 
15 min at the same temperature, by monitoring fluorescence intensity alterations in a 
SPECTRAmax Gemini EM fluorimeter (Molecular Devices, Union City, CA), using the 
excitation and emission wavelengths of 470 and 535 nm, respectively. At the 
concentration at which the probes were incorporated in the vesicles (1%), Rho-PE 
efficiently suppressed the emission of NBD-PE at 535 nm, when the excitation 
wavelength was set at 470 nm. Due to the energy transfer dependence on the 
distance between the donor and acceptor probes, the mixing of components of the 
complexes with lipids of the fluorescently-labeled preparations generated an increase 
of NBD-fluorescence, reflecting an increase in the average distance between probes in 
the lipid environment. The percentage of component mixing was calculated according 
to the equation: 
𝐶𝑜𝑚𝑝𝑜𝑛𝑒𝑛𝑡 𝑚𝑖𝑥𝑖𝑛𝑔 =
𝐹 − 𝐹0
𝐹100 − 𝐹0
× 100 
where F corresponds to the fluorescence detected after 15 minutes of complex 
incubation with the vesicles, F0 corresponds to the initial vesicle fluorescence in the 
absence of the complexes, and F100 corresponds to the maximal fluorescence, which 
was obtained after complete lysis of the vesicles with octaethylene glycol 
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monododecyl ether (C12E8) (0.5% v/v). For each complex formulation, three 
independent experiments were carried out at pH 7.4. Experiments with vesicles 
mimicking the composition of the late endosome were also performed at pH 5.2. 
Briefly, after incubation of the complexes with the vesicles at 37 °C for 15 min at pH 
7.4, the pH was lowered to 5.2 by the addition of HCl (1 M) and NBD-PE fluorescence 
was measured (F). The percentage of component mixing at pH 5.2 was calculated 
according to the above equation, where F0 and F100 correspond to the minimum 
fluorescence obtained with the labeled vesicles at pH 7.4 and to the maximum 
fluorescence, obtained with C12E8 at pH 7.4, respectively.   
 
3.2.3.6 Calcein release 
Calcein fluorescence dequenching is commonly used to assess vesicle membrane 
destabilization by monitoring the release of their aqueous content. Calcein 
fluorescence dequenching is observed when the fluorophore encapsulated inside the 
vesicles at a self-quenching concentration leaks out and dilutes in the surrounding 
buffer upon membrane destabilization. The relief of self-quenching of encapsulated 
calcein measures the leakage of vesicle contents and, hence, the stability of the 
vesicles under given conditions. 
Calcein release experiments were performed in order to assess the ability of cationic 
surfactant-based gene delivery systems to destabilize vesicles (LUV) mimicking the 
lipid composition of non-raft regions of the cytoplasmic membrane (POPC:DOPE at 
2:1 molar ratio), lipid-rafts (SM:DMPC:Chol at 1:1:1 molar ratio), late endosomal 
membrane (POPC:DOPE:SM:BMP at 5:2:1:2 molar ratio) and mitochondrial 
membrane (DOPC:DOPE:TOCL at 1:1:1 molar ratio), which were prepared as 
described in the previous section, but using 80 mM calcein (Sigma, St. Louis, MO) in 
50 mM HEPES and 1 mM EDTA (pH 8.4) to resuspend the dried films of lipid 
mixtures. Free calcein was separated from the dye-containing LUV by size exclusion 
chromatography on a Sephadex G-75 column, using a buffer (20 mM HEPES, 140 mM 
NaCl and 1 mM EDTA, pH 7.4) with the same osmolarity (300 mOsm) of the calcein 
solution. Phospholipid content was determined as previously described. Vesicle 
leakage assays were performed on a 96-well black-walled plate, using labeled lipid 
vesicles (400 µM) and surfactant-based complexes (100 µM in surfactant). After 
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incubation of the vesicles with the complexes at 37 °C for a period of 15 min, calcein 
release was measured at the same temperature by monitoring fluorescence intensity 
in a SPECTRAmax Gemini EM fluorimeter (Molecular Devices, Union City, CA), using 
the excitation and emission wavelengths of 494 and 517 nm, respectively. The 
percentage of complex-induced leakage from the vesicles was calculated according to 
the equation: 
𝐶𝑎𝑙𝑐𝑒𝑖𝑛 𝑟𝑒𝑙𝑒𝑎𝑠𝑒 =
𝐼 − 𝐼0
𝐼100 − 𝐼0
× 100 
where I corresponds to the fluorescence detected after 15 min incubation of the 
surfactant-based complexes with the vesicles, I0 corresponds to the vesicle 
fluorescence in the absence of complexes, and I100 corresponds to the maximum 
fluorescence, which was obtained after the complete lysis of the vesicles with C12E8 
(0.5% v/v). For each condition, three independent assays were performed. 
 
3.2.4 CELL CULTURE AND MAINTENANCE 
All cells lines were maintained at 37 °C in the appropriate medium and humidified 
atmosphere containing 5% CO2. HeLa cells (human epithelial cervical carcinoma cell 
line) and A549 cells (human epithelial lung adenocarcinoma) were maintained in 
culture in Dulbecco's modified Eagle's medium–high glucose (DMEM–HG; Sigma, St. 
Louis, MO, USA), supplemented with heat inactivated fetal bovine serum (FBS; Sigma, 
St. Louis, MO, USA) (10% v/v), penicillin (100 U/mL) and streptomycin (100 μg/mL). 
HT1080 cells (human fibrosarcoma, stably transfected in order to permanently 
express GFP) were maintained in Dulbecco’s modified Eagle’s low glucose medium 
(DMEM-LG; Sigma, St. Louis, MO, USA) supplemented with heat-inactivated FBS (10% 
v/v), penicillin (100 U/mL) and streptomycin (100 μg/mL). The cells were grown in 
monolayer and detached by treatment with 0.25% trypsin solution (Sigma, St. Louis, 
MO, USA). 
 
3.2.5 TRANSFECTION 
Cells plated at a density of 25 000 cells/cm2 were incubated for 24 h at 37 °C, under 
5% CO2, in complete medium supplemented with FBS (10% v/v) and antibiotics 
before transfection. Immediately before addition of plain or ternary complexes, cells 
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were washed and the medium was replaced with fresh medium. Surfactant-, peptide- 
and polymer-based complexes, prepared at different (+/-) charge ratios as described 
above (section 3.2.1), were added to the cells in a total volume of 100 µL in order to 
obtain a final concentration of 1µg/mL for DNA (pEGFP-C1) and 50 nM for siRNA. 
Lipofectamine 2000 (Invitrogen, Carlsbad, CA) diluted in OptiMEM was used, 
according to the manufacturer’s instructions, as a positive control for DNA and siRNA 
delivery. Parallel gene silencing studies employing a nonsilencing siRNA sequence 
(Mut sequence) were performed, to ensure the specificity of the selected siRNA and 
the absence of off-target effects. Following 4 h of incubation, the medium was 
replaced with fresh medium containing FBS (10% v/v) and antibiotics, and the cells 
were further incubated for 44 h to allow gene expression/silencing. 
Flow cytometry, QRT-PCR and Western blot were used as complementary techniques, 
for an accurate evaluation of transfection efficiency. 
 
3.2.5.1 Analysis of GFP expression by flow cytometry 
Multiple physical characteristics of cells, such as relative hydrodynamic diameter, 
relative granularity or internal complexity, and relative fluorescence intensity, can be 
evaluated by flow cytometry as cells pass through a laser beam. The mode of 
scattering of the incident laser light and emitting fluorescence by cells were recorded 
and used to determine the different properties of the cells. Flow cytometry measures 
the fluorescence per cell, which constitutes an advantage with respect to other 
techniques, in which light absorption and emission at specific wavelengths are 
measured for an entire population of cells (Cardoso et al. 2009). 
In the present work, the transfection efficiency mediated by the different complexes 
was evaluated through analysis of the expression of green fluorescent protein (GFP) 
by flow cytometry. Briefly, 48 h after transfection, cells (HeLa, A549 or HT1080) were 
washed once with PBS and detached with trypsin at 0.25% (10 min at 37 °C). Cells 
were further washed three times by centrifugation (200 g, 4 °C, 5 min) in ice-cold PBS. 
The resulting pellet was resuspended in ice-cold PBS, and the samples were 
immediately analyzed. Flow cytometry analysis was performed in live cells using a 
Becton Dickinson FACSCalibur flow cytometer (BD Biosciences, San Jose, CA, USA). 
Data were collected and analyzed using CellQuest software. To discriminate between 
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viable and dead cells and to exclude doublets, cells were appropriately gated by 
forward/side scatter and pulse width from a total of 10,000 events. The fluorescein 
isothiocyanate (FITC) bandpass filter was used in emission detection. GFP expression 
was evaluated through the analysis of the percentage of transfected cells and of the 
geometric mean fluorescence intensity with respect to control cells (non-transfected 
cells). GFP silencing was evaluated through the analysis of the fluorescence intensity 
with respect to cells treated with mut siRNA (scrambled sequence) complexes. The 
analysis of the percentage of transfected cells (transfection efficiency) gives 
information on the number of cells expressing detectable GFP with respect to the total 
number of live cells, whereas the analysis of fluorescence intensity (transfection 
activity) indicates the average amount of reporter gene expression in the cells. 
 
3.2.5.2 Determination of mRNA levels by quantitative real time polymerase chain 
reaction (QRT-PCR) 
QRT-PCR is a useful tool to quantify the levels of mRNA of a given target protein upon 
cell transfection. Following 24 h of cell incubation with target or mut siRNAs, total 
RNA was extracted from cells using the MasterPure RNA Purification Kit (Epicenter 
Biotechnologies, Madison, WI, USA), according to the manufacturer’s 
recommendations for cultured cells. RNA conversion into cDNA was performed using 
the Superscript III First Strand Synthesis Kit (Invitrogen, Karlsruhe, Germany), 
according to the manufacturer’s instructions. For each sample, cDNA was produced 
from 0.5 µg of total RNA in an iQ5 thermocycler (Bio-Rad), by applying the following 
protocol: 10 min at 25 °C (stabilization of the primers and template), 30 min at 55 °C 
(cDNA synthesis), and 5 min at 85 °C (reaction termination with inactivation of the 
reverse transcriptase). After cDNA synthesis, 30 min incubation with RNase H at 37 °C 
was performed to remove any remaining RNA contamination. Finally, the cDNA was 
diluted 1:3 with RNase-free water prior to quantification by QRT-PCR (Cardoso et al., 
2007). Quantitative PCR was performed in an iQ5 thermocycler using 96-well 
microtiter plates and the iQ SYBR Green Supermix Kit (Bio-Rad). Primers for the 
selected target (survivin) and reference genes (HPRT) were acquired from Qiagen 
(QuantiTect Primer). As expected, the expression of the reference gene did not vary 
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between samples. Target gene expression was normalized to the amount of total RNA, 
by comparison of the target gene with the endogenous reference gene. 
A master mix was prepared for each primer set, containing a fixed volume of SYBR 
Green Supermix and the appropriate amount of each primer to yield a final 
concentration of 150 nM. For each reaction, 20 µL of master mix were added to 5 µL of 
template cDNA. All reactions were performed at least in duplicate (two cDNA 
reactions per RNA sample) at a final volume of 25 µL per well, using the iQ5 Optical 
System Software (Bio-Rad). The reaction conditions consisted of enzyme activation 
and well-factor determination at 95 °C for 1 min and 30 s, followed by 40 cycles at 
95 °C for 10 s (denaturation), 30 s at 55 °C (annealing), and 30 s at 72 °C (elongation). 
The melting curve protocol started immediately after amplification and consisted of 
1 min heating at 55 °C followed by eighty 10 s steps, with an increase in temperature 
of 0.5 °C at each step. This protocol allows to evaluate the efficiency of sample 
amplification and to determine the integrity and purity of the cDNA. Threshold values 
for threshold cycle (Ct) determination were generated automatically by the iQ5 
Optical System Software (Cardoso et al. 2007). 
Target gene expression in cells transfected with the target siRNAs was compared with 
that in cells treated with mut siRNAs to determine gene knockdown. Differences in 
gene expression between nontransfected cells and cells transfected with the mut 
siRNAs indicate the presence of nonspecific effects. The percentage of gene 
knockdown was determined by the ∆∆Ct method, using one of the reference genes 
(HPRT gene), according to the equations: 
∆𝐶𝑡(𝑡𝑎𝑟𝑔𝑒𝑡  𝑠𝑖𝑅𝑁𝐴) = 𝐶𝑡(𝑡𝑎𝑟𝑔𝑒𝑡  𝑔𝑒𝑛𝑒 ) − 𝐶𝑡(𝐻𝑃𝑅𝑇  𝑔𝑒𝑛𝑒 ) 
∆𝐶𝑡(𝑚𝑢𝑡  𝑠𝑖𝑅𝑁𝐴) = 𝐶𝑡(𝑡𝑎𝑟𝑔𝑒𝑡  𝑔𝑒𝑛𝑒 ) − 𝐶𝑡(𝐻𝑃𝑅𝑇  𝑔𝑒𝑛𝑒 ) 
∆∆𝐶𝑡 = ∆𝐶𝑡(𝑡𝑎𝑟𝑔𝑒𝑡  𝑠𝑖𝑅𝑁𝐴) − ∆𝐶𝑡(𝑚𝑢𝑡  𝑠𝑖𝑅𝑁𝐴) 
% 𝑘𝑛𝑜𝑐𝑘𝑑𝑜𝑤𝑛 = 100% − (2−∆∆𝐶𝑡 × 100) 
The ∆∆Ct value indicates the changes in RNA transcription caused by treatment with 
target siRNAs. A positive ∆∆Ct value indicates downregulation of the target mRNA. 
The selected housekeeping genes should have amplification efficiencies similar to the 
target gene. The amplification efficiencies can be determined according to: 
𝐸 = 10−1/𝑆 − 1 
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where S is the slope of the standard curve obtained for each gene. To compare the 
amplification efficiencies of the target and reference genes, the Ct values of the target 
gene are subtracted from the Ct values of the reference gene. The difference in Ct 
values is then plotted against the logarithm of the total RNA amount. If the slope of 
the resulting straight line is less than 0.1, amplification efficiencies are comparable. 
 
3.2.5.3 Determination of GFP levels by Western blot analysis 
Western blot experiments were performed 72 h after transfection to detect the 
maximum protein knockdown. Briefly, protein extracts were obtained from cells 
transfected in 6-well microplates using a lysis buffer (50 mM NaCl, 50 mM EDTA, 1% 
Triton X-100) containing a protease inhibitor cocktail (Sigma), DTT (10 mg/ml), and 
PMSF (1 mM). During this procedure, all samples were maintained at 4 °C to minimize 
protein degradation. Protein content was determined using the Bio-Rad protein 
quantification kit, and 20 µg of total protein were resuspended in protein loading 
buffer (20% glycerol, 10% SDS, and 0.1% bromophenol blue), incubated for 2 min at 
95 °C, and loaded onto a 15% polyacrylamide gel. After electrophoresis, the proteins 
were blotted onto a PVDF membrane according to standard protocols. After blocking 
in 5% nonfat milk, the membrane was incubated with the appropriate primary 
antibody (anti-survivin 1:200, Santa Cruz) overnight at 4 °C, and with the appropriate 
secondary antibody (1:10,000, Sigma) for 2 h at room temperature. Equal protein 
loading was shown by reprobing the membrane with an anti-α-tubulin antibody 
(1:10,000, Sigma) and with the appropriate secondary antibody. After this incubation 
period, the membrane was washed several times with saline buffer (TBS/T: 25 mM 
Tris–HCl, 150 mM NaCl, 0.1% Tween, and 5 mg/mL nonfat powder milk), and 
incubated with ECF (alkaline phosphatase substrate; 20 mL of ECF/cm2 of 
membrane) for 5 min at room temperature. The membrane was then submitted to 
fluorescence detection at 570 nm using a Storm-860 (Molecular Dynamics, CA). The 
analysis of band intensity was performed using the Image J software (Wayne Rasband 
National Institutes of Health, USA). Target band intensity of all samples was 
normalized for individual α-tubulin band intensities to correct for variation in total 
protein content, and any differences in sample handling. Results were expressed as 
percentage of protein levels with respect to nontransfected controls.  
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3.2.6 EVALUATION OF CELL VIABILITY 
The delivery systems used to transfect cells may lead to toxicity, which can be a 
limitation to their application in vitro and in vivo. Therefore, evaluation of the 
biological activity of DNA and siRNA complexes should be accompanied by studies on 
their cytotoxicity. Cell viability under the different experimental conditions was 
assessed by a modified Alamar Blue assay (Simões et al. 1999). This assay is simple, 
involving the use of a sole reagent and limited manipulation. Alamar Blue is nontoxic 
to the cells and to the user and, because no cell lysis is required, the cells can still be 
used for other experiments or submitted to further analysis. This assay measures the 
extent of the conversion of a dye (resazurin) in its metabolite (resorufin), thus 
reflecting the redox activity of viable cells (Konopka et al., 1996). 
Briefly, 48 h (for flow cytometry and QRT-PCR analysis) or 72 h (for Western blot 
analysis) after transfection, 0.3 mL of resazurin (10% v/v) dye in complete DMEM–HG 
(HeLa and A549 cells) or DMEM-LG (HT1080 cells) medium were added to each well. 
After color development (45 min to 1 h of incubation at 37 °C), 150 μL of the 
supernatant were collected from each well and transferred to 96-well plates. The 
absorbance at 570 and 600 nm (information provided by the supplier) was measured 
in a SPECTRAmax PLUS 384 spectrophotometer (Molecular Devices, Union City, CA) 
and cell viability was calculated according to the equation:  
𝐶𝑒𝑙𝑙 𝑣𝑖𝑎𝑏𝑖𝑙𝑖𝑡𝑦 (% 𝑜𝑓 𝑡𝑕𝑒 𝑐𝑜𝑛𝑡𝑟𝑜𝑙) =
𝐴570 − 𝐴600
𝐴′570 − 𝐴′600
× 100 
where A570 and A600 are the absorbances of the samples, and A’570 and A’600 are those 
of the control (non-treated cells), at the indicated wavelengths.  
 
3.2.7 ASSESSMENT OF COMPLEX-CELL INTERACTIONS 
Different experiments were performed to examine the mechanisms by which 
complexes delivered genetic material into cells. Standard protocols to assess the 
relative contribution of membrane interaction or of endocytosis to the process of 
intracellular nucleic acid delivery mediated by complexes were carried out. 
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3.2.7.1 Cell association 
Cell association experiments were performed at 37 °C under the same experimental 
conditions described for transfection. Briefly, HeLa cells were incubated for 4 h with 
the complexes containing the fluorescent probe Rh-PE (Avanti Polar Lipids, Alabaster, 
AL) at 5 mol%, in a final volume of 0.5 mL of serum-free OptiMEM. The medium 
containing the complexes that did not associate to cells was then collected and the 
fluorescence was measured at 37 °C following the addition of C12E8 (Sigma, St. Louis, 
MO), at a final concentration of 0.5% (v/v). To assess the fluorescence of complexes 
associated with the cells, cells were rinsed with serum-free OptiMEM, detached from 
the culture plates and then suspended in 0.5 mL of medium. The fluorescence of the 
cell suspension was measured at 37 °C in the presence of C12E8, as described above. 
The extent of cell association was determined according to the equation: 
𝐶𝑒𝑙𝑙 𝑎𝑠𝑠𝑜𝑐𝑖𝑎𝑡𝑖𝑜𝑛 =
𝐹𝑐𝑒𝑙𝑙𝑠
𝐹𝑛𝑜𝑛𝑎𝑠𝑠𝑜𝑐𝑖𝑎𝑡𝑒𝑑 + 𝐹𝑐𝑒𝑙𝑙𝑠
× 100 
where Fcells is the value of fluorescence of the complexes associated with the cells and 
Fnonassociated is the value of fluorescence of nonassociated complexes (supernatant) 
(Pedroso de Lima et al. 2003). 
 
3.2.7.2 Cellular internalization pathways 
To address the mechanisms through which surfactant-based complexes were 
internalized by cells, transfection experiments were performed both at low 
temperature (4 °C) and in the presence of inhibitors for different endocytic pathways. 
For this purpose, plated HeLa cells were washed with PBS and incubated (37 °C, 30 
min) in serum-free OptiMEM with the following inhibitors of endocytosis (from 
Sigma): (i) chlorpromazine (30 μM); (ii) fillipin III (5 μg/mL) or (iii) amiloride 
hydrochloride (5 mM). Parallel experiments were performed by incubating HeLa cells 
(not treated with these inhibitors) at 4 °C for 30 min. Thereafter, cells either 
inhibitor-treated or maintained at 4 °C were incubated with the complexes for 1 h. To 
confirm that the endocytosis inhibitors tested compromised selectively different 
endocytic pathways, their effects on the cellular uptake of fluorescently labeled 
markers (transferrin as a known marker of clathrin-mediated endocytosis, and 
lactosylceramide as a marker of raft/caveolae-dependent endocytosis) were 
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analyzed. Cytotoxicity was assessed following cell treatment with each of the drugs by 
the Alamar blue assay, as described above (section 3.2.6). Flow cytometry analysis 
was performed as described above (section 3.2.5.1) to evaluate transfection efficiency 
of the complexes in cells pre-incubated at 4 °C (a condition that impairs any energy-
dependent endocytic pathway) or at 37 °C with each of the endocytosis inhibitors 
(Pedroso de Lima et al. 2003). 
 
3.2.7.3 Analysis of siRNA internalization and intracellular distribution by confocal 
microscopy 
The efficiency of siRNA entry into the cell and its intracellular distribution is usually 
performed employing fluorescently labeled siRNAs. In the present work, HT1080 cells 
(0.2 × 105 cells/well) were plated onto 8-well chambered coverslips (Lab-Tek II, 
Thermo, Waltham, MA) and incubated for 24 h before addition of siRNA delivery 
systems. Following incubation for 4 h with naked or complex-formulated Cy3-labeled 
siRNAs, or following further 20 h of incubation in serum-containing medium, cells 
were rinsed twice with PBS and incubated with Hoechst 33342 dye (1 μg/mL, 
Molecular Probes, Eugene, OR) and immediately visualized by confocal microscopy in 
a Zeiss Axiovert confocal scanning microscope (Zeiss, Jena, Germany), under the 60⨯ 
oil immersion objective.  
 
3.2.8 STATISTICAL ANALYSIS 
Data are presented as mean ± SD of at least three independent experiments. The 
significance of the results was statistically analyzed by a one-way analysis of variance 
(ANOVA) with Tukey's multiple pairwise comparison, unless stated otherwise. 
Statistical significance was set at p < 0.05.  
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4.1 Abstract 
 
Gemini surfactants have been successfully used as components of gene delivery 
systems. In the present work, a family of gemini surfactants, represented by the 
general structure [CmH2m+1(CH3)2N+(CH2)sN+(CH3)2CmH2m+1]2Br−, or simply m-s-m, 
was used to prepare cationic gene carriers, aiming at their application in transfection 
studies. An extensive characterization of the gemini surfactant-based complexes, 
produced with and without the helper lipids cholesterol and DOPE, was carried out in 
order to correlate their physico-chemical properties with transfection efficiency. The 
most efficient complexes were those containing helper lipids, which, combining 
amphiphiles with propensity to form structures with different intrinsic curvatures, 
displayed a morphologically labile architecture, putatively implicated in the efficient 
DNA release upon complex interaction with membranes. While complexes lacking 
helper lipids were translocated directly across the lipid bilayer, complexes containing 
helper lipids were taken up by cells also by macropinocytosis. This study contributes 
to shed light on the relationship between important physico-chemical properties of 
surfactant-based DNA vectors and their efficiency to promote gene transfer, which 
may represent a step forward to the rational design of gene delivery systems. 
 
 
 chapter 4 
104 
 
  
 bis-quat gemini surfactants as gene delivery systems 
105 
 
4.2 INTRODUCTION 
 
Gemini surfactants are amphiphilic molecules composed of two sets of a polar head 
group plus an hydrocarbon chain, linked by a spacer at the level or close to the head 
group (Menger & Littau 1991). Interest in these molecules originally sparkled from 
the work of Menger and Littau in 1991 (Menger & Littau 1991), and, over the last 
twenty years, several families of gemini surfactants were produced and extensively 
studied in terms of their aggregation and surface properties (Alami et al. 1993; 
Buijnsters et al. 2002; Silva et al. 2012). Gemini surfactants have been shown to 
present several relevant biological activities, namely as antimicrobial (Murguía et al. 
2008; Badr et al. 2010; Colomer et al. 2011; Hoque et al. 2012; Obłąk et al. 2014) and 
antifungal (Murguía et al. 2008; Obłąk et al. 2013) agents. Their application in drug 
delivery has also been reported as a promising approach. In fact, recent studies have 
shown that gemini surfactants are able to facilitate drug delivery by enhancing the 
drug load and the cellular entry of a peptide-based drug delivery system (Ding et al. 
2011), and a cyclodextrin-modified gemini surfactant was used to successfully deliver 
anticancer drugs (Singh et al. 2012). However, the most extensively studied 
application of cationic gemini surfactants regards their use as nucleic acid delivery 
systems (Rosenzweig et al. 2001; Bombelli et al. 2005a; Badea et al. 2005; Badea et al. 
2007; Wang & Wettig 2011; Damen et al. 2010; Donkuru et al. 2010; Cardoso et al. 
2011; Mohammed-Saeid et al. 2012; Grigoriev et al. 2012; Wang et al. 2013). 
The therapeutic potential of DNA depends on the development of efficient and safe 
vehicles that can overcome the potential bottle-neck for intracellular gene delivery. 
Due to the propensity of gemini surfactants for structure modulation (Menger & 
Littau 1991; Rosenzweig et al. 2001; Wang et al. 2007) these compounds have been 
designed in order to promote low toxicity and immunogenicity, high stability in 
biological fluids and biodegradability, which are essential requirements for safe gene 
delivery systems (Kirby et al. 2003).  
In the case of bis-quat gemini surfactants, the presence of two quaternary ammonium 
groups per surfactant molecule, which increases their strength of interaction with 
DNA (Rosenzweig et al. 2001), as well as the hydrophobic contribution from the 
spacer, which increases surfactant tendency to self-assemble (Menger & Keiper 
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2000), contribute to enhance the formation of stable gemini surfactant-DNA 
complexes (Karlsson et al. 2002; Bombelli et al. 2005b), when compared to the 
monomeric counterparts of the gemini. The length and corresponding conformational 
flexibility of the spacer (Luciani et al. 2007), and the hydrophobicity of the two main 
hydrocarbon chains (Wang et al. 2007), influence the type of self-assembled 
structures formed a priori, as well as their complexation with DNA. Thus, gemini 
surfactants present a rich mesomorphism in aqueous solution, with the ability to 
form inter alia non-lamellar structures (Zana 2002a; In & Zana 2007), regarded as an 
important feature for transfection competence (Zuhorn et al. 2002; Wasungu et al. 
2006a; Koynova et al. 2006). In this context, cationic gemini surfactants exhibit 
suitable features for the design of promising gene delivery systems. 
In several cases, however, gemini surfactants were found to be unable to efficiently 
mediate gene delivery per se, benefiting from the addition of other components, such 
as helper lipids, to perform this task (Badea et al. 2005). The lipid 1,2-dioleoyl-sn-
glycero-3-phosphoethanolamine (DOPE) has been reported to enhance transfection 
efficiency (Hui et al. 1996; Cardoso et al. 2011) by facilitating the formation of non-
bilayer structures (Siegel & Epand 1997), and the enhancing effect of cholesterol on 
transfection has been assigned to its ability tostabilize a fluid, yet ordered, lamellar 
phase (liquid-ordered phase, Lo) (Feigenson 2006), which may guide a lipid/DNA 
arrangement that combines stability with lability, two essential features of an 
efficient gene delivery system. The incorporation of helper lipids in the surfactant-
based system has the potential to promote structural alterations and increase the 
susceptibility for DNA exposure in the presence of model membranes containing 
anionic lipids (Cardoso et al. 2011).On the other hand, in complexes formulated with 
three components—gemini surfactant, helper lipids and DNA—the order of 
component addition is decisive to the achievement of the maximal performance of the 
systems (Badea et al. 2005), as has been described for other types of gene delivery 
vectors, such as those formulated with cationic lipids (Penacho et al. 2008) or cell-
penetrating peptides (Trabulo et al. 2008; Cardoso et al. 2013). 
In the present study, the main purpose is to unveil the properties of gemini 
surfactant-based delivery systems that promote high transfection efficiency, in 
parallel with low cytotoxicity, with the ultimate goal of paving the way to a more 
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rational design of DNA delivery systems. In a previous work (Cardoso et al. 2011), a 
gemini surfactant of the alkanediyl-α,ω-bis(alkyldimethylammonium bromide) 
family, or m-s-m (Figure 4.1), containing 14 carbon atoms-long hydrocarbon chains 
and a two carbon atom-long spacer (14-2-14) showed that, in the presence of helper 
lipids, was able to protect DNA from degradation and to efficiently transfect cultured 
mouse mammary adenocarcinoma cells. In the present work, we aimed at further 
investigating this approach, by broadening the study to five bis-quaternary gemini 
surfactants of the m-s-m family differing in the length of their spacer or main 
hydrocarbon chains. These surfactants were used to assess their ability to mediate 
transfection, either per se or in a mixture with the helper lipids DOPE and cholesterol, 
kept at constant molar ratio and hence treated here as single helper lipid component. 
Efforts have thus been made to unveil the properties that underlie the most suitable 
gene delivery systems. With this purpose, an extensive characterization of gemini-
based complexes was performed in terms of their physicochemical properties (size, 
surface charge, and colloidal stability), surfactant/lipid mesomorphic behavior and 
protection conferred to the carried nucleic acids. Complex-membrane interaction, 
membrane association/binding and cellular internalization, regarded as major events 
for an effective gene delivery, were also addressed.  
 
Figure 4.1 Schematic representation of the general structure of the bis-quaternary gemini surfactants 
used in this work (s = 2, 5 or 10 and m = 12, 14 or 16). 
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4.3 MATERIALS AND METHODS 
 
Materials 
The gemini surfactants were synthesized by the method reported by Menger (Menger 
& Littau 1993) and purified by recrystallization. The purity of the compounds was 
evaluated by NMR and mass spectrometry and further confirmed by the cmc values, 
obtained by surface tension measurements, which were all in very good agreement 
with those already reported in the literature (Burrows et al. 2007; Zana 1997). The 
lipids 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE), cholesterol, 1,2-
dioleoyl-sn-glycero-3-phosphocholine (DOPC) and 1-palmitoyl-2-oleoyl-sn-glycero-3-
phospho-L-serine (POPS) were purchased from Avanti Polar Lipids (Alabaster, AL). 
All the other chemicals were of the highest grade. 
 
Cells 
HeLa cells (human epithelial cervical carcinoma cell line) were maintained in culture 
at 37 °C, under 5% CO2, in Dulbecco's modified Eagle's medium–high glucose (DMEM–
HG; Sigma, St. Louis, MO, USA), supplemented with 10% (v/v) heat inactivated fetal 
bovine serum (FBS; Sigma, St. Louis, MO, USA), penicillin (100 U/mL) and 
streptomycin (100 μg/mL). The cells were grown in monolayer and detached by 
treatment with 0.25% trypsin solution (Sigma, St. Louis, MO, USA). 
 
Complex Preparation 
Plain complexes of surfactant/DNA or ternary complexes of surfactant/helper 
lipid/DNA were prepared using two different methods (A and B). Method A was 
previously reported (Cardoso et al. 2011) and consisted of dissolving gemini 
surfactants or their mixture with DOPE and cholesterol in chloroform, at the desired 
molar ratios (3:2:1 and 3:4:2). Solutions were then dried under vacuum in a rotatory 
evaporator and the resulting lipid films were hydrated with deionised water to a final 
lipid concentration of 2 mM. Surfactant or surfactant plus lipid dispersions were then 
sonicated for 3 min, extruded 21 times through two stacked polycarbonate filters of 
50 nm pore diameter, using a Liposofast device (Avestin, Toronto, Canada), and after 
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a three-fold dilution with deionised water, they were filter-sterilized utilizing 0.22 μm 
pore-diameter filters (Schleicher & Schuell, BioScience, Germany). Plain complexes 
(surfactant/DNA) and ternary complexes (surfactant/DNA/lipid) were prepared by 
mixing 100 μL of a HEPES-buffered saline solution (HBS; 100 mM NaCl, 20 mM 
HEPES, pH 7.4) containing 0.5 μg of pEGFP-C1 plasmid DNA encoding GFP (Clontech, 
CA, USA) with a volume of the previously prepared surfactant suspensions (without 
or with lipids), to obtain surfactant/DNA (+/-) charge ratios in the range of 2/1 to 
8/1. The resulting mixtures were then incubated for 15 min at room temperature. 
Method B consisted of an adaptation of the method described by Badea and 
coworkers (Badea et al. 2005). Briefly, aqueous solutions (0.5 mM) of gemini 
surfactants were filtered through 0.22 μm pore-diameter filters (Schleicher & Schuell, 
BioScience, Germany), and a solution of DOPE and cholesterol (2:1 molar ratio) in 
chloroform was dried under vacuum in a rotatory evaporator, the resulting lipid film 
being hydrated with HBS (pH 9.0) to a final lipid concentration of 0.5 mM. The 
resulting multilamellar vesicles (MLV) of DOPE plus cholesterol were then sonicated 
for 3 min and filtered through 0.22 μm pore-diameter filters (Schleicher & Schuell, 
BioScience, Germany). Complexes were prepared by mixing 100 μl of HBS containing 
0.5 µg of pEGFP-C1 plasmid DNA encoding GFP with aliquots of the aqueous gemini 
surfactant solution, to obtain surfactant/DNA (+/-) charge ratios in the range of 2/1 
to 8/1 thereafter incubated at room temperature for 15 min. To produce the ternary 
complexes, a volume of DOPE:Chol liposomes was added to surfactant/DNA 
complexes to obtain surfactant/lipid molar ratios in the range of 1/1 to 1/2, followed 
by 30 min incubation at room temperature. 
The two methods are depicted in Figure 3.1 in Chapter 3 (Materials and Methods). 
 
Differential Scanning Calorimetry Measurements 
Aqueous solutions of gemini surfactants were incubated with DNA which, in the case 
of ternary complexes, was followed by incubation with a DOPE:Chol MLV suspension. 
In parallel, equivalent formulations lacking DNA were also prepared. The 
preparations with gemini surfactants (2.5 to 3.0 wt%) were let to stabilize at room 
temperature for 15 min and for an extra period of 30 min when they also contained 
helper lipids. The mixtures were then centrifuged at 45,000 g for 45 min at 4 °C. The 
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pellets were sealed into aluminum pans, and heating scans were performed over an 
appropriate temperature range in a Perkin–Elmer Pyris 1 differential scanning 
calorimeter at a scan rate of 5 °C/min. To check the reproducibility of data, three 
heating scans were recorded for each sample. Two distinct temperatures were 
automatically defined in the thermotropic profiles: the temperature of the onset (Ton) 
and the temperature at the endothermic peak (Tm). 
Data acquisition and analysis were performed using the software provided by 
Perkin–Elmer. 
 
Video-Enhanced Light Microscopy Analysis (VELM) 
High-contrast imaging of aqueous dispersions of gemini surfactants (2.5-3.0 wt%), of 
gemini surfactant/DNA complexes (56 mM in gemini surfactant) and of gemini 
surfactant/DNA/helper lipids (200 µM in gemini surfactant) was carried out with an 
Olympus BX51 light microscope, under differential interference contrast (DIC) mode. 
Images were acquired with an Olympus C5060 video camera and software CellA. 
Samples of gemini surfactant for microscopic observations were prepared by 
dispersion of the solid surfactant in high purity Milli-Q water. Complexes of gemini 
surfactant/DNA and gemini surfactant/DNA/helper lipids were prepared using the 
Method B, as described above. For the thermal study of the dispersions, carefully 
sealed slide/coverslip preparations were made, and temperature was controlled 
using a Linkam THMS600 heating stage (±0.1 °C). 
 
Physical Properties (Zeta Potential, Particle Size and Colloidal Stability) 
The zeta potential of the surfactant-containing structures was measured using a zeta 
sizer Nano ZS, ZN 3500, with a 532 nm laser (Malvern Instruments, UK). The 
measurements were performed in the aqueous buffer HBS, at 25 °C, using DTS 1060C 
disposable zeta cells and the protocol for general purposes (medium viscosity 0.89 
cP, medium refractive index 1.33, sample viscosity 0.89 cP, particle refractive index 
1.45 and equilibration time 3 min). Values of dielectric constant of 78.5 and beam 
mode F(Ka) of 1.5 (Smoluchowsky) were used for zeta potential determination. 
The size of the surfactant-containing particles complexed with DNA was assessed 
using a Submicron Particle Size Analyzer, Beckman Coulter N4 Plus. The colloidal 
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suspensions were diluted with HBS, and particle size analysis was carried out at a 
scattering angle of 90º and a temperature of 25 °C. 
The turbidity of gemini surfactants and complex dispersions, providing a measure of 
their colloidal stability, was monitored as a function of time in a SPECTRAmax PLUS 
384 spectrophotometer (Molecular Devices, Union City, CA) at a wavelength of 550 
nm. The final concentration of lipid plus gemini surfactant was 0.1 mM in HBS buffer, 
pH 7.4 and the turbidity values were registered over a period of 48 h. 
 
PicoGreen Fluorescence Assay 
Complexes containing 0.2 μg of plasmid DNA, prepared in a total volume of 100 μL of 
HBS, were allowed to incubate for further 15 min at 37 °C and were then transferred 
to a 96-well (blackwalled) plate (Corning, NY, USA). Hundred microliters of PicoGreen 
(Molecular Probes, Eugene, OR), diluted according to the manufacturer's instructions 
(1:200 dilution in HBS buffer), were added to each sample. The fluorescence intensity 
of PicoGreen, directly proportional to the amount of accessible/free plasmid DNA, 
was monitored in a SpexFluorolog Spectrometer for determining the extent of gemini 
surfactant-DNA complexation. The excitation and emission wavelengths were set at 
485 and 520 nm, respectively. The degree of plasmid DNA protection conferred by 
the complexes, taken as proportional to the surfactant/DNA complexation, was 
calculated as follows: 
PDNA = 1- [(F-F100)/(F0-F100)] 
where F is the fluorescence intensity measured after adding the PicoGreen solution to 
the complexes, F0 (corresponding to 0% of plasmid DNA protection) was obtained by 
using free plasmid DNA in the same amount as that associated with the complexes, 
F100 (corresponding to 100% of plasmid DNA protection) is the residual fluorescence 
intensity of a negative control obtained by using a PicoGreen solution without 
plasmid DNA, which mimicked a situation of 0% of DNA available to the PicoGreen 
solution.  
Destabilization of the complexes was accomplished by incubating them for 15 min 
with small unilamellar vesicles (SUV) of DOPC or of a mixture of DOPE:DOPC:POPS 
(2:1:1 molar ratio) and evaluated through PicoGreen fluorescence intensity as the 
difference between the protection obtained for complexes in absence of the lipid 
vesicles and that obtained in their presence. 
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Cell Viability 
Cell viability was assessed by a modified Alamar Blue assay (Simões et al. 1999). This 
assay takes into account the redox capacity of cells and measures the extent of the 
produced metabolites (resorufin) as a result of cell growth (Konopka et al. 1996). 
Briefly, 48 h after transfection 0.3 ml of 10% (v/v) resazurin dye in complete DMEM–
HG medium was added to each well. After 45 min of incubation at 37 °C, 150 μL of the 
supernatant was collected from each well and transferred to 96-well plates. The 
absorbance at 570 and 600 nm (information provided by the supplier) was measured 
in a SPECTRAmax PLUS 384 spectrophotometer (Molecular Devices, Union City, CA) 
and cell viability was calculated according to the equation:  
Cell viability (% of control) = [(A570 – A600)/(A'570 - A'600)] x100 
where A570 and A600 are the absorbances of the samples, and A’570 and A’600 are those 
of the control (non-treated cells), at the indicated wavelengths.  
 
Transfection Efficiency 
HeLa cells (0.8x105 cells/well) were seeded onto 12-well plates. Following overnight 
culture, cells were incubated with the different DNA complexes (0.5 μg of pEGFP-C1 
per well) at 37 °C, under 5% CO2, for 4 h, in OptiMEM medium. After this period, the 
medium was replaced with fresh medium containing 10% (v/v) FBS and antibiotics, 
and the cells were further incubated for 44 h to allow gene expression. The 
transfection efficiency mediated by the different complexes was evaluated through 
analysis of the expression of green fluorescent protein (GFP) by flow cytometry. 
Briefly, 48 h after transfection, cells were washed once with PBS and detached with 
0.25% trypsin (10 min at 37 °C). Cells were further washed three times by 
centrifugation (200g, 4 °C, 5 min) in ice-cold PBS. The resulting pellet was 
resuspended in ice-cold PBS, and the samples were immediately analyzed. Flow 
cytometry analysis was performed in live cells using a Becton Dickinson (NJ, USA) 
FACSCalibur flow cytometer. Data were collected and analyzed using CellQuest 
software. Live cells were gated by forward/side scattering from a total of 10,000 
events. 
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Cell Association 
Cell association experiments were performed at 37 °C under the same experimental 
conditions described for transfection. Briefly, HeLa cells were incubated for 4 h with 
the complexes containing 5 mol% of the fluorescent probe rhodamine-
phosphoethanolamine (Rh-PE; Avanti Polar Lipids, Alabaster, AL), in a final volume of 
0.5 ml of serum-free OptiMEM. The medium containing the nonassociated complexes 
was then collected and the fluorescence was measured at 37 °C following the addition 
of octaethylene glycol monododecyl ether (C12E8; Sigma, St. Louis, MO), at a final 
concentration of 0.5% (v/v). To assess the fluorescence associated with the cells, cells 
were rinsed with serum-free OptiMEM, detached from the culture plates and then 
suspended in 0.5 ml of medium. The fluorescence of the cell suspension was 
measured at 37 °C in the presence of C12E8, as described above. The extent of cell 
association was determined according to the following equation: 
% cell association= [Fcells/(Fnonassociated + Fcells)] × 100 
where Fcells is the value of fluorescence of the complexes associated with the cells and 
Fnonassociated is the value of fluorescence of nonassociated complexes (supernatant). 
 
Cellular Internalization Pathways 
To address the mechanisms through which surfactant-based complexes are 
internalized by cells, recognized inhibitors of different endocytic pathways were 
used. For this purpose, plated HeLa cells washed with PBS were pre-treated for 30 
min, at 37 °C, in serum-free OptiMEM, with the following endocytosis inhibitors (from 
Sigma): (i) chlorpromazine (30 μM); (ii) fillipin III (5 μg/mL) or (iii) amiloride 
hydrochloride (5 mM). The cells were then incubated with the complexes in the 
presence of each drug, for 1 h, at 37 °C, in serum-free OptiMEM. In order to confirm 
that these drugs compromise selectively different endocytic pathways, the effect of 
the drugs on the cellular uptake of the fluorescently labeled markers, transferrin, a 
known marker of clathrin-mediated endocytosis, and lactosylceramide, a marker of 
raft/caveolae-dependent endocytosis, was analyzed. Cytotoxicity was assessed 
following cell treatment with each of the drugs by the Alamar Blue assay, as described 
above. Flow cytometry analysis was performed as described above (Transfection 
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Efficiency section) to evaluate transfection efficiency of the complexes in cells pre-
incubated with each of the drugs. 
 
Statistical Analysis 
Data are presented as mean ± SD. The significance of the results was statistically 
analyzed by a one-way analysis of variance (ANOVA) with Tukey's multiple pairwise 
comparison. Statistical significance was set at p < 0.05. 
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4.4 RESULTS 
 
4.4.1 SELECTION OF THE METHOD OF PREPARATION OF GEMINI-BASED DNA COMPLEXES 
Two methods of preparation of gemini surfactant/DNA complexes were tested in 
order to select the one that originates the most effective and less cytotoxic complexes 
(see Figure 3.1 in Chapter 3). Figure 4.2 illustrates the cell viability (a) and the 
percentage of transfected cells (b) obtained with complexes composed of the 
surfactants 12-2-12 and 16-2-16 with DNA, at different (+/-) charge ratios, produced 
by the two methods. As shown in Figure 4.2, complexes prepared by the method A 
revealed higher cytotoxicity, mainly for the highest (+/-) charge ratios tested (Figure 
4.2a), and lower transfection efficiency (Figure 4.2b) than complexes prepared by 
the method B. It is particularly relevant the striking increase of the transfection 
ability of 16-2-16-based complexes, when prepared by the method B as compared to 
the method A.  
 
Figure 4.2 Cell viability (a) and transfection efficiency (b) of 12-2-12- (■) and 16-2-16-based (□) 
complexes prepared by the two methods described in the experimental section and illustrated in 
Figure 3.1. Cell viability and transfection efficiency were evaluated by the Alamar blue assay and flow 
cytometry analysis, respectively. Pairwise data comparisons were performed for the complexes 
produced by the method A vs. the same complex formulations produced by the method B (*p < 0.05, 
***p < 0.001). 
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Noteworthy, at the 4/1 (+/-) charge ratio, these complexes prepared by the method B 
exhibited also a relatively low cytotoxicity. The cytotoxicity and transfection 
competence of 14-2-14-based complexes (Figure 4.3), with or without the helper 
lipids DOPE:Chol (2:1), were not affected by the method of complex preparation. On 
the basis of these data, the surfactant-based complexes used in the present study 
were formulated following the method B, since besides being advantageous for 
complexes prepared with 12-2-12 and 16-2-16 surfactants, this method is simpler 
and less time consuming than method A.  
 
Figure 4.3 Cell viability (a) and transfection efficiency (b) of 14-2-14-based complexes formulated 
without (white and light grey bars) or with the helper lipids (HL) DOPE and cholesterol (black and 
dark grey bars), prepared by method A (white and black bars) and method B (light grey and dark grey 
bars), as indicated. Data comparisons were performed for each formulation prepared by the methods A 
and B (*p < 0.5). 
 
4.4.2 EVALUATION OF THE THERMAL BEHAVIOR OF GEMINI SURFACTANTS AND CORRESPONDING 
COMPLEXES WITH DNA 
In order to characterize the structures formed by gemini surfactants or mixtures of 
gemini surfactants plus helper lipids and the corresponding complexes with DNA, 
DSC and VELM experiments were performed. Figure 4.4 shows the thermal profiles 
of surfactants containing a spacer with two carbon atoms and hydrocarbon chains 
with increasing length (Figure 4.4a), as well as profiles of14-2-14 and 16-2-16 
surfactants as compared to those of the respective complexes with DNA (Figure 4.4b 
and c). Both 14-2-14 and 16-2-16, but not 12-2-12, presented an endothermic peak, 
denoting the presence of a phase transition. Taking into account that the endotherms 
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observed for these surfactants occurred at temperatures close to those reported for 
their Krafft temperatures, assessed by conductimetry (Zhao et al. 1998), they should 
represent a transition from an aqueous dispersion of surfactant crystallites to a 
micellar solution. 
 
 
Figure 4.4 DSC thermograms of 12-2-12, 14-2-14 and 16-2-16 pure gemini surfactant structures (a), of 
complexes of 14-2-14 with DNA (b) and of complexes of 16-2-16 with DNA (c) at the 8/1 (+/-) charge 
ratio. The DSC profiles are heating scans. The thermograms are typical of at least three independent 
experiments. The DSC profiles of 14-2-14 and 16-2-16 pure surfactant structures are also represented 
in the panels b and c to facilitate comparison with the respective DNA complexes. 
 
Observations by VELM (Figure 4.5) in fact confirm the presence of dispersed 
crystallites that disappear to yield an isotropic solution at about the same 
temperature as that of the DSC endothermic peaks. The temperature range of the 
phase transition of 16-2-16 surfactant structures detected by DSC and VELM was 
shifted to higher values as compared to that of 14-2-14 surfactant structures. 
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Figure 4.5 VELM micrographs of gemini surfactant dispersions prepared at 3.0 wt% (the same 
concentration as that used in DSC), namely: a) 14-2-14 and b) 16-2-16. For 14-2-14, the crystals 
started disappearing at ≈ 35 °C and full solubilization proceed until about 40 °C. For 16-2-16, 
crystallites solubilize within the range 45-50 °C, consistently with the Krafft temperature obtained in 
the present work by DSC, and in other works by conductimetry (Zhao et al., 1998).  
 
The complexation of 14-2-14 and 16-2-16 surfactants with DNA resulted in a split of 
the endotherm (Figure 4.4b and c). As clearly seen by VELM (Figure 4.6), these 
complexes form solid-like aggregates of large dimensions (typically > 25 μm), which 
remain insoluble upon heating to 80 °C. However, the heating probably induced the 
solubilization of surfactant crystallites that are not associated to DNA, giving rise to 
DSC peaks (Figure 4.4b and c) centered at the temperature of the corresponding 
DNA-free surfactants. On the other hand, the decrease of the enthalpy (∆H) of 
complex transitions as compared to that of free surfactant transitions (data not 
shown) may reflect the presence of most of the surfactant in the insoluble form (DNA-
surfactant complex). The shoulder of the peaks, shifted to slightly higher 
temperatures, can be explained by the presence of surfactant molecules establishing 
weak interactions with DNA. VELM observations clearly show that these peaks cannot 
be attributed to the solubilization of the large DNA-surfactant aggregates formed, 
since they remain noticeable at temperatures up to 80 °C (Figure 4.6). 
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Figure 4.6 VELM micrographs of plain complex dispersions (14-2-14 plus DNA, at a +/- charge ratio of 
8/1) observed upon heating. The flocs appear to be solid in nature and remain insoluble from room to 
high temperature (80 °C). Bars: 25 µm. 
 
The addition of helper lipids to the previous systems completely abolished their 
phase transitions (data not shown).  
 
4.4.3 PHYSICOCHEMICAL AND MORPHOLOGICAL CHARACTERIZATION OF GEMINI SURFACTANT-
BASED COMPLEXES WITH DNA IN THE ABSENCE OR PRESENCE OF HELPER LIPIDS 
The surface charge density and hydrodynamic diameter were determined for the 
complexes formulated with gemini surfactants and their mixtures with helper lipids, 
at the (+/-) charge ratios of 2/1, 4/1 and 8/1.  
As expected, in the absence of helper lipids, addition of DNA to the gemini surfactants, 
which exhibit a high positive surface charge, resulted in a decrease of the Zeta 
potential (Table 4.1). The only exception was observed for the 16-2-16-based 
complexes, which did not undergo a zeta potential change, with respect to the pure 
gemini, over the range of charge ratios tested (2/1, 4/1 and 8/1). The addition of 
DOPE and cholesterol to the gemini surfactants decreased consistently the zeta 
potential displayed by the pure surfactants. In the case of lipid mixtures with the 12-
2-12 and 12-10-12 surfactants, the surface charge decreased to negative values, 
despite the positive charge of surfactants and the zwitterionic character of helper 
lipids. 
Although the addition of the helper lipids to surfactant-DNA complexes, prepared at 
the 8/1 and 4/1 (+/-) charge ratios has in general resulted in a decrease of the Zeta 
potential, complexes at the 2/1 (+/-) charge ratio showed high variability regarding 
that effect. 
 
 chapter 4 
122 
 
Table 4.1 Zeta potential of HBS buffer dispersions of the surfactants or surfactants plus helper lipids 
(no DNA) and of the respective complexes with DNA at 8/1, 4/1 and 2/1 (+/-) theoretical charge 
ratios. 
 
 ζ-potential (mV)* 
no DNA plus DNA 
 8/1 (+/-) 4/1 (+/-) 2/1 (+/-) 
DOPE:Chol -26.0 (±0.1) - - - 
12-2-12 +89.0 (±12.5) +4.3 (±5.0) -3.6 (±3.3) +12.4 (±3.9) 
12-2-12: DOPE:Chol -25.9 (±4.7) -32.4 (±0.7) -34.0 (±2.3) +30.4 (±1.7) 
14-2-14 +43.3 (±0.8) +16.9 (±2.3) +12.9 (±3.4) +7.8 (±3.6) 
14-2-14: DOPE:Chol +30.4 (±6.9) -10.5 (±5.7) +13.0 (±6.4) +1.6 (±8.3) 
16-2-16 +22.2 (±3.2) +23.7 (±7.4) +22.8 (±4.8) +15.4 (±6.6) 
16-2-16: DOPE:Chol +3.9 (±9.9) -4.8 (±6.9) -13.9 (±6.6) +21.1 (±7.7) 
12-5-12 +14.3 (±2.9) +6.5 (±1.6) -0.3 (±1.4) +3.8 (±2.0) 
12-5-12: DOPE:Chol +7.6 (±1.9) -2.8 (±7.1) -3.2 (±4.5) +2.8 (±1.8) 
12-10-12 +39.1 (±9.6) +6.0 (±1.5) +5.2 (±1.4) +1.2 (±1.6) 
12-10-12: DOPE:Chol -18.6 (±2.4) -19.7 (±1.9) -10.5 (±0.4) +12.0 (±1.7) 
*The values represented are means ± standard deviation, obtained for triplicates, in 
three independent experiments. 
 
Size distribution of the complexes was evaluated as monomodal or as polydisperse, 
when the polydispersity index (PI) was found to be lower or higher than 0.3, 
respectively. Although, the polydisperse complex suspensions displayed more than 
one population, most of them presented a predominant population with an average 
size above 3 µm (Table 4.2). 
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Table 4.2 Size of HBS buffer dispersions of DNA complexes composed of surfactants or surfactants 
plus helper lipids at 2/1, 4/1 and 8/1 (+/-) theoretical charge ratios. 
 
a) The values represented are means ± standard deviation, obtained for triplicates, in 
three independent experiments. 
 
Observation of gemini surfactant-based complexes containing 12-2-12, 14-2-14 or 
16-2-16 and helper lipids, by VELM, confirmed the presence of a rich variety of self-
assembled aggregates, in particular giant vesicles of diameters between 1-6 μm 
(Figure 4.7a-c). It was also possible to observe vesicles with a fine inner structure 
(Figure 4.7a, right-hand side) and irregularly-shaped aggregates of larger 
dimensions, which appear to be composed by flocculated vesicles of smaller size 
(Figure 4.7b, right-hand side; Figure 4.7c, left-hand side). On the other hand, under 
polarized light some vesicles displayed birefringence, which unequivocally indicates 
their multilamellar structure (Figure 4.7a, left-hand side, inset). 
 
Hydrodynamic diameter (nm)a) 
2/1 (+/-) 4/1 (+/-) 8/1 (+/-) 
12-2-12 
269 ± 72 ~42% 
>3000 590 ± 83 
2243 ± 460 ~57% 
12-2-12: DOPE:Chol 2425 ± 427 
294 ±99 ~15% 
481 ± 70 
>3000 ~81% 
14-2-14 >3000 
402 ± 92 ~63% 153 ± 76 ~35% 
1953 ± 782 ~37% 858 ± 125 ~50% 
14-2-14: DOPE:Chol >3000 
225 ± 74 ~10% 212 ± 62 ~21% 
>3000 ~89% 2152 ± 685 ~78% 
16-2-16 
243 ± 85 ~10% 
>3000 >3000 
>3000 ~80% 
16-2-16: DOPE:Chol 
273 ± 106 ~23% 
>3000 
1441 ± 47 ~9% 
>3000 ~76% >3000 ~91% 
12-5-12 
324 ± 70 ~8% 322 ± 40 ~43% 198 ± 40 ~43% 
>3000 ~91% 2632 ± 583 ~56% 1628 ± 561 ~56% 
12-5-12: DOPE:Chol >3000 
236 ± 60 ~30% 
421 ± 91 
1973 ± 895 ~70% 
12-10-12 >3000 
320 ± 67 ~32% 282 ± 79 ~44% 
>3000 ~68% 2468 ± 356 ~55% 
12-10-12: DOPE:Chol >3000 
224 ± 83 ~34% 210 ± 48 ~37% 
>3000 ~67% 1910 ± 500 ~63% 
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Figure 4.7 VELM micrographs of ternary complex dispersions (gemini/helper lipids plus DNA, at a +/- 
charge ratio of 8/1) containing: a) 12-2-12; b) 14-2- 14; c) 16-2-16. Arrows point to some of the 
morphologies described in the text: birefringent multilamellar vesicles (a, right-hand side), smaller 
vesicles (b, left-hand side) and flocs of presumably vesicular aggregates (b, right-hand side; c, left-
hand-side).  
 
All complexes were found to be extremely stable over a period of at least 24 h, as 
assessed by monitoring the absorbance at 550 nm over a period of 48 h (data not 
shown).  
 
4.4.4 EVALUATION OF THE COMPLEXATION OF GEMINI SURFACTANTS WITH DNA  
The ability of gemini surfactants to complex and protect DNA was assessed by the 
PicoGreen fluorescence assay. PicoGreen is a DNA-intercalating agent, whose 
fluorescence is dramatically enhanced upon binding to DNA and quenched by 
condensation of the DNA structure; thus, allowing the determination of 
free/accessible DNA. As shown in Figure 4.8, for all the complexes tested, the 
increase in the amount of surfactant with respect to DNA (increase of (+/-) charge 
ratio) in the complex formulations resulted in a more extensive gemini-DNA 
interaction, as deduced by the reduction of PicoGreen fluorescence. With the 
exception of the 14-2-14 and 12-10-12 surfactants, which conferred almost full DNA 
protection even at the lowest (+/-) charge ratio tested, it is noticeable that the helper 
lipids enhanced DNA shielding, at least at the lowest (+/-) charge ratios. Interestingly, 
the lowest protection levels were observed for the 12-2-12 surfactant, which presents 
both the shortest and most flexible hydrocarbon chains and spacer, eventually 
supporting the weakest hydrophobic interactions with the DNA molecules. 
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Figure 4.8 Gemini-DNA interactions, as assessed by PicoGreen accessibility to DNA complexed with 
gemini surfactants or gemini surfactants plus the helper lipids (HL) DOPE and Cholesterol (2:1 molar 
ratio) at the indicated (+/-) charge ratios. The maximum fluorescence (control) corresponds to 
maximum DNA accessibility. Data comparisons were performed for the complexes at different (+/−) 
charge ratios vs. the same complex formulations at the immediately precedent (+/−) charge ratio (*p < 
0.05, **p < 0.01, ***p < 0.001) and for complexes formulated without helper lipids vs. complexes 
formulated with helper lipids (###p < 0.001). 
 
4.4.5 EVALUATION OF THE INTERACTION OF GEMINI SURFACTANT-BASED DNA COMPLEXES WITH 
MODEL MEMBRANES 
Figure 4.9 reports the destabilization of surfactant-based DNA complexes, as 
assessed by the PicoGreen fluorescence assay, upon interaction with zwitterionic 
vesicles composed of DOPC (Figure 4.9a) and anionic vesicles composed of 
DOPE:DOPC:POPS (Figure 4.9b). As shown, zwitterionic vesicles were unable to 
destabilize the complexes to a great extent. In fact, in some conditions, an increased 
“stabilization” of the structures was even observed, suggesting that the wrapping of 
the lipid vesicles around the complexes promoted a decrease of DNA exposure to the 
fluorescent probe. Complexes containing helper lipids were more extensively 
destabilized by the zwitterionic and anionic lipid vesicles than their counterparts 
lacking helper lipids. On the other hand, the extent of destabilization of complexes 
prepared with helper lipids decreased with the increase of surfactant hydrocarbon 
chain length. For complexes containing surfactants with spacers of different length, 
the lowest degree of destabilization (and, in some cases, higher degree of 
stabilization) was found with the surfactant presenting the intermediate spacer (5 
carbon atoms). The pattern of complex destabilization regarding its dependence on 
surfactant characteristics was similar for both zwitterionic and anionic vesicles. 
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However, destabilization induced by the anionic vesicles occurred in a larger extent 
than that observed for zwitterionic vesicles. 
 
 
Figure 4.9 Destabilization of gemini surfactant-based DNA complexes induced by zwitterionic lipid 
vesicles of DOPC (a) or anionic vesicles of DOPE:DOPC:POPS at 2:1:1 molar ratio (b), as assessed by 
PicoGreen accessibility. The complexes containing the surfactants indicated in the figure were 
prepared at 2/1 (□), 4/1 (■) and 8/1 (■) (+/-) charge ratios and with (striped bars) or without (plain 
bars) helper lipids. Maximum destabilization corresponds to maximum DNA accessibility. 
 
4.4.6 COMPARISON OF THE CYTOTOXICITY OF DIFFERENT GEMINI SURFACTANT-BASED DNA 
COMPLEXES 
Figure 4.10 presents the results of viability observed in HeLa cells following 
incubation with gemini surfactant-based complexes, adding or not the helper lipids 
DOPE and cholesterol (2:1 molar ratio). As shown, complexes formulated with the 
gemini surfactants containing two carbon atom-long spacers exerted very low 
cytotoxicity on HeLa cells, at the lowest (+/-) charge ratios tested (2/1 and 4/1), and 
complexes prepared with 14-2-14 maintained a low cytotoxicity even at the highest 
(+/-) charge ratio tested (8/1). The addition of helper lipids to complexes composed 
of 12-2-12 or 16-2-16 and DNA, at the 8/1 (+/-) charge ratio, decreased their 
cytotoxicity. On the other hand, gemini surfactants containing longer spacers (s = 5 or 
10) produced highly toxic complexes, even at the lowest charge ratios tested, which 
was not reverted by the addition of helper lipids. Hence, complexes formulated with 
surfactants owning spacers longer than two carbon atoms revealed to be unsuitable 
for the delivery of nucleic acids, being therefore excluded from the subsequent 
experiments. 
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Figure 4.10 Viability of HeLa cells upon incubation with complexes composed of 12-2-12 (■), 14-2-14 
(■), 16-2-16 (■), 12-5-12 (■) or 12-10-12 (□) surfactants and DNA, containing or not the helper lipids 
(HL) DOPE and Cholesterol (2:1 molar ratio). Cell viability is expressed as a percentage of a control 
(non-treated cells). Pairwise data comparisons were performed for the complexes produced without 
helper lipids vs. the same complexes containing helper lipids (*p < 0.05). 
 
4.4.7 TRANSFECTION EFFICIENCY OF NON-TOXIC GEMINI SURFACTANT-BASED DNA COMPLEXES 
Aiming at establishing a putative dependence of the biological activity of the non-
toxic complexes and their physico-chemical properties, the ability of complexes 
formulated with 12-2-12, 14-2-14 and 16-2-16 gemini surfactants to transfect HeLa 
cells was evaluated (Figure 4.11). As shown in the figure, an increase of transfection 
competence was noticed with the increase of surfactant hydrocarbon chain length. On 
the other hand, the addition of helper lipids to the composition of the complexes 
resulted in an improvement of their ability to mediate gene expression. This effect 
was particularly relevant for the complexes formulated with the surfactants 12-2-12 
and 14-2-14, which displayed low levels of transfection in the absence of the helper 
lipids (maximum transfection of 6.6 and 14.4%, respectively), that increased to a 
maximum of 45.7 and 44.2%, respectively, in the presence of the lipids. The gemini 
surfactant 16-2-16, which already displayed relatively high transfection levels 
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(maximum of 32.1%) in the absence of helper lipids, also showed to benefit from the 
addition of these lipids, mainly at the highest (+/-) charge ratio tested, with a 
maximum of 53.9% transfected cells. 
 
Figure 4.11 Transfection efficiency of gemini surfactant-based DNA complexes containing12-2-12 (■), 
14-2-14 (■) and 16-2-16 (□) gemini surfactants with or without helper lipids (HL), prepared at the 
indicated (+/-) charge ratios. Data comparisons were performed for HL-containing complexes vs.the 
corresponding HL-free complexes at the same (+/−) charge ratio (*p < 0.05, ***p < 0.001). 
 
4.4.8 EVALUATION OF THE EXTENT OF COMPLEX-CELL ASSOCIATION 
In order to gain insights into the mechanisms underlying the effects of gemini 
hydrocarbon chain length, the presence of helper lipids and the charge ratio of 
gemini-based complexes on transfection efficiency, the influence of those parameters 
on the extent of complex association with HeLa cells was evaluated. For this purpose, 
the gemini-based complexes, prepared without or with helper lipids at different (+/-) 
charge ratios and containing a rhodamine-labeled lipid, were incubated with HeLa 
cells at 37 °C. It is important to note that cell association encompasses the processes 
of binding, fusion with the plasma membrane, endocytosis and fusion with the 
endosomal membrane (da Cruz et al. 2001). Figure 4.12 shows that complex-cell 
association was not affected by the gemini hydrocarbon chain length, whereas the 
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addition of helper lipids decreased the extent of cell-association for all the complexes. 
The (+/-) charge ratio of surfactant-based complexes did not influence cell 
association in the absence of helper lipids. However, for complexes containing helper 
lipids the increase of (+/-) charge ratio promoted a reduction of cell-association.  
 
 
Figure 4.12 Effects of surfactant chain length, surfactant/DNA (+/-) charge ratio and presence of 
helper lipids on the extent of association of gemini surfactant-based complexes to HeLa cells at 37 °C. 
Extent of complex-cell association is expressed as a percentage of the total rhodamine fluorescence 
corresponding to the complexes associated to cells plus that of the nonassociated complexes 
(fluorescence of the supernatant). Data represent the mean ± SD from two independent experiments 
carried out in triplicate. Data comparisons were performed for complexes without helper lipids vs. the 
same complexes formulated with helper lipids (***p < 0.001, ns, non-significant).  
 
4.4.9 CELLULAR INTERNALIZATION PATHWAYS OF GEMINI SURFACTANT-BASED DNA COMPLEXES 
Eukaryotic cells use different endocytic pathways to internalize extracellular 
molecules, and the selected mechanism determines their intracellular fate. Therefore, 
the route of internalization of DNA complexes might affect the kinetics of their 
intracellular processing and, consequently, transfection efficiency. 
Cellular internalization mechanisms of gemini surfactant-based complexes were 
examined by flow cytometry by evaluating the transfection levels of cells pre-
incubated with the pharmacological inhibitors of clathrin-mediated endocytosis 
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(chlorpromazine), macropinocytosis (amiloride hydrochloride) and endocytic 
processes occurring in lipid raft domains of the membrane (filipin III). It is important 
to note that, among these inhibitors, only chlorpromazine is currently accepted as 
being an inhibitor of a specific endocytosis pathway (clathrin-mediated endocytosis), 
by preventing clathrin-coated pit formation at the plasma membrane. Although the 
other inhibitors are less specific, amiloride hydrochloride inhibits the Na+/H+ 
exchanger protein, and hence, contributes to the acidification and suppression of the 
forming micropinosome ruffle; thus, being recognized as an inhibitor of 
macropinocytosis. On the other hand, filipin III binds cholesterol; therefore, making 
lipid rafts unavailable for both caveolae and non-caveolae mediated endocytosis. 
Studies were conducted to investigate the internalization pathways of gemini 
surfactant-based DNA complexes composed of 16-2-16 without helper lipids (data 
not shown) and with helper lipids, prepared at 2/1, 4/1 and 8/1 (+/-) charge ratios, 
as well as complexes composed of 12-2-12 or 14-2-14 and helper lipids at the 8/1 
(+/-) charge ratio (Figure 4.13).  
Similar transfection efficiency was observed in cells that had been exposed to the 
endocytosis inhibitors, prior to transfection with complexes of 16-2-16 plus DNA (at 
2/1, 4/1 and 8/1 +/- charge ratios) and in untreated control cells (data not shown). 
This indicates that the internalization of these complexes did not involve commonly 
reported endocytic pathways, but most likely, occurred through direct membrane 
translocation at non-raft domains. On the other hand, complexes produced from the 
gemini surfactants plus DNA and helper lipids presented a decrease in the 
transfection efficiency when cells were incubated with amiloride hydrochloride, 
indicating that, at least partially, these complexes are internalized by 
macropinocytosis (Figure 4.13). 
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Figure 4.13 Effect of different endocytosis inhibitors on transfection mediated by gemini/DNA/lipid 
complexes. HeLa cells were incubated with either 30 μM of chlorpromazine (□), 5μg/ml of fillipin III 
(■), or 2.5 mM of amiloride hydrochloride (■) and then transfected with the complexes containing 
helper lipids and prepared at the indicated charge ratios. Transfection in the presence of each inhibitor 
is expressed as percentage of transfected cells but not treated with the drugs (control). Data is 
presented as mean ± standard deviation, representative of at least three independent experiments. 
Data comparisons were performed between each condition tested and the respective control 
corresponding to 100% of transfected cells (*p<0.05, **p<0.01, ***p<0.001). 
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4.5 DISCUSSION 
 
A variety of molecules have been studied over the years with the ultimate goal of finding 
systems able to efficiently deliver their cargo to target cells without presenting the 
disadvantages associated with viral vectors. In parallel to the comprehensive evaluation of 
transfection efficiency of a multitude of nonviral delivery systems, several different 
approaches have been employed to correlate structure and biological activity by 
determining characteristics shared by the systems that are able to efficiently accomplish 
that task (Aleandri et al. 2013; Foldvari et al. 2006). 
In the present work, we attempted to correlate the transfection efficiency of DNA 
complexes based on gemini surfactants from the alkanediyl-α,ω-
bis(alkyldimethylammonium bromide) family with their physico-chemical properties, 
aiming at unraveling key features amenable to efficient gene delivery. 
The method of complex preparation revealed to be determinant for the efficiency of 
transfection as well as for the cytotoxic profile. The main difference between the two 
methods tested for complex formation relied on the order of component addition, which 
was also shown to affect the efficiency of other delivery systems (Badea et al. 2005; 
Trabulo et al. 2008; Cardoso et al. 2013). Additionally, the complexes formed by the 
simple mixture of their components without further extrusion (method B) were larger than 
the ones formed by the method A, which underwent an additional step of extrusion. This 
fact can be deduced by comparing the size of the 14-2-14-based complexes produced here 
(sizes from 400 to more than 3000 nm in the absence of helper lipids and larger than 2000 
nm in their presence) with that of complexes based on the same surfactant but formulated 
with the extrusion step (sizes from 230 to 2100 nm in the absence of helper lipids and from 
170 to 1600 nm in their presence), as previously reported (Cardoso et al. 2011). In vitro 
studies have shown that complexes with a large size are often well succeeded in 
transfection, which has been assigned to their capacity to sediment over the adherent 
cultured cells, increasing the contact area between the complex and the cellular surface, 
and hence facilitating their internalization. Furthermore, large complexes are able to carry 
great amounts of DNA, which associated to a high efficiency of internalization should 
contribute to high transfection levels. On the other hand, although the small size of 
delivery systems has been described as an essential feature for in vivo application 
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involving intravenous administration, so that capillary retention of the complexes can be 
avoided, other in vivo administration routes (intraperitoneal, intramuscular or subcutaneous 
routes) do not exhibit the same size requirement, the retention issue being circumvented in 
such cases (Neves et al. 2006; Pfeiffer et al. 2006; Donkuru et al. 2010). 
Interestingly, most of the complexes produced in the present study that were able to 
efficiently transfect cells showed sizes larger than 3 µm. The size of the complexes has 
been shown to affect their route of internalization (Rejman et al. 2004; Conner & Schmid 
2003). In this regard, macropinocytosis has been reported to allow internalization of 
particles larger than 1 µm and, consistently, this pathway showed to be an important 
mechanism for the uptake of the large gemini-based complexes containing helper lipids. 
However, the cell uptake mechanism of 16-2-16/DNA complexes, apparently a direct 
translocation across the membrane, should depend, rather than on their size (large as well), 
on other characteristics of the particles, such as their ability to interact with cellular 
membranes, as demonstrated in the present work and evoked as being determinant for the 
success of transfection of nonviral delivery systems (Barenholz 2001).  
Another physico-chemical property traditionally recognized as being determinant of 
transfection efficiency regards the Zeta potential displayed by the complexes. Although 
most of nonviral delivery systems present positive Zeta potential, due to the presence of 
excess positive charges from the cationic component, complexes presenting negative Zeta 
potential have also been reported in the literature as being successfully used in drug 
delivery (Simões et al. 1998; Faneca et al. 2004; Donkuru et al. 2010), which has been 
assigned to reduced interactions with negatively charged serum proteins. This finding is in 
accordance with our observation that DNA complexes formulated with 12-2-12, 14-2-14 or 
16-2-16 gemini surfactants and helper lipids, although displaying negative Zeta potentials, 
were able to efficiently transfect HeLa cells. This issue will be further explored, towards a 
putative application of these surfactants to produce nucleic acid delivery systems to be 
administered in vivo. The negative surface charge of these complexes probably results 
from the different supramolecular arrangement of the molecules, which depends on the 
interplay of hydrophobic interactions established between surfactant hydrocarbon chains 
and the plasmid DNA, and electrostatic interactions between the charged surfactant polar 
groups and DNA phosphate groups. However, it is interesting to note that structures 
composed of gemini surfactants and helper lipids in the absence of DNA also present a 
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negative surface charge, which may result from the adsorption of inorganic anions from the 
medium, which might also explain the negative Zeta potential of the helper lipids per se 
(Table 4.1). 
A relationship between the transfection efficiency of nonviral delivery systems and their 
ability to adopt different structures has also been described in the literature (Foldvari et al. 
2006). Thus, the coexistence of distinct packing arrangements may originate structural 
defects, which can favor drug delivery (Barenholz 2001). The supramolecular structure 
adopted by the surfactants in solution depends on inherent characteristics of the molecules, 
such as the length of their chains and spacer, and on the concentration at which they are 
present in the aqueous medium (lyotropism). In this regard, it is important to mention that 
aqueous dispersions of 16-s-16 gemini surfactants have been shown to exhibit a richer 
phase behavior, presenting more phases across a concentration range, than those of 12-s-12 
(Zana & In 2005; Fuller et al. 1996; Alami et al. 1993). The present study of the thermal 
behavior of hydrated gemini surfactant structures, by DSC and VELM, showed that 
structures composed of 14-2-14 and 16-2-16 gemini surfactants, but not of 12-2-12, present 
a phase transition in the temperature range assayed. More interesting, in the context of this 
study, is the finding that ternary complexes (surfactant/DNA/helper lipids) displaying 
transfection capacity can form a diversity of vesicle structures in solution, as revealed by 
VELM micrographs (Figure 4.7). Thus, individual vesicles of different size and structure, 
including multilamellar vesicles, have been observed together with irregular aggregates of 
large dimensions, which seem to result from the flocculation of vesicles of smaller size. In 
fact, DNA complexes of 16-2-16 plus DOPE were shown to present at least two coexisting 
phases, one lamellar phase enriched in cationic surfactant and one ambiguous structure, 
enriched in the helper lipid, which could correspond to a lamellar or an inverted hexagonal 
phase. Furthermore, these complexes were found to be compacted in a multilamellar 
sandwiched structure (Muñoz-Úbeda et al. 2012). Unfortunately, VELM micrographs did 
not reveal structural details of samples composed of plain complexes, which appeared as 
clear and colorless liquids, probably corresponding to dispersions of very small crystallites 
(smaller than 400 µm). Other systems exhibiting a lamellar-to-non-lamellar phase 
transition at a temperature close to the physiological temperature, have been shown to 
mediate transfection more efficiently than those lacking that feature (Zuhorn et al. 2007; 
Wasungu et al. 2006a). This fact was interpreted in terms of pH-driven interaction of the 
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delivery system with the endosomal membrane, after the gene-carrying particles had been 
endocytosed (Zuhorn et al. 2007; Wasungu et al. 2006b). Such transition from lamellar-to-
non-lamellar phases could not be identified at the experimental conditions used herein. 
However, the rich variety of self-assembled aggregates revealed by VELM, which could 
result from the combination of amphiphiles which tend to form aggregates of opposite 
curvature — gemini with propensity to form micelles of high positive curvature and DOPE 
able to form inverted structures of negative curvature — allow to predict the generation of 
structures with high curvature strain andintermediate spontaneous curvatures, i.e., bilayer 
structures. 
In this context, it is noteworthy that the complexes used herein able to efficiently mediate 
transfection were internalized through direct membrane translocation with some 
contribution of macropinocytosis. This indicates that complex interaction with the 
endosomal membrane is important only for a relatively small portion of complexes that are 
endocytosed. On the other hand, the multiplicity of aggregates originated by gemini-
surfactant-based complexes with helper lipids in aqueous dispersions, at concentrations 
close to those used in the preparation of complexes for the transfection studies, could 
provide the complexes with sufficient lability to allow DNA dissociation upon interaction 
with certain membrane structures. Therefore, in order to better appreciate the ability of 
gemini surfactant-based complexes to mediate effective delivery of the DNA cargo into the 
cell, assays of complex destabilization in the presence of lipid membrane models were 
performed. Successful transfection depends on surpassing a series of cellular barriers, 
including nucleic acid release from the delivery system. On the other hand, a premature 
release of the cargo may lead to its degradation before reaching the cell target, thus, 
preventing transgene expression. The studies of complex destabilization induced by lipid 
vesicles showed that complexes formulated with the surfactant containing the spacer of 
intermediate length (s = 5) were more prone to be destabilized both by zwitterionic and 
anionic vesicles, as compared to complexes prepared with surfactants containing the 
shortest and the longest spacer (Figure 4.9). This behavior is consistent with what has been 
reported in the literature, stating that a more efficient DNA compaction is promoted by 
gemini surfactants having either short (< 4) or long (> 10) spacers, as compared to 
surfactants having intermediate length spacers (Karlsson et al. 2002). In fact, surfactants 
containing short or long spacers induce more efficiently a Ψ-phase in DNA, which is a 
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tightly packed condensed form of DNA (Zuidam et al. 1999). A distance of 4.9 Å between 
surfactant amine groups has been reported to be ideal for their interaction with adjacent 
phosphate groups of DNA (Wettig et al. 2008), this distance being closer to the one 
measured for gemini surfactants containing < 3 carbon atom long spacers. The similar 
destabilization pattern obtained for complexes containing surfactants with short and long 
spacers might reflect the ability of the 12-10-12 surfactant to coil its spacer, originating a 
headgroup area resembling that of 12-2-12 surfactant, as previously reported (Almeida et 
al. 2011).  
On the other hand, gemini surfactant-based complexes with long spacers induced high 
levels of cytotoxicity, which made them unsuitable for gene delivery purposes. In this 
regard, it was reported (Almeida et al. 2011) that the highly toxic 12-10-12 gemini 
surfactant was able to induce leakage of aqueous contents from lipid models formulated to 
mimic the composition of a cell membrane, while the less toxic 12-2-12 and 14-2-14 
gemini surfactants showed only a residual percentage of membrane destabilization.  
Regarding the gemini surfactant-based complexes with competence for gene delivery, it 
was shown that they combine low cytotoxicity with high cell association, different levels 
of DNA interaction and intermediate capacity to be destabilized in the presence of 
membrane lipid models. It was also shown that all the gemini surfactant-based complexes 
able to promote transfection without inducing cytotoxicity benefit from the addition of 
helper lipids. However, although improving transfection ability, these lipids induced a 
reduction of the extent to which complexes associate to cells. Therefore, other steps in the 
transfection process, rather than cell-association, are improved by the addition of helper 
lipids, such as the propensity of DNA to dissociate from the complexes, resulting from a 
general decrease of the positive surface charge density of the complexes, which in some 
cases involves an inversion of the charge from positive to negative. 
Altogether, our results draw attention to the importance of conducting studies on DNA 
complex-membrane interactions in order to fully evaluate the physical and structural 
properties that a delivery system should present to enhance its performance, and contribute 
to establish guidelines towards the design of efficient nonviral systems for nucleic acid 
delivery.  
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New Serine-derived Gemini surfactants as gene 
delivery systems 
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Marques, M.C. Pedroso de Lima and A.S. Jurado, “New Serine-
derived Gemini surfactants as gene delivery systems” Under review 
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5.1 ABSTRACT 
 
Gemini surfactants have been extensively used for in vitro gene delivery. Amino acid-
derived gemini surfactants gather the special aggregation properties characteristic of 
the gemini surfactants allied to high biocompatibility and biodegradability. In this 
work, new serine-derived gemini surfactants, differing in alkyl chain lengths and in 
the linker group bridging the spacer to the headgroups (amine, amide and ester),were 
evaluated for their ability to mediate gene delivery either per se or in combination 
with helper lipids. Gemini surfactant-based DNA complexes were characterized in 
terms of hydrodynamic diameter, surface charge, stability in aqueous buffer and 
ability to protect DNA. Efficient formulations, able to transfect up to 50% of the cells 
without causing toxicity, were found at very low surfactant/DNA charge ratios (1/1 
to 2/1). The most efficient complexes presented sizes suitable for intravenous 
administration and negative surface charge, a feature known to preclude potentially 
adverse interactions with serum components. This work brings forward a new family 
of gemini surfactants with great potential as gene delivery systems. 
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5.2 INTRODUCTION 
 
New biocompatible materials, such as gemini surfactants mimicking natural 
amphiphilic structures, featured by low toxicity and high biodegradability and thus 
overcoming environmental concerns and suiting pharmaceutical applications, have 
recently emerged (Morán et al. 2004). Gemini surfactants composed of two sets of an 
ionic group and an hydrocarbon chain, linked by a spacer at the level of or close to the 
head group (Menger & Littau 1991), have shown to exhibit special surface and 
aggregation properties, which allow a decrease of the concentration needed for a 
therapeutic effect and thus minimize their potential toxicity (Alami et al. 1993; 
Buijnsters et al. 2002; Silva et al. 2012). The inclusion of aminoacid moieties in these 
structures has shown to influence their intermolecular behavior, due to the chiral 
centers that allow the formation of aggregates with a variety of morphologies (Fan et 
al. 2008; Silva et al. 2012; Brito et al. 2013), and to enhance their biodegradability and 
thus their safe use in biological applications (McGregor et al. 2001; Yang et al. 2010). 
The presence of various functional groups in the amino acid offers the possibility of a 
great structural variability in the resulting surfactants that can be finely tuned in 
order to obtain an effective control of their aggregation properties and biological 
activity. For example, their sensitivity to pH, which is of the utmost relevance in 
biomedical applications, can be tailored through the introduction of amide/ester 
bonds. In particular, pH-sensitivity of surfactants used as gene delivery systems can 
promote DNA release inside the cells in response to the low pH of the endosomal 
compartment. 
Serine-derived gemini surfactants have been recently synthesized for the first time 
(Silva et al. 2012). These surfactants are modified in two serine amino acid residues, 
which are polar yet uncharged, thus acquiring one positive charge at the amine 
functional group of each serine residue. This new family of serine-derived gemini 
surfactants comprises three different series of compounds, designated, according to 
the nature of the spacer linkage to the headgroup, as the amine series (Figure 5.1A), 
the amide (Figure 5.1B) and the ester series (Figure 5.1C). For the amine series, 
compounds with different alkyl chain lengths were prepared. The impact of this new 
family of gemini surfactants on the viability of HeLa cells has been studied aiming at 
their application in the pharmaceutical field (Silva et al. 2013). With respect to their 
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monomeric counterparts as well as to conventional bis-quaternary gemini surfactants 
with similar hydrocarbon chains and spacer length, serine derivatives show the 
advantage of exerting lower cytotoxic effects. 
In the present work, six members of this new family of serine-derived gemini 
surfactants were studied towards their application as gene delivery systems in gene 
therapy. For this purpose, serine-derived gemini surfactants were complexed with a 
reporter gene and evaluated for their capacity to mediate transfection, while inducing 
low cytotoxicity. Complexes were characterized in terms of physico-chemical 
properties relevant for their in vivo application, such as their hydrodynamic diameter, 
surface charge and stability in an aqueous buffer. Furthermore, the ability of the 
complexes to condense and protect DNA was assessed using a DNA-intercalating 
agent, as an approach to predict the degree of DNA protection from nuclease 
degradation. However, in order to promote an efficient gene delivery, the complexes 
should be able to dissociate upon interaction with cell membrane structures. In this 
context, membrane-mimicking lipid models were used to evaluate complex cell 
interactions. In an attempt to unravel the intracellular traffic of the complexes 
(leading to the endolysosomal degradative route or bypassing this obstacle), the 
cellular internalization pathways used for the uptake of the complexes able to 
efficiently mediate transfection were also evaluated. 
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Figure 5.1 Schematic representation of serine-derived gemini surfactants: (A) amine series, herein 
designated (nSer)2Nm, (m=5 and n=12, 14, 16 and 18); (B) amide, (12Ser)2CON5, and ester, 
(12Ser)2COO5, series (n=12). All the surfactants contain fully saturated alkyl chains. 
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5.3 MATERIALS AND METHODS 
 
Materials 
The gemini surfactants were synthesized by the method reported by Silva (Silva et al. 
2012) and purified by column chromatography. The purity of the compounds was 
assessed by NMR and mass spectrometry and further confirmed by the cmc values, 
obtained by surface tension measurements, which were all in very good agreement 
with those already reported (Silva et al. 2012). The lipids 1,2-dioleoyl-sn-glycero-3-
phosphoethanolamine (DOPE), cholesterol, 1,2-dioleoyl-sn-glycero-3-phosphocholine 
(DOPC) and 1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-L-serine (POPS) were 
purchased from Avanti Polar Lipids (Alabaster, AL). All the other chemicals were of 
the highest grade. 
 
Preparation of DNA complexes 
Complexes were prepared using the method described by (Badea et al. 2005) with a 
few modifications (Cardoso et al. 2014). Briefly, aqueous solutions (0.5 mM) of gemini 
surfactants were filtered through 0.22 μm pore-diameter filters (Schleicher & Schuell, 
BioScience, Germany) and a solution of 1,2-dioleoyl-sn-glycero-3-
phosphoethanolamine (DOPE) and cholesterol (Chol) (Avanti Polar Lipids, Alabaster, 
AL, USA) in chloroform was dried under vacuum in a rotatory evaporator, the 
resulting lipid films being hydrated with HBS (pH 9.0) to a final lipid concentration of 
0.5 mM. The resulting multillamelar vesicles (MLV) of DOPE plus cholesterol were 
then sonicated for 3 min and filtered through 0.22 μm pore-diameter filters 
(Schleicher & Schuell, BioScience, Germany). Plain complexes were prepared by 
mixing 100 µL of HBS containing 0.5 µg of pEGFP-C1 plasmid DNA encoding GFP with 
aliquots of the aqueous gemini surfactant solution, to obtain a gemini/DNA charge 
ratios in the range of 1/1 to 8/1 thereafter incubated at room temperature for 15 
min. To produce ternary complexes, a volume of DOPE:Chol liposomes was added to 
surfactant/DNA complexes to obtain surfactant/helper lipids molar ratios in the 
range of 1/1 to 1/4, followed by 30 min incubation at room temperature. 
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Cells 
HeLa cells (human epithelial cervical carcinoma cell line) were maintained in culture 
at 37 °C, under 5% CO2, in Dulbecco’s Modified Eagle’s medium-high glucose (DMEM-
HG; Sigma, St Louis, MO, USA) supplemented with 10% (v/v) heat inactivated fetal 
bovine serum (FBS; Sigma, St. Louis, MO, USA), penicillin (100 U/mL) and 
streptomycin (100 µg/mL). The cells were grown in monolayer and detached by 
treatment with 0.25% trypsin solution (Sigma, St. Louis, MO, USA). 
 
Cell Viability 
Cell viability was assessed by a modified Alamar Blue assay (Simões et al. 1999). This 
assay takes into account the redox capacity of cells and measures the extent of the 
produced metabolites (resorufin) as a result of cell growth (Konopka et al. 1996). 
Briefly, 48 h after transfection 0.3 mL of 10% (v/v) resazurin dye in complete DMEM-
HG medium were added to each well. After 45 min of incubation at 37 °C, 150 μL of 
the supernatant was collected from each well and transferred to 96-well plates. The 
absorbance at 570 and 600 nm (information provided by the supplier) was measured 
in a SPECTRAmax PLUS 384 spectrophotometer (Molecular Devices, Union City, CA) 
and cell viability was calculated according to the equation: 
Cell viability (% of control) = [(A570 - A600)/(A'570 - A'600)] x100 
where A570 and A600 are the absorbances of the samples, and A’570 and A’600 are those 
of the control (non-treated cells), at the indicated wavelengths.  
 
Transfection efficiency 
HeLa cells (0.8 x 105 cell/well) were seeded onto 12-well plates. Following overnight 
culture, cells were incubated with the different DNA complexes (0.5 μg of pEGFPC1 
per well) at 37 °C under 5% CO2 for 4 h, in OptiMEM medium, or in DMEM medium 
containing 5 or 10% (v/v) FBS. After this period, the medium was replaced with fresh 
medium containing 10% (v/v) FBS and antibiotics, and the cells were further 
incubated for 44 h to allow gene expression. The transfection efficiency mediated by 
the different complexes was evaluated trough analysis of the expression of green 
fluorescent protein (GFP) by flow cytometry. Briefly, 48 h after transfection, cells 
were washed once with PBS and detached with 0.25% trypsin (10 min at 37 °C), and 
again washed three times by centrifugation (200g, 4 °C, 5 min) in ice-cold PBS. The 
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resulting pellet was resuspended in ice-cold PBS and the samples were immediately 
analyzed. Flow cytometry analysis was performed in live cells using a Becton 
Dickinson (NJ, USA) FACScalibur flow cytometer. Data were collected and analyzed 
using CellQuest software. Live cells were gated by forward/side scattering from a 
total of 10,000 events. 
 
Cellular internalization pathways 
To address the mechanisms through which surfactant-based complexes are 
internalized by cells, recognized inhibitors of different endocytic pathways were 
used. Thus, plated HeLa cells washed with PBS were pre-treated for 30 min, at 37 °C, 
in serum-free OptiMEM, with the following endocytosis inhibitors (from Sigma): (i) 
chlorpromazine (30 μM); (ii) fillipin III (5 μg/mL) or (iii) amiloride hydrochloride 
(5 mM). The cells were then incubated with the complexes in the presence of each 
inhibitor, for 1 h, at 37 °C, in serum-free OptiMEM. To confirm that inhibitors 
compromise selectively different endocytic pathways, their effect on the cellular 
uptake of the fluorescently labeled markers, transferrin, a known marker of clathrin-
mediated endocytosis, and lactosylceramide, a marker of raft/caveolae-dependent 
endocytosis, was analyzed. Cytotoxicity was assessed following cell treatment with 
each of the drugs by the Alamar blue assay (as described above). Flow cytometry 
analysis was performed as described in the Transfection Efficiency section to evaluate 
transfection efficiency of the complexes in cells pre-incubated with each of the drugs. 
 
Surfactant-DNA interactions 
Complexes containing 0.2 μg of plasmid DNA, prepared in a total volume of 100 μL of 
HBS, were allowed to incubate for further 15 min at 37 °C and were then transferred 
to a 96-well (blackwalled) plate (Corning, NY, USA). Hundred microliters of PicoGreen 
(Molecular Probes, Eugene, OR), diluted according to the manufacturer's instructions 
(1:200 dilution in HBS buffer), were added to each sample. The fluorescence intensity 
of PicoGreen, which is directly proportional to the amount of accessible/free plasmid 
DNA, was monitored in a Spex Fluorolog Spectrometer for determining the extent of 
gemini surfactant-DNA complexation. The excitation and emission wavelengths were 
set at 485 and 520 nm, respectively. The degree of plasmid DNA protection conferred 
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by the complexes, taken as proportional to the surfactant/DNA complexation, was 
calculated as follows: 
PDNA = 1- [(F-F100)/(F0-F100)] 
where F is the fluorescence intensity measured after adding the PicoGreen solution to 
the complexes, F0 (corresponding to 0% of plasmid DNA protection) was obtained by 
using free plasmid DNA in the same amount as that associated with the complexes, 
F100 (corresponding to 100% of plasmid DNA protection) is the residual fluorescence 
intensity of a negative control obtained by using a PicoGreen solution without 
plasmid DNA, which mimicked a situation of 0% of DNA available to the PicoGreen 
solution.  
Destabilization of the complexes was accomplished by incubating them for 15 min 
with small unilamellar vesicles (SUV) of DOPC or of a mixture of DOPE:DOPC:POPS 
(2:1:1 molar ratio) and evaluated through PicoGreen fluorescence intensity as the 
difference between the protection obtained for complexes in absence of the lipid 
vesicles and that obtained in their presence. 
 
Physico-Chemical Properties of the DNA complexes (Particle Size, Zeta Potential, 
Colloidal Stability) 
The size of the surfactant-based structures was assessed using a Submicron Particle 
Size Analyzer, Beckman Coulter N4 Plus. The colloidal suspensions of the complexes 
were diluted with HBS, and the particle size analysis was carried out at a scattering 
angle of 90° and a temperature of 25 °C. 
The zeta potential of the surfactant-based structures was measured using a zeta sizer 
Nano ZS, ZN 3500, with a 532 nm laser (Malvern Instruments, UK). The 
measurements were performed in HBS, at 25 °C, using DTS 1060C disposable zeta 
cells and the protocol for general purposes (medium viscosity 0.89 cP, medium 
refractive index 1.33, sample viscosity 0.89 cP, particle refractive index 1.45 and 
equilibration time 3 min).Values of dielectric constant of 78.5 and beam mode F(Ka) 
of 1.5 (Smoluchowsky) were used for zeta potential determination. 
The turbidity of gemini surfactants and complex dispersions, providing a measure of 
their colloidal stability, was monitored as a function of time on a SPECTRAmax PLUS 
384 spectrophotometer (Molecular Devices, Union City, CA) at a wavelength of 
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550 nm. The final concentration of lipid plus gemini surfactant was 0.1 mM in HBS 
buffer, pH 7.4. The turbidity values were registered over a period of 48 h. 
 
Statistical analysis 
Data are presented as mean ± SD. The significance of the results was statistically 
analyzed by a one-way analysis of variance (ANOVA) with Tukey’s multiple pairwise 
comparison. Statistical significance was set at p < 0.05. 
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5.4 RESULTS 
 
5.4.1 BIOLOGICAL ACTIVITY OF SERINE-DERIVED GEMINI SURFACTANT-BASED DNA COMPLEXES 
At cellular level, an efficient nonviral gene delivery system has to 
encapsulate/complex the nucleic acids and confer protection from degradation by 
intracellular and extracellular nucleases, carry them into the cell, release its cargo 
next to the intracellular target and promote high gene expression, without causing 
cytotoxicity. In this regard, cytotoxicity of the plain (gemini surfactant/DNA) and 
ternary (gemini surfactant/DNA/helper lipids) complexes was evaluated, and those 
complexes that did not promote significant loss of cell viability were selected for 
evaluating their ability to mediate transfection. The internalization pathways used by 
the complexes able to efficiently mediate gene expression were also assessed. 
 
Cytotoxicity induced by serine-derived gemini surfactant-based DNA complexes 
Figure 5.2 shows the results obtained for the toxicity of surfactant-based DNA 
complexes in HeLa cells. As observed, the cytotoxic effect was dependent on the (+/-) 
charge ratio of the complexes, increasing for the highest charge ratios tested. The 
complexes that induced the highest loss of cell viability were those formulated with 
(12Ser)2CON5 and (18Ser)2N5 at the 8/1 (+/-) charge ratio, both in the absence and 
presence of helper lipids. On the other hand, complexes prepared with (12Ser)2COO5 
and (16Ser)2N5 were the least toxic, particularly at the lowest charge ratios assayed. 
Furthermore, at the highest charge ratio, cytotoxicity was found to decrease with 
increasing hydrocarbon chain length of the surfactant, for alkyl chains from 12 to 16 
carbon atoms-long. However, this trend was reverted by (18Ser)2N5-based 
complexes, which induced the highest cytotoxicity among the complexes containing 
surfactants of the amine series. Concerning the effect of the nature of the spacer 
linkage on cell viability, comparison of the analogous compounds of each series 
shows that complexes containing surfactants of the ester series are the least 
cytotoxic, followed by complexes containing surfactants of the amine series and at 
last those with surfactants of the amide series. 
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Figure 5.2 Viability of HeLa cells upon incubation with complexes composed of the surfactant 
(indicated in the figure), without (□) or with (■) the helper lipids DOPE and cholesterol (2:1 molar 
ratio), at the indicated (+/-) charge ratios. Cell viability was expressed as a percentage of a control 
(non-treated cells). Pairwise data comparisons were performed for the helper lipids-containing 
complexes vs. the corresponding helper lipids-free complexes at the same (+/−) charge ratio (*p < 
0.05, **p< 0.01). 
 
Transfection efficiency of serine-derived gemini surfactant-based DNA complexes 
Complexes that did not cause significant toxicity to HeLa cells were selected for the 
evaluation of their ability to mediate gene delivery. As observed in Figure 5.3A, 
complexes prepared in the absence of helper lipids lack the ability to efficiently 
mediate gene expression. The only exception was found for complexes composed of 
(18Ser)2N5 surfactant prepared at the 2/1 (+/-) charge ratio, which were able to 
transfect 21 and 32% of cells in the presence and absence of helper lipids, 
respectively, albeit no significant difference was obtained between the two 
formulations. Although the gemini surfactants of each series (amine, amide and ester) 
with 12 carbon alkyl chains (C12) were unable to efficiently mediate transfection per 
se, the corresponding complexes formulated with the helper lipids DOPE and 
cholesterol presented significant transfection efficiency (up to 27%, 37% and 50%, 
respectively for (12Ser)2CON5, (12Ser)2N5 and (12Ser)2COO5). Interestingly, the 
highest levels of transfection were found for the lowest charge ratios tested (1/1 to 
2/1). Comparison with the commercial reagent Lipofectamine 2000 showed that, 
although this reagent was able to transfect more cells than the serine-derived gemini 
surfactant-based complexes (74%, data not shown), it induced significantly higher 
levels of cytotoxicity (only 35.6% of viable cells, data not shown). 
 serine-derived gemini surfactants as gene delivery systems 
155 
 
Transfection experiments in the presence of increasing amounts of serum were 
performed using the formulations containing the ester, the amide and the amine 
gemini surfactants with 12C tails and helper lipids. As illustrated in Figure 5.3B, 
transfection efficiency of complexes containing the ester gemini surfactant, prepared 
at the 3/2 and 2/1 (+/-) charge ratios, showed to be independent of the presence of 
serum.  
 
 
Figure 5.3 Transfection efficiency of gemini surfactant-based DNA complexes formulated without (□) 
or with (■) the helper lipids DOPE and cholesterol (2:1 molar ratio), at the indicated (+/-) charge ratios 
(A) and of (12Ser)2COO5:HL-based DNA complexes prepared at 3/2 (■) and 2/1 (■) (+/-) charge ratio, 
performed in the absence (0%) or presence of increasing amounts of serum (5 and 10%) (B). Data 
comparisons were performed for helper lipid-containing complexes vs. the corresponding helper lipid-
free complexes at the same (+/−) charge ratios (*p < 0.05, **p< 0.005, ***p < 0.001). No significant 
statistical differences were found between cells transfected in the presence of each percentage of 
serum and in absence of serum. 
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Cellular internalization pathways used for the uptake of serine-derived gemini 
surfactant-based DNA complexes  
The mechanisms involved in the internalization of serine-derived gemini surfactant-
based DNA complexes by HeLa cells were studied for the complexes that presented 
the highest transfection ability. Cells were treated with drugs that selectively inhibit 
endocytic processes that occur at different membrane domains, namely clathrin-
mediated endocytosis, which takes place in non-lipid raft domains, macropinocytosis, 
which occurs in mixed raft and non-raft domains, and raft-mediated endocytosis, 
which includes caveolae-mediated endocytosis (El-Sayed & Harashima 2013). 
Cellular internalization mechanisms were identified by flow cytometry, through the 
evaluation of transfection efficiency of cells pre-incubated with the pharmacological 
inhibitors of clathrin-mediated endocytosis (chlorpromazine), macropinocytosis 
(amiloride hydrochloride) and endocytic processes occurring in lipid raft domains of 
the cell membrane (filipin III). 
The complexes containing surfactants with 12 carbon alkyl chains of each of the three 
series and helper lipids showed to be preferentially internalized by macropinocytosis, 
since the lowest level of transfection was observed upon treatment of cells with 
amiloride hydrochloride (Figure 5.4). Among these complexes, those prepared with 
(12Ser)2CON5 and (12Ser)2COO5 surfactants were also internalized through 
cholesterol-enriched membrane domains (lipid-rafts),as concluded from the 
significant reduction in transfection observed in filipin III-treated cells. The clathrin-
mediated endocytosis showed to have also a significant contribution to internalize 
complexes prepared with (12Ser)2N5 and (12Ser)2COO5. Complexes prepared with 
(18Ser)2N5 in the absence and presence of helper lipids were compared in terms of 
the cellular internalization pathways. While the complexes devoid of helper lipids 
were not internalized by any of the endocytic pathways evaluated, suggesting the 
capacity to cross membranes through direct interaction with membrane lipids, the 
complexes formulated with helper lipids were partly taken up by a clathrin-mediated 
endocytosis process and partly by macropinocytosis.  
Noteworthy, the transfection efficiency observed for all the studied complexes upon 
cell treatment with endocytosis inhibitors did not decay to residual values, suggesting 
that a membrane lipid-mediated process may be involved in their cell uptake. 
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Figure 5.4 Effect of different endocytosis inhibitors on transfection mediated by surfactant-based DNA 
complexes. HeLa cells were incubated with either 30 μM of chlorpromazine (□), 5μg/mL of fillipin III 
(■), or 2.5 mM of amiloride hydrochloride (■) and transfected with the complexes indicated in the 
figure. Transfection in the presence of each inhibitor was expressed as percentage of transfected cells 
with each complex but not treated with the inhibitors of internalization pathways. Data are presented 
as mean ± standard deviation, representative of at least three independent experiments. Data 
comparisons were performed between each condition tested and the respective control corresponding 
to 100% of transfected cells (*p<0.05, **p<0.01, ***p<0.001). 
 
 
5.4.2 CHARACTERIZATION OF SERINE-DERIVED GEMINI SURFACTANT/DNA COMPLEXES  
Interaction of gemini surfactants with opposing charged DNA is regarded as a key 
feature for the efficient nucleic acid complexation and protection from nuclease 
degradation. As other nonviral gene delivery systems, gemini surfactant-based DNA 
complexes should meet some criteria, in terms of surface charge, hydrodynamic 
diameter and stability, towards successful transfection. In this regard, complexes 
displaying high transfection efficiency as well as those unable to transfect cells were 
evaluated for those parameters in order to ascertain the physico-chemical properties 
responsible for efficiency in gene delivery. 
 
Protection of DNA by serine-derived gemini surfactants 
The ability of gemini surfactants to interact and protect DNA was evaluated using the 
fluorescent probe PicoGreen, which intercalates nucleic acid double strands and 
whose fluorescence is dramatically enhanced in this condition. Figure 5.5 displays 
the percentage of DNA inaccessible to the probe, expressed in terms of DNA 
protection conferred by the gemini surfactants or the gemini surfactants plus the 
helper lipids DOPE and cholesterol. A higher degree of DNA protection was observed 
with increasing (+/-) charge ratio of the complexes, formulated both in the absence 
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and presence of helper lipids. The ester-derived surfactant showed the lowest levels 
of protection (Figure 5.5A), displaying high protection ability only at the highest 
(+/-) charge ratio tested (8/1). Protection promoted by (14Ser)2N5 and (18Ser)2N5 
was very efficient even at the (+/-) charge ratio of 2/1 (more than 80%) in contrast to 
(12Ser)2N5, which showed high protection only at the (+/-) charge ratio of 4/1 or 
higher, and to (16Ser)2N5, which exhibited much lower protection levels at all the 
(+/-) charge ratios assayed. Therefore, no linear relationship between alkyl chain 
length and efficiency of DNA protection was found. The addition of helper lipids to the 
complexes decreased the degree of DNA protection conferred by the surfactants at 
the highest charge ratios, except in the case of the complexes containing (14Ser)2N5 
and (18Ser)2N5, which showed similar abilities to protect DNA in the absence and 
presence of helper lipids over the range of charge ratios tested. On the other hand, at 
the lowest charge ratios, (12Ser)2COO5 and (12Ser)2N5 complexes exhibited higher 
capacity to avoid DNA-probe interactions in the presence of helper lipids. In contrast, 
complexes of (16Ser)2N5 and helper lipids conferred lower protection to DNA than 
the corresponding complexes composed of neat surfactant at all the charge ratios 
tested. 
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Figure 5.5 Gemini-DNA interactions, as assessed by PicoGreen accessibility to DNA complexed with 
gemini surfactants (A) or gemini surfactants plus the helper lipids (HL) DOPE and Cholesterol (2:1 
molar ratio) (B), at the indicated (+/-) charge ratios. The maximum fluorescence (control) corresponds 
to maximum DNA accessibility. Data comparisons were performed for the complexes at different (+/−) 
charge ratios vs. the same complex formulations at the immediately precedent (+/−) charge ratio (*p < 
0.05, **p < 0.01, ***p < 0.001). 
 
 
Physico-chemical properties of surfactant-based DNA complexes 
The size of the complexes was evaluated by dynamic light scattering and was found to 
vary depending on composition and charge ratio (Table 5.1). The sizes of the 
complexes were found to range from 163 nm to more than 3 µm, all samples showing 
a polydispersity index higher than 0.3, and being therefore analyzed as polydisperse 
samples. Complexes formulated with the surfactants having long hydrocarbon chains 
(16 and 18 carbon atoms) showed at all (+/-) charge ratios an increase in size 
promoted by the addition of the helper lipids. The complexes formulated with 
surfactants containing short hydrocarbon chains (C12 and C14) showed the same 
tendency, except at the lowest (+/-) charge ratio assayed (1/1 for the complexes of 
surfactants C12 and 2/1 for the (14Ser)2N5-based complexes), under which condition 
the helper lipids induced a decrease in size. 
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Table 5.1 Hydrodynamic diameter of DNA complexes formulated with gemini surfactants at different 
(+/-) charge ratios, in the absence and in the presence of the helper lipids DOPE and cholesterol. 
 
 
 
Hydrodynamic Diameter /nm1)  
 1/1 3/2 2/1 4/1 8/1 
(12Ser)2CON5 970 ± 140 1741 ± 186 1662 ± 467 560 ± 140 290 ± 27 
(12Ser)2CON5:DOPE:Chol 933 ± 98 >3000 2221 ± 674 1032 ± 43 460 ± 45 
(12Ser)2COO5 490 ± 200 271 ± 63 393 ± 41 355 ± 41 2000 ± 348 
(12Ser)2COO5:DOPE:Chol 387 ± 13 410 ± 14 454 ± 12 960 ± 140 2413 ± 266 
(12Ser)2N5 810 ± 220 1232 ± 114 2239 ± 629 526 ± 65 267 ± 13 
(12Ser)2N5:DOPE:Chol 800 ± 170 2827 ± 376 2747 ± 362 1022 ± 95 500 ± 250 
(14Ser)2N5 - - 2389 ± 692 312 ± 43 163 ± 9 
(14Ser)2N5:DOPE:Chol - - 1624 ± 399 1582 ± 151 919 ± 36 
(16Ser)2N5 - - 233 ± 25 497 ± 85 1374 ± 102 
(16Ser)2N5:DOPE:Chol - - 607 ± 42 780 ± 190 1824 ± 399 
(18Ser)2N5 - - 850 ± 120 196 ± 14 166 ± 9 
(18Ser)2N5:DOPE:Chol - - 2527 ± 478 304 ± 31 222 ±10 
1) Results represent mean ± SD of at least three independent experiments. All samples were 
polydisperse.  
 
The surface charge of the complexes composed of gemini surfactant/DNA and gemini 
surfactant/DNA/helper lipids was assessed by Zeta potential measurements (Table 
5.2). The surface charge of the structures formed by gemini surfactants and gemini 
surfactants plus helper lipids in aqueous suspensions, in the absence of DNA, was also 
measured for comparison. As observed in Table 5.2, the particles composed of 
surfactants exhibited a positive surface charge. The complexation of DNA by the 
surfactants containing C12 alkyl chains led to a change in the Zeta potential to 
negative values, although for complexes of (12Ser)2CON5 the signal inversion 
occurred only at the lowest (+/-) charge ratios assayed (1/1 and 3/2). Surfactants 
with longer hydrocarbon chains maintained the positive Zeta potential upon 
complexation with DNA, at least at (+/-) charge ratios higher or equal to 2/1. In the 
absence of DNA, the addition of helper lipids to the surfactants containing 12 carbon 
alkyl chains did not alter the sign of the surface charge. However, for surfactants with 
longer hydrocarbon chains, the helper lipids inverted the Zeta potential value, from 
positive to negative. Complexes of (12Ser)2CON5 prepared with helper lipids showed 
a highly positive charge over the range of (+/-) charge ratios tested. The 
incorporation of helper lipids into the complexes of surfactants (12Ser)2N5 and 
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(12Ser)2COO5 produced structures with positive Zeta potential at high 
surfactant/DNA charge ratio and with negative Zeta potential at low surfactant/DNA 
charge ratio. The opposite occurred for complexes of surfactants containing longer 
hydrocarbon chains and formulated with helper lipids. Complexes of (14Ser)2N5 and 
(16Ser)2N5 displayed negative Zeta potential at the highest (+/-) charge ratio (8/1) 
and positive surface charge at the other (+/-) charge ratios. Furthermore, (18Ser)2N5-
containing complexes formulated with helper lipids presented a highly negative Zeta 
potential in the range of charge ratios assayed.  
 
Table 5.2 Zeta potential of DNA complexes formulated with gemini surfactants at different (+/-) 
charge ratios, in the absence or in the presence of the helper lipids DOPE and cholesterol. 
 
 ζ-potential /mV1) 
 1/1 3/2 2/1 4/1 8/1 no DNA 
(12Ser)2CON5 -14 ± 11 -5 ± 12 +18 ± 8 +18 ± 6 +14 ± 5 +6 ± 8 
(12Ser)2CON5:DOPE:Chol +21 ± 8 +28 ± 7 +30 ± 9 +36 ± 8 +32 ± 10 +30 ± 8 
(12Ser)2COO5 -16 ± 11 -26 ± 7 -27 ± 8 -23 ± 10 -10 ± 10 +2 ± 9 
(12Ser)2COO5:DOPE:Chol -35 ± 7 -38 ± 7 -37 ± 7 -21 ± 10 +4 ± 13 +14 ± 8 
(12Ser)2N5 -21 ± 8 -23 ± 9 -21 ± 7 -7 ± 14 -3 ± 11 +17 ± 9 
(12Ser)2N5:DOPE:Chol -38 ± 7 -28 ± 8 -13 ± 10 +13 ± 7 +19 ± 5 +17 ± 9 
(14Ser)2N5 - - +13 ± 10 +9 ± 3 +13 ± 7 +6 ± 2 
(14Ser)2N5:DOPE:Chol - - +27 ± 2 +25 ± 3 -35 ± 2 -40 ± 3 
(16Ser)2N5 - - +22 ± 5 +31 ± 2 +23 ± 2 +52 ± 9 
(16Ser)2N5:DOPE:Chol - - +18 ± 2 +16 ± 1 -39 ± 2 -42 ± 3 
(18Ser)2N5 - - +31 ± 3 +29 ± 5 +34 ± 4 +46 ± 5 
(18Ser)2N5:DOPE:Chol - - -35 ± 4 -43 ± 2 -44 ± 2 -49 ± 3 
1) Results represent mean ± SD of at least three independent experiments. All samples were 
monodisperse.  
 
Evaluation of the colloidal stability of the surfactant-based DNA complexes, by 
monitoring the absorbance at 550 nm over a period of 48 h, revealed that all 
complexes were extremely stable over a period of at least 24 h (data not shown). This 
aspect is particularly important for intravenous administration of freshly prepared 
complexes, in order to ensure their prolonged blood circulation. 
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5.4.3 INTERACTION OF SURFACTANT/DNA COMPLEXES WITH LIPID MEMBRANE MODELS 
Destabilization of DNA complexes upon interaction with cellular membranes is 
essential for nucleic acid release in or close to their intracellular target, in order to 
allow gene expression. 
Destabilization of the serine-derived gemini surfactant-based DNA complexes was 
evaluated upon interaction with lipid vesicles with different composition (neutral 
DOPC vesicles, and negatively charged DOPE:DOPC:POPS (2:1:1) vesicles). Figure 5.6 
shows the effects exerted by the two lipid membrane models on complex stability, 
reflected by the exposure of the DNA to the fluorescent probe (PicoGreen). Complexes 
prepared at high (+/-) charge ratios were more extensively destabilized than those 
prepared at lower charge ratios. Among the complexes formulated with surfactants 
containing 12 carbon alkyl chains, those possessing an ester bond presented the 
lowest level of destabilization and their stability did not show to be affected by the 
presence of helper lipids. In contrast, the addition of helper lipids to complexes 
formulated with (12Ser)2N5 and (12Ser)2CON5 surfactants led to a decrease in the 
susceptibility to destabilization induced by both types of membranes. Differences in 
the destabilizing effects exerted by the zwitterionic and the anionic vesicles were 
noticeable for complexes formulated with surfactants containing hydrocarbon chains 
with 14 or more carbon atoms. Whereas complexes containing surfactants with 14 
and 16 carbon alkyl chains were less destabilized by anionic lipid vesicles than by the 
zwitterionic vesicles, complexes formulated with (18Ser)2N5 were not destabilized by 
DOPC vesicles but presented a high degree of destabilization in the presence of the 
anionic lipid mixture, especially those complexes containing helper lipids. 
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Figure 5.6 Destabilization of surfactant-based complexes upon interaction with lipid vesicles of DOPC 
(A) or of a mixture of DOPE:DOPC:POPS (2:1:1 molar ratio) (B), evaluated in terms of PicoGreen 
(fluorescent probe) access to DNA. The surfactant/DNA (white bars) or surfactant/DNA/helper lipids 
(black bars) complexes, at the indicated (+/-) charge ratios, were incubated with a PicoGreen solution 
(dilution 1:200) and lipid vesicles were then added in a two-fold excess over the surfactant 
concentration. Data are presented as percentage of maximum complex destabilization obtained with a 
control prepared with PicoGreen and free DNA (in the same amount as that associated with the 
complexes), corresponding to maximum PicoGreen accessibility to DNA. The results represent the 
mean ± standard deviation obtained from three independent experiments. Data comparisons were 
performed between formulations prepared with and without helper lipids (*p<0.05, **p<0.005, 
***p<0.001). 
 
  
 chapter 5 
164 
 
  
 serine-derived gemini surfactants as gene delivery systems 
165 
 
5.5 DISCUSSION 
A systematic comparative study of the ability of six members of a new family of 
serine-derived gemini surfactants to safely mediate gene delivery and transfection 
has been conducted in the present work. The gemini surfactants of this family were 
selected in order to examine the influence of i) the length of the hydrocarbon chains 
(C12, C14, C16 and C18), specifically in the amine series, and ii) the nature of the 
linkage between the cationic headgroup and the spacer (amine, amide and ester) on 
the transfection efficiency. For this purpose, plain gemini surfactant/DNA complexes 
and ternary complexes of gemini surfactant/DNA/helper lipids, resulting from the 
addition of DOPE and cholesterol liposomes (2/1 molar ratio) to plain complexes, 
were evaluated as safe gene delivery systems and characterized in terms of their 
physico-chemical properties. Destabilization of the gemini surfactant-based 
complexes was monitored upon the addition of membrane mimicking lipid vesicles in 
order to shed light on the importance of complex-membrane interactions in their 
ability to mediate gene delivery. For the sake of clarity, these data will be discussed 
from two perspectives: a) the influence of the hydrocarbon chain length and b) the 
importance of the nature of the headgroup/spacer linkage in the biological activity of 
serine-derived gemini surfactants. 
 
Influence of the hydrocarbon chain length on the biological activity of serine-derived 
gemini surfactants 
Concerning the surfactants of the amine series (effect of alkyl chain length), in the 
presence of helper lipids, all the surfactants studied were able to mediate gene 
delivery to some extent. There was no linear relationship between alkyl chain length 
and transfection efficiency, the surfactant containing the 16 carbon alkyl chain, 
(16Ser)2N5, being the least efficient. This relationship seems to contrast with that 
observed for complexes of conventional bis-quaternary gemini surfactants, for which 
the surfactant containing 16 carbon alkyl chains exhibited the highest transfection 
efficiency (Cardoso et al. 2014). However, care must be taken before a direct 
comparison is made. The different behavior of the conventional versus the serine-
derived gemini surfactants in terms of transfection can be assigned either to the 
nature of their headgroups (simple alkyl ammonium vs. serine-derived ammonium), 
or to the length of the spacers (2 methylene vs. 5 methylene groups). In fact, the 
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volume occupied by the cationic headgroup of serine-derived gemini surfactants is 
much larger than that of the conventional bis-quat gemini surfactants, whose 
headgroups are composed of simple dimethyl quaternary ammonium groups instead 
of the larger serine residues. On the other hand, the spacer length is important in 
governing gemini surfactant interactions with other molecules. According to Wettig et 
al. (Wettig et al. 2007), surfactant ammonium groups should be 4.9 Å apart in order 
to better interact with adjacent phosphate groups of DNA. This distance has been 
reported to be equivalent to the trimethylene spacing in spermine, which is closest to 
that determined for gemini surfactants containing a two (Karlsson et al. 2002) to 
three methylene spacer (Wettig et al. 2007). However, the presence of large 
headgroups, such as those of the serine-derived gemini surfactants, can result in an 
efficient accommodation of the DNA phosphate groups due to the flexibility of the 
surfactant chemical structure, namely at the level of the number of rotatable C-C 
bonds (Karlsson et al. 2002). 
DNA protection provided by the complexes prepared with serine-derived gemini 
surfactants with different hydrocarbon chain lengths followed a trend similar to that 
observed for the transfection efficiency, i.e. the (16Ser)2N5-based complexes were 
those that confer the lowest protection to DNA and exhibit the lowest transfection 
efficiency. Interestingly, these complexes showed also the lowest cytotoxicity. Taking 
into consideration the effects on cytotoxicity and DNA protection exerted by plain 
complexes prepared with gemini surfactants containing 14, 16 and 18 carbon alkyl 
chains at the 8/1 (+/-) charge ratio, the following sequence 
(18Ser)2N5≥(14Ser)2N5>(16Ser)2N5 can be established. This turning point has been 
already found in terms of the cytotoxicity of this series of serine-derived surfactants 
(Silva et al. 2013), an event that we interpreted in light of the cutoff-effect described 
for the interaction of alcohols of increasing chain length with lipid membranes 
(Peoples et al. 1996). However, the cytotoxicity of the surfactants per se was found to 
vary with the hydrocarbon chain length inversely to the corresponding complexes, i.e. 
(16Ser)2N5>(14Ser)2N5>(18Ser)2N5. 
In order to improve the transfection efficiency of serine-derived gemini surfactants, 
the helper lipids DOPE and cholesterol were used in combination. The helper lipid 
DOPE confers the system the ability to escape lysosomal degradation, while 
cholesterol was found to be a more biocompatible lipid and less prone to interact 
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with serum proteins (Faneca et al. 2002; Liu et al. 1997; Templeton et al. 1997). The 
addition of helper lipids to complexes containing serine-derived gemini surfactants 
with 14 to 18 carbon atom alkyl chains increased their cytotoxicity. Apparently, 
helper lipid-induced cytotoxicity had only a negative impact on the transfection 
efficiency in the case of complexes prepared with (18Ser)2N5. Despite the increase of 
cytotoxicity, the addition of helper lipids promoted increased transfection levels for 
complexes containing (14Ser)2N5 and did not significantly affect transfection induced 
by complexes containing (16Ser)2N5. In view of the disparity of effects exerted by 
helper lipids on the transfection efficiency of complexes containing gemini 
surfactants with hydrocarbon chains of different length, it is expected that those 
lipids induce the formation of structurally different aggregates, depending on the 
incorporated surfactants.  
Regarding the interaction of the complexes with lipid vesicles, it is interesting to 
observe that the plain complexes containing the surfactants with the shortest 
hydrocarbon chains were more extensively destabilized than those containing 
surfactants with longer hydrocarbon chains, and that only the (18Ser)2N5 surfactant-
containing complexes were preferentially destabilized by anionic lipid vesicles. 
Curiously, the addition of helper lipids to (18Ser)2N5-containing complexes 
significantly increased their destabilization, specially by the anionic lipid vesicles, in 
contrast to what occurred with the other complexes. The negative impact that helper 
lipids exhibited on the transfection efficiency of (18Ser)2N5-based complexes may be 
attributed not only to the increased cytotoxicity, but also to a detrimental lack of DNA 
protection upon interaction with membranes. 
 
Importance of the nature of the headgroup/spacer linkage in the biological activity of 
serine-derived gemini surfactants 
Regarding the influence of the nature of the headgroup/spacer linkage on the 
biological behavior of gemini surfactants, it has been shown that the incorporation of 
chemical bonds susceptible of being enzymatically cleaved, such as ester and amide, 
in the molecular structure of delivery system components, reduces their cytotoxicity 
and enhances their ability to produce efficient complexes with DNA (Ilies et al. 2006). 
Consistent with this finding, data obtained with complexes prepared with surfactants 
of each of the three series (amine, amide and ester) possessing C12 alkyl chains 
 chapter 5 
168 
 
showed low cytotoxicity and high transfection efficiency, although the latter was 
observed only when complexes were formulated with helper lipids. The lowest 
cytotoxicity and the highest transfection efficiency were displayed by complexes 
containing the surfactant of the ester series. 
It is worth noting that the ester gemini surfactant presents two more rotatable bonds 
than the amine and amide derivatives with the same hydrocarbon chain length. On 
the other hand, the effective length of the spacer for the gemini surfactants of the 
ester and amide series, i.e. the distance separating the two quaternary ammonium 
groups, corresponds to 11 methylene groups, because the linkage of the spacer to the 
serine residue is made through the α-carboxylate group of the aminoacid, rather than 
directly to the charged nitrogen atom. Therefore, these gemini surfactants should 
have the ability to coil their flexible spacer in order to place the charged headgroups 
at the ideal distance to interact with the phosphate groups of DNA molecules 
(Karlsson et al. 2002). This ability to refine the interaction with DNA molecules is 
likely higher in the ester series since the amide linkage, in contrast with the ester 
linkage, has a high double bond character that constrains free rotation of this bond, 
thus reducing the flexibility of the spacer. This could explain the higher transfection 
efficiency of complexes formulated with surfactant of the ester series in the presence 
of helper lipids as compared to those incorporating the other 12 carbon alkyl chain-
containing surfactants with amide or amine linkages to the headgroup. However, the 
transfection efficiency of complexes composed of (12Ser)2COO5 plus helper lipids 
does not seem to be related with the DNA protection afforded by these components. 
Indeed, the ester derivative gemini surfactant formulated with helper lipids conferred 
lower protection to DNA than the amide derivative and similar to that conferred by 
the amine derivative, both also formulated with helper lipids. Considering the plain 
complexes (without helper lipids), it is probable that the interaction of the least 
flexible surfactant molecules (amine and amide derivatives) with DNA originates 
more steric hindrance with consequent higher protection levels, as compared to 
those afforded by the surfactant of the ester series. Furthermore, addition of helper 
lipids to these systems leveled the protection conferred to DNA, which implicates a 
new structural arrangement of the surfactant molecules around DNA, at least at the 
highest charge ratios tested at which the protection levels decreased upon addition of 
the helper lipids. A possible explanation for this could be the existence of liposomes in 
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suspension that do not take part in the complex formation but displace some 
surfactant molecules from the DNA complex to partition in the lipid bilayer, whenever 
this process is thermodynamically favorable. The interaction between DOPE and 
gemini surfactants was described as antagonistic in nature, due to their differences 
regarding the preferred curvature of the aggregates (Akbar et al. 2012). In light of 
these data, we would expect the serine-derived gemini surfactants, which aggregate 
into micelles in aqueous environment, to interact with DOPE in an antagonistic 
manner. However, the serine-derived gemini surfactants are pre-complexed with 
DNA, which most likely alters the suppramolecular aggregates formed. Moreover, 
DOPE, mixed with cholesterol, is prepared at basic pH, and added to the 
surfactant/DNA complexes in the form of vesicles. 
For those formulations able to efficiently mediate transfection, a compromise should 
exist between the ability to complex and protect DNA and to release it inside the cell. 
The eventual intracellular degradation of the labile amide and ester bonds may lead 
to the disaggregation of the complexes and consequent nucleic acid release. In fact, 
although the complexes incorporating (12Ser)2COO5,containing or not helper lipids, 
showed to be less efficient in releasing DNA upon interaction with membranes, as 
compared to complexes prepared with the amide, (12Ser)2CON5, or amine, 
(12Ser)2N5, homologues, they presented the highest transfection efficiency. Thus, 
DNA release should occur inside the cell, where acidification of the endosomal 
compartment could trigger structural changes in the surfactant molecules (e.g. 
hydrolysis of the ester bond), leading to complex destabilization and nucleic acid 
release into the cytoplasm. 
Regardless of what has been described for lipoplexes about the relationship between 
size and transfection efficiency (Simões et al. 2005), large complexes containing the 
gemini surfactants were found not to be those presenting the highest transfection 
ability. In fact, the complexes that induced the highest transfection levels (formed by 
the ester derivative, DNA and helper lipids at low (+/-) charge ratios) displayed 
rather small sizes (387 to 454 nm). Interestingly, complexes of serine-derived gemini 
surfactants showed to be generally smaller than those of conventional 12-5-12 
gemini surfactant, using the same methodology for preparation of both types of 
complexes. Furthermore, 12-5-12 surfactant produced complexes which, besides 
exhibiting very low transfection efficiency, they revealed to be highly cytotoxic, even 
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when formulated with helper lipids, thus being unsuitable for gene delivery purposes 
(Cardoso et al. 2014). The small sizes of the complexes are important for intravenous 
administration to circumvent capillary retention. Noteworthy, the hydrodynamic 
diameter of the most efficient complexes described here is similar to that reported for 
branched PEI-based DNA complexes, which have been used for intravenous 
administration in Balb/c mice (Tripathi et al. 2013), indicating that serine-derived 
surfactant-based formulations possess dimensions suitable for use in vivo. However, 
other routes for in vivo administration of DNA complexes that are not constrained by 
their size have been applied (Neves et al. 2006; Pfeiffer et al. 2006; Donkuru et al. 
2010). Therefore, the potential of large DNA complexes such as those based on 
(12Ser)2N5 for in vivo application should not be excluded. 
Another relevant feature presented by the complexes containing the ester-derived 
surfactant is their negative Zeta potential at all charge ratios tested (except at the 
highest charge ratio, in the presence of helper lipids). Complexes containing the C12 
amine-derived surfactant shared this feature in most conditions. Such negatively 
charged complexes should escape from the unspecific electrostatic interaction with 
serum proteins, a drawback associated with the use of highly positive charged 
particles for gene delivery in vivo. In fact, these complexes were also those which 
showed ability to transfect HeLa cells in the presence of serum, with no significant 
efficiency reduction with respect to that obtained in the absence of serum. 
Noteworthy, the high transfection efficiency of DNA complexes formulated with the 
ester derivative was observed at low surfactant/DNA charge ratios (1/1 to 2/1). This 
is particularly relevant for a potential application in vivo, since a decrease in 
surfactant dose ensures a decrease in toxicity, thus reducing the safety concerns 
regarding the fate of the complex debris into the organism and in the environment. 
 
 
  
 serine-derived gemini surfactants as gene delivery systems 
171 
 
5.6 Conclusion 
 
The most efficient complexes were those prepared with C12 surfactants and helper 
lipids, reaching 50% of transfected cells without causing cytotoxicity. These 
complexes have the particularity of being most efficient at low surfactant/DNA charge 
ratios, which is advantageous in terms of cell, organism and environmental toxicity. 
Some of the most efficient complexes were found to have sizes compatible with 
intravenous administration, as well as negative surface charge, which increases the 
likelihood of reaching the desired target cells, and were shown to mediate 
transfection even in the presence of serum. The most efficient and least cytotoxic 
complexes were produced from the biodegradable ester derivative, which supports 
the concept that cleavable chemical bonds would facilitate the release of DNA inside 
the cells. 
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Gemini Surfactants Mediate Efficient 
Mitochondrial Gene Delivery and Expression 
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6.1 ABSTRACT 
 
Gene delivery targeting mitochondria has the potential to transform the therapeutic 
landscape of mitochondrial genetic diseases. Taking advantage of the non-universal 
genetic code used by mitochondria, a plasmid DNA construct was designed with the 
ability to be specifically expressed in these organelles. In the present work, gemini 
surfactants were shown to successfully deliver plasmid DNA to mitochondria. Gemini 
surfactant-based DNA complexes were taken up by cells through a variety of routes, 
including endocytic pathways, and showed propensity for inducing membrane 
destabilization under acidic conditions, thus facilitating cytoplasmic release of DNA. 
Furthermore, the complexes interacted extensively with lipid membrane models 
mimicking the composition of the mitochondrial membrane, which predicts a favored 
interaction of the complexes with mitochondria in the intracellular environment. This 
work unravels new possibilities for gene therapy towards mitochondrial diseases. 
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6.2 INTRODUCTION 
 
Along evolution, most of the genes coding for proteins engaged in mitochondrial 
function were transferred to the nuclear DNA. Indeed, mitochondrial DNA encodes 
only 2 rRNAs, 22 tRNAs and 13 subunits of the mitochondrial respiratory chain 
(Howell 1999). However, since the mitochondrial DNA (mtDNA) nucleotide sequence 
was first reported by Anderson et al. (Anderson et al. 1981), more than 100 
pathogenic mutations related with mitochondrial disorders have been described 
(DiMauro & Schon 2001; Yoon et al. 2010). The high rate of mutation that occurs in 
mtDNA has been related both with the lack of histones and effective DNA repair 
mechanisms, as well as with the large amount of reactive oxygen species (ROS) 
generated in the mitochondrial matrix where mtDNA is located. 
Mitochondrial pathologies with origin in mtDNA are diverse and encompass 
encephalomiopathies, such as mitochondrial encephalopathy with lactic acidosis and 
strokelike episodes (MELAS) and myoclonic epilepsy with ragged-red fibers 
(MERRF), and neuropathies, such as Leber hereditary optic neuropathy 
(LHON).(Howell 1999; Mukhopadhyay & Weiner 2007) Abnormal mitochondrial 
function plays a role in the pathogenesis of many other diseases, including 
Huntington’s disease (Panov et al. 2002), Alzheimer’s disease (Castellani et al. 2002), 
Parkinson’s disease (Arduíno et al. 2012), cancer (Clark et al. 2002), obesity and 
diabetes (Boddapati et al. 2005). Current therapies targeting mitochondrial disorders 
are mostly based on ROS scavenging and antioxidants (Scarpelli et al. 2010). Allotopic 
expression of mitochondrial proteins has also been explored, but all human mtDNA-
expressed proteins contain hydrophobic transmembrane-spanning regions, which 
compromise the protein configuration during mitochondrial import through the 
TOM/TIM protein import complexes (Doyle & Chan 2008). Mitochondrial gene 
therapy, through delivery of a plasmid DNA targeting mitochondria, has therefore 
emerged as a promising strategy to correct mtDNA mutations responsible for several 
mitochondrial diseases (Weissig & Torchilin 2001b).  
Each mitochondrion contains between 1000 and 5000 DNA copies, and a certain 
threshold of mutated copies must be reached for a mitochondrial pathology to display 
its phenotype, the exact threshold for a given disorder being highly dependent on the 
particular mutation (Doyle & Chan 2008). Therefore, mitochondrial transfection able 
to correct some of the mutated copies of mtDNA could be sufficient for the successful 
gene therapy of mitochondrial diseases with origin in mtDNA mutations. Several 
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studies have reported the use of different vehicles for the delivery of molecules to 
mitochondria, including fluorescent probes (Yasuzaki et al. 2010), proteins 
(Shokolenko et al. 2010), nucleic acids (D’Souza et al. 2003; Weissig & Torchilin 
2001c; Lee et al. 2008), and peptide nucleic acids (PNA) (Chinnery et al. 1999; 
Muratovska et al. 2001). Lyrawati et al. (Lyrawati et al. 2011) were the pioneers to 
demonstrate the expression in mitochondria of a synthetic mitochondrial plasmid 
DNA (mpDNA)-encoded protein, but, to the best of our knowledge, no further work 
aiming at exploring this approach has been reported. These researchers designed a 
plasmid DNA encoding GFP to be translated exclusively in mitochondria, taking 
advantage of the fact that the genetic code used by mitochondria is different from that 
used in the nucleus, by four codons (Wallace 1999; Wallace 2007; Yoon et al. 2010). 
One of these codons (uga), which functions as a stop codon if recognized by the 
cytosolic ribosomal machinery, but codes for a tryptophan if read by the 
mitochondrial ribosomes, was included in mpDNA for GFP (Lyrawati et al. 2011). In 
order to promote the plasmid DNA delivery to mitochondria, Lyrawati and coworkers 
used DQAsomes produced according to the method described by Weissig et al. 
(Weissig et al. 1998). This delivery system was based on the use of dequalinium, an 
amphiphile with delocalized cationic charge and exhibiting the ability to 
preferentially accumulate near mitochondria and fuse with the outer membrane of 
this organelle (Weissig & Torchilin 2001b,c; D’Souza et al. 2003). However, 
transfection efficiency of complexes of dequalinium with mpDNA, designated 
DQAsomes, in a mouse macrophage cell line was found to be very low (Lyrawati et al. 
2011). Traditionally, mitochondriotropic molecules have been described as cationic 
amphiphiles with delocalized charge (Weissig & Torchilin 2001d). However, a 
thorough revision work on mitochondriotropic agents carried out by Horobin and 
coworkers (Horobin et al. 2007), involving a systematic characterization of a large 
number of molecules previously described in literature as accumulating at or near 
mitochondria, showed that they exhibited interesting features that comprise electric 
potential, ion-trapping and complex formation with cardiolipin (Horobin et al. 2007). 
In addition, it has been shown that liposomes taken up by cells can selectively target 
mitochondria if they are properly modified to present known mitochondriotropic 
residues, such as stearyl-triphenylphosphonium bromide (TPP) (Boddapati et al. 
2005), or the mitochondrial signaling peptide(Lee et al. 2008). 
In the present work, the ability of gemini surfactants to mediate mitochondrial 
delivery and expression of the mpDNA produced by Lyrawati and coworkers 
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(Lyrawati et al. 2011) was assessed in HeLa cells. Two families of cationic gemini 
surfactants, conventional and serine-derived bis-quaternary (bis-quat) ammonium 
salts, previously shown to efficiently mediate nuclear transfection (unpublished 
work), were used to target mitochondria (Figure 6.1). Gemini surfactants have been 
extensively used as nuclear transfection agents due to their particular aggregation 
properties (low cmc), which allows the use of small amounts of surfactants, therefore 
reducing their potential cytotoxicity (Alami et al. 1993; Buijnsters et al. 2002; Silva et 
al. 2012). They have also been shown to efficiently condense and protect DNA 
(Bombelli et al. 2005; Karlsson et al. 2002), a requirement for successful gene 
delivery, either targeting the nucleus or mitochondria. Protonable groups can be 
introduced in the structure of gemini surfactants, conferring them an additional 
advantage to enhance gene delivery upon internalization of their DNA complexes 
endocytosis, since the conformational change upon pH decrease at the endolysosomal 
route can contribute to the nucleic acid release in the cytoplasm (Wettig et al. 2007). 
Furthermore, the versatility of gemini surfactants for structural modulation allows 
for improvement of their efficiency as gene delivery systems.  
In this work, gemini-based gene delivery systems were found to exhibit high ability to 
mediate gene expression in mitochondria without causing significant cytotoxicity. 
Moreover, these systems were shown to be internalized into cells by different routes, 
including endocytic and non-endocytic (direct membrane translocation) pathways. 
The interaction of the complexes with lipid membrane models mimicking the 
cytoplasmic and the mitochondrial membranes occurred in great extent, supporting 
the relevance of such interactions for efficient mitochondrial targeting and gene 
delivery. 
 
 
Figure 6.1 Schematic representation of the gemini surfactants used in this work. Conventional bis-quat 
gemini surfactant 14-2-14 (A) and serine-derived bis-quat gemini surfactants (nSer)2N5 (n=14 and 16) 
(B). 
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6.3 MATERIALS AND METHODS 
 
Materials 
The conventional gemini surfactant 14-2-14 was synthesized by a previously 
established method (Menger & Littau 1991) and the serine-derived gemini 
surfactants were synthesized by using the method recently reported by Silva (Silva et 
al. 2012). The surfactants were purified either by recrystallization (conventional bis-
quat gemini surfactants) or by column chromatography (serine-based gemini 
surfactants). Purities were confirmed by NMR and high resolution mass spectroscopy, 
and further confirmed by the cmc values obtained by surface tension, all in good 
agreement with values previously reported (Silva et al. 2012). The lipids 1,2-dioleoyl-
sn-glycero-3-phosphoethanolamine (DOPE), cholesterol (Chol), 1-palmitoyl-2-oleoyl-
sn-glycero-3- phosphocholine (POPC), bovine brain sphingomieline (SM), 1,2-
dimyristoyl-sn-glycero-3-phosphocholine (DMPC), bis(monooleoylglycero)phosphate 
(18:1 BMP), 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC) and 1’,1',2,2'-
tetraoleoyl cardiolipin (TOCL) were purchased from Avanti Polar Lipids (Alabaster, 
AL). The fluorescent lipids N-(7-nitrobenz-2-oxa-1, 3-diazol-4-yl)-
Phosphatidylethanolamine (NBD-PE) and 1% rhodamine-phosphatidylethanolamine 
(Rho-PE) were acquired from Molecular Probes (Eugene, OR). All the other chemicals 
were of the highest grade. 
 
Preparation of mpDNA complexes 
Surfactant-based complexes were prepared using a GFP-coding plasmid DNA, 
designed to be specifically expressed in mitochondria (mpDNA, kindly provided by 
Dr. Diana Lyrawati) (Lyrawati et al. 2011), by employing the method described by 
Badea and coworkers (Badea et al. 2005) with a few modifications. Briefly, aqueous 
solutions (0.5 mM) of gemini surfactants were prepared and filtered through 0.2 μm 
pore diameter filters (Schleicher & Schuell). 1,2-dioleoyl-sn-glycero-3-
phosphoethanolamine (DOPE) and cholesterol (Chol) (Avanti Polar Lipids, Alabaster, 
AL, USA) were dissolved in chloroform, mixed at a 2:1 molar ratio and dried under 
vacuum in a rotatory evaporator. The dried lipid films were hydrated with HBS, pH 
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9.0, to obtain multilamellar lipid vesicles (MLV) at a final lipid concentration of 0.5 
mM, which were then filtered through 0.2 μm pore diameter filters. Plain complexes 
(gemini surfactant/mpDNA) were prepared as follows: plasmid DNA encoding 
mitochondrial GFP (mpGFP) was mixed with aliquots of gemini surfactant solution to 
obtain gemini surfactant/mpDNA charge ratios of 8/1, 10/1 and 12/1 and incubated 
at room temperature for 15 min. Ternary complexes (surfactant/mpDNA/helper 
lipids) were prepared at a 1/1 surfactant/helper lipid molar ratio, by adding 
DOPE:chol MLV (HL) to plain complexes. All the complexes (plain and ternary 
complexes) were allowed to incubate for further 30 min at room temperature for full 
stabilization.  
 
Cells 
HeLa cells (human epithelial cervical carcinoma) were maintained at 37 °C, under 5% 
CO2, in Dulbecco’s Modified Eagle’s medium-high glucose (DMEM; Sigma, St Louis, 
MO, USA) supplemented with 10% (v/v) heat inactivated fetal bovine serum (FBS), 
and with 100 units of penicillin and 100 µg of streptomycin (Sigma) per mL. 
For cell viability determination and flow cytometry experiments (see next sections), 
0.8 × 105 HeLa cells/well were seeded onto 12-well plates, 24 h prior to incubation 
with gemini surfactant-based complexes. 
 
Cell viability 
Cell viability was assessed by a modified Alamar Blue assay (Simões et al. 1999). 
Briefly, 0.4 mL of 10% (v/v) resazurin dye in complete DMEM medium were added to 
each well, 48 h after the addition of the complexes. After 45 min of incubation at 37 
°C, 180 μL of the supernatant were collected from each well and transferred to 96-
well plates. The absorbance at 570 and 600 nm (as indicated by the supplier) was 
measured in a SPECTRAmax PLUS 384 spectrophotometer (Molecular Devices, Union 
City, CA). Cell viability was calculated, as a percentage of control cells (i.e. non-treated 
cells), according to the equation: 
Cell viability (% of control) = [(A570 – A600)/(A'570 - A'600)] x100  (Equation 1) 
where A570 and A600 are the absorbances of the samples, and A’570 and A’600 are those 
of the control (non-treated cells), at the indicated wavelengths.  
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Transfection efficiency 
The transfection mediated by the different complexes was evaluated by analyzing 
GFP expression by flow cytometry. HeLa cells were incubated with the different 
complexes (0.5 μg of mpDNA per well) in serum-free OptiMEM medium at 37 oC 
under 5% CO2 for 4 h. The medium was then replaced with complete DMEM medium, 
and cells were further incubated for 44 h to allow gene expression. Cells were washed 
once with PBS and detached upon incubation with 0.25% trypsin solution (Sigma, St. 
Louis, MO, USA) at 37 °C for 10 min. Cells were further washed three times by 
centrifugation (950 rpm, 4 °C, 5 min) in ice-cold PBS, being then resuspended in ice-
cold PBS and immediately analyzed. Flow cytometry was performed in a FACScalibur 
flow cytometer (BD Biosciences, San Jose, CA) and data were obtained and analyzed 
using CellQuest software. Live cells were gated by forward/side scattering from a 
total of 10,000 events. Transfection efficiency was determined in terms of the 
percentage of transfected cells. 
 
Cellular internalization pathways 
To address the mechanisms through which surfactant-based complexes were 
internalized by cells, transfection experiments were performed both at low 
temperature (4 °C) and in the presence of inhibitors of different endocytic pathways. 
For this purpose, plated HeLa cells washed with PBS were incubated (37 °C, 30 min) 
in serum-free OptiMEM, with the following inhibitors of endocytosis (from Sigma): (i) 
chlorpromazine (30 μM); (ii) fillipin III (5 μg/mL) or (iii) amiloride hydrochloride 
(5 mM). Parallel experiments were performed by incubating HeLa cells (not treated 
with these inhibitors) at 4 °C for 30 min. Thereafter, cells either inhibitor-treated or 
maintained at 4 °C were incubated with the complexes for 1 h. To confirm that the 
endocytosis inhibitors tested compromised selectively different endocytic pathways, 
their effects on cellular uptake of the fluorescently labeled markers, transferrin, a 
known marker of clathrin-mediated endocytosis, and lactosylceramide, a marker of 
raft/caveolae-dependent endocytosis, were analyzed. Cytotoxicity was assessed 
following cell treatment with each of the drugs by the Alamar blue assay, as described 
above. Flow cytometry analysis was performed as described above to evaluate 
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transfection efficiency of the complexes in cells pre-incubated at 4 °C (a condition that 
impairs any energy-dependent endocytic pathway) or with each of the endocytosis 
inhibitors. 
 
Surfactant-mpDNA interactions 
Surfactant-based complexes containing 0.2 μg of mpDNA, prepared in a total volume 
of 100 μL of HBS (pH 7.4) or MES buffer (pH 6.4 and 5.2), were incubated at 37 °C for 
15 min, and then transferred to a 96-well (blackwalled) plate (Corning, NY, USA). 
Hundred microliters of PicoGreen (Molecular Probes, Eugene, OR), diluted according 
to the manufacturer's instructions (1:200 dilution in HBS buffer), were added to each 
sample. The fluorescence intensity of PicoGreen, which is directly proportional to the 
amount of accessible/free mpDNA, was monitored in a Spex Fluorolog Spectrometer 
for determining the extent of gemini surfactant-mpDNA complexation. The excitation 
and emission wavelengths were set at 485 and 520 nm, respectively. The degree of 
mpDNA protection conferred by the complexes (PmpDNA), taken as proportional to the 
surfactant/mpDNA complexation, was calculated as follows: 
PmpDNA = 1- [(F-F100)/(F0-F100)]   (Equation 2) 
where F is the fluorescence measured after adding the PicoGreen solution to the 
complexes, F0 (corresponding to 0% of plasmid mpDNA protection) was obtained by 
using free mpDNA in the same amount as that associated with the complexes, F100 
(corresponding to 100% of mpDNA protection) is the residual fluorescence of a 
negative control obtained by using a PicoGreen solution without mpDNA, which 
mimicked a situation of 0% of mpDNA available to PicoGreen.  
 
Physical properties of surfactant-based mpDNA complexes (particle size and Zeta 
potential) 
The size of the surfactant-based complexes was assessed using a Submicron Particle 
Size Analyzer, Beckman Coulter N4 Plus. The colloidal suspension of the complexes 
was diluted with HBS, and the particle size analysis was carried out at a scattering 
angle of 90° and at 25 °C. 
The Zeta potential of the surfactant-based complexes was measured using a Zeta sizer 
Nano ZS, ZN 3500, with a 532 nm laser (Malvern Instruments, UK). The 
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measurements were performed in HBS, at 25 °C, using DTS 1060C disposable Zeta 
cells and the protocol for general purposes (medium viscosity 0.89 cP, medium 
refractive index 1.33, sample viscosity 0.89 cP, particle refractive index 1.45 and 
equilibration time 3 min). Values for the dielectric constant of 78.5 and beam mode 
F(Ka) of 1.5 (Smoluchowsky) were used for Zeta potential determination. 
 
Fluorescence polarization measurements 
The probes 1,6-diphenyl-1,3,5-hexatriene (DPH) and 3-(p-(6-phenyl)-1,3,5-
hexatrienyl)phenylpropionic acid (DPH-PA) in dimethylformamide were injected (a 
few microliters) into the surfactant or surfactant:lipid mixture, or the respective 
complexes in aqueous dispersions (final surfactant:lipid concentration of 200 μM), in 
order to obtain a final surfactant or surfactant plus lipid/probe molar ratio of about 
200/1, as previously described (Jurado et al. 1991). Probe addition was performed at 
55 °C and the mixture was incubated at room temperature, in the dark for probe 
protection, for a period of 15 h to reach equilibrium. In order to correct fluorescence 
measurements for the contribution of light scattering, appropriate blanks with 
equivalent volumes of dimethylformamide were prepared, although these corrections 
were found to be negligible. The fluorimetric measurements of DPH- or DPH-PA-
labelled surfactant:lipid systems, in the absence or presence of mpDNA at different 
cationic surfactant/mpDNA charge ratios, were performed in a Perkin Elmer LS 55B 
fluorescence spectrophotometer (Perkin Elmer, U.S.A), equipped with polarization 
filters. The excitation and emission wavelengths were set at 336 and 450 nm, 
respectively (5 nm excitation and 6 nm emission band pass). The fluorescence 
polarization (P) was calculated according to Shinitzky and Barenholz (Shinitzky & 
Barenholz 1978), using the equation: 
P = (Iǀǀ-GI+)/(Iǀǀ+GI+)    (Equation 3) 
where Iǀǀ and I+ are the intensities of the light emitted with its polarization plan 
parallel and perpendicular to that of the exciting beam, respectively. G, the 
instrumental grating factor, is given by the ratio of vertically to horizontally polarized 
emission components where the excitation light is polarized in the horizontal plane. 
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Interaction of surfactant-based mpDNA complexes with lipid vesicles (component 
mixing) 
Förster Resonance Energy Transfer (FRET) experiments were performed in order to 
assess the extent of the interaction between components of the cationic surfactant-
based complexes and vesicles mimicking the lipid composition of non-raft regions of 
the cytoplasmic membrane (POPC:DOPE at a 2:1 molar ratio), lipid-rafts 
(SM:DMPC:Chol at a 1:1:1 molar ratio), late endosomal membrane 
(POPC:DOPE:SM:BMP at a 5:2:1:2 molar ratio) and mitochondrial membrane 
(DOPC:DOPE:TOCL at a 1:1:1 molar ratio). For this purpose, the vesicles were labeled 
with 1% N-(7-nitrobenz-2-oxa-1, 3-diazol-4-yl)phosphatidylethanolamine (NBD-PE) 
and 1% rhodamine-phosphatidylethanolamine (Rho-PE) (Molecular Probes, Eugene, 
OR), upon addition to the lipid mixtures in chloroform. The solvent was removed by 
evaporation in a rotatory evaporator and the dried lipid films were hydrated in HBS 
saline buffer (pH 7.4). The resulting MLV were then sonicated for 3 min and extruded 
15 times through two stacked polycarbonate filters of 100 nm pore diameter using a 
Liposofast device (Avestin, Toronto, Canada) to obtain large unilamellar vesicles 
(LUV). Phospholipid content was determined by measuring the inorganic phosphate 
(Murphy & Riley 1962) released after hydrolysis of dried phospholipids, at 180 °C, in 
70% HClO4 (Bottcher et al. 1961). Component mixing assays were performed in a 96-
well black-walled plate, using 400 µM of lipid vesicles and 100 µM of the different 
surfactant-based complexes, prepared as previously described. Component mixing 
was measured at 37 °C, after an incubation period of 15 min at the same temperature, 
in a SPECTRAmax Gemini EM fluorimeter (Molecular Devices, Union City, CA), using 
the excitation and emission wavelengths of 470 and 535 nm, respectively. At the 
concentration at which the probes were incorporated into the vesicles (1%), Rho-PE 
efficiently suppresses the emission of NBD-PE at 535 nm, when the excitation 
wavelength is set at 470 nm. Due to the energy transfer dependence on the distance 
between the donor and acceptor probes, the mixing of components of the complexes 
with lipids of the fluorescently-labeled preparations generates an increase of NBD-
fluorescence, which reflects alterations in the distribution of probes in the lipid 
environment. The percentage of component mixing, taken as proportional to FRET 
reduction, was calculated according to equation 4: 
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Component mixing (%) = (F-F0)/(F100-F0)x100,   (Equation 4) 
where F corresponds to the fluorescence detected after 15 minutes of complex 
incubation with the vesicles, F0 corresponds to the initial vesicle fluorescence in the 
absence of the complexes, and F100 corresponds to the maximal fluorescence, which 
was obtained after complete lysis of the vesicles with 0.5% (v/v) octaethylene glycol 
monododecyl ether (C12E8). For each complex, three independent experiments were 
carried out at pH 7.4. Parallel experiments with vesicles mimicking the composition 
of the late endosome were also performed at pH 5.2. Briefly, after incubation of the 
complexes with the vesicles at 37 °C for 15 min at pH 7.4, the pH was lowered to 5.2 
upon addition of HCl (1 M) and NBD-PE fluorescence was measured (F). The 
percentage of component mixing at pH 5.2 was calculated according to Equation 4, 
where F0 and F100 corresponded to the minimum fluorescence obtained with the 
labeled vesicles at pH 7.4 and to the maximum fluorescence, obtained with C12E8 at 
pH 7.4, respectively.   
 
Destabilization of lipid vesicles induced by surfactant-based mpDNA complexes (calcein 
release) 
Calcein release experiments were performed in order to assess the ability of cationic 
surfactant-based gene delivery systems to destabilize vesicles mimicking the lipid 
composition of non-raft regions of the cytoplasmic membrane (POPC:DOPE at a 2:1 
molar ratio), lipid-rafts (SM:DMPC:Chol at a 1:1:1 molar ratio), late endosomal 
membrane (POPC:DOPE:SM:BMP at a 5:2:1:2 molar ratio) and mitochondrial 
membrane (DOPC:DOPE:TOCL at a 1:1:1 molar ratio). Lipid mixtures at the indicated 
molar ratios were dissolved in chloroform and dried under vacuum in a rotatory 
evaporator. The dried lipid films were hydrated with 80 mM calcein solution (Sigma, 
St. Louis, MO) in 50 mM HEPES and 1 mM EDTA (pH 8.4), submitted to 3 minutes of 
sonication, and then extruded 15 times through two stacked polycarbonate 
membranes of 100 nm pore diameter, using a Liposofast device (Avestin, Toronto, 
Canada), to obtain LUV. Free calcein was removed from the probe-containing LUV by 
size exclusion chromatography on a Sephadex G-75 column, using a buffer solution 
(20 mM HEPES, 140 mM NaCl and 1 mM EDTA, pH 7.4) with the same osmolarity as 
that of the calcein solution. Vesicle phosphate content was determined by the Murphy 
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and Riley method (Murphy & Riley 1962) and leakage assays were performed on a 
96-well black-walled plate, using 400 µM of lipid vesicles and 100 µM of surfactant-
based complexes. After incubation of labeled vesicles with surfactant-based 
complexes, at 37 °C for a period of 15 min, calcein release was measured in a 
SPECTRAmax Gemini EM fluorimeter (Molecular Devices, Union City, CA), using the 
excitation and emission wavelengths of 494 and 517 nm, respectively. The percentage 
of vesicle leakage, taken as percentage of calcein release, was calculated according to 
equation 5: 
Calcein release (%) = [(I-I0)/(I100-I0)]x100%,  (Equation 5) 
where I corresponds to the fluorescence detected after 15 min of incubation of the 
surfactant-based complexes with the vesicles, I0 corresponds to the vesicle 
fluorescence in the absence of the complexes, and I100 corresponds to the maximum 
fluorescence, obtained after the complete lysis of the vesicles with 0.5% (v/v) C12E8. 
For each surfactant concentration, three independent experiments were performed.  
 
Statistical analysis 
Results from all experiments are represented as mean ± SD. Data were analyzed using 
GraphPad Software, Inc., CA, USA. Statistical significances of differences between data 
were evaluated using ANOVA Tukey's multiple comparison test when comparing all 
experimental means. 
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6.4 RESULTS 
 
6.4.1 CYTOTOXICITY AND TRANSFECTION EFFICIENCY OF GEMINI SURFACTANT-BASED COMPLEXES 
CONTAINING MPDNA 
Gemini surfactants from two different families, conventional and serine-derived bis-
quat ammonium salts, were used to prepare complexes with mpDNA, in order to 
evaluate their ability to mediate mitochondrial GFP expression. The surfactants 
selected for this purpose, namely conventional bis-quat 14-2-14 and serine-derived 
bis-quats (14Ser)2N5 and (16Ser)2N5, were those displaying the lowest cytotoxicity 
when complexed with a nuclear DNA plasmid coding for GFP, as evaluated in previous 
studies performed in our laboratory (unpublished work). Figure 6.2 shows the 
percentage of transfected cells (A) and of viable cells (B) obtained with mpDNA 
complexes prepared with the abovementioned gemini surfactants, at different gemini 
surfactant/DNA (+/-) charge ratios, in the absence or presence of the helper lipids 
(HL) DOPE and cholesterol (at a 2:1 molar ratio). As observed, for all the complexes, 
the transfection efficiency showed an increase with increasing complex (+/-) charge 
ratios. The enhancement of transfection efficiency was most notorious for complexes 
prepared with conventional bis-quat 14-2-14, when the (+/-) charge ratio increased 
from 8/1 to 10/1. Although the transfection efficiency of complexes prepared from 
serine-derived surfactants was not significantly different for the various charge 
ratios, the tendency for an increase of transfection with an increase of (+/-) charge 
ratio is clear, except for complexes of (16Ser)2N5 prepared with helper lipids, which 
showed low levels of transfection regardless the (+/-) charge ratio (Figure 6.2A). In 
contrast, cell viability decreased with increasing (+/-) charge ratios of the complexes, 
except for complexes of (16Ser)2N5 containing helper lipids, which exhibited low 
cytotoxicity for all the (+/-) charge ratios assayed (Figure 6.2B). The most promising 
formulations for gene delivery were gemini surfactant-based mpDNA complexes 
containing 14-2-14 and 14-2-14 plus helper lipids at the 10/1 (+/-) charge ratio, 
(14Ser)2N5 plus helper lipids at the 10/1 (+/-) charge ratio and (16Ser)2N5 at the 
12/1 (+/-) charge ratio, which present a suitable conjugation of high transfection 
efficiency with low cytotoxicity. 
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Figure 6.2 Transfection efficiency (A) and cytotoxicity (B) of gemini surfactant-based complexes 
(indicated in the figure), at 8/1 (□), 10/1 (■) and 12/1 (■) (+/-) charge ratios. Transfection efficiency 
was deduced from the percentage of transfected cells, from a total of 10,000 events, and cytotoxicity 
from the percentage of viable cells with respect to a control (non-treated cells). Pairwise data 
comparisons were performed as indicated in the figure (*p < 0.05, **p < 0.01, ***p < 0.001). 
 
 
6.4.2 CELLULAR INTERNALIZATION PATHWAYS OF GEMINI SURFACTANT-BASED MPDNA COMPLEXES 
The mechanisms of cellular internalization were evaluated for the complexes that 
showed to be the most promising gene delivery systems for mitochondrial targeting. 
For this purpose, HeLa cells were incubated at 4 °C, in order to prevent uptake of the 
complexes by endocytosis, or treated with drugs that selectively inhibit different 
endocytic pathways, namely clathrin-mediated endocytosis (chlorpromazine), raft-
mediated endocytosis (filipin III) and macropinocytosis (amiloride hydrochloride), 
and transfected with the complexes. Transfection efficiency was evaluated by flow 
cytometry analysis of GFP expression and the results are presented in Figure 6.3 as 
percentages of the maximum transfection obtained with the same complexes in 
untreated cells. As observed, more than one pathway showed to be relevant for the 
internalization of the studied complexes and all of them led to transfection. 
Endocytosis showed to be important for the uptake of 14-2-14-based complexes 
containing or not helper lipids, as concluded by the significant decrease in 
transfection observed upon cell incubation at 4 °C. The mechanisms involved in the 
internalization of the complexes are raft-mediated endocytosis and macropinocytosis 
(but not clathrin-mediated endocytosis). In contrast, transfection efficiency mediated 
by (14Ser)2N5:HL-based complexes was not affected by incubation at low 
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temperature or cell pre-treatment with the different endocytosis inhibitors, thus 
suggesting an energy-independent mechanism for their internalization. Concerning 
complexes prepared with the (16Ser)2N5 surfactant, internalization occurred by 
clathrin-mediated and raft-mediated endocytosis, but not by macropinocytosis. Since 
the transfection efficiency of the complexes did not decay to residual values upon cell 
incubation at low temperature or after cell pre-treatment with endocytosis inhibitors, 
it is fair to deduce that all of them can be partly (or entirely in the case of 
(14Ser)2N5/mpDNA/HL complexes) translocated across the cell membrane, by a non-
endocytic pathway. 
 
Figure 6.3 Effect of different endocytosis inhibitors on transfection mediated by surfactant-based DNA 
complexes. HeLa cells were incubated at 4 °C (□), or treated at 37 °C with either 30 μM of 
chlorpromazine (■), 5μg/ml of fillipin III (■), or 2.5 mM of amiloride hydrochloride (■), and 
transfected with the complexes indicated in the figure. Transfection efficiency in the presence of each 
inhibitor was expressed as percentage of control (untreated) cells transfected with the corresponding 
complex. Data are presented as mean ± standard deviation, representative of at least three 
independent experiments. Data comparisons were performed between each condition tested and the 
respective control corresponding to 100% of transfected cells (*p<0.05, **p<0.01, ***p<0.001). 
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6.4.3 PHYSICO-CHEMICAL PROPERTIES OF GEMINI SURFACTANT-BASED COMPLEXES (HYDRODYNAMIC 
DIAMETER AND ZETA POTENTIAL) 
The hydrodynamic diameter and Zeta potential of gemini surfactant-based complexes 
were found to depend on their composition (Table 6.1). Regarding complex size, all 
samples showed to be polydisperse. The complexes 14-2-14/DNA and 
(16Ser)2N5/DNA, formulated in the absence of helper lipids, presented very similar 
diameters, centered at ca. 550 nm, while in the presence of helper lipids, 14-2-
14/DNA complexes underwent a significant size increase to 800 nm. The complexes 
of (14Ser)2N5/DNA/HL showed to be the smallest (ca. 270 nm).  
Regarding the complex surface charge, assessed in terms of Zeta potential, 14-2-
14/DNA complexes were found to be neutral, while the same complexes formulated 
with helper lipids showed a high positive charge; (16Ser)2N5/DNA complexes also 
showed a high positive Zeta potential. On the other hand, (14Ser)2N5/DNA/HL 
complexes presented a highly negative Zeta potential. Taking into account that all the 
complexes were formulated at high (+/-) charge ratios (10/1 and 12/1), the results 
obtained indicate that a specific arrangement of the molecules or a different degree of 
particle hydration could be on the origin of the differences observed for the size and 
surface charge of the complexes. In particular, the highly negative Zeta potential of 
the (14Ser)2N5/DNA/HL complexes probably results from the adsorption of 
inorganic anions from the medium. 
 
Table 6.1 Hydrodynamic diameter and Zeta potential of DNA complexes formulated with gemini 
surfactants or gemini surfactants plus helper lipids (HL) at the indicated (+/-) charge ratios. 
 
Complexes 
(+/-) charge 
ratio 
Hydrodynamic Diameter 
(nm)1) 
Zeta potential 
(mV) 1) 
14-2-14/DNA 10/1 555 ± 77 +3.8 ± 1.9 
14-2-14/DNA/HL 10/1 802 ± 47 +32.2 ± 2.7 
(14Ser)2N5/DNA/HL 10/1 274 ± 12 -34.3 ± 4.1 
(16Ser)2N5/DNA 12/1 528 ± 56 +35.1 ± 3.0 
1) Results represent mean ± SD of at least three independent experiments. All samples were 
polydisperse with relation to size and monodisperse with relation to Zeta potential.  
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6.4.4 DPH AND DPH-PA FLUORESCENCE POLARIZATION IN GEMINI SURFACTANT-BASED 
STRUCTURES AND IN THEIR COMPLEXES WITH DNA 
Fluorescence polarization of the probes DPH and DPH-PA embedded in structures of 
14-2-14, 14-2-14 plus helper lipids, (14Ser)2N5 plus helper lipids and (16Ser)2N5, as 
well as in the respective complexes with DNA, was determined at 37 °C. As observed 
in Figure 6.4, for formulations prepared in the absence of DNA, fluorescence 
polarization (P) values registered for DPH distributed over the wide range from 0.105 
to 0.174, which was dramatically narrowed, from 0.141 to 0.166 upon addition of 
mpDNA (Figure 6.4A). The fluorescence polarization values observed when DPH-PA 
was embedded in DNA-devoid formulations ranged from 0.167 to 0.209. These values 
are higher than those observed with DPH and did not follow the same trend as that 
observed with this probe (Figure 6.4B). Based on DPH-PA fluorescence polarization 
measurements, two groups of complexes should be considered, plain complexes 
(surfactant plus DNA) presenting lower P values (0.170-0.174) and complexes 
containing helper lipids, presenting higher P values (0.212-0.224).  
 
Figure 6.4 Fluorescence polarization values (P) of DPH (A) and DPH-PA (B) incorporated in 14-2-14 
(○), 14-2-14:HL (■), (14Ser)2N5:HL (▲) and (16Ser)2N5 () structures complexed (DNA) or not (no 
DNA) with mpDNA. DNA was added to obtain complexes of 14-2-14 and of (14Ser)2N5 at the 10/1 
(+/-) charge ratio and complexes of (16Ser)2N5 at the 12/1 (+/-) charge ratio. 
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6.4.5 EFFECT OF PH ON MPDNA PROTECTION CONFERRED BY GEMINI SURFACTANT-BASED 
COMPLEXES 
The ability of gemini surfactants to complex and protect mpDNA from access to other 
molecules was evaluated using the fluorescent probe PicoGreen, whose fluorescence 
dramatically increases when it intercalates nucleic acid double strands. mpDNA 
protection was evaluated at conditions that reflect those observed when i) complexes 
were prepared (25 °C and pH 7.4, dotted bars), ii) complexes interacted with cells 
(37 °C and pH 7.4, white bars), and iii) complexes were internalized by cells through a 
endolysosomal pathway (37 °C and pH 6.4, grey bars, or pH 5.2, black bars). As 
Figure 6.5 shows, mpDNA complexation was found to be highly efficient at room 
temperature, with a minimum mpDNA complexation of approximately 80% for 
complexes of (14Ser)2N5/DNA/HL. Upon temperature increase, no disassembly of the 
complexes was observed, as the mpDNA protection levels remained constant at 37 °C 
(pH 7.4). At this temperature (37 °C), lowering the pH led, in most cases, to a decrease 
in DNA protection. Indeed, complexes of (16Ser)2N5 started to disassemble at pH 6.4, 
as indicated by the 20.2% of DNA protection observed at this pH. At pH 5.2, for all the 
complexes devoid of helper lipids, total dissociation of DNA from the cationic 
surfactant was achieved. Complexes containing helper lipids underwent a much lower 
destabilization upon pH decrease. However, for complexes of 14-2-14/DNA/HL, 
31.8% of the associated DNA became free at the lowest pH assayed. Only (14Ser)2N5-
based complexes were capable of conferring mpDNA protection in a pH-independent 
manner. 
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Figure 6.5 Protection conferred to DNA by the gemini-based complexes, as assessed by PicoGreen 
accessibility to the nucleic acid, at 25 °C, pH 7.4 (dotted bars), 37 °C, pH 7.4 (□), 37 °C, pH 6.4 (■) and 
37 °C, pH 5.2 (■). Maximum DNA accessibility (0% DNA protection) was taken as the maximum 
fluorescence obtained using the same amount of DNA as that used for the preparation of the complexes 
in the presence of PicoGreen, and maximum DNA protection corresponded to the minimum 
fluorescence, taken from the residual PicoGreen fluorescence in the absence of DNA. Data comparisons 
were performed for the protection conferred by each complex at 25 °C and pH 7.4 vs. that conferred by 
the same complex at 37 °C and pH 7.4 (not significant) and for the protection conferred by each 
complex at 37 °C and pH 7.4 vs. that conferred by the same complex at 37 °C and pH 6.4 and 5.2 (*p < 
0.05, ***p < 0.001). 
 
 
6.4.6 INTERACTION OF GEMINI SURFACTANT-BASED COMPLEXES WITH LIPID MEMBRANE MODELS  
Interaction of gemini surfactant-based complexes with lipid membrane models 
mimicking different cell membrane structures was evaluated by FRET and calcein 
release assays. The lipid models used in this study were designed to resemble the 
lipid composition of raft and non-raft regions of the cytoplasmic membrane, and late 
endosome and mitochondria membranes. FRET between the fluorescent lipids NBD-
PE (donor) and Rho-PE (acceptor) incorporated in the same vesicle population was 
evaluated upon addition of surfactant-based complexes, by monitoring the 
fluorescence increase of the donor probe (NBD-PE) (Figure 6.6A). All the complexes 
showed to interfere with FRET between NBD-PE and Rho-PE incorporated in vesicles 
mimicking non-raft and raft portions of the cytoplasmic membrane, and the 
mitochondrial membrane, but did not extensively impair FRET in vesicles mimicking 
the late endosomal membrane (maximum of 22% of FRET decrease promoted by 
(14Ser2)N5/DNA/HL complexes, Figure 6.6A). Interestingly, upon reduction of pH 
(in order to resemble the acidification of endosomes), a small increase in the 
interaction between complexes of 14-2-14 plus helper lipids and the late endosome 
membrane model was observed. However, for the other complexes studied, 
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interaction with this model membrane was not enhanced under these conditions. 
Regarding leakage of vesicle contents, evaluated in terms of fluorescence increase of 
calcein encapsulated in the vesicles at a self quenching concentration, all the 
complexes induced calcein release from vesicles mimicking non-raft regions of the 
cytoplasmic membrane. However, complexes based on the serine-derived surfactants 
were less efficient in promoting vesicle leakage than those composed of the 
conventional gemini surfactant (14-2-14). Vesicles mimicking the mitochondrial 
membrane also showed an extensive leakage with all the complexes assayed, whereas 
vesicles mimicking the composition of lipid-rafts and of the late endosomal 
membrane were only slightly destabilized by gemini surfactant-based complexes 
(maximum of 17 and 26% of calcein release, both promoted by 14-2-14/DNA 
complexes, Figure 6.6B). 
 
Figure 6.6 FRET (A) and calcein release (B) assays performed in lipid vesicles mimicking the lipid 
composition of non-raft domains of the cytoplasmic membrane (□), lipid-rafts (■), late endosomal 
membrane at pH 7.4 (■) or pH 5.2 (striped bars)  and mitochondrial membrane (■), induced by the 
surfactant-based complexes indicated in the figure. The surfactant-based DNA complexes were added 
to vesicles containing two fluorescent lipids NBD-PE and Rho-PE (FRET) or to vesicles loaded with 
calcein (calcein release) at a 1:4 complex:vesicle molar ratio. FRET reduction and calcein release 
induced by the complexes are presented as percentage of maximum FRET reduction or maximum 
calcein release obtained with a control prepared with each type of vesicle to which the detergent C12E8 
(0.5% v/v) was added. The results represent the mean ± standard deviation obtained from three 
independent experiments. Pairwise data comparisons were performed between complex-induced 
FRET reduction in the late endosome membrane model at pH 7.4 and in the same model at pH 5.2 (*p < 
0.05) and between maximum FRET reduction or maximum calcein release (controls) and complex-
induced FRET reduction or calcein release, respectively (#p < 0.05, ##p < 0.005, ###p < 0.001).  
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6.5 DISCUSSION 
 
In this work, the ability of gemini surfactants to mediate gene delivery to 
mitochondria using intact cells was studied, employing a plasmid specifically 
designed to be expressed in these organelles. Although a number of studies have 
focused on nucleic acid delivery to mitochondria (Weissig & Torchilin 2001a; Weissig 
& Torchilin 2001d; D’Souza et al. 2003; Boddapati et al. 2005; Lee et al. 2008; 
Yasuzaki et al. 2010), to the best of our knowledge, only one study evaluated the 
expression in mitochondria of a transgene, which revealed to occur at a limited extent 
(1-5%) (Lyrawati et al. 2011). 
In the present study, conventional and serine-derived bis-quat gemini surfactants 
showed to be able to efficiently mediate gene delivery to mitochondria in HeLa cells 
and to promote gene expression, either per se, or in combination with the helper 
lipids DOPE and cholesterol. Transfection of up to 40.4% of the cells was achieved, 
which is almost twice that attained with Lipofectamine 2000TM (25.1%, data not 
shown). The most promising systems, i. e. those combining high transfection 
efficiency and low cytotoxicity, were selected for subsequent physico-chemical 
characterization in order to disclose the properties shared by delivery systems able 
to efficiently target mitochondria.  
The selected complexes, 14-2-14/mpDNA, 14-2-14/mpDNA/HL, 
(14Ser)2N5/mpDNA/HL and (16Ser)2N5/mpDNA, presented sizes from 273.7 nm to 
801.9 nm and significantly different surface charges, from highly positive to highly 
negative. It is worth mentioning that the complexes displaying the smallest size 
(presumably compatible with intravenous administration), i.e. those consisting of 
(14Ser)2N5/mpDNA/HL, exhibited negative Zeta potential, which can prevent 
undesired interactions with serum proteins (Faneca et al. 2002; Templeton et al. 
1997; Liu et al. 1997). Therefore, the (14Ser)2N5-based complexes display a 
combination of features that render them promising for in vivo studies.  
The four selected gemini surfactants showed a convergence of the values of 
fluorescence polarization of DPH and DPH-PA upon addition of DNA. These 
fluorescent probes are expected to monitor the structural order of the 
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surfactant/mpDNA or surfactant/mpDNA/HL systems in the hydrophobic core, i.e., 
far from the aqueous medium, the preferred DPH environment, and closer to the 
water/lipid interface, where electrostatic interactions dominate and DPH-PA is 
located. In the case of the structures containing (16Ser)2N5 gemini surfactant, DNA 
addition promoted a decrease in molecular packing (taking this as proportional to P 
values) in both the core and close to the surface region. However, for all other 
complexes, DNA addition promoted an increase in the packing reported by each of the 
fluorescent probes, similarly to what was described previously (Cardoso et al. 2011). 
Therefore, a given range of molecular packing seems to be ideal for most of the 
transfection-competent complexes, probably by optimizing complex-membrane 
interactions, regarding either the cytoplasmic or intracellular membranes. FRET 
assays conducted with lipid vesicles mimicking different cellular membrane 
structures allowed to estimate the extent of complex-membrane interactions. 
Interestingly, all the studied complexes seemed to interact efficiently with lipid-raft 
and non-raft regions of the cytoplasmic membrane, which could be responsible for 
the pathway taken by the complexes to be internalized into the cells. In fact, with the 
exception of (14Ser)2N5-based complexes, all complexes were taken up through 
endocytic routes taking place in raft (those inhibited by filipin III) or non-raft 
(clathrin-mediated endocytosis) regions of the cytoplasmic membrane or in mixed 
raft and non-raft domains, in the case of macropinocytosis (El-Sayed & Harashima 
2013). Interestingly, the studies of aqueous contents leakage in models resembling 
the cytoplasmic membrane lipid composition showed that gemini surfactant-based 
complexes were able to induce destabilization of non-raft domains but not of lipid-
rafts. Lipid-rafts are cholesterol-enriched membrane regions, which are found to be 
detergent-resistant at low temperatures (Simons & Gerl 2010). Therefore, it is not 
surprising that vesicles composed of SM:DMPC:Chol (1:1:1), such as those used in this 
work to mimic lipid-rafts, were not easily disrupted by gemini surfactants, as has 
been previously shown for other surface-active agents (Chen et al. 2009). The low 
extent of aqueous content release from lipid-raft-mimicking vesicles in the presence 
of gemini surfactant-based complexes indicates that the uptake of these complexes 
(inhibited by cell treatment with filipin III) should be driven by an energy-dependent 
process, involving one or several proteins that mediate cellular internalization in 
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these domains. On the other hand, the extensive calcein release induced by the 
complexes in the non-raft membrane model, allied to the observed extensive 
reduction of FRET, suggests that gemini surfactant-based complexes, whose 
internalization was shown not to be affected by the endocytosis inhibitors assayed, 
could be internalized by passive translocation across non-raft domains of the 
cytoplasmic membrane.  
Taking into account FRET and calcein release assays, the interaction of the complexes 
with the late endosomal membrane model seemed to occur at a very low extent, even 
at acidic pH (5.2), a condition mimicking the environment found in the endosomal 
lumen. However, it is expected that three of the four complexes studied travel 
through the endolysosomal route, according to their internalization by energy-
dependent endocytic pathways. Although these complexes were able to efficiently 
release the mpDNA in the acidic endosome milieu (as deduced from the PicoGreen 
assay conducted at low pH), the transfection efficiency should be counteracted by 
their inability to destabilize the endosomal membrane. Therefore, although a 
significant portion of the complexes appear to be internalized independently of 
endocytosis, the complexes that are endocytosed seem to be, at least partially, 
trapped in this degradative pathway. Hence, it is expected that the performance of the 
complexes studied herein can be further improved, by facilitating their escape from 
the endolysosomal route. This can be accomplished by including in their composition 
molecules that undergo protonation under acidic conditions, thus leading to 
endosomal membrane destabilization and thereby promoting cytoplasmic release of 
the carried DNA (Wettig et al. 2007). Interestingly, the (14Ser)2N5-based complexes, 
which showed to be apparently internalized through direct membrane translocation, 
were those that, in contrast to the others, did not dissociate upon pH decrease 
(Figure 6.5). Since this fact did not interfere with their transfection efficiency, other 
factors may contribute to the release of nucleic acids from the complexes during their 
intracellular trafficking to mitochondria, which did not involve transport through the 
endolysosomal pathway. 
On the other hand, DNA delivery to mitochondria has been described to be a passive 
process, as long as the complexes accumulate in the surroundings of this organelle 
(Koulintchenko et al. 2006). DNA entry into mitochondria involves translocation 
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across two membranes. The outer membrane has been considered relatively 
permeable, due to the presence of the voltage-dependent anion channel (VDAC) 
(Koulintchenko et al. 2006; Weber-Lotfi et al. 2009). This channel was shown to allow 
the uptake of nucleic acids with up to 4 kb regardless of their sequence (Ibrahim et al. 
2011), and, therefore, mpDNA should be internalized through this pathway (Lyrawati 
et al. 2011). On the other hand, the complexes are expected to cross the cardiolipin-
enriched inner membrane, considering the extensive degree of interaction observed 
between the complexes and the mitochondrial membrane model, as assessed by FRET 
and calcein release. Interestingly, selective mitochondrial accumulation of DNA has 
been described to involve, not only electric potential and ion-trapping, but also 
complex formation with cardiolipin (Horobin et al. 2007). According to the studies of 
Rashid and coworkers (Rashid & Horobin 1990), using cationic fluorescent probes, 
only moderately lipophylic molecules are able to passively penetrate mitochondrial 
membranes and the cationic molecules would form insoluble salts with cardiolipin 
(Rashid & Horobin 1990; Horobin et al. 2007). It is possible that the cationic 
amphiphilic gemini surfactant-based complexes used herein could also strongly 
interact with the cardiolipin-enriched mitochondrial inner membrane, favoring 
mpDNA translocation into mitochondria.  
In summary, in this work gemini surfactant-based complexes have been shown to be 
able to efficiently deliver plasmid DNA to mitochondria and to promote gene 
expression through the machinery of this organelle. These complexes presented 
variable sizes, from those suitable for intravenous administration (smaller than 300 
nm) to larger ones (up to 800 nm), variable surface charge (from positive to 
negative), and high ability to efficiently protect the nucleic acids. Complexes 
internalized by cells through endocytosis should undergo structural changes upon pH 
decrease so that they can release the DNA at the endosomal level, while those 
internalized through direct membrane translocation, which showed no ability to 
release the nucleic acids at low pH, should deliver the mpDNA upon interaction with 
mitochondrial membranes. All the complexes revealed the capacity to strongly 
interact with vesicles mimicking the mitochondrial membrane composition, 
suggesting that DNA could be passively taken up by mitochondria. Although a high 
yield of accumulation of the gemini surfactant-based complexes used in the 
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surroundings of mitochondria is deduced from the observation of significant levels of 
gene expression, improved transfection could be achieved by modulation of the 
vehicle gemini surfactants, namely by using a mitochondrial leader peptide (Lee et al. 
2008), to increase mitochondrial tropism, or by conferring pH-sensitivity to the gene 
delivery system to enhance endosomal escape (Abes et al. 2006a,b). On the other 
hand, a decrease of the cytotoxicity of the most efficient complexes to mediate 
transfection (e.g. those including helper lipids) could be obtained by addition of an 
antioxidant molecule to the gemini surfactant formulation, as suggested by other 
authors (Lee et al. 2013). 
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6.6 CONCLUSION 
 
In this work, we approached mitochondrial gene delivery from a functional 
perspective, using a GFP-encoding plasmid DNA designed for specific mitochondrial 
expression. Gemini surfactant-based mpDNA complexes showed significant efficiency 
to mediate gene expression in this organelle. This work paves the way to a new era of 
mitochondrial gene delivery, bringing new therapeutic possibilities to patients 
suffering from mitochondrial diseases originated in mitochondrial DNA.  
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7.1 ABSTRACT 
 
The present work aims to gain insights into the role of peptide-lipid interactions in 
the mechanisms of cellular internalization and endosomal escape of the S4(13)-PV 
cell-penetrating peptide, which has been successfully used in our laboratory as a 
nucleic acid delivery system. A S4(13)-PV analogue, S4(13)-PVscr, displaying a 
scrambled amino acid sequence, deficient cell internalization and drug delivery 
inability, was used in this study for comparative purposes. DSC, fluorescence 
polarization and SAXS/WAXS techniques showed that both peptides interacted with 
anionic membranes composed of phosphatidylglycerol or a mixture of this lipid with 
phosphatidylethanolamine, increasing the lipid order, shifting the phase transition to 
higher temperatures and raising the correlation length between the bilayers. 
However, S4(13)-PVscr, in contrast to the wild-type peptide, did not promote lipid 
domain segregation and induced the formation of an inverted hexagonal lipid phase 
instead of a cubic phase in the lipid systems assayed. Electron microscopy showed 
that, as opposed to S4(13)-PVscr, the wild-type peptide induced the formation of a 
non-lamellar organization in membranes of HeLa cells. We concluded that lateral 
phase separation and destabilization of membrane lamellar structure without 
compromising membrane integrity are on the basis of the lipid-driven and receptor-
independent mechanism of cell entry of S4(13)-PV peptide. 
Overall, our results can contribute to a better understanding of the role of peptide-
lipid interactions in the mechanisms of CPP membrane translocation, helping in the 
future design of more efficient CPP-based drug delivery systems. 
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7.2 INTRODUCTION 
 
Cell-penetrating peptides (CPPs) constitute an expanding peptide family whose 
members share the ability to cross biological membranes and gain access into living 
cells (Morris et al. 2008; Trabulo et al. 2010). Although biomembranes are generally 
impermeable to large or highly charged molecules, accumulating evidences have 
demonstrated the capacity of CPPs to mediate intracellular delivery of a wide variety 
of exogenous charged molecules, especially peptides and proteins (Morris et al. 2008; 
Tunnemann et al. 2006) and nucleic acids, such as splice correcting oligonucleotides 
(Trabulo et al. 2010a), siRNA (Morris et al. 2008; Crombez et al. 2009) and plasmid 
DNA (Trabulo et al. 2008). Thus, CPPs opened new possibilities in biomedical 
research and therapy, offering new tools for intracellular delivery of drugs or genetic 
cargo as an alternative to the conventional pharmaceutical approaches involving viral 
vectors (Pfeifer & Verma 2001), lipid-based carriers (Simões et al. 2005) and physical 
methods to enhance internalization of therapeutic molecules into cells (Niidome & 
Huang 2002). 
Although CPPs have been widely used to deliver cargo molecules into cells, the 
mechanisms underlying CPP cellular uptake are far from being fully understood. 
Several endocytotic and non-endocytotic pathways for CPP internalization have been 
proposed depending on CPP own features, the carried cargo, the cell type and the 
membrane lipid composition (Morris et al. 2008; Trabulo et al. 2010a). In this 
context, the interactions between CPPs and membrane lipids have been suggested to 
play a major role in CPP membrane translocation (Morris et al. 2008). With respect to 
the membrane, the transverse as well as the lateral structure of the membrane lipid 
bilayer assume high relevance. Membrane outer regions, with a high density of 
negative charges mainly conferred by membrane-associated glycosaminoglycan 
(GAG)-linked proteins (proteoglycans) or neuraminic acid-containing 
oligosaccharides attached to membrane embedded glycoproteins and gangliosides, 
may establish electrostatic interactions with the positively charged regions of CPPs 
resulting from the high density of basic amino acid residues (e.g. Arg and Lys) (Morris 
et al. 2008). On the other hand, the hydrophilic-hydrophobic interface of the lipid 
bilayer interacts with the amphiphilic portions of the peptides, modulating their 
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folding/unfolding and hence their membrane penetration. The heterogeneous lateral 
structure of the lipid bilayer and the lipid-microdomain organization are not less 
important in terms of membrane transposition by CPP molecules, since domain 
boundaries enhance bilayer permeability and may favor the insertion of those foreign 
molecules (Vereb et al. 2003). 
In order to study the role of CPP-lipid interactions in translocation of CPP-conjugated 
drug delivery systems through the cell membrane, different biophysical approaches 
have been adopted, most of them using membrane models (Peetla et al. 2009; Alves et 
al. 2008; Alves et al. 2009; Dennison et al. 2007). These simple experimental systems 
have allowed addressing the influence of structural and physical features of CPPs and 
their conjugates in the efficiency of the delivery process. In this regard, the amino acid 
composition and sequence, as well as the peptide conformation, have been shown to 
be important features of CPPs towards the success of cargo delivery (Trabulo et al. 
2010b). Moreover, the size, the interfacial properties of CPP-based drug delivery 
systems and other physical characteristics, such as hydrophobicity/hydrophilicity 
and surface charge of the vectors or their components, can significantly influence 
their interactions with membrane lipids, and hence the efficiency of vector 
internalization (Morris el al. 2008; Guterstam et al. 2009; Mano et al. 2006). On the 
other hand, studies of CPP-lipid interactions in membrane models manipulated to 
mimic biomembranes have shown the importance of the degree of lipid saturation, 
the cholesterol content and the membrane local charge on the ability of the peptide to 
interact, disturb and penetrate model membranes (Arsov et al. 2008; Hallock et al. 
2002; Mano et al. 2007). 
The peptide S4(13)-PV, a chimeric CPP containing a cell-penetrating sequence of 13 
amino acids derived from dermaseptin S4 peptide and the nuclear localization signal 
of the simian virus 40 (SV40) large T antigen (Trabulo et al. 2010b), has shown to be 
efficiently taken up by cells through an apparently receptor- and energy-independent 
process and, less efficiently, through clathrin-mediated endocytosis (Mano et al. 
2006; Mano et al. 2005). The high translocation ability of S4(13)-PV peptide across 
cell membranes is reflected in its competence to generate nucleic acid carrier systems 
with great potential to deliver plasmid DNA (Trabulo et al. 2008), splice switching 
oligonucleotides (Trabulo et al. 2010a) and siRNA (unpublished data). However, 
 S4(13)-PV interaction with membranes 
209 
 
these features are not fully shared by its analogue [S4(13)-PVscr], which displays a 
scrambled sequence and was herein used for comparison, hence reflecting the 
relevance of the cell penetrating amino acid sequence and resulting α-helical 
conformation upon membrane interaction for translocation and biological activity 
(Mano et al. 2006). 
In the present study, biophysical and ultrastructural studies were performed to 
characterize membrane interactions of the wild type S4(13)-PV peptide [S4(13)-PVwt] 
and its scrambled analogue in order to uncover the mechanisms underlying their 
membrane translocation and ability for nucleic acid delivery, hence, contributing to 
the advance in the application of this CPP for therapeutic purposes. 
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7.3 MATERIALS AND METHODS 
 
Chemicals 
The lipids 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE), 1,2-dioleoyl-sn-
glycero-3-phospho-(1'-rac-glycerol) (DOPG), 1,2-dipalmitoyl-sn-glycero-3-
phosphoethanolamine (DPPE), 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC), 
1,2-dipalmitoyl-sn-glycero-3-phospho-(1'-rac-glycerol) (DPPG) and 1-palmitoyl-2-
oleoyl-sn-glycero-3-phospho-(1'-rac-glycerol) (POPG) were purchased from Avanti 
Polar Lipids, Alabaster, AL. The fluorescent probes 3-(p-(6-phenyl)-1,3,5-
hexatrienyl)phenylpropionic acid (DPH-PA), 2-(9-anthroyloxy) stearic acid (2-AS), 6-
(9-anthroyloxy) stearic acid (6-AS), 12-(9-anthroyloxy) stearic acid (12-AS) and 16-
(9-anthroyloxy) palmitic acid (16-AP) were obtained from Molecular Probes Inc. 
(Eugene, OR). 
 
Peptides 
Peptide S4(13)-PV [S4(13)-PVwt, Table 7.1] was prepared as a C-terminal amide by 
solid-phase methodologies based on classical Fmoc (1-(9H-fluoren-9-yl)-
methoxycarbonyl)/tert-Butyl chemistry (Fields & Noble 1990), as previously 
described (Trabulo et al. 2008). The scrambled peptide [S4(13)-PVscr, Table 7.1] was 
generated on the basis of S4(13)-PV peptide sequence, so that the resulting peptide 
had the same amino acid composition and overall charge, but a distinct primary 
sequence. Both peptides were acetylated at their N-terminus and isolated in high 
purity level (>95%). Freeze-dried peptides were reconstituted in ultra-pure water. 
Concentration of S4(13)-PV peptides was determined by amino acid analysis and 
light absorption at 280 nm. Amino acid analysis was performed in a Beckman 6300 
automatic analyzer, (CA, USA), following acid hydrolysis of the peptide. 
 
Table 7.1 Amino acid sequences of the S4(13)-PVwt and a scrambled analogue, S4(13)-PVscr used in the 
present study. 
 
 
 
Peptide Sequence 
S4(13)-PVwt ALWKTLLKKVLKAPKKKRKVC-NH2 
S4(13)-PVscr KTCKVAKWLKKAKPLRKLVKC-NH2 
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Lipid Preparations 
Liposomes were prepared by hydration of lipid films as previously described (Jurado 
et al. 1991). Briefly, lipid films, resulting from the evaporation to dryness of aliquots 
of lipid solutions in chloroform (DPPC, DMPG, DPPG or a mixture of POPG/DPPE at 
3/7 molar ratio) were hydrated with an appropriate volume of 50 mM KCl, 10 mM 
Tris–maleate buffer (pH 7.4) and liposome dispersions were obtained by 
handshaking in a water bath set 7–10 °C above the transition temperature of the 
phospholipids. Then, the suspensions of multilamellar vesicles were vortexed for 
1 min to disperse aggregates. For DSC experiments, liposomal samples (75 mM in 
phospholipid) were used immediately after preparation. However, for 
spectrofluorimetric techniques, liposomes (200 μM in phospholipid) were 
subsequently sonicated in a low energy water sonifier for a few seconds to decrease 
the light scattered by the multilamellar vesicle (MLV) suspensions. For fluorescence 
polarization measurements, the probes (DPH-PA, 2-AS, 6-AS, 12-AS or 16-AP) were 
then incorporated in liposomes, by injecting a few microliters of the concentrated 
probe solution in dimethylformamide into liposome suspensions to obtain a 
lipid/probe molar ratio of 200/1. Thereafter, the liposome suspensions were 
incubated for 30 minutes in a water bath set 7-10 °C above the transition 
temperature of the phospholipids and let to stabilize overnight at room temperature, 
in the dark. Blank samples were prepared with equivalent volumes of the probe 
solvent.  
For SAXS and WAXS measurements, lipid films obtained as described above were 
dried under a stream of N2 and left overnight under reduced pressure to remove all 
traces of the organic solvents. The lipid films were hydrated with 50 mM KCl, 10 mM 
Tris–maleate buffer (pH 7.4) or buffered solutions of S4(13)-PV peptides (wt and scr) 
added to obtain lipid/peptide molar ratios from 50/1 to 100/1. Lipid suspensions 
were then heated above the lipid phase transition temperature in a water bath, mixed 
by vortexing for about 5 min and centrifuged for 30 s at 2000 g. This procedure was 
repeated three times. Finally, the samples were aged overnight at 4 °C and shaken 
under vortex at room temperature for 5 min. The dispersions were transferred into 
glass capillaries, transparent to X-rays, of 1.5 mm diameter (Hilgenberg, Malsfeld, 
Germany). The flame-sealed capillaries were stored at 4 °C until the time of the 
measurements. 
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DSC Scans 
The MLV suspensions incubated with peptide (peptide/lipid molar ratios in the range 
of 20/1 to 80/1) were sealed into aluminum pans. Heating scans were performed 
over an appropriate temperature range in a Perkin–Elmer Pyris 1 differential 
scanning calorimeter, at a scan rate of 5 °C.min-1. To check the reproducibility of data, 
three heating scans were recorded for each sample. Data acquisition and analysis 
were performed using the software provided by Perkin–Elmer. Two distinct 
temperatures were automatically defined in the thermotropic profiles: the 
temperature of the onset (Ton) and the temperature at the endothermic peak (Tm). To 
define the range of the phase transition or lateral phase separation (Tf−Ton), a third 
temperature corresponding to the completion of the phase transition (Tf) was 
determined by extrapolating to the baseline a tangent to the descendent slope of the 
endothermic peak. These critical transition temperatures were estimated as the mean 
value of heating scans obtained, at least, from three different samples of the same 
lipid preparation. To determine the total amount of phospholipid contained in the 
pans, these were carefully opened at the end of the DSC assay and the lipid was 
dissolved in chloroform/methanol (3:1) and dried with N2 flow. Phospholipid content 
was determined by measuring the inorganic phosphate (Bartlett 1958) released after 
hydrolysis of dried phospholipids, at 180 °C, in 70 % HClO4 (Bottcher et al. 1961). The 
calorimetric enthalpy changes (ΔH) of the thermotropic events, expressed in 
kcal/mol, were normalized to the exact phospholipid content in each pan. 
 
SAXS and WAXS 
SAXS and WAXS experiments were performed at the beamline A2 of Doris III at 
HASYLAB (DESY, Hamburg, Germany) with a monochromatic radiation of wavelength 
0.15 nm. The SAXS detector was calibrated with rat-tail tendon and the WAXS 
detector by polyethyleneterephthalat (PET). Heating and cooling scans were 
performed at a rate of 1 K.min-1 in the range of 10 °C to 70 °C. Data was recorded for 
10 s every min. Static exposures were also taken below and above the main transition 
temperature of the lipids DPPC and DPPG and only above the main transition 
temperature of DOPE or the lipid mixture DOPG:DOPE (3:7), and compared at the 
same temperatures in heating/cooling cycles to check for possible radiation damage. 
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In order to minimize sample exposure to X-ray, a shutter mounted before the sample 
was kept closed when no data were acquired. 
Lamellar lattice distances, d, were calculated from the small angle Bragg reflections 
using s = n/d, where s is the lamellar spacing and n the order of the reflection (n = 1, 
2…). To obtain a more precise position for s, the diffraction peaks were fitted with 
Lorentzians and the positions of maximal intensities and peak half-widths at one half 
of the maximal intensity were determined.  
 
Fluorescence Polarization Measurements 
The fluorescence polarization measurements of MLV suspensions were performed 
with a Perkin Elmer LS 55B fluorescence spectrophotometer (Perkin Elmer, U.S.A), 
equipped with polarization filters and a thermostated cell holder. The excitation 
wavelength was set at 336 nm and the emission wavelength at 450 nm (5 nm 
excitation and 6 nm emission band pass) for DPH-PA and at 365 nm and 450 nm for 
the 2-AS, 6-AS, 12-AS and 16-AP. The fluorescence polarization (P) was calculated 
according to the equation  
 𝑃 =
𝐼𝐼𝐼 − 𝐺𝐼⏊
𝐼𝐼𝐼 + 𝐺𝐼⏊
 
where III and I⏊ are the intensities of the emitted light when the polarizer and 
analyzer are in the vertical position (III) or the polarizer is in the vertical and the 
analyzer in the horizontal position (I⏊). The instrumental grating correction factor for 
the optical system (G) is given by the ratio of the vertically to the horizontally 
polarized emission components when the excitation light is polarized in the 
horizontal plane. All fluorescence measurements were corrected for the contribution 
of light scattering by using appropriate blanks without added fluorescent probes. 
The degree of fluorescence polarization reflects probe rotational diffusion and, 
therefore, reports the structural order or membrane fluidity in the bilayer lipid 
environments where the probes are embedded. Thus, the term fluidity is 
operationally used in this work as being inversely proportional to the polarization 
parameter, and it essentially reflects the rate and the range of motion of phospholipid 
acyl chains (Lentz 1989). 
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Labeling of peptides with nanogold cluster and treatment of cells with peptides 
Peptides were tagged with nanogold (Monomaleimido Nanogold, Nanoprobes, NY, d 
1.4 nm) as described earlier (Palm-Apergi et al. 2009). A covalent bond was formed 
between the thiol group of peptide and the maleimide group of label by incubation at 
a molar ratio 2.5:1 in 50 % methanol at 30 °C for 90 min. Methanol was removed and 
the conjugate concentrated by speed-vac to reach 50-100 µM concentration of labeled 
peptide. The conjugate with 1:1 peptide/nanogold ratio was purified to homogeneity 
by size-exclusion chromatography and concentrated. 
HeLa cells cultured under standard conditions were seeded onto glass coverslips in 
24-well plates, grown to 80-90% confluence and incubated with culture medium 
containing 1 or 3 µM gold-labeled peptides at 37 °C for 1 h or 4 h. After incubation, 
the cells were washed twice with cell culture medium and processed for electron 
microscopy as described earlier (Padari et al. 2010). 
 
Statistical Analysis of Data  
The results of DSC and fluorescence polarization are presented as mean ± standard 
deviation of at least three independent experiments. Multiple comparisons are 
performed using one-way analysis of variance (ANOVA) with Tukey’s multiple 
pairwise comparison. Statistical significance was set at P < 0.05. Errors in 
experimental values of x-ray diffraction in the determination of d and ξ were assessed 
based on error estimates of the partial molecular volumes of lipids and water. 
 
  
 chapter 7 
216 
 
  
 S4(13)-PV interaction with membranes 
217 
 
7.4 RESULTS 
 
7.4.1 PEPTIDES S4(13)-PVWT AND S4(13)-PVSCR DIFFERENTLY AFFECT THE THERMODYNAMIC 
PROPERTIES OF ZWITTERIONIC (DPPC) AND ANIONIC (DPPG) LIPID SYSTEMS 
In order to evaluate the effect of the peptides S4(13)-PVwt and S4(13)-PVscr on the 
thermodynamic properties of lipid bilayers, DSC studies were performed using, as a 
first approach, liposomes prepared from a single synthetic lipid. A zwitterionic 
(DPPC) and an anionic phospholipid (DPPG) were used for this purpose and several 
lipid/peptide molar ratios were assayed, as depicted in Figures 7.1 and 7.2. 
 
 
Figure 7.1 DSC profiles (heating scans) of DPPC bilayers in the presence of different concentrations of 
the peptides S4(13)-PVwt (A) and S4(13)-PVscr (B). The lipid/peptide molar ratios are indicated on the 
scans, which are representative of at least three independent experiments. 
 
According to what has been extensively documented in literature (Gennis 1989), 
aqueous dispersions of DPPC exhibited two endothermic events (Figure 7.1): a pre-
transition near 36 °C and a more energetic main transition at around 42 °C. The first 
endotherm is due to a transition between two gel phases: Lβ’, characterized by tightly 
packed molecules with tilted acyl chains in the all-trans conformation and Pβ’ phase, 
where acyl chains are still highly ordered and tilted, but the lipid hydration is 
enhanced and the bilayer forms periodic membrane ripples (Gennis 1989). The main 
transition, whose enthalpy reflects the disruption of van der Waals interactions 
between the hydrocarbon chains, arises from the conversion of the Pβ’ gel phase to a 
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fluid Lα phase, where the fatty acid chains are highly disordered due to 
conformational changes (trans-gauche isomerization), the headgroups undergo 
extensive rotational motion and the whole molecules display lateral diffusion rates of 
the order of 10-8 cm2 s-1. 
In the presence of S4(13)-PVwt or S4(13)-PVscr (Figure 7.1 and Table 7.2), the main 
phase transition of DPPC liposomes did not show significant alterations. However, the 
wild-type peptide (Figure 7.1A and Table 7.2) induced a shift of the pre-transition to 
lower temperatures (from 35.8 °C in the absence of peptide to 33.2 °C at the 
maximum peptide concentration tested) and a decrease in enthalpy (from 
1.14 kcal/mol to 0.24 kcal/mol, in the same conditions). The scrambled peptide 
(Figure 7.1B and Table 7.2), at a peptide/lipid molar ratio of 1/40, also promoted an 
enthalpy decrease of the pre-transition of DPPC membranes (to 0.23 Kcal/mol). Since 
the enthalpy of the main transition was not significantly altered (Table 7.2), these 
findings suggest that both peptides did not deeply penetrate the hydrophobic core of 
DPPC bilayers. However, some interactions might be established between the cationic 
peptides and the negatively charged phosphate groups of the phospholipids, 
stabilizing, in the case of the S4(13)-PVwt, the ripple phase, as indicated by the 
decrease of the pre-transition midpoint. 
 
Table 7.2 Characterization of the phase transitions detected by DSC (temperature of the endothermic 
peaks, Tp and Tm, and enthalpy change, ∆H) in liposomes of DPPC in the absence and presence of the 
peptides S4(13)-PVwt or S4(13)-PVscr, at the lipid/peptide molar ratios indicated in the table. 
 
  Pre-transition Main transition 
Peptide type 
DPPC/peptide 
molar ratio 
Tp (°C)1) 
∆H 
(kcal/mol)1) 
Tm (°C)1) 
∆H 
(kcal/mol)1) 
no peptide  35.76 ± 0.20 2.4 ± 0.50 42.24 ± 0.34 19.37 ± 1.16 
S4(13)-PVwt 
80/1 35.70 ± 0.14 0.98 ± 0.34 42.22 ± 0.09 12.28 ± 1.35 
60/1 34.93 ± 0.12 0.97 ± 0.68 42.31 ± 0.20 15.54 ± 2.06 
40/1 34.04 ± 0.42*** 0.90 ± 0.33* 42.30 ± 0.20 15.48 ± 3.06 
20/1 33.18 ± 0.12*** 0.51 ± 0.32* 42.24 ± 0.25 12.97 ± 2.43 
S4(13)-PVscr 40/1 36.49 ± 1.40 0.48 ± 0.40 42.55 ± 0.51 12.99 ± 2.25 
 
1) These values (means ± standard deviation) were obtained from three DSC experiments. Comparisons 
were performed in the presence vs. absence of the peptide (*p<0.01, ***p<0.0001). 
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A distinct scenario resulted from peptide interactions with DPPG membranes 
displaying a net negative charge (Figure 7.2). A pre-transition of DPPG vesicles in 
media with low ionic strength has been referred in the literature (Wilkinson & 
McIntosh 1986). However, this was not observed with the liposome samples we used 
for DSC assays, most likely because they were prepared in a salt-containing buffer, 
reducing the repulsive electrostatic interactions between the phosphate groups and 
then decreasing the area required for the phospholipid headgroups. In fact, the pre-
transition has been registered only with lipids featured by a large area requirement 
for the polar groups (Gennis 1989). Therefore, a single endothermic event was 
observed in our assays, corresponding to the main transition centered at around 
41 °C, in agreement with what has been reported in the literature (Wilkinson & 
McIntosh 1986). The wild-type peptide induced a split of this endotherm in two 
components (Figure 7.2A, Table 7.3), suggesting a non-homogeneous distribution of 
the peptide within the membrane. The lower temperature component, which is 
preserved in the lipid/peptide range of 80/1 to 40/1, centered at the temperature of 
the pure lipid transition, is assigned to less disturbed lipid molecules, which remain 
in peptide-poor regions. In contrast, the higher temperature component is assigned to 
lipids residing in peptide-rich domains or those being in closer proximity to peptides, 
undergoing high perturbation. With increasing concentrations of the peptide, the 
second peak was progressively favored, leading to a situation (with the higher 
concentration of peptide tested, 20/1) where the splitting was vanished and only one 
peak was detected at the highest temperature (42 °C), probably due to a 
homogeneous lipid population, which is under the influence of peptide molecular 
interactions. Interestingly, the enthalpy of the main transition of DPPG liposomes in 
the absence of peptide (∆H = 5.9 Kcal/mol) was approximately equivalent to the sum 
of the enthalpies of the two endotherms obtained in peptide-containing preparations 
at peptide/lipid molar ratios from 80/1 to 60/1 (Table 7.3). At a peptide/lipid molar 
ratio of 40/1, the enthalpy of the lower temperature endotherm further decreased, 
but that of the higher temperature endotherm stopped increasing and, at the maximal 
peptide/lipid ratio tested (20/1), the enthalpy of the single endotherm was much 
lower (approximately one half) than that observed in the absence of the peptide. This 
probably indicates that a fraction of DPPG molecules were somehow “sequestered” by 
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tight interaction with the peptide, being inhibited to participate in the bulk phase 
transition. 
 
 
Figure 7.2 DSC profiles (heating scans) of DPPG bilayers in the presence of different concentrations of 
the peptides S4(13)-PVwt (A) and S4(13)-PVscr (B). The lipid/peptide molar ratios are indicated on the 
scans, which are representative of at least three independent experiments. 
 
 
Table 7.3 Characterization of the phase transitions detected by DSC (temperature of the endothermic 
peak, Tm and enthalpy change, ∆H) in liposomes of DPPG in the absence and presence of the peptides 
S4(13)-PVwt or S4(13)-PVscr, at the lipid/peptide molar ratios indicated in the table. 
 
 Main transition 
Peptide type 
DPPG/ peptide 
molar ratio 
Tm (°C)1) ∆H (kcal/mol)1) 
no peptide  41.28 ± 0.56 - 5.92 ± 0.17 - 
S4(13)-PVwt 
80/1 41.22 ± 0.20 42.07 ± 0.13 2.35 ± 3.7 3.03 ± 0.33 
60/1 41.05 ± 0.40 41.82 ± 0.15 2.15 ± 1.70 3.65 ± 1.73 
40/1 41.54 ± 0.30 42.45 ± 0.36 1.65 ± 1.91 3.05 ± 0.74 
20/1 - 42.24 ± 0.32** - 3.11 ± 1.26 
S4(13)-PVscr 
80/1 41.48 ± 0.36  4.14 ± 1.20  
60/1 40.36 ± 1.43  2.68 ± 0.10*  
40/1 41.38 ± 0.32  2.35 ± 0.17*  
1) These values (means ± standard deviation) were obtained from three DSC 
experiments. Comparisons were performed in the presence vs absence of the peptide 
(*p<0.05, **p<0.01). 
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Despite having similar physico-chemical properties (length of the primary sequence, 
charge and amino acid composition), the scrambled peptide differently affected DPPG 
model membranes, its action being limited to a concentration-dependent decrease in 
the enthalpy of the main transition (Figure 7.2B and Table 7.3), which reinforces its 
different ability to interact and disturb the lipid bilayer.  
 
7.4.2 PEPTIDES S4(13)-PVWT AND S4(13)-PVSCR INDUCE STRUCTURAL CHANGES IN ZWITTERIONIC 
(DPPC) OR ANIONIC (DPPG) LIPID SYSTEMS  
The degree of peptide-induced perturbation of the different DPPC phases (Lβ’, Pβ’ and 
Lα) at a peptide/lipid molar ratio of 1/50 was evaluated by X-ray diffraction patterns 
at small and wide angles (SAXS and WAXS), which provide information on the long-
range bilayer organization and the hydrocarbon chain packing, respectively. 
SAXS (data not shown) and WAXS patterns (Figure 7.3A) taken at different 
temperatures in heating scans allowed the determination of the pre-transition (Lβ’  
Pβ’) and the main transition (Pβ’  Lα) temperatures of DPPC bilayers (≈35 °C and 
42 °C, respectively), which are in agreement with the results obtained by DSC and 
previously published data (Lúcio et al. 2008). Thus, the WAXS patterns of DPPC, 
showing two WAXS reflection peaks at 28, 32 and 34 °C (Figure 7.3A), are typical of a 
Lβ’ phase with orthorhombic hydrocarbon chain packing. At 36 °C, a broad single 
Bragg peak was observed, indicating a transition to the Pβ’ phase, and the main phase 
transition occurred at 42 °C, where a defined WAXS peak is no longer visible. 
As shown in Figure 7.3B and C, the peptides did not alter the main phase transition 
temperature of DPPC, but promoted some perturbation of the chain packing 
regarding the Lβ’ phase, shifting DPPC pre-transition to lower temperatures (34 °C). 
This effect, which is particularly evident for the S4(13)-PVwt peptide, corroborates 
DSC data. 
Deconvolution of the WAXS patterns in the Lβ’ phase (20 °C) gives the lattice distances 
of the orthorhombic lattice of the DPPC chain packing, i.e., 4.12 ± 0.05 Å and 
4.04 ± 0.05 Å (data not shown), which are also in good agreement with the literature 
(Lúcio et al. 2008). Neither this chain packing nor the correlation length (ξ) between 
the bilayers (data not shown) was affected by the presence of the peptides. 
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Figure 7.3 WAXS patterns of (A) DPPC; (B) DPPC/S4(13)-PVscr (50/1 molar ratio) and (C) 
DPPC/S4(13)-PVwt (50/1 molar ratio), at different temperatures. Solid lines give the best fit of the 
Lorentzian’s analysis model to the scattered intensities. Dotted lines represent the transition points 
observed between Lβ’ and Pβ’ phases (pre-transition) and between Pβ’ and Lα phases (main transition). 
 
A very different scenario was provided by SAXS and WAXS studies with DPPG 
membranes. It should be emphasized that in these lipid preparations (much more 
concentrated than those used in DSC assays), it was possible to detect the pre-
transition by SAXS and WAXS. The SAXS patterns of DPPG exhibited very diffuse 
scattering especially at higher temperatures, which results in broad Bragg peaks with 
low correlation length between the bilayers (ξ). This has been previously observed 
(Danner et al. 2008; Pabst et al. 2007; Prossnigg et al. 2010) and explained because of 
the electrostatic repulsion, which leads to the formation of uncorrelated bilayers. 
DPPG lamellar distances (d) determined in each lipid phase are displayed in 
Table 7.4. In the Lβ’ gel phase, the DPPG bilayer including the water layer showed to 
be 5.02 ± 0.07 nm thick. Along a heating scan, the spacing increased to 5.76 ± 0.07 nm 
in the ripple gel phase Pβ’, and decreased again to 5.40 ± 0.07 nm in the Lα phase, in a 
similar fashion to what has been described in the literature (Pabst et al. 2007).  
In the presence of S4(13)-PV peptides, no significant effects were denoted in the Lα 
and Pβ’ phases of DPPG bilayers (Table 7.4). Thus, the position of the Bragg peaks 
was not altered and d values show only a very small increase as compared with pure 
DPPG bilayers. 
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However, the addition of peptides led to a lipid phase separation in the Lβ’ phase. 
Hence, the coexistence of a non-affected DPPG gel phase, showing d values (≈ 5.0 nm) 
not significantly different from those of pure DPPG bilayers, and a phase with much 
smaller d values (≈ 3.0 nm), characteristic of a LβI interdigitated phase (Table 7.4), 
indicates a non-homogeneous distribution of peptides in the most ordered phase (Lβ’) 
of DPPG membranes.  
 
Table 7.4 Long range distances (d) and correlation length (ξ) determined from SAXS patterns in DPPG 
bilayers in the absence and in the presence of the peptides S4(13)-PVwt or S4(13)-PVscr (100/1 or 50/1 
lipid/peptide molar ratio), at 20, 38 and 50 °C and physiological pH. 
 
 
The interdigitated phase visible in the SAXS regime was confirmed in the 
corresponding WAXS patterns (Figure 7.4), which exhibit sharp peaks (gray lines at 
10 and 20 °C) in addition to the β’ pattern assigned to an orthorhombic packing of 
hydrocarbon chains (dashed black lines at 10 and 20 °C). At 38 °C, a single phase was 
observed again, which is assigned to a ripple phase as indicated by the broad peak, 
similarly to what was observed in pure DPPG bilayers. 
Sample 
T (°C) / 
expected lipid phase 
dSAXS (Å) ξ (Å) 
DPPG 
20 (Lβ’) 50.2 ± 0.7  187 ± 10  
38 (Pβ’) 57.6 ± 0.7  32 ± 15  
50 (Lα) 54.1 ± 0.7  33 ± 15  
DPPG:S4(13)-
PVscr (100/1) 
20 (Lβ’) 50.4 ± 0.7 36.8 ± 0.7 180 ± 10 140 ± 10 
38 (Pβ’) 57.9 ± 0.7  34 ± 15  
50 (Lα) 54.2 ± 0.7  23 ± 15  
DPPG:S4(13)-
PVscr (50/1) 
20 (Lβ’) 50.4 ± 0.7 36.5 ± 0.7 5 ± 3 18 ± 15 
38 (Pβ’) 57.6 ± 0.7  32 ± 15  
50 (Lα) 54.7 ± 0.7  22 ± 10  
DPPG:S4(13)-
PVwt (100/1) 
20 (Lβ’) 50.7 ± 0.7 37.5 ± 0.7 22 ± 15 105 ± 15 
38 (Pβ’) 59.0 ± 0.7  34 ± 15  
50 (Lα) 54.8 ± 0.7  23 ± 15  
DPPG:S4(13)-
PVwt (50/1) 
20 (Lβ’) 51.7 ± 0.7 37.2 ± 0.7 38 ± 15 114 ± 15 
38 (Pβ’) 58.9 ± 0.7  30 ± 15  
50 (Lα) 54.9 ± 0.7  32 ± 15  
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Figure 7.4 WAXS patterns of (A) DPPG/S4(13)-PVscr (50/1 molar ratio) and (B) DPPG/S4(13)-PVwt 
(50/1 molar ratio) at different temperatures. Solid lines give the best fit of the Lorentzian’s analysis 
model to the scattered intensities. At the temperatures of 10 and 20 °C the fitting can be described as 
the superimposition of three peaks corresponding to the orthorhombically packed acyl chains (dashed 
black lines) and interdigitated acyl chains (gray line). 
 
Besides studying the influence of the peptides on each lipid phase, WAXS heating 
scans were taken at different temperatures to determine the effect of the peptides on 
the main phase transition temperature (Pβ’ →Lα). Both peptides shifted DPPG main 
transition to higher temperatures (data not shown), from an ordered to a disordered 
phase where a defined WAXS peak is no longer visible. Probably peptide-induced 
broadening of this transition impeded the detection of the temperature upshift in DSC 
scans in the case of the scrambled peptide (Figure 7.2B and Table 7.3). 
 
7.4.3 PEPTIDES S4(13)-PVWT AND S4(13)-PVSCR ALTER MEMBRANE ORDER PARAMETERS 
MONITORED AT DIFFERENT DEPTHS OF AN ANIONIC LIPID (DPPG) SYSTEM  
Fluorescence polarization measurements using fluorescent probes that intercalate at 
different depths of the lipid bilayer were performed in order to uncover how the 
S4(13)-PV peptides affect the lateral pressure profile across the thickness of a DPPG 
membrane. As a first approach, a fluorescence polarization thermogram in DPPG 
liposomes was obtained with the probe DPH-PA, which monitors the hydrophobic 
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region of the bilayer closer to the surface, at which this molecule is anchored by its 
negatively charged group (Trotter & Storch 1988). The fluidity-related spectroscopic 
parameter (P) in DPPG bilayers undergoes, as expected, an abrupt decrease within a 
relatively narrow temperature range (Figure 7.5A), reflecting a sharp phase 
transition with a temperature midpoint (Tm) at 42 °C, as indicated by the peak of the 
fluorescence polarization derivative curve (inset in Figure 7.5A), in accordance with 
the above results obtained by DSC and X-ray diffraction. Also consistent with DSC 
data, both peptides, at a 40/1 lipid/peptide molar ratio, broaden DPPG transition 
profile, affecting its cooperativity. Additionally, an increase of the order parameter 
over all the transition temperature range and in the fluid phase was observed (Figure 
7.5A), this effect being more pronounced for the scrambled peptide. The peptide-
induced increase of lipid order may result from the electrostatic interaction between 
the peptides and the lipid membranes, with a consequent shielding of the surface net 
charge that might decrease the repulsive forces between the lipid headgroups. 
In order to further characterize peptide-induced perturbation across the bilayer 
thickness, fluorescence polarization studies were performed with n-(9-anthroyloxy) 
stearic acid (n = 2, 6 and 12) and 16-(9-anthroyloxy) palmitic acid, at lipid/peptide 
molar ratios of 80/1 and 40/1 and at two different temperatures, one below (12 °C) 
and other above (60 °C) the DPPG main phase transition (Figure 7.5B). For both 
temperatures, peptide-induced ordering effect was more pronounced in the extremes 
of the hydrocarbon chains (at the level of carbons 2 and 16 of the stearoyl and 
palmitoyl chains, respectively). This effect was shown to be dependent on peptide 
concentration and more evident at 12 °C, temperature at which the coexistence of a 
Lβ’ phase and a LβI interdigitated phase was demonstrated by the SAXS and WAXS 
patterns. Peptide-induced broadening of phase transition, as detected by DPH-PA, is 
also indicative of lateral phase separation. 
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Figure 7.5 Fluorescence polarization (P) of DPH-PA (A) or 2-AS, 6-AS, 12-AS and 16-AP (B) in DPPG 
bilayers in the absence and in the presence of S4(13)-PVwt or S4(13)-PVscr. In A, thermograms were 
obtained in the absence (●) and in the presence of S4(13)-PVwt (△) or S4(13)-PVscr (□), at a 
lipid/peptide molar ratio of 40/1. The inset shows the first derivative of the polarization curves. In B, 
the fluorescence polarization of 2-AS, 6-AS, 12-AS and 16-AP (the carbon number of the stearic or 
palmitic chain where the 9-anthroyloxy group is attached being represented in the x axis) was 
measured at 12 ºC (filled symbols) and 60 ºC (open symbols), in the absence (●, ○) or the presence of 
S4(13)-PVwt at a lipid/peptide molar ratio of 40/1 (▲, △) and 80/1 (▼, ▽) or S4(13)-PVscr at a 
lipid/peptide molar ratio of 40/1 (■, □). The results shown are representative of at least three 
independent experiments. 
 
It should be noted that the interpretation of fluorescence polarization data in these 
conditions is complicated by the uncertainty of the localization of the fluorescent 
probes in the plane of the membrane and their preferential distribution between the 
different coexisting domains. Taking into account these limitations, the increase of 
fluorescence polarization of 2-AS at temperatures below and above the main phase 
transition may be a consequence of the interaction of the cationic peptide with the 
overall negative charges of DPPG headgroups, thus reducing electrostatic repulsion. A 
tighter packing of lipid molecules would be hence favored in the segment of the 
hydrocarbon chains closer to the phospholipid polar groups. This effect was not 
however detected by DPH-PA at 12 °C, probably because this probe monitors the lipid 
order in a deeper region of the lipid bilayer. On the other hand, the ordering effect 
induced by the peptide in the hydrophobic core of the bilayer, as monitored by 16-AP, 
might result from the interdigitation of phospholipid hydrocarbon chains, thus 
increasing van der Waals interactions. 
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7.4.4 THE S4(13)-PVWT PEPTIDE PROMOTES LIPID DOMAIN SEGREGATION IN A POPG/DPPE LIPID 
SYSTEM 
To further characterize peptide-membrane interactions, a binary lipid system 
containing a partially unsaturated anionic lipid (POPG) and a saturated zwitterionic 
lipid (DPPE) was used to mimic a physiologically more relevant membrane. The 
mixture of POPG/DPPE at a molar ratio of 3/7 constitutes a useful model system for 
DSC studies, since, in spite of the different transition temperatures of its lipid 
components (-2 °C for POPG and 63 °C for DPPE), it gives rise to a single, yet broad 
and assymetric peak, which reflects a certain lateral phase separation. 
The incorporation of the S4(13)-PVwt peptide into this membrane system produced 
significant changes in the thermotropic behavior of the lipid mixture (Figure 7.6). 
Relatively low peptide concentrations (lipid/peptide molar ratio of 80/1) promoted 
an alteration of the DSC profile, giving rise to a shoulder and a peak, which can be 
assigned to different lipid domains. The peptide apparently induced a displacement of 
the minor lipid (POPG) to segregated domains, corresponding to the lower melting 
temperature component (shoulder in the DSC profile). As a consequence, 
DPPE-enriched domains then exhibit a more cooperative transition, at higher 
temperatures (the peak in the DSC scan). The lower temperature component seems to 
shift to higher temperatures as the peptide concentration increased, from 80/1 to 
40/1 lipid/peptide molar ratio, suggesting a peptide-induced increase of lipid order. 
At the highest peptide concentration assayed (20/1), the endotherm became more 
symmetric, although still comprising two distinct components. Thus, the 
deconvolution of this peak reflects an effective lateral phase separation between a 
higher temperature component, assigned to the DPPE-enriched and peptide-poor 
domains, and a low temperature component, representing the more disordered 
domains of the anionic lipid POPG to which the peptide preferentially interacts. 
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Figure 7.6 DSC profiles (heating scans) of POPG/DPPE (3/7 molar ratio) bilayers in the presence of 
different concentrations of the peptide S4(13)-PVwt. The lipid/peptide molar ratios are indicated on 
the scans, which are representative of at least three independent experiments. 
 
7.4.5 PEPTIDES S4(13)-PVWT AND S4(13)-PVSCR AFFECT THE PHASE BEHAVIOR OF A 
DOPG/DOPE LIPID SYSTEM 
To evaluate the effect of the peptides S4(13)-PVwt and S4(13)-PVscr on lipid 
mesomorphism, a mixture of DOPG and DOPE (3/7 molar ratio) was chosen as a 
model system, since it undergoes a lamellar-to-inverted hexagonal phase (Lα→HII) 
transition at temperatures easily available in laboratory (Morein et al. 2000). In this 
context, the ability of the peptides used in this work to induce non-lamellar phases 
was studied by evaluating their capacity to lower the temperature at which the above 
lipid mixture undergoes a transition from the lamellar to a non-lamellar phase. As 
reported in the literature, the Lα phase of DOPG/DOPE mixture (3/7 molar ratio) is 
stable up to 50 °C, an isotropic phase (I) having been detected by 31P NMR only at 
temperatures above 60 °C (Prossnigg et al. 2010). SAXS studies at 65 ºC showed 
reflections consistent with the formation of a cubic phase (belonging to the space 
group Pn3m) and a small amount of HII phase (Morein et al. 2000). 
In the present work, SAXS measurements were performed at two different 
temperatures: 20 and 50 °C, where only lamellar phases (Lα) are expected. At the 
temperatures tested, several small angle diffraction peaks were detected in the 
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DOPG/DOPE mixture. The observed reflections in the absence of the peptides are 
consistent with the coexistence of two lamellar phases: a remaining Lβ’ corresponding 
to the peaks positioned at lower lattice spacings (higher lattice distances in 
Table 7.5) and a Lα phase corresponding to the peaks positioned at higher lattice 
spacings (lower lattice distances in Table 7.5). The first and second order Bragg 
peaks of each of these lipid phases presented an indexed ratio of 1:2, which indicates 
the lamellar nature of these phases. 
 
Table 7.5 Long range distances (d) and correlation length (ξ) determined from SAXS patterns for 
DOPE:DOPG (7:3) bilayers in the presence of the peptides S4(13)-PVwt or S4(13)-PVscr (50/1 
lipid/peptide molar ratio), at 20 and 50 °C and physiological pH. 
 
 
Concentration-dependent effects were detected upon interaction of either of the two 
peptides with the lipid mixture. For sake of clarity, only the results obtained with the 
highest peptide/lipid molar ratio (1/50) are shown. Both peptides showed a 
significant effect on the lipid mixture phase behavior at this concentration, promoting 
the formation of more defined Bragg peaks (data not shown) and rising the 
correlation length (ξ) between the bilayers (Table 7.5), thus indicating an increase of 
the lipid order. Moreover, both peptides promoted the formation of non-lamellar 
phases at lower temperatures (50 °C) than those at which these phases have been 
reported in this lipid mixture (about 65 °C (Morein et al. 2000)). In the presence of 
S4(13)-PVscr, several small angle reflections were observed at 50 °C (Table 7.5). The 
first order reflection at 5.06 ± 0.05 nm and the second order reflection at 
2.63 ± 0.05 nm were assigned to the lamellar phase (indexed ratio of 1:2), whereas 
Sample 
T (°C) / 
expected 
lipid phase 
dSAXS (Å) 
ξ (Å) 
1st Order Diffraction Peak 
2nd Order Diffraction 
Peak 
Lipid mixture 
DOPE:DOPG (7:3) 
20 (Lα) 61.3 ± 0.5 47.5 ± 0.5  29.6 ± 0.5 25.6 ± 0.5 33 ± 10 
50 (Lα) 61.3 ± 0.5 50.2 ± 0.5  29.8 ± 0.5 27.1 ± 0.5 43 ± 10 
Lipid mixture: 
S4(13)-PVscr (50:1) 
20 (Lα) 61.3 ± 0.5 51.4 ± 0.5  29.7 ± 0.5 26.6 ± 0.5 99 ± 10 
50 (Lα) 59.8 ± 0.5 50.6 ± 0.5 46.5 ± 0.5 29.7 ± 0.5 26.3 ± 0.5 136 ± 10 
Lipid mixture: 
S4(13)-PVwt (50:1) 
20 (Lα) 61.0 ± 0.5 57.1 ± 0.5  29.9 ± 0.5 28.5 ± 0.5 539 ± 10 
50 (Lα) 65.5 ± 0.5 54.2 ± 0.5 46.5 ± 0.5 29.8 ± 0.5 27.3 ± 0.5 522 ± 10 
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the first order reflections at 4.65 ± 0.05 nm and 5.98 ± 0.05 nm and the second order 
reflections at 2.63 ± 0.05 nm and 2.97 ± 0.05 nm were assigned to an inverted 
hexagonal (HII) phase (indexed ratio of 1:√3:2). S4(13)-PVwt peptide also proved to be 
able to promote the formation of non-lamellar phases, identified in this case as a 
cubic phase and a small amount of HII phase. Thus, the first order reflections at 
4.65 ± 0.05 nm, 5.42 ± 0.05 nm and 6.55 ± 0.05 nm, and the second order reflections 
at 2.73 ± 0.05 nm and 2.98 ± 0.05 nm (Table 7.5) were assigned to the cubic phase 
(indexed ratio of 1:√3:√4:√5) and a HII phase (indexed ratio of 1:√3:2). 
 
7.4.6 PEPTIDE S4(13)-PVWT INDUCES FORMATION OF QUASI-HEXAGONAL DOMAINS IN MEMBRANES 
OF HELA CELLS 
The observation that S4(13)-PVwt peptide was able to affect the phase behavior in a 
model lipid system prompted us to analyze the interaction of the peptide with the 
plasma membrane of cells at the ultrastructural level by using transmission electron 
microscopy. The peptide was tagged for better visualization with nanogold label as 
described earlier (Padari et al. 2010) and the electron microscopy studies were 
performed at peptide concentrations, which would enable a non-endocytotic uptake 
to occur (Mano et al. 2005) and could favor lipid transition from a lamellar to a non-
lamellar phase. Incubation of HeLa cells with 3 µM labeled wild-type peptide resulted 
in formation of peptide-containing particles at/on the cell surface (Figure 7.7A, B). 
Analogous structures were not observed with the scrambled peptide (not shown). A 
closer inspection revealed that the formed particles were not random aggregates but 
multi-layered and well-structured (Figure 7.7A a’, a’’ and 7.7B b’) with an average 
distance between layers of 9.5-10 nm. The nanogold label on S4(13)-PV peptide 
locates between the layers and is detectable as black dots of a non-uniform size with a 
diameter in the range of 5-15 nm (Figure 7.7A a’, a’’ and 7.7B b’). These findings 
suggest that the peptide has induced and stabilized the non-lamellar organization of 
cellular membranes, which is reminiscent of quasi-hexagonal domains (Siegel & 
Epand 1997; Siegel 1993). The plasma membrane, which is usually very well 
distinguishable in its lamellar organization in electron micrographs, becomes 
undetectable (Figure 7.7A). However, in some regions of the plasma membrane the 
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formation of non-lamellar lipid phase did not interfere markedly with its regular 
organization (Figure 7.7B).  
 
Figure 7.7 Transmission electron micrographs showing the interaction of S4(13)-PVwt peptide with 
plasma membrane of HeLa cells and peptide translocation into the cells. HeLa cells were incubated 
with 3 μM S4(13)-PVwt during 1 h at 37 °C. Black dots correspond to the nanogold label, visualized by 
silver enhancement to ~10 nm. S4(13)-PV peptide-containing quasi-hexagonal structures are observed 
at the surface of HeLa cells (A, B) and their fingerprint pattern is evidenced in enlarged sections (a’, a’’, 
a’’’ for image A and b’ for image B).  
 
The peptide-containing structures that resembled quasi-hexagonal domains were 
very rarely detected on the cell surface at 1 µM S4(13)-PV concentration in parallel 
with peptide nanoparticles (Padari et al. 2010). Whereas the latter were typical and 
abundant at 1 µM concentration of S4(13)-PV, the former were very seldom found. In 
addition, the non-lamellar formations detected at 1 µM concentration were always 
markedly smaller and less organized than those observed at the high peptide 
concentration. Furthermore, the appearance of quasi-hexagonal domains was a time-
dependent process, since such structures were only detected upon 1 h or longer 
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incubation at the physiological temperature, suggesting the recruitment of specific 
lipids or slow separation of particular phases in the plasma membrane.  
In addition to their presence at the cell surface, the putative non-lamellar structures 
were found in the membrane of intracellular vesicles, at 3 µM concentration of 
S4(13)-PV peptide (Figure 7.7A a’’’). Such peptide-induced arrangements were 
somewhat surprisingly also observed after incubation of HeLa cells with 1 µM 
S4(13)-PV (Figure 7.8), although the respective structures were markedly smaller 
and their organization was not as typical as that seen with the peptide at 3 µM 
concentration. At the low peptide concentration, quasi-hexagonal domains were 
detected in intracellular vesicles after 4 h incubation (Figure 7.8A), although 
occasionally such structures could also be observed after 1 h (Figure 7.8B). Although 
the SAXS assay demonstrated the induction of the cubic phase in the membrane-
mimicking system by the S4(13)-PV peptide, characteristic structures were not 
detected by electron microscopy after peptide incubation with HeLa cells.  
 
Figure 7.8 Transmission electron micrographs showing the interaction of S4(13)-PVwt peptide with 
the endosomal membrane of HeLa cells. The cells were incubated with 1 µM S4(13)-PVwt for 4 h (A) or 
1 h (B), at 37 °C. Black dots correspond to the nanogold label, visualized by silver enhancement to ~10 
nm. Quasi-hexagonal domains are detected in endocytotic vesicles after 1 h or 4 h incubation and 
evidenced in enlarged section (a for A image). 
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7.5 DISCUSSION 
 
In the field of CPP pharmacological application, the characterization of 
peptide-membrane interactions has assumed a high relevance to clarify the molecular 
mechanisms underlying CPP ability to transpose membranes and induce a desirable 
biological response. In the present work, we focused on the S4(13)-PV peptide and its 
scrambled analogue, which have been studied in our laboratory showing different 
capacities to translocate across cell membranes (Mano et al. 2006) and, accordingly, 
different competences for nucleic acid delivery (Trabulo et al. 2010b). These studies 
have shown a good correlation between the extent of cellular uptake and the 
conformational behavior of the peptides upon interaction with negatively charged 
membrane models (Mano et al. 2006; Mano et al. 2007). In this regard, more efficient 
internalization of the wild-type peptide has been attributed to its ability to adopt an 
amphipathic α-helical conformation, whose content increased with the negative 
charge density of the membrane model. In contrast, the scrambled peptide showed 
less significant conformational changes, suggesting that the sequence derived from 
the Dermaseptin S4 peptide [1-13 amino acid residues of the S4(13)-PVwt] is required 
for the formation of α-helical structures in the presence of negatively charged 
membranes (Mano et al. 2007).  
Aiming at gaining further insight into the molecular mechanisms responsible for the 
distinct internalization properties of S4(13)-PVwt and S4(13)-PVscr peptides, we 
attempted herein to unveil the other side of peptide/membrane interactions, that is, 
how the physical properties of membrane lipids are affected by each of the peptides. 
For reasons of simplicity, we chose as a primary approach membrane models 
composed of a single synthetic phospholipid, DPPC, because of the relevance of 
phosphatidylcholine species in eukaryotic plasma membranes, typically found in the 
outer monolayer of these membranes, or DPPG, which, although rare in mammalian 
cell membranes, allows to model an anionic membrane mimicking the outer surface 
of cellular membranes whose negative charges are mainly conferred by gangliosides 
and proteoglycans.  
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The minor effects exerted by both peptides on the thermodynamic and structural 
properties of the neutrally charged DPPC bilayers, in contrast to our observations for 
the anionic DPPG membranes, as monitored by DSC, fluorescence polarization and 
X-ray diffraction, evidenced the importance of the electrostatic interactions between 
the cationic peptide and the lipid headgroups in terms of membrane physical 
alterations. Therefore, this type of interactions is equally important both from the 
peptide and the lipid perspective. As mentioned above, the secondary structure of the 
S4(13)-PV peptide is significantly affected in the presence of vesicles containing 
negatively charged phospholipids but no conformational changes were observed 
when neutral membranes are added to the peptide solution in buffer (Mano et al. 
2006). Moreover, POPC vesicles did not affect the peptide fluorescence emission 
spectrum, but a blue-shift occurred when the vesicles included increasing amounts of 
the anionic lipid POPG (Mano et al. 2007). Consistently, the intrinsic fluorescence of 
the S4(13)-PV peptide was efficiently quenched by acrylamide in the presence of 
neutral lipid vesicles consisting of POPC, in a similar way to that occurring in buffer, 
but the quenching significantly decreased when increasing amounts of POPG were 
added to the binary system (Mano et al. 2006; Mano et al. 2007). Overall, these results 
indicate that electrostatic interactions between the S4(13)-PV peptide and the lipid 
bilayer are required to trigger a sequence of events: conformational alterations in the 
peptide followed by its incorporation into the lipid bilayer and, finally, disturbance of 
membrane physical properties. However, the possibility for perturbations of the 
membrane structure to occur upon a first contact of the peptide with the membrane 
surface, due to electrostatic interactions, should not be excluded. In this case, 
alterations of the lipid environment would be responsible for peptide conformational 
changes and its insertion into the lipid bilayer. The similar dependence on the 
presence of negative charges in model membranes observed for the S4(13)-PVwt 
behavior regarding, on the one hand, its conformational preference and incorporation 
into the membrane (Mano et al. 2006; Mano et al. 2007), and on the other hand, its 
impact on the physical properties of the bilayer structure, strongly suggests a 
phenomenological correlation between these two types of events. An identical 
preference for interacting with anionic versus zwitterionic lipids, affecting the 
physical properties of the former in a larger extent than the latter, was demonstrated 
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for penetratin (Alves et al. 2009), an extensively studied CPP, which similarly to the 
S4(13)-PVwt peptide adopts a helical structure upon interaction with anionic 
membranes (Alves et al. 2008). According to the same authors (Alves et al. 2009), the 
electrostatic interaction of the positive charges of penetratin with the anionic lipid 
headgroups might trigger peptide conformational changes, creating hydrophobic 
patches in its structure, which prompt the peptide to partially insert into the lipid 
bilayer. 
From the analysis of the differential effects exerted by the wild-type peptide and its 
scrambled analogue on membranes containing exclusively an anionic lipid (DPPG) or 
prepared from a mixture of an anionic (POPG or DOPG) and a zwitterionic (DPPE or 
DOPE) lipid, new insights are gained to explain the mechanisms of cellular uptake for 
both peptides. 
In the simplest model, we emphasize the capacity of the wild-type peptide, not shared 
by the scrambled analogue, to promote lateral phase separation. This effect denoted 
in DSC scans, associated to the appearance of an interdigitated phase (LβI) coexisting 
with the gel phase characteristic of DPPG pure systems, as revealed by SAXS and 
WAXS patterns, reflects the capacity of the S4(13)-PVwt peptide to induce 
heterogeneities in the lipid matrix of the membrane. As a consequence, defect lines 
and discontinuities in the boundary of adjacent lipid domains displaying different 
physical properties may favor peptide insertion into the bilayer and eventual 
translocation across the bilayer thickness. In contrast, the scrambled peptide, being 
less efficient in the creation of heterogeneities in the membrane, may have more 
limited capacity to be taken up by this process. The preferential peptide insertion into 
defect regions in the bilayer has been demonstrated by atomic force microscopy with 
an acylated peptide (Pedersen et al. 2005) and a mechanism of peptide membrane 
translocation involving phospholipid segregation has been proposed for penetratin 
(Lamazière et al. 2010). 
Data obtained with the binary lipid systems, besides confirming the capacity of the 
S4(13)-PVwt peptide to promote lipid domain segregation (Figure 7.6) also showed 
peptide capacity to induce non-lamellar phases (Table 7.5). The isotropic phase 
detected in the DOPG/DOPE (7:3) mixture at high temperatures has been reported by 
other authors (Morein et al. 2000) as corresponding to a cubic phase belonging to the 
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space group Pn3m, with characteristics (hysteretic phase behavior and optical 
transparency) pointing to a bicontinuous cubic structure. In fact, mixtures composed 
of a non-bilayer lipid (DOPE in the present case) and a bilayer stabilizer lipid (DOPG 
in the considered mixture) commonly form this type of structure. Studies with WALP 
model peptides (Lamazière et al. 2010) showed that the formation of the isotropic 
phase in this lipid system, which is by itself able to form this kind of structure at 
adequate temperature and water content, is afforded by very low peptide 
concentrations if an even slight hydrophobic mismatch occurs. This process to induce 
the lamellar to non-lamellar transition involving reduction of the bilayer rupture 
tension (Evans & Needham 1987) might be involved in the case of S4(13)-PVwt 
peptide. Although the precise hydrophobic length of this peptide is not known, the 
detection of a LβI interdigitated phase in DPPG bilayers in the presence of high 
peptide/lipid ratios makes the hypothesis of hydrophobic mismatch a reasonable 
assumption. In fact, the interdigitated phase is commonly triggered to counteract the 
void volume created in the hydrophobic core of the bilayer as a consequence of the 
intercalation of molecules featuring a polar group and a short hydrophobic chain (for 
instance drugs such as ethanol), which does not extend along the full length of the 
fatty acid chains of phospholipids (Nambi et al. 1988). Therefore, the interdigitated 
phase is a solution in conditions where the acyl chains assume the extended (all-
trans) conformation. However, at higher temperatures, the free space created in the 
core of the bilayer may induce a higher disorder in the acyl chains leading to an 
unbalance in the lateral pressure profile across the membrane thickness prone to the 
formation of non-lamellar phases. 
Taking into account that non-lamellar phases have been extensively reported in the 
literature as being involved in destabilization of the bilayer, increase of membrane 
permeability and phenomena of membrane fusion and fission (Lewis et al. 1997), it 
will be easy to infer the impact of these structures, transiently formed in the 
membrane and at localized regions of the bilayer, on the entry of the S4(13)-PV 
peptides into the cell. The formation of a non-lamellar phase in DMPG liposomes and 
the induction of a negative lipid curvature in different lipid systems were also 
demonstrated in the presence of penetratin (Alves et al. 2008; Alves et al. 2009), 
supporting a mechanism proposed for its translocation (Derossi et al. 1998) which 
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involves inverted micelles entrapping the peptide, crossing the bilayer thickness and 
releasing it inside the cell. 
The current study revealed that besides inducing a non-lamellar organization of lipids 
in membrane mimicking systems, the S4(13)-PV peptide can propagate and stabilize 
analogous lipid arrangements (quasi-hexagonal structures) in membranes of HeLa 
cells, as detected by transmission electron microscopy. In analogy with membrane-
mimetic lipid systems, the quasi-hexagonal structures appeared in cell membranes at 
high peptide to lipid ratios, although not being the prevalent structure. To the best of 
our knowledge, the formation of non-lamellar structures in cellular membranes upon 
cell incubation with cell-penetrating peptides has not been reported yet. The inability 
of the scrambled analogue to promote such membrane alterations would consistently 
justify its incompetence for delivery. The distinct behavior between the S4(13)-PV 
wild-type peptide and its scrambled analogue corroborates previous ultrastructural 
studies (Padari et al. 2010) which showed that the S4(13)-PVwt peptide assembled in 
small nanoparticle-like spherical structures upon interaction with the plasma 
membrane of HeLa cells, whereas the scrambled analogue gave rise to larger irregular 
aggregates. Although the formation of nanoparticle-regular structures seemed to 
firstly involve peptide association with the cell surface anionic glycosaminoglycans 
(GAG), it was observed that nanoparticles were formed even on the surface of a 
mutant cell line derived from CHO-K1 (pgs A-745), which lacks the capacity to 
synthesize proteoglycans, due to a deficiency in xylosyltransferase I, involved in GAG 
biosynthesis. Consistently, previous studies with this cell line and the corresponding 
wild type (CHO-K1) using flow cytometry and confocal microscopy (Mano et al. 2005) 
showed that the peptide concentration was determinant for the role played by 
proteoglycans in S4(13)-PV cellular internalization. Thus, while at low peptide 
concentrations (≤ 1µM) the cellular uptake was significantly decreased in cells 
lacking proteoglycans (pgs A-745), at higher concentrations (2.0 µM) peptide uptake 
by these cells was not significantly different from that observed in the wild-type cells. 
In the present work, the mechanisms underlying the successful cell internalization of 
the S4(13)-PV peptide, as opposed to the scrambled analogue, were investigated in 
conditions (high peptide concentrations) at which the peptide is taken up by an 
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energy-independent pathway and a GAG-non-requiring process, focusing in particular 
on the membrane lipid component and peptide effects on its mesomorphic behavior. 
Considering the whole set of our results, describing the S4(13)-PV peptide 
interactions with lipid membranes in terms of the consequences for both the peptide 
and the lipid component, we propose that electrostatic interactions with negatively 
charged phospholipid headgroups should trigger two kinds of events: change in 
peptide conformation, adopting an amphipathic α-helix, and lateral separation of lipid 
domains with different physical properties, creating conditions for generating non-
lamellar lipid phases. Non-bilayer phases could be favored by an eventual mismatch 
between the hydrophobic lipid matrix and the hydrophobic peptide length.  
At the cell surface, the negative charges should be provided by proteoglycans or 
gangliosides, which with other lipids (saturated phospholipids and cholesterol) form 
specific domains in the plasma membrane (lipid rafts) of a liquid-ordered phase 
characterized by a high conformational order but relatively low constraints in 
molecular lateral diffusion. Lateral phase separation and rearrangement of lipid 
organization and distribution in the plane of the membrane, as a consequence of 
peptide-lipid interactions, are also predictable and peptide incorporation through 
defect zones in the interfacial boundaries of lipid domains will be easily achieved. 
Subsequent alterations of bilayer thickness, undulations and changes in membrane 
curvature may also occur and have been proposed to be involved in the translocation 
of other CPPs (Lamazière et al. 2010). 
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7.6 CONCLUSION 
 
In conclusion, data obtained so far with S4(13)-PV peptides provide important details 
on the mechanism of action of these CPPs and may be useful for other amphipathic 
peptides. It should be emphasized that insights gained by the use of complementary 
biophysical techniques and transmission electron microscopy could be helpful for 
understanding the molecular mechanisms of membrane physical modulation by 
external agents, and can constitute a successful approach to clarify the specificity of 
biological responses triggered by apparently similar molecules. In terms of cell-
penetrating peptides, it should be stressed that peptide interactions with the 
phospholipid matrix play a determinant role in the success of their pharmacological 
application and should be taken into account in the design of novel molecules. 
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8.1 ABSTRACT 
 
The successful application of gene therapy approaches is highly dependent on the 
efficient delivery of nucleic acids into target cells. In the present study, new peptide-
based non-viral systems were developed to enhance plasmid DNA and siRNA 
delivery, aiming at generating appropriate gene delivery and gene silencing tools for 
pre-clinical and clinical application. For this purpose, a new cell-penetrating peptide 
derived from the wild-type S4(13)-PV peptide was synthesized through the addition 
of a five-histidine tail to its N-terminus, H5-S4(13)-PV, and its ability to mediate gene 
expression and gene silencing was evaluated and compared to that of the wild-type 
peptide. Plasmid delivery systems involving S4(13)-PV, H5-S4(13)-PV or the 
combination of each of these peptides with cationic liposomes displayed different 
levels of transfection efficiency and cytotoxicity. The histidine-enriched peptide, H5-
S4(13)-PV, proved to be generally more efficient and less toxic than the wild-type 
peptide. In addition, complexes of H5-S4(13)-PV with siRNAs, but not of S4(13)-PV, 
were efficiently internalized by cells and presented high knockdown activity. The 
association of cationic liposomes to binary complexes of S4(13)-PV with siRNAs 
enhanced silencing efficiency, although such enhancement was not enough to reach 
the efficiency levels observed in H5-S4(13)-PV/siRNA complexes. For the latter 
complexes, the addition of cationic liposomes did not result in a further improvement 
of gene silencing. Interestingly, systems containing the S4(13)-PV or the H5-S4(13)-
PV peptide exhibited superior biological activity when compared to those containing 
the reverse NLS or scrambled peptides, suggesting that both the cell-penetrating 
sequence and the NLS of the S4(13)-PV peptide influence the competence of binary 
and ternary complexes to accomplish nucleic acid delivery. In order to unravel the 
cancer therapeutic potential of formulations with the histidine-enriched peptide, 
their efficiency to mediate silencing of the oncogenic protein survivin was evaluated. 
As opposed to complexes with the wild type peptide, H5-S4(13)-PV complexes 
showed to be able to promote a high survivin knockdown at the level of both protein 
and mRNA, in HT1080 cells. 
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8.2 INTRODUCTION 
 
In order to improve the clinical efficacy of gene-based therapeutic strategies, a great 
deal of efforts has been expended on the discovery of potent therapeutic genes or 
gene-modulating molecules and on the enhancement of the efficiency of gene delivery 
systems. Viral and non-viral systems have been developed to mediate the delivery of 
plasmid DNA and siRNAs to target cells. However, gene therapy approaches that are 
both highly efficient and clinically viable are still scarce (Fonseca et al. 2009; de 
Fougerolles et al. 2007; Eguchi & Dowdy 2009). Cell-penetrating peptides (CPPs) 
have been extensively applied for nucleic acid delivery, using both covalent and non-
covalent association strategies (Heitz et al. 2009). While the covalent linkage of CPPs 
to nucleic acids allows the formation of small, monomeric conjugates of known 
stoichiometry with high reproducibility, the preparation of non-covalent complexes is 
technically simpler, originates nanoparticles with a net positive charge, and decreases 
the risk of altering the biological activity of the cargo (Heitz et al. 2009; Meade & 
Dowdy 2008).  
Many CPPs are derived from transduction domains of proteins, which are known for 
their remarkable properties of cell penetration, although model and designed CPPs 
have also been generated. Several modifications of natural occurring sequences have 
been introduced in CPPs in order to achieve higher transfection efficiencies mediated 
by CPP-based delivery systems. Among others, a new HIV-1 Tat peptide-based gene 
delivery system was designed by fusing the original Tat with histidine and cysteine 
residues (Lo & Wang 2008). The rationale behind these modifications was based on 
the features of these amino acids. The specific pKa of the histidine imidazole group, 
being close to the endosomal pH, allows protonation and leads to osmotic swelling, 
mimicking the proton-sponge effect observed with polyethyleneimine (PEI), thus 
facilitating nucleic acid release (Lo & Wang 2008; Midoux & Monsigny 1999). On the 
other hand, the cysteine residue disulfide interactions allow the stabilization and 
protection of the CPP-nucleic acid complexes in the extracellular medium, while their 
lability in the endosomal reducing environment contributes to nucleic acid release 
(Lo & Wang 2008). 
Motivated by the improvements observed for the Tat peptide following these 
modifications, a similar approach was tested with the S4(13)-PV peptide, a 
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Dermaseptin derived peptide fused to the nuclear localization sequence of the SV40 
large T antigen (Hariton-Gazal et al. 2002), which has been extensively studied in our 
laboratory. For this purpose, a S4(13)-PV analogue with a five-histidine tail at the N-
terminus was synthesized, originating a new peptide called herein H5-S4(13)-PV. 
Following our previous work on the development of S4(13)-PV peptide-based vectors 
for nucleic acid delivery (Trabulo et al. 2008; Trabulo et al. 2010a), and aiming at 
identifying the molecular features responsible for efficient nucleic acid delivery, the 
new peptide was here compared with the wild-type, S4(13)-PV, and its scrambled, 
S4(13)-PVscr, and reverse NLS, S4(13)-PVrev, analogues (Table 8.1), in terms of its 
ability to efficiently deliver plasmid DNA and siRNA to different cell lines. Ternary 
systems produced through the addition of dioleoyltrimethylammoniumpropane: 
dioleoylphosphatidylethanolamine (DOTAP:DOPE) liposomes to the CPP-nucleic acid 
complexes were also assayed, since previous work had revealed that the association 
of these vesicles with CPP complexes led to the formation of more efficient plasmid 
delivery systems (Trabulo et al. 2008). 
Our results showed that the histidine tail preserves or improves the S4(13)-PV 
peptide ability to efficiently deliver reporter plasmid DNA and siRNAs to different cell 
lines. In order to test the efficiency of the new CPP-based delivery systems to silence 
endogenous genes, the survivin gene was selected as a target. Survivin is a member of 
the IAP family, playing an important role in cell proliferation and inhibition of 
apoptosis (Ryan et al. 2009; Mesri et al. 2001; Tamm et al. 1998; Li et al. 1998; 
Hoffman et al. 2002; Beltrami et al. 2004; Dohi et al. 2004; Li et al. 1999; Uchida et al. 
2004; Liu et al. 2006). Due to its overexpression in cancer cells, while no expression 
or very low levels of expression are detected in normal cells, survivin constitutes a 
particularly promising target for cancer therapy. Moreover, survivin renders 
malignant cells resistant to conventional anti-tumoral treatments, by counteracting 
pro-apoptotic stimuli and, therefore, enhancing cancer cell survival (Ryan et al. 2009; 
Yonesaka et al. 2006; Kappler et al. 2005; Olie et al. 2000). 
Altogether, the present findings open a new window to extend the use of CPPs, 
including the S4(13)-PV peptide and its histidine derivative, as appropriate tools for 
nucleic acid delivery, with potential for clinical applications in different pathologies, 
such as cancer. 
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8.3 MATERIALS AND METHODS 
 
Materials 
The cationic lipid 1,2-dioleoyl-3-trimethylammonium-propane (DOTAP) and 1,2-
dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE) were purchased from Avanti 
Polar Lipids (Alabaster, AL, USA). The primers for survivin and for HPRT-1 genes 
were pre-designed by Qiagen (QuantiTect Primer, Qiagen). The antibody anti-survivin 
was purchased from Santa Cruz (Santa Cruz Biotechnology, Inc., Heidelberg, 
Germany) and the remaining antibodies were obtained from Sigma (St. Louis, MO, 
USA). The anti-GFP siRNA (5’-GCAAGCUGACCCUGAAGUUCAU-3’) and Cy3-labeled 
non-specific siRNA sequence were purchased from Ambion (Austin, TX, USA). The 
anti-survivin siRNA (5’-GGACCACCGCAUCUCUACAdTdT-3’) and the non-silencing 
siRNA used as control were obtained from Dharmacon (Lafayette, CO, USA). Fmoc-
protected amino acids, Fmoc-Rink Amide-MBHA LL resin (0.36 mmol/g) and coupling 
reagent O-(benzotriazol-1-yl)-N,N,N’,N’-tetramethyluronium-hexaflurophosphate 
(HBTU) were provided by Novabiochem (VWR International, Portugal). All the other 
chemicals were of the highest grade. 
 
Peptide synthesis 
Peptide synthesis was performed using a Liberty Microwave Peptide Synthesizer 
(CEM Corporation, Mathews, NC, USA). Peptide analysis by HPLC was done using a 
Hitachi-Merck LaChrom Elite system equipped with a quaternary pump, a 
thermostatted (Peltier effect) automated sampler and a diode-array detector (DAD). 
An LCQ-DecaXP LC-MS system from ThermoFinnigan, equipped with both a DAD 
detector and an electrospray ionization-ion trap mass spectrometer (ESI/IT MS), was 
also used for peptide analysis. Peptide quantitation was performed by measuring the 
absorbance at 280 nm in a spectrophotometer Helios Gama (Spectronic Unicam). 
The peptide (C-terminal amide) was assembled by Fmoc/tBu solid-phase peptide 
synthesis (SPPS) methodologies assisted with microwave (MW) energy (Collins & 
Leadbeater 2007). The resin was pre-conditioned for 15 min in N,N-
dimethylformamide (DMF) and then transferred into the MW-reaction vessel. The 
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initial Fmoc deprotection step was carried out using 20% piperidine in DMF 
containing 0.1 M of 1-hydroxybenzotriazole (HOBt) in two MW irradiation pulses: 30 
sec at 24 W plus 3 min at 28 W, in both cases temperature being no higher than 75 °C. 
The C-terminal amino acid was then coupled to the deprotected Rink amide resin, 
using 5 molar equivalents (eq) of the Fmoc-protected amino acid in DMF (0.2 M), 5 eq 
of 0.5 M HBTU/HOBt in DMF and 10 eq of 2 M N-ethyl-N,N-diisopropylamine (DIPEA) 
in N-methylpyrrolidone (NMP); the coupling step was carried out for 5 min at 35 W 
MW irradiation, with maximum temperature reaching 75 °C. The remaining amino 
acids were sequentially coupled in the C→N direction by means of similar 
deprotection and coupling cycles, except for incorporation of: (i) Fmoc-Arg(Pbf)-OH, 
whose coupling was done in two steps, 25 min with no MW irradiation (room 
temperature) followed by 5 min coupling at 25 W; (ii) Fmoc-Cys(Trt)-OH, Fmoc-
Trp(Boc)-OH and Fmoc-His(Trt)-OH, all coupled also in two steps, firstly with 2 min 
coupling without MW irradiation (room temperature), then followed by 4 min 
coupling at 25 W, with maximum temperature reaching 50 °C. Double-coupling was 
employed to all lysines in the sequence (residues 5, 6, 7, 10 and 14), incorporated as 
Fmoc-Lys(Boc)-OH. Following completion of sequence assembly, the peptide was 
released from the resin with concomitant removal of side-chain protecting groups, by 
a 3 h-acidolysis at room temperature using a trifluoroacetic acid (TFA)-based cocktail 
(Fields & Noble 1990; Carpino et al. 2003) containing thioanisole, 1,2-ethanedithiol 
and anisole as scavengers (TFA/thioanisole/1,2-ethanedithiol/anisole 90:5:3:2 
v/v/v/v). Crude product was purified by reverse-phase liquid chromatography to 
give the target peptide, as confirmed by HPLC, LC-ESI/IT MS and aminoacid analysis. 
 
Table 8.1 Sequences of the S4(13)-PV and derived peptides used in the present study. 
 
S4(13)-PV ALWKTLLKKVLKAPKKKRKVC-NH2 
H5-S4(13)-PV HHHHHALWKTLLKKVLKAPKKKRKVC-NH2 
S4(13)-PVscr KTLKVAKWLKKAKPLRKLVKC-NH2 
S4(13)-PVrev ALWKTLLKKVLKAVKRKKKPC-NH2 
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Cells 
HeLa cells (human epithelial cervical carcinoma) and A549 cells (human epithelial 
lung adenocarcinoma) were maintained at 37 °C, under 5% CO2, in Dulbecco Modified 
Eagle medium-high glucose (DMEM; Sigma) supplemented with 10% (v/v) heat-
inactivated fetal bovine serum (FBS; Biochrom KG) and 100 units penicillin and 
100 µg streptomycin (Sigma) per ml. HT1080 cells (human fibrosarcoma) were 
maintained at 37 °C, under 5% CO2, in Dulbecco Modified Eagle low glucose (DMEM-
LG; Sigma) supplemented with 10% (v/v) heat-inactivated fetal bovine serum (FBS; 
Biochrom KG) and 100 units penicillin and 100 µg streptomycin (Sigma) per mL.  
For flow cytometry and cell viability experiments, 1.0 × 105 HeLa, A549 or HT1080 
cells/well were seeded onto 12-well plates; for fluorescence microscopy studies, 
0.2 × 105 HT1080 cells/well were plated onto 8-well chambered coverslips (Lab-
Tek™ II Chamber Slide™ System Nunc™). For QRT-PCR and Western blot experiments, 
1.0 × 105 HeLa, A549 and HT1080 cells/well were plated onto 6-well plates. Cells 
were plated twenty-four hours prior to incubation with the complexes. 
 
Cationic liposome preparation 
Small unilamellar vesicles (SUV) were prepared by extrusion of multilamellar vesicles 
composed of the cationic lipid DOTAP and DOPE at a 1:2 molar ratio. Briefly, lipid 
solutions in chloroform were mixed at the desired molar ratio, and dried under 
vacuum, at room temperature, using a rotary evaporator. The dried lipid films were 
then hydrated with 1.0 ml high purity water, and the obtained multilamellar vesicles 
were briefly sonicated and extruded 21 times through two stacked polycarbonate 
filters (50 nm pore diameter) using a Liposofast device (Avestin). The lipid 
concentration of the resulting SUV was determined by the Bartlett method (Bartlett 
1958), which measures the inorganic phosphate released after the hydrolysis of dried 
phospholipids, at 180 °C, in 70% HClO4 (Bottcher et al. 1961). 
 
Complex preparation 
The complexes (binary and ternary) were prepared in HEPES-buffered saline solution 
(HBS; 140 mM NaCl, 10 mM HEPES, pH 7.4). Binary complexes were produced by 
gently mixing the plasmid DNA or the siRNA with each of the CPPs, at the desired 
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charge ratio, followed by 15 min (plasmid DNA complexes) or 30 min (siRNA 
complexes) incubation at room temperature. Ternary plasmid DNA complexes were 
obtained by gently mixing peptide/pDNA complexes, prepared at the desired charge 
ratio, with DOTAP:DOPE liposomes. Mixtures were then incubated for 15 min, at 
room temperature. SiRNA formulations containing both CPP and cationic liposomes 
were prepared following two different protocols, which involved the addition of each 
CPP to the siRNAs, followed by the addition of the cationic liposomes (termed herein 
CPP/siRNA/DOTAP:DOPE complexes), or the mixing of the CPPs with the cationic 
liposomes, before the addition of the siRNAs (termed herein 
CPP/DOTAP:DOPE/siRNA complexes). After the addition of each component, the 
mixtures were gently mixed and incubated for 30 min at room temperature to allow 
formation of the complexes exhibiting the desired charge ratios. 
 
Cell transfection 
Twenty-four hours after plating, cells were incubated in antibiotic- and serum-free 
OptiMEM (Invitrogen, CA, USA) with the complexes (binary and ternary) containing 
plasmid DNA (1 µg/mL) or siRNA (50 nM), for 4 h at 37 °C. After this incubation 
period, the transfection medium was replaced with fresh medium containing 10% 
(v/v) FBS plus antibiotics, and the cells were further incubated for 44 h to allow gene 
expression/silencing. The efficiency of transfection and knockdown mediated by the 
different complexes was evaluated by analyzing GFP expression by flow cytometry, as 
described below.  
 
Analysis of GFP expression by flow cytometry 
Flow cytometry analysis of GFP expression was performed in live cells using a Becton 
Dickinson FACSCalibur flow cytometer (BD Biosciences, San Jose, CA, USA). Data were 
obtained and analyzed using CellQuest software. Forty-eight hours after transfection, 
the cells (HeLa, A549 or HT1080) were washed once with PBS and detached with 
trypsin (10 min at 37 °C). The cells were then further washed, resuspended in cold 
PBS and immediately analysed. To discriminate between viable and dead cells and to 
exclude doublets, cells were appropriately gated by forward/side scatter and pulse 
width from a total of 10,000 events. The FITC bandpass filter was used in emission 
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detection. GFP expression was evaluated through the analysis of the percentage of 
transfected cells and of the geometric mean fluorescence intensity with respect to 
control cells (non-transfected cells). GFP silencing was evaluated through the analysis 
of the fluorescence intensity with respect to cells treated with siRNA mut (scrambled 
sequence) complexes. 
 
Analysis of siRNA internalization and intracellular distribution by confocal microscopy 
HT1080 cells (0.2 × 105 cells/well) were plated onto 8-well chambered coverslips. 
Following overnight culture, the cells were treated for 4 h with the different delivery 
systems, formulated with Cy3-labelled siRNAs (50 nM), in OptiMEM medium. After 
this period, or following further 20 h incubation in serum-containing medium, cells 
were rinsed twice with PBS and incubated with Hoechst 33342 dye (1 μg/mL, 
Molecular Probes, Eugene, OR). Cells were then rinsed twice with PBS and directly 
observed in the chambers in 0.5 mL of OptiMEM. Fluorescence distribution inside live 
cells was analyzed under a Zeiss Axiovert 200 M fluorescence microscope (Carl Zeiss, 
Oberk), using the 60 × oil immersion objective. 
 
Extraction of RNA and cDNA synthesis 
RNA was recovered from A549, HeLa and HT1080 cells, 48 h after cell transfection, 
using the MasterPure™ RNA Purification Kit (Epicentre Biotechnologies, Madison, 
WI, USA), according to the manufacturer’s instructions, and then treated with DNase 
I. Briefly, cells were lysed using the Tissue and Cell Lysis Solution from the 
MasterPure™ RNA Purification Kit containing Proteinase K, and cell lysates were 
collected to microcentrifuge tubes. MPC Protein Precipitation Reagent was added to 
protein extract from the lysates. Then, 500 μL of isopropanol were added to the 
recovered supernatant to promote total nucleic acid precipitation, which was pelleted 
by centrifugation. Removal of contaminating DNA from the RNA was then performed 
by addition of a DNase I solution and carrying out another step of protein removal 
using MPC Protein Precipitation Reagent. RNA was finally pelleted by centrifugation, 
rinsed twice with 70% ethanol, and resuspended in TE buffer. After quantification, 
RNA was converted to cDNA using the Superscript III First Strand Synthesis Kit 
(Invitrogen, Karlsruhe, Germany), according to the manufacturer's instructions. 
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Quantitative real time polymerase chain reaction (QRT-PCR) 
Quantitative PCR was performed in an iQ 5 thermocycler using 96-well microtitre 
plates and the iQ SYBR Green Supermix Kit, as described before (Cardoso et al. 2008). 
The primers for the target gene (survivin) and the reference gene (HPRT-1) were pre-
designed by Qiagen (QuantiTect Primer, Qiagen). Survivin mRNA fold decrease with 
respect to control samples was determined by the Pfaffl method (Cardoso et al. 2012), 
taking into consideration the different amplification efficiencies of both genes in all 
experiments. The amplification efficiency for each target or reference gene was 
determined according to the equation: E = 10-1/S-1, where S is the slope of the 
obtained standard curve. 
 
Western blot analysis 
Seventy-two hours after transfection of cells (HeLa, A549 or HT1080 cells) with the 
siRNA complexes, total protein extracts were obtained using a lysis buffer (50 mM 
NaCl, 50 mM EDTA, 1% Triton X-100) supplemented with a protease inhibitor 
cocktail (Sigma), 10 μg/mL DTT and 1 mM PMSF. Protein content was determined 
using the Bio-Rad DC protein assay (Bio-Rad). For each sample, 20 μg of total protein 
was resuspended in loading buffer (20% glycerol, 10% SDS, 0.1% bromophenol blue), 
incubated for 5 min at 95 °C and loaded onto a 15% polyacrylamide gel. After 
electrophoresis, the proteins were blotted onto a PVDF membrane according to 
standard protocols. After blocking in 5% non-fat milk, the membrane was incubated 
overnight at 4 °C with the appropriate primary antibody (anti-survivin 1:200, Santa-
Cruz), and thereafter with the appropriate secondary antibody (1:10,000, Sigma) for 
2 h at room temperature. Equal protein loading was shown by reprobing the 
membrane with an anti-α-tubulin antibody (1:10,000, Sigma) and with the 
appropriate secondary antibody. After this incubation period, the membrane was 
washed several times with saline buffer (TBS/T containing 25 mM Tris–HCl, 150 mM 
NaCl, 0.1% Tween and 5 mg/mL non-fat powder milk), incubated with ECF (alkaline 
phosphatase substrate; 20 μL of ECF/cm2 of membrane) for 5 min at room 
temperature and submitted to fluorescence detection at 570 nm using a VersaDoc 
Imaging System Model 3000 (Bio-Rad). For each membrane, the analysis of band 
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intensity was performed using the Image J software (Wayne Rasband National 
Institutes of Health, USA). 
 
Evaluation of cell viability 
Cell viability was assessed under the different experimental conditions by a modified 
Alamar Blue assay, as described previously (Simões et al. 1999). Briefly, 48 h (for flow 
cytometry and QRT-PCR analysis) or 72 h (for Western blot analysis) after 
transfection, the cells were incubated with DMEM (HeLa and A549 cells) or DMEM-LG 
(HT1080 cells) containing 10% (v/v) resazurin dye. After 1 h of incubation at 37 °C, 
the absorbance of the medium was measured at 570 nm and 600 nm. Cell viability 
was calculated as a percentage of control cells (non-transfected cells), according to 
the equation: 
Cell viability (% of control) = [(A570-A600)/(A’570-A’600)] × 100 
where A570 and A600 are the absorbances of the samples, and A’570 and A’600 are the 
absorbances of control cells, at the indicated wavelengths. 
 
  
chapter 8 
 
254 
 
  
S4(13)-PV peptides for DNA and siRNA delivery 
255 
 
8.4 RESULTS 
 
8.4.1 PLASMID DNA DELIVERY MEDIATED BY S4(13)-PV- AND H5-S4(13)-PV-BASED VECTORS 
In order to comparatively evaluate the biological activity of the S4(13)-PV peptide, 
previously used as a component in plasmid DNA delivery systems (Trabulo et al. 
2008), and that of a new histidine-enriched derivative (H5-S4(13)-PV), transfection 
and cell viability experiments were performed in two tumoral cell lines (HeLa and 
A549). Complexes of each peptide with a plasmid DNA encoding the GFP gene were 
prepared, either per se or in combination with DOTAP:DOPE (1:2 molar ratio) 
liposomes, using the order of component addition that was previously shown to 
originate complexes with the highest transfection ability (Trabulo et al. 2012).  
The ability of peptide-based binary complexes, S4(13)-PV/pDNA or 
H5-S4(13)-PV/pDNA, and ternary complexes, S4(13)-PV/pDNA/DOTAP:DOPE or 
H5-S4(13)-PV/pDNA/DOTAP:DOPE, as well as of DOTAP:DOPE/pDNA and 
Lipofectamine/pDNA lipoplexes (used as positive controls) to transfect HeLa and 
A549 cells was assessed by flow cytometry analysis. Figure 8.1 presents the 
percentage of transfected cells (A and C) and the mean GFP fluorescence intensity (B) 
obtained with CPP-based complexes in both cells lines. Regarding HeLa cells, a highly 
transfectable cell line, the highest number of transfected cells was achieved with the 
binary (80.1%) and ternary (77.7%) complexes containing the wild-type CPP, 
prepared at 10/1 and 10/1/1 (+/-) charge ratios, respectively. Both values were 
higher than that obtained with LipofectamineTM 2000 (74.0% of transfected cells). As 
observed, the H5-S4(13)-PV peptide, although unable to efficiently deliver plasmid 
DNA to HeLa cells when formulated in a binary complex (achieving only 
approximately 11% of transfected cells), was able to transfect a considerable number 
of cells (approximately 60%) when present in ternary complexes at 5/1/1 and 
10/1/1 peptide/pDNA/lipid charge ratios. Regarding the mean fluorescence 
intensity, which represents the average amount of DNA copies delivered to each cell, 
the results indicated that the binary complexes containing the S4(13)-PV or H5-
S4(13)-PV peptide delivered a low amount of plasmid copies per cell (Figure 8.1B). 
On the other hand, ternary complexes containing the H5-S4(13)-PV peptide, prepared 
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at the 5/1/1 and 10/1/1 charge ratios, delivered a higher number of plasmid copies 
(reflected by a 8-11 fold fluorescence increase relative to the non-treated control 
cells) than the same formulations containing the wild-type CPP (3-4 fold increase 
relative to the non-treated control cells). These results indicate that the delivery 
ability of the complexes was increased upon addition of DOTAP:DOPE (2:1 molar 
ratio) liposomes, this increase being significantly more pronounced in H5-S4(13)-
PV/pDNA formulations than in S4(13)-PV/pDNA formulations. 
Figure 8.1 Transfection efficiency mediated by different CPP-based systems in HeLa (A and B) and 
A549 (C) cells. Cells were incubated with the different complexes containing 1 µg/ml of GFP-encoding 
plasmid DNA for 4 h at 37 ºC, as described in Materials and Methods. Flow cytometry analysis of live 
cells was performed 48 h after transfection to determine the percentage of transfected cells (A and C) 
and the increase in cell green fluorescence (B) with respect to control, non-treated cells (NTC). 
Complexes of DNA with DOTAP:DOPE liposomes or LipofectamineTM 2000 were used for comparison. 
All results are presented as mean ± SD of at least three independent experiments. Data comparisons 
were performed between formulations containing S4(13)-PV and H5-S4(13)-PV (*p < 0.05, 
***p < 0.001), between DOTAP:DOPE/pDNA lipoplexes and the same lipoplexes containing S4(13)-PV 
or H5-S4(13)-PV (#p < 0.05, ##p < 0.01) and between S4(13)-PV/pDNA or H5-S4(13)-PV/pDNA and the 
corresponding ternary complexes containing DOTAP:DOPE (§§p < 0.01, §§§p < 0.001). 
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Concerning A549 cells, S4(13)-PV peptide-containing binary and ternary complexes 
were able to transfect a considerable number of cells, only surpassed by 
LipofectamineTM 2000 (Figure 8.1C). H5-S4(13)-PV-based plasmid vectors, at the 
different charge ratios assayed, showed similar or lower transfection efficiencies as 
compared to the corresponding S4(13)-PV/pDNA complexes. For the transfection of 
these cells, both S4(13)-PV- and H5-S4(13)-PV-based formulations did not benefit 
from the addition of the lipid component. The fluorescence fold increase relative to 
the non-treated control cells showed values lower than 1.6 for all tested conditions, 
being only significant for the binary complexes composed of the histidine-enriched 
CPP at the 10/1 charge ratio (data not shown). 
The viability of A549 and HeLa cells (Figure 8.2) was determined following exposure 
to the formulations assayed for transfection, as described in Materials and Methods. 
HeLa cells (Figure 8.2A) showed to be more susceptible to complex-mediated 
cytotoxicity than A549 cells (Figure 2B), particularly at the highest peptide/DNA 
(+/-) charge ratios. The tested formulations did not significantly affect the viability of 
A549 cells (Figure 8.2B), especially when compared to that of the commercially 
available transfection reagent LipofectamineTM 2000. In HeLa cells, the wild-type CPP, 
S4(13)-PV, showed to be more toxic than its histidine derivative, when formulated 
both in binary and ternary complexes. This cytotoxic effect was mostly significant for 
the formulations with high peptide amounts, i.e. CPP/pDNA at a 10/1 charge ratio 
and CPP/pDNA/DOTAP:DOPE at a 10/1/1 charge ratio. In these cases, the cell 
viability in the presence of complexes containing the wild-type peptide was about 
30% of that observed in the presence of complexes prepared with the new histidine-
enriched peptide, although the former complexes were more efficient in transfecting 
HeLa cells (Figure 8.1A) than the corresponding complexes prepared with H5-
S4(13)-PV peptide. 
chapter 8 
 
258 
 
 
Figure 8.2 Cell viability in the presence of different CPP-based gene delivery systems. HeLa (A) and 
A549 (B) cells were incubated with the different complexes containing 1 µg/ml of GFP-encoding 
plasmid DNA for 4 h, following additional 44 h of incubation with complete medium. After this period, 
cell viability was determined by a modified Alamar Blue assay as described in Materials and Methods. 
Complexes of DNA with DOTAP:DOPE and with LipofectamineTM 2000 were used for comparison. Cell 
viability is expressed as percentage of the control (non-transfected cells). All results are presented as 
mean ± SD of at least three independent experiments. Data comparisons were performed between 
formulations containing S4(13)-PV and H5-S4(13)-PV (*p < 0.05, ***p < 0.001), between 
DOTAP:DOPE/pDNA lipoplexes and the same lipoplexes containing S4(13)-PV or H5-S4(13)-PV 
(###p < 0.001) and between S4(13)-PV/pDNA or H5-S4(13)-PV/pDNA and the corresponding ternary 
complexes containing DOTAP:DOPE (§p < 0.05). 
 
8.4.2 SIRNA DELIVERY MEDIATED BY S4(13)-PV- AND H5-S4(13)-PV-BASED VECTORS 
In order to select the peptides owing the most suitable features to be used in a gene 
silencing approach, the cytotoxic effects of siRNA delivery systems generated by 
complexation of the S4(13)-PV peptide or one of its derivatives, H5-S4(13)-PV, reverse 
NLS and scrambled, with a siRNA targeting GFP were evaluated in HT1080 GFP 
expressing cells (Figure 8.3). 
Significant differences were observed in the cytotoxicity levels induced by binary 
complexes prepared with the different peptides. The formulations containing S4(13)-
PV or its histidine analogue displayed no relevant toxicity (89% and 100% cell 
viability, respectively). However, cell viability decreased to 61.9% and 5.3% in the 
presence of complexes containing the scrambled, S4(13)-PVscr, and the reverse NLS, 
S4(13)-PVrev, peptides, respectively. Therefore, these complexes were discarded for 
the experiments of gene silencing and only the binary complexes that presented low 
toxicity profiles were evaluated concerning their ability to deliver siRNA (using 
confocal microscopy) and to induce GFP silencing (using flow cytometry) in HT1080 
cells. 
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Figure 8.3 Cell viability in the presence of S4(13)-PV, S4(13)-PVscr, S4(13)-PVrev and H5-S4(13)-PV 
peptide-based complexes at a peptide/siRNA charge ratio of 3/2. HT1080 cells were incubated with 
the different complexes containing 50 nM of anti-GFP siRNA and, after 4 h incubation, the medium was 
replaced and the cells were further incubated for 44 h before analysis of cell viability by a modified 
Alamar Blue assay, as described in Materials and Methods. All results are presented as mean ± SD of at 
least three independent experiments. 
 
Figure 8.4 displays the internalization pattern of Cy-3-labelled siRNAs delivered to 
HT1080 cells through complexation with S4(13)-PV or H5-S4(13)-PV, after 4 (A-C) or 
24 (D-F) hours of incubation. Representative flow cytometry histograms (G-I) 
reflecting GFP silencing upon transfection with the same complexes are presented in 
parallel. Figure 8.4J summarizes the silencing efficiency of the binary formulations 
prepared with each of the four studied peptides, at the 3/2 (+/-) charge ratio, as 
assessed by flow cytometry. 
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Figure 8.4 SiRNA internalization (A-F) and gene silencing efficiency (G-J) evaluated in vitro with 
different CPP-based systems. For cellular internalization experiments, HT1080 cells (green) were 
incubated with S4(13)-PV- or H5-S4(13)-PV-based complexes containing 50 nM of mut Cy3-labelled 
siRNA (red) at the 3/2 charge ratio. Cell nuclei were labeled with Hoechst 33342 dye (blue). 
Representative confocal microscopy images of each experimental condition (630 ×), taken upon 4 (A-
C) and 24 h (D-F) cell incubation, are presented. Representative histograms of GFP knockdown 
obtained by flow cytometry for the same formulations at 48 h post-transfection are also presented (G-
I). Results for non-transfected cells (NTC) are shown as a control. GFP knockdown mediated by S4(13)-
PV, S4(13)-PVscr, S4(13)-PVrev or H5-S4(13)-PV peptide-based complexes at a peptide/siRNA charge 
ratio of 3/2 was quantified (J). HT1080 cells were incubated with the different complexes containing 
50 nM of mut siRNA (■) or anti-GFP siRNA (■). After 4 h incubation, the medium was replaced and the 
cells were further incubated for 44 h before flow cytometry analysis. Data presented in (J) are 
mean ± SD of at least three independent experiments. Pairwise comparisons were performed between 
formulations containing the anti-GFP siRNA and those containing the mut siRNA (###p < 0.001) and 
between S4(13)-PVscr, S4(13)-PVrev or H5-S4(13)-PV formulations containing the anti-GFP siRNA and 
the S4(13)-PV formulation containing the same siRNA (***p < 0.001). Results for non-treated cells 
(NTC) were used as a control. 
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Confocal studies revealed that siRNA internalization occurred at a similar extent for 
complexes containing the S4(13)-PV peptide and for those containing 
LipofectamineTM 2000 (data not shown), although a more uniform distribution 
pattern could be observed when the delivery system included the CPP. However, the 
superior efficiency of S4(13)-PV binary complexes to mediate siRNA intracellular 
delivery was not accompanied by an improved GFP knockdown (Figure 8.4H). In fact, 
only low levels of biological activity were detected for siRNA/S4(13)-PV complexes. In 
contrast, the histidine-derivative peptide (H5-S4(13)-PV) was able to promote 
efficient intracellular siRNA delivery (Figure 4C, F), while simultaneously mediating 
significant GFP knockdown (Figure 4I). Complexes formulated with this peptide 
promoted a 69% reduction of GFP levels, while the other peptides did not induce 
significant silencing or (in the case of S4(13)-PV) induced a non-specific silencing 
(Figure 8.4J). 
Following the same strategy previously employed to improve S4(13)-PV-mediated 
pDNA (Trabulo et al. 2008) and oligonucleotide (Trabulo et al. 2010a) delivery, 
DOTAP:DOPE (1:2 molar ratio) liposomes were added to the formulations containing 
S4(13)-PV peptide and siRNA, in an attempt to enhance the RNA interference activity 
of these peptides. Parallel experiments were performed with both the scrambled and 
reverse NLS peptides in order to determine whether the sequence and structure of 
this CPP would be involved in the gene silencing activity of the complexes. All 
possible orders of addition of the components of the ternary complexes were tested, 
aiming at clarifying the importance of the siRNA “wrapping” by the CPP or by the 
liposomes to the biological activity of the CPP formulations. Figure 8.5 (panels A and 
B) shows typical results obtained for GFP knockdown mediated by the different 
generated systems. As observed, the differences found in GFP expression when 
comparing equivalent systems, containing either anti-GFP siRNAs or mut siRNAs, 
were only significant for DOTAP:DOPE/siRNA and S4(13)-PV-containing systems 
(Figure 8.5A and B). It is also possible to note that the protocol of preparation of the 
ternary complexes did not play a crucial role in gene silencing efficiency. In fact, either 
the addition of cationic liposomes to pre-formed CPP/siRNA complexes (Figure 8.5A) 
or the addition of siRNAs to a mixture of cationic liposomes and CPPs (Figure 8.5B) 
resulted in the formation of efficient systems, with the latter strategy being only 
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slightly superior. Although a third protocol involving the addition of CPPs to pre-
formed complexes of cationic liposome/siRNA was found to be less efficient (data not 
shown), the resulting ternary complexes still exhibited considerable biological 
activity.  
 
Figure 8.5 GFP knockdown mediated by siRNA complexes prepared with S4(13)-PV (wt), S4(13)-PVscr 
(scr), S4(13)-PVrev (rev) or H5-S4(13)-PV (H5) and DOTAP:DOPE liposomes at the peptide/lipid/siRNA 
4/1/1.5 charge ratio, using two different protocols: addition of cationic liposomes to the pre-formed 
CPP/siRNA complexes (A) or addition of siRNAs to a mixture of cationic liposomes and CPPs (B). 
HT1080 cells were incubated with the different complexes containing 50 nM of anti-GFP siRNA for 4 h 
at 37 ºC. Parallel experiments were performed using mut siRNAs. Forty-eight hours post-transfection, 
the efficiency of GFP knockdown mediated by the different complexes was evaluated by flow 
cytometry analysis of GFP expression. All results are presented as mean ± SD of at least three 
independent experiments. Pairwise comparisons were performed between formulations containing 
the anti-GFP siRNA and the mut siRNA (*p < 0.05, **p < 0.01, ***p < 0.001), between the 
DOTAP:DOPE/anti-GFP siRNA formulation and equivalent formulations containing S4(13)-PV, S4(13)-
PVscr, S4(13)-PVrev or H5-S4(13)-PV (##p < 0.01), and between the Lipofectamine/anti-GFP siRNA 
formulation and equivalent formulations containing S4(13)-PV, S4(13)-PVscr, S4(13)-PVrev or 
H5-S4(13)-PV (§§p < 0.01). Results for non-treated cells (NTC) are shown as a control. 
 
When comparing the various CPP-based systems, generated by addition of siRNAs to a 
mixture of cationic liposomes and the peptide (Figure 8.5B), the formulation 
containing the S4(13)-PV peptide was found to be the most efficient to mediate GFP 
knockdown. Remarkably, this system was not only significantly more efficient than 
DOTAP:DOPE/siRNA complexes, but also greatly superior to equivalent systems 
prepared with the reverse NLS, scrambled or H5-S4(13)-PV peptides. It should be 
noted that no significant GFP knockdown was observed for H5-S4(13)-PV ternary 
complexes containing mut siRNAs. 
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8.4.3 SURVIVIN SILENCING IN DIFFERENT HUMAN CANCER CELL LINES MEDIATED BY S4(13)-PV- 
AND H5-S4(13)-PV-BASED VECTORS 
Following the demonstration of the feasibility of CPP-based delivery systems to 
mediate GFP knockdown in HT1080 cells, the next step consisted of employing the 
developed S4(13)-PV and H5-S4(13)-PV delivery systems to silence the endogenous 
gene survivin using different human tumor cell lines towards their potential 
application in a target gene therapy to cancer. In this context, survivin mRNA and 
protein levels were determined by QRT-PCR and Western blot, respectively, following 
the delivery of anti-survivin siRNAs by binary and ternary complexes containing 
S4(13)-PV or H5-S4(13)-PV. 
Figure 8.6 presents survivin mRNA levels 48 h upon cell transfection with binary 
complexes, composed of peptide and siRNA (Figure 8.6A), or with ternary complexes 
generated by addition of siRNA to a mixture of peptide and DOTAP:DOPE liposomes 
(Figure 8.6B). The binary delivery systems achieved variable silencing efficiencies, 
depending on the cell line and on the peptide incorporated in the formulation. While 
formulations containing the S4(13)-PV peptide were unable to efficiently decrease 
survivin mRNA levels in the three cell lines tested (HT1080, A549 and HeLa; Figure 
8.6A), complexes containing the H5-S4(13)-PV peptide presented different mRNA 
knockdown values, varying from 0% silencing in HeLa cells to 50% in A549 cells and 
70% in HT1080 cells (Figure 8.6A). In an attempt to improve survivin silencing in 
A549 and HeLa cells, DOTAP:DOPE liposomes (1:2 molar ratio) were added to each 
CPP formulation by complexing the cationic liposomes with the CPP prior to the 
addition of the siRNA. This strategy was not tested in HT1080 cells based on the 
results from the experiments on GFP silencing, where its application did not result in 
any significant improvement (data not shown). Figure 8.6B shows that the ternary 
complexes containing the wild-type or the histidine derivative CPP decreased 
survivin mRNA levels in the A549 cell line, resulting in 40% and 28% knockdown, 
respectively. Application of this approach also led to promising results in HeLa cells, 
since 23% and 39% survivin knockdown were observed for the wild-type and 
histidine-enriched peptide-containing formulations, respectively. In both cell lines, 
the silencing effect obtained with lipoplexes containing exclusively the DOTAP:DOPE 
lipids and siRNA, but no CPP, was negligible. In A549 cells, this formulation appears 
even to mediate enhanced survivin expression. Therefore, our results, showing a 
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survivin knockdown of 23 to 40% in both cell lines with the ternary systems, 
S4(13)-PV/DOTAP:DOPE/siRNA and H5-S4(13)-PV/DOTAP:DOPE/siRNA, significantly 
superior to that obtained with DOTAP:DOPE/siRNA complexes, suggest a clear 
advantage of combining the S4(13)-PV peptide or its histidine derivative with the 
liposome formulation towards the generation of an efficient non-viral siRNA-based 
anti-tumoral approach. 
 
 
Figure 8.6 Survivin mRNA knockdown mediated by S4(13)-PV and H5-S4(13)-PV peptide-based 
complexes in HT1080, A549 and HeLa cells. (A) Binary complexes of S4(13)-PV/siRNA () or H5-
S4(13)-PV/siRNA (); (B) Lipoplexes of DOTAP:DOPE/siRNA () and ternary complexes of S4(13)-
PV/DOTAP:DOPE/siRNA () or H5-S4(13)-PV/DOTAP:DOPE/siRNA (). Cells were incubated with 
the different complexes containing 50 nM of anti-survivin siRNA for 4 h at 37 ºC. Parallel experiments 
were performed using mut siRNAs. Forty-eight hours post-transfection, the efficiency of survivin 
knockdown mediated by the different complexes was evaluated by quantitative PCR. For 
determination of survivin mRNA levels, RNA was recovered from cells 48 h post-transfection and 
converted to cDNA, which was analyzed by quantitative PCR. Survivin mRNA expression, determined 
by the Pfaffl method, as described in the Materials and Methods section, is presented as the changes in 
RNA transcription caused by the treatment with anti-survivin siRNAs, normalized to RNA transcription 
changes in cells treated with mut siRNAs (set to 1). All results are presented as mean ± SD of at least 
three independent experiments. Data comparisons were performed for each cell line between the 
formulations containing S4(13)-PV and H5-S4(13)-PV (***p < 0.001) and between DOTAP:DOPE/siRNA 
lipoplexes and the same lipoplexes containing S4(13)-PV or H5-S4(13)-PV (##p < 0.01, ###p < 0.001). 
 
Figure 8.7 presents survivin protein levels, assessed by Western blot analysis and 
normalized with α-tubulin levels, following transfection with both binary and ternary 
complexes. A pattern similar to that observed for mRNA expression was apparent 
with binary complexes (Figure 8.7A). As observed, a superior knockdown of survivin 
was achieved with complexes containing the histidine-derivative peptide, although 
the results were only statistically significant for HT1080 cells, in which survivin 
protein levels decreased 44% (Figure 8.7A and C). Off-target effects could be 
observed for binary complexes containing the S4(13)-PV, since unspecific silencing 
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was detected following transfection with the mut siRNA, as displayed in Figure 8.7C. 
Figure 8.7B shows survivin protein levels upon cell transfection with ternary 
complexes containing the DOTAP:DOPE lipids in addition to the CPP, S4(13)-PV or 
H5-S4(13)-PV, and siRNAs, prepared as previously mentioned. No decrease in the 
protein expression was achieved with these formulations or with the lipoplexes 
without CPP, although a decrease in survivin mRNA levels has been observed for the 
ternary complexes in both A549 and HeLa cells (Figure 8.6B). 
 
 
Figure 8.7 Survivin knockdown mediated by S4(13)-PV and H5-S4(13)-PV peptide-based complexes 
in HT1080, A549 and HeLa cells. (A) Binary complexes of S4(13)-PV/siRNA () or H5-S4(13)-
PV/siRNA (); (B) Lipoplexes of DOTAP:DOPE/siRNA () and ternary complexes of S4(13)-
PV/DOTAP:DOPE/siRNA () or H5-S4(13)-PV/DOTAP:DOPE/siRNA (); (C) Representative Western 
blot images illustrating the survivin protein levels in non-treated HT1080 cells (NTC) or following 
siRNA (targeting survivin or siRNA mut) delivery by S4(13)-PV or H5-S4(13)-PV. Cells were incubated 
for 4 h at 37 ºC, with the different complexes containing 50 nM of anti-survivin siRNA. The medium 
was then replaced and the cells were further incubated for 72 h before survivin and α-tubulin analysis. 
For each membrane, the analysis of band intensity was performed using the Image J software (Wayne 
Rasband National Institutes of Health, USA). Results in A and B are expressed as survivin fold change 
with respect to a control (cells treated with the same formulation containing siRNA mut, which was set 
to 1). Data comparisons were performed for each cell line between formulations containing S4(13)-PV 
and H5-S4(13)-PV (**p < 0.01). All results are presented as mean ± SD of at least three independent 
experiments.  
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8.5 DISCUSSION 
 
Since the 1970’s, when gene therapy was first described (Carl R et al. 1971), great 
efforts have been expended towards the discovery of appropriate delivery systems 
able to surpass the cell membrane and release the different types of nucleic acid 
molecules, ranging from long DNA molecules to small double-stranded siRNAs, into 
the target intracellular compartment. Despite the recent advances concerning plasmid 
DNA and siRNA delivery to target cells, further work should be developed to achieve 
high levels of cellular uptake and long-term stability, while avoiding unspecific effects, 
so that nucleic acid therapeutics can reach their full potential as a clinically relevant 
option (de Fougerolles 2008; Pai et al. 2006; Ryther et al. 2005; Oh & Park 2009). 
One of the major obstacles for a successful gene therapy strategy results from the 
impermeability of the cellular membranes to most charged molecules, which has, 
however, been surpassed by the use of vectors, including cell-penetrating peptides. 
CPPs constitute a relatively new branch of non-viral vectors that emerged following 
the description of the RNA/DNA-binding domains of the human immunodeficiency 
virus (HIV-1) Tat protein (Frankel & Pabo 1988) and of the Drosophila Antennapedia 
homeodomain protein (Joliot et al. 1991). Since then, several CPPs have been 
described and used as delivery systems for nucleic acids and other biomolecules 
(Heitz et al. 2009). Based on previous work from our laboratory, studies were 
performed in order to compare the transfection efficiency and cytotoxicity obtained 
with previously developed S4(13)-PV-based complexes and new complexes 
formulated with the S4(13)-PV analogue, H5-S4(13)-PV peptide. This new peptide 
emerged as an effort to increase the intracellular bioavailability of the nucleic acids 
carried by CPP-based vectors, through the addition of histidine residues to the original 
peptide, which is expected to enhance its endosomolytic properties, favoring 
endosomal escape (Lo & Wang 2008), due to the protonation of histidine side chains in 
the endosome acidic environment. 
The transfection efficiency and cell viability levels achieved following pDNA delivery 
by S4(13)-PV or H5-S4(13)-PV complexes diverged between the two tested cell lines. 
HeLa cells proved to be more efficiently transfected than A549, although they are also 
more severely affected in terms of cytotoxicity exerted by the complexes. In fact, the 
ability to transfect a high number of cells is often associated with high cytotoxicity. 
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This was also observed with S4(13)-PV-based binary and ternary complexes, that 
transfected the largest number of HeLa cells at charge ratios at which they exerted the 
highest cytotoxicity, consistent with our previous results (Trabulo et al. 2008). 
However, the same complexes produced from the histidine-derivative peptide induced 
low levels of toxicity, even at high peptide concentrations (Figure 8.2). Noteworthy, 
the H5-S4(13)-PV ternary complexes retained an elevated percentage of transfected 
cells and high levels of transgene expression (Figure 8.1). This effect is most likely 
linked to the endosomal escape process. The acidification of the endosomal lumen will 
allow the protonation of the imidazole group in the histidine residues, leading to 
osmotic swelling and membrane destabilization (Lo & Wang 2008; Midoux & 
Monsigny 1999). Moreover, it is possible that, under the acidic conditions in the 
endosome, the peptide undergoes conformational changes, which may enhance the 
interaction of the complexes with the endosomal membrane and consequent 
cytoplasmic release of DNA. This process might have an important outcome in the free 
nucleic acid yield, directly contributing to the amount of DNA that reaches the cell 
nucleus. An additional mechanism that might contribute to the enhanced DNA delivery 
by the complexes containing the histidine-enriched peptide involves favored 
interactions of the complexes at the cell membrane level resulting in their more 
efficient uptake. 
On the other hand, the lower levels of protein expression in A549 cells relative to HeLa 
cells suggest that these cell lines have different patterns of interaction with the 
complexes, probably due to different proteoglycan content at the cell surface, or to the 
preferential use of different internalization pathways that may or may not converge in 
the endolysosomal route. 
The potential of complexes based on S4(13)-PV peptide and its derivatives to promote 
siRNA delivery was also addressed in HT1080 GFP expressing cells. In this regard, we 
aimed at establishing the most suitable peptide structural features, which warrant 
efficient siRNA-mediated gene knockdown without causing cytotoxicity. Cell viability 
(Figure 8.3) indicates that the peptide primary structure plays a crucial role in terms 
of the cytotoxicity displayed by the corresponding peptide-based complexes. Thus, the 
reverse NLS peptide, whose amino acid sequence only differs from that of the original 
peptide in the relative position of three aminoacids of the NLS sequence, originates 
much more toxic complexes compared to the scrambled peptide, which preserves all 
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the S4(13)-PV amino acid residues, although exhibiting a random order. However, as 
can be observed in Table 8.1, the proline residue position in the scrambled peptide is 
maintained with respect to the wild-type and to the histidine-derivative peptides. 
Proline residues have been suggested to play a relevant role in membrane protein 
structure and dynamics (Oh & Park 2009; Frankel & Pabo 1988). Proline presents its 
side chain bonded to the tertiary nitrogen in a cyclic pyrrolidine ring, which makes it 
the only mammalian imino acid. The consequent absence of a proton in this residue 
impairs its participation in the formation of hydrogen bonds. This feature fixes the 
peptide backbone around proline residues, providing a kink or hinge that constrains 
the conformation of the adjacent residues (Carver, E R, Blout 1967) and leaves the 
neighboring carbonyl groups free to participate in alternative hydrogen bonds (Veis & 
Nawrot 1970). Therefore, peptide-siRNA association and interaction of the resulting 
complexes with the cellular membrane may be affected by the different peptide 
conformations, which, in the case of the reverse NLS peptide, could be caused by the 
change of location of the proline residue, leading to a more cytotoxic effect. 
The GFP knockdown experiments also shed light on the mechanism of cytotoxicity 
associated with the use of complexes containing the reverse NLS peptide; the off-
target effects of these complexes, reflected on the high silencing activity obtained with 
the mut siRNA (79%), suggest that theses complexes can strongly interfere with the 
cellular mechanisms involved in protein synthesis, impairing the production of 
proteins essential for normal cell function and thus resulting in high toxicity.  
The cell internalization extent of siRNA delivered by S4(13)-PV and H5-S4(13)-PV 
peptide-based complexes, observed by confocal microscopy, correlates with their 
silencing efficiencies (Figure 8.4). Furthermore, the diffuse pattern of siRNA 
distribution inside HT1080 cells transfected with complexes containing the histidine-
derivative peptide suggests an efficient endosomal release of the complex cargo. On 
the other hand, cells transfected with complexes containing the wild-type peptide 
presented a punctuated siRNA distribution in the cytoplasm, which probably reflects 
endosomal entrapment. In addition, the amount of siRNAs inside the cells transfected 
with complexes of the wild-type peptide appears to be lower than that inside the cells 
transfected with histidine-derivative complexes. This observation might be explained 
by a putatively higher affinity of complexes containing the H5-S4(13)-PV towards the 
cell surface proteoglycans. 
chapter 8 
 
270 
 
In agreement with what has been previously observed for oligonucleotides (Trabulo et 
al. 2010a), S4(13)-PV peptide/siRNA complexes did not mediate significant gene 
silencing (Figure 8.4J). Also consistent with previous studies for plasmid DNA and 
oligonucleotides, ternary systems combining siRNAs with cationic liposomes and cell-
penetrating peptides displayed higher biological activity than binary peptide/siRNA 
complexes (Trabulo et al. 2008; Trabulo et al. 2010a), excepting the complexes 
containing the H5-S4(13)-PV peptide (Figures 8.4J and 8.5B). 
The results presented in Figure 8.5 show that the protocol of preparation of the 
ternary complexes, specifically the order of component addition, did not play a crucial 
role in their gene silencing efficacy, although a small improvement in complex 
efficiency could be obtained when combining cationic liposomes with the cell 
penetrating peptide prior to siRNA addition. Most importantly, the systems containing 
the S4(13)-PV peptide showed superior biological activity with respect to similar 
formulations including the reverse NLS or scrambled peptides. This indicates that the 
amino acid sequence in the S4(13)-PV peptide is required to provide complexes with 
capacity to promote siRNA internalization and silencing of the target mRNA. The 
different efficiencies in GFP silencing displayed by the systems containing the S4(13)-
PV and reverse NLS peptides corroborates the previous assumption that the location 
of the proline residue in the NLS sequence should be important for the biological 
activity of the S4(13)-PV-based complexes. In fact, the NLS sequence per se would not 
be required for siRNAs to accomplish their function, since these molecules do not need 
to reach the cell nucleus for silencing their target genes. 
Since the relevance of a delivery system for potential clinical application can only be 
fully evaluated in a therapeutic context, we investigated the efficiency of the developed 
CPP-based systems to mediate silencing of an endogenous gene encoding an oncogenic 
protein (survivin). This protein presents a huge potential as a therapeutic target in 
cancer therapy due to its contribution to cancer survival, metastization and cell 
resistance to chemo and radiotherapy (Altieri 2008). The binary systems containing 
S4(13)-PV showed to be unable to decrease the messenger RNA or protein levels of 
survivin in any of the three cell lines tested (HT1080, A549 and HeLa). In contrast, 
similar complexes generated from the H5-S4(13)-PV peptide silenced the survivin 
gene to different extents, depending on the cell line. The highest knockdown effect was 
obtained in HT1080 cells (73% decrease in mRNA and 44% decrease in protein 
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levels). The different ability of the H5-S4(13)-PV peptide-based complexes to silence 
survivin gene in different cell lines may be explained by specific features of cells, 
including internalization preferred pathways, surface proteoglycans content and 
metabolic activity. In addition, the different levels of survivin mRNA and protein 
expression among various tumor cells (Li 2003) may contribute to different silencing 
efficiencies. Importantly, it was shown that the addition of DOTAP:DOPE liposomes, 
both to S4(13)-PV- and H5-S4(13)-PV-containing systems, led to an increase in mRNA 
silencing efficiency (Figure 8.6B). Although the ability of ternary complexes to silence 
survivin mRNA in both A549 and HeLa cells was superior to that of 
DOTAP:DOPE/siRNA complexes, the levels of protein knockdown did not follow the 
same pattern, remaining similar to those observed in cells transfected with lipoplexes 
devoid of CPP (Figure 8.7B). This may be due to specific cellular mechanisms that 
regulate survivin levels in cancer cells. In this regard, some studies have reported the 
existence of an additional pool of survivin in mitochondria, which can exert its action 
whenever the levels of cytoplasmic survivin are lower than a defined threshold needed 
for cancer cell survival (Dohi et al. 2004; Carver & Blout 1967). 
Nevertheless, a challenging finding in the present work was that siRNA complexes 
containing the histidine-enriched S4(13)-PV peptide showed high competence to 
deliver siRNA into the cells (as demonstrated in GFP-expressing HT1080 cells) and to 
promote specific knockdown. On the other hand, in HeLa cells, H5-S4(13)-PV-
containing formulations exhibited an efficiency in transfection with plasmid DNA 
comparable to those containing the wild-type peptide, with the advantage of 
presenting a much lower cytotoxicity. 
Overall, our findings reveal that the H5-S4(13)-PV peptide deserves to be further 
explored aiming at generating efficient nucleic acid delivery-based strategies in the 
context of therapies for cancer and other diseases. Moreover, our studies on the 
development of new CPP-based nucleic acid delivery systems and on the 
establishment of significant structure-activity relationships may open new avenues 
towards in vivo application of increasingly promising gene therapy approaches.  
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Application of Thermoresponsive PNIPAAM-b-
PAMPTMA Diblock Copolymers in siRNA Delivery  
 
 
A.M. Cardoso, M.T. Calejo, C.M. Morais, A.L. Cardoso, A.R. Cruz, K. Zhu, M.C. 
Pedroso de Lima, A.S. Jurado and B. Nyström, “Application of 
Thermoresponsive PNIPAAM-b-PAMPTMA Diblock Copolymers in siRNA 
Delivery” Published in the Molecular Pharmaceutics, 11, 2014, 819– 827. 
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9.1 ABSTRACT 
 
Gene knockdown has emerged as an important tool for cancer gene therapy as well as 
for viral infections and dominantly inherited genetic disorders. The generation of 
suitable siRNA delivery systems poses some challenges, namely to avoid nuclease 
degradation, to surpass the cytoplasmic membrane and to release the nucleic acids into 
the cytosol. Aiming at evaluating the ability of thermoresponsive block copolymers 
formed by units of N-isopropylacrylamide and of (3-acrylamidopropyl)trimethyl-
ammonium chloride to efficiently deliver siRNAs, an extensive study was performed 
with four different copolymers using a human fibrosarcoma cell line as cell model. The 
silencing ability and cytotoxicity of the generated copolymer-based siRNA delivery 
systems were found to be dependent on the cloud point of the polymer, which 
corresponds to the transition temperature at which the aggregation or precipitation of 
the polymer molecules becomes thermodynamically more favorable than their 
solubilization. In the present study, a system capable of delivering siRNAs efficiently, 
specifically and without presenting relevant cytotoxicity, even in the presence of 
serum, was developed. Confocal fluorescence experiments showed that the ability of 
the generated systems to silence the target gene is related to some extent to nucleic 
acid internalization, being also dependent on polymer-siRNA dissociation at 37 °C. 
Thus, a delicate balance between nucleic acid internalization and intracellular release 
must be met in order to reach an ideal knockdown efficiency. 
The special features and potential for manipulation of the N-isopropylacrylamide-
based copolymers make them suitable materials for the design and synthesis of new 
and promising siRNA delivery systems. 
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9.2 INTRODUCTION 
 
RNA interference (RNAi) is a powerful gene silencing process that holds a great 
therapeutic potential in several diseases, such as cancer (Brower 2010). Small 
interfering RNAs (siRNAs), first described in 2001 as promoting effective RNA 
interference in mammalian cells without inducing interferon immunological response 
(Elbashir et al. 2001), are short double stranded RNA (dsRNA) molecules (less than 30 
nucleotides in length) that mediate post-transcriptional silencing of target genes 
through degradation of their mRNAs (Jinek & Doudna 2009). This process is highly 
efficient and sequence-dependent, thus conferring specificity to the silencing 
mechanism. In Nature, siRNAs are produced as an anti-viral defense, silencing mobile 
genetic elements resulting from viral infections. For therapeutic purposes, siRNAs have 
been delivered into cells using adequate carrier systems able to overcome membrane 
barriers and to release the nucleic acids into the cytosol, in order to allow their loading 
into the RNA-induced silencing complex (RISC) and the consequent specific mRNA 
knockdown (Jinek & Doudna 2009). Several different non-viral delivery systems, 
including cationic lipids, peptides and polymers, have been developed to introduce 
siRNAs into the cell cytoplasm, where they are active (Wu & McMillan 2009; Gavrilov & 
Saltzman 2012; Troiber & Wagner 2011; Meade & Dowdy 2008). 
Some polymeric units, such as N-isopropylacrylamide (NIPAAM), are 
thermoresponsive and display a non-linear relationship between solubility and 
temperature, exhibiting a sharp thermotropic transition between a soluble and an 
insoluble state (Schild 1992). The phase transition temperature, known as cloud point 
or lower critical solution temperature (LCST), represents a transition from a hydrated 
form (due to the formation of water-polymer hydrogen bonds) to a non-hydrated form 
of the polymers, in which the disruption of the hydrogen bonds is entropically favored, 
leading to collapse or macroscopic phase separation of the polymers depending on the 
polymer concentration (Masci et al. 2012). Since the cloud point of NIPAAM was 
known, in 1992 (Schild 1992), homopolymers formed by NIPAAM units, or copolymers 
designed to exhibit different combinations and ratios between NIPAAM and other 
different units, have been extensively studied for biomedical applications, including 
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controlled delivery of therapeutic molecules and tissue engineering (Ward & Georgiou 
2011). One of the reasons why the polymers containing NIPAAM have gained 
increasing interest in therapeutic applications resides on the possibility of modulating 
their thermoresponsiveness by varying several parameters, such as salt concentration, 
pH and composition or relative abundance of polymer components (Jain & Bates 2003; 
Pamies et al. 2009). 
A polymer composed of several NIPAAM units, that is a poly-NIPAAM (PNIPAAM), 
hydrophobically aggregates at temperatures above 32 °C, depending on concentration 
and molecular weight (Pamies et al. 2009), and this proximity to human body 
temperature makes it particularly interesting for pharmaceutical and biomedical 
applications (Theato et al. 2013). Importantly, by copolymerization with other 
hydrophilic or hydrophobic blocks, one can increase or decrease the phase transition 
temperature of the polymer, for specific applications (Alexander 2006). For instance, 
copolymerization with hydrophilic blocks to produce polymers with a cloud point close 
to 37 °C has revealed to be particularly advantageous, since these molecules are 
sensitive to the physiological temperature, thus changing their structure when 
incorporated in the human organism. Therefore, complexes of these copolymers with 
nucleic acids, formed at temperatures below the polymer cloud point, are expected to 
display the ability to release the complexed molecule into human cells or body fluids 
due to a collapse of the polymeric structure at the physiological temperature (Ward & 
Georgiou 2011). In this context, the addition of a cationic unit, such as (3-
acrylamidopropyl)trimethylammonium chloride (AMPTMA), to the NIPAAM structure 
was envisaged to accomplish two purposes: to increase the cloud point of the polymer 
(Ward & Georgiou 2011; Pamies et al. 2009) and to confer positive charges to the 
overall molecule (Guo et al. 2010). The addition of cationic units to hydrophobic 
polymers has been reported as making the polymer more prone to efficiently complex 
negatively charged biomolecules such as nucleic acids and to interact with negatively 
charged cell membranes (Guo et al. 2010). This approach has been applied to design 
new copolymer-based plasmid DNA delivery systems, creating molecular combinations 
with delivery competence that none of the individual components of the copolymer 
exhibit due to cytotoxicity or impairment of specific steps in the delivery process, such 
as cellular internalization and endosomal escape. The main objective of combining two 
PNIPAAM-b-PAMPTMA for siRNA delivery 
279 
 
distinct monomers in the copolymer is to ally advantageous properties of each one 
and to minimize their deficiencies in order to accomplish an effective delivery (Takeda 
et al. 2004). 
In this work, four diblock copolymers were synthesized as poly(N-
isopropylacrylamide)n-block-poly((3-acrylamidopropyl)trimethylammonium 
chloride)m, abbreviated herein as PNIPAAMn-b-PAMPTMA(+)m, or n:m (n = 48 or 65 
and m = 6, 10 or 20), which exhibit different cloud points and molecular weights. These 
block copolymers, which have already shown to be promising candidates as DNA 
nonviral carriers (Calejo et al. 2013b), were used in the present work to investigate 
their ability to efficiently deliver siRNA to HT1080 cells (a human fibrosarcoma cell 
line) in the absence and presence of serum. To the best of our knowledge, only one 
study has addressed the generation of a PNIPAAM-containing system for siRNA 
delivery (Kim et al. 2010), which was composed of quantum dots co-grafted with a cell 
penetrating peptide. Our results show that nucleic acid protection conferred by the 
polymers, associated with their ability to mediate cell internalization of the siRNAs 
and the polymer-siRNA dissociation is responsible for silencing a target protein.  
These data shed light on the great variety of existing possibilities to design new and 
more efficient siRNA delivery systems, with the ultimate goal of developing a useful 
tool to modulate gene expression with implications in several fields, such as functional 
genomics, drug validation, and even transgenic design (Caplen 2004; Fire et al. 1998; 
Hannon & Rossi 2004; Napoli et al. 1990). 
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9.3 MATERIALS AND METHODS 
 
Materials 
The anti-GFP siRNA (5’-GCAAGCUGACCCUGAAGUUCAU-3’) and Cy3-labeled non-
specific siRNA sequence were purchased from Ambion (Austin, TX, USA). The non-
silencing siRNA sequence used as control was obtained from Dharmacon (Lafayette, 
CO, USA). All the other chemicals were of the highest grade. 
 
Charged Block Copolymers 
The cationic diblock copolymers poly(N-isopropylacrylamide)n-block-poly((3-
acrylamidopropyl)trimethylammonium chloride)m (PNIPAAMn-b-PAMPTMA(+)m) with 
n = 48 or 65 and m = 6, 10 or 20 (Figure 9.1) were synthesized via a simple “one-pot” 
atom transfer radical polymerization (ATRP) procedure, as previously reported 
(Dedinaite et al. 2010; Kjøniksen et al. 2009). The chemical structure of the diblock 
copolymers used in this study is illustrated in Figure 9.1, and their cloud point values 
and molecular weights are presented in Table 9.1. 
Figure 9.1 Schematic representation of the chemical structure of the PNIPAAMn-b-PAMPTMA(+)m 
diblock copolymers (n = 48 or 65 and m = 6, 10 or 20). 
 
Table 9.1 Cloud points and molecular weights of the PNIPAAMn-b-PAMPTMA(+)m block copolymers. 
 
 
Polymer 
(n:m) 
PNIPAAM48-b-
PAMPTMA(+)6 
(48:6) 
PNIPAAM48-b-
PAMPTMA(+)10 
(48:10) 
PNIPAAM48-b-
PAMPTMA(+)20 
(48:20) 
PNIPAAM65-b-
PAMPTMA(+)20 
(65:20) 
Cloud Point (°C)a 35 36 37 34 
Mw (g/mol)a 6770 7600 9690 11600 
a Cloud point and molecular weight data were taken from Calejo et al. 2013b. 
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Cells 
HT1080 cells (a human fibrosarcoma cell line that was stably transfected to express 
GFP endogenously) were maintained at 37 °C, under 5% CO2, in Dulbecco Modified 
Eagle low glucose (DMEM-LG; Sigma) supplemented with 10% (v/v) heat-inactivated 
fetal bovine serum (FBS; Biochrom KG), and with 100 units penicillin and 100 µg 
streptomycin (Sigma) per mL.  
 
Preparation of polymer/siRNA complexes 
Polymers were dissolved in cell culture medium (OptiMEM or DMEM-LG) and gently 
mixed with siRNA targeting GFP (50 nM/well), at the desired polymer/siRNA (+/-) 
charge ratios. The mixtures were further incubated for 20 min at room temperature. 
Polymer/siRNA complexes were used immediately after being prepared.  
 
Determination of the hydrodynamic diameter of polymer/siRNA complexes 
Polyplexes were characterized with respect to their hydrodynamic diameter in HBS 
buffer, at 25 and 37 °C, by photon correlation spectroscopy-based technique (PCS) 
using a Coulter N4 Plus (Coulter Corporation, Miami, FL, USA). PCS uses photon 
correlation spectroscopy of scattered laser light to determine its time-dependent 
fluctuations resulting from the Brownian motion of particles in suspension. The light 
intensity scattered at a given angle is detected by a detector (at fixed angle of 90°) 
whose output current is passed to an fotocorrelator, which analyses time dependence, 
determining the rate of diffusion or Brownian motion of the particles and hence their 
hydrodynamic diameter (Cardoso et al. 2009). Complexes were prepared immediately 
before analysis. All complexes showed a monomodal hydrodynamic diameter 
distribution. 
 
Evaluation of cell viability 
Cell viability was assessed under the different experimental conditions by a modified 
Alamar blue assay, as described previously (Simões et al. 1999). Briefly, 48 h post-
transfection, the cells were incubated with DMEM-LG (10% serum) containing 10% 
(v/v) resazurin dye. After 1 h incubation at 37 °C, the absorbance of the medium was 
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measured at 570 nm and 600 nm (supplier indication). Cell viability was calculated as 
a percentage of the non-transfected control cells, according to Eq. 1: 
  Cell viability (% of control) = [(A570 – A600)/(A'570 - A'600)] x100   (1) 
where A570 and A600 are the absorbances of the samples, and A’570 and A’600 are those 
of the control (non-treated cells), at the indicated wavelengths. 
 
Analysis of GFP silencing 
HT1080 cells (1.0x105 cells/well) were seeded in 12-well plates. Following overnight 
culture, the cells were incubated with the different complexes (50 nM of siRNA per 
well) at 37 °C for 4 h, in OptiMEM (no serum) or DMEM-LG (10% serum) media. After 
this period, the medium was replaced with fresh complete medium containing 10% 
(v/v) FBS and antibiotics, and the cells were further incubated for 44 h to allow gene 
expression. Parallel experiments were performed with a control siRNA (non-target 
siRNA or siRNA mut). The knockdown efficiency mediated by the different complexes 
was evaluated by analyzing GFP silencing by flow cytometry. Briefly, 48 h after 
transfection, the cells were washed once with PBS and detached with trypsin (10 min 
at 37 °C). The cells were further washed three times by centrifugation (5 min, 1000 
rpm) in ice-cold PBS and immediately analyzed, using a Becton Dickinson FACSCalibur 
flow cytometer (BD Biosciences, San Jose, CA, USA). Data obtained were analyzed 
using CellQuest software. To discriminate between viable and dead cells and to exclude 
doublets, cells were appropriately gated by forward/side scatter and pulse width from 
a total of 10,000 events. The FITC bandpass filter was used in emission detection. GFP 
silencing was expressed as geometric mean fluorescence intensity with respect to 
control (non-treated) cells. 
 
Analysis of siRNA internalization and intracellular distribution 
HT1080 cells (0.2×105 cells/well) were plated in 8-well chambered coverslips (Lab-
Tek™ II Chamber Slide™ System Nunc™). Following overnight culture, the cells were 
incubated, for 4 h, with the different polymer/siRNA delivery systems formulated with 
non-coding Cy3-labelled siRNAs (50 nM), in OptiMEM medium. After this period, cells 
were washed twice with PBS and incubated with Hoechst 33342 dye (1 μg/mL, 
Molecular Probes, Eugene, OR). Cells were then washed twice with PBS and directly 
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observed in the chambers in 0.5 mL of OptiMEM. Fluorescence distribution inside cells 
was analyzed under a Zeiss Axiovert 200 M confocal microscope (Carl Zeiss, Oberk) 
without fixation, using the 60× oil immersion objective. 
 
Analysis of siRNA protection 
Complexes containing 14 pmol of siRNA prepared in a total volume of 100 μL of HBS 
were allowed to incubate for 20 min at room temperature and then transferred to a 
96-well (blackwalled) plate (Corning, NY, USA). A total of 100 μL of PicoGreen dye 
(Molecular Probes, Eugene, OR), upon 1:200 dilution in HBS buffer (according to the 
manufacturer's instructions), was added to each well. The fluorescence of PicoGreen, 
directly proportional to the amount of accessible/free siRNA, was monitored in a Spex 
Fluorolog Spectrometer at 25 and 37 °C. The excitation and emission wavelengths were 
set at 485 and 520 nm, respectively. The amount of siRNA protected by the cationic 
polymers was calculated as a percentage of a control containing only a PicoGreen 
solution, according to Eq. 2: 
PsiRNA = 1- [(F-F100)/(F0-F100)]    (2) 
where F is the fluorescence measured after adding the complexes to the PicoGreen 
solution, F0 is the maximum fluorescence of a positive control, which accounts for 0% 
of siRNA protection, and F100, the minimum fluorescence of a negative control taken as 
100% of protection. For the positive control, free siRNA, in the same amount as that 
associated with the complexes, was used and a PicoGreen solution without siRNA was 
used as the negative control. 
 
Statistical Analysis 
Data are presented as mean ± SD. The significance of the results was statistically 
analyzed by a one-way analysis of variance (ANOVA) with Tukey's multiple pairwise 
comparison, unless stated otherwise. Statistical significance was set at p < 0.05. 
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9.4 RESULTS 
 
9.4.1 HYDRODYNAMIC DIAMETER OF THE POLYMER/SIRNA COMPLEXES 
Due to the temperature-dependent structural properties displayed by the polymers 
used in this study, the average diameter of their complexes with siRNA was evaluated 
at 25 and 37 °C. As shown in Table 9.2, polyplexes prepared from n:m 48:20 exhibited 
the largest hydrodynamic diameters at 25 °C (820 and 583 nm, when prepared at 2/1 
and 10/1 (+/-) charge ratios, respectively). For the same length of polymer 
thermoresponsive moiety (n = 48), the increase in the number of cationic units (from 
6 to 20) led to a progressive increase of polyplex hydrodynamic diameter. However, the 
length of the thermoresponsive component also influenced polyplex dimensions. Thus, 
for the same number of cationic units (m = 20), the increase of the thermoresponsive 
moiety length (from 48 to 65) promoted a decrease of polyplex hydrodynamic 
diameter.  
Complexes exhibited at 37 °C the same diameter as that observed at 25 °C, except for 
those generated from the n:m 48:20 polymer, which showed a significant reduction in 
hydrodynamic diameter with increasing temperature (to 263 and 140 nm when 
prepared at 2/1 and 10/1 (+/-) charge ratios, respectively). 
 
Table 9.2 Mean hydrodynamic diameter of the polymer/siRNA complexes obtained at 25 and 37 °C. 
 
  Hydrodynamic diameter (nm)a 
n:m (+/-) charge ratio 25 °C 37 °C 
48:6 
2/1 179 ± 34 134 ± 63 
10/1 280 ± 7 309 ± 78 
48:10 
2/1 306 ± 68 217 ± 38 
10/1 336 ± 12 427 ± 16 
48:20 
2/1 820 ± 82 264 ± 51*** 
10/1 583 ± 23 140 ± 61*** 
65:20 
2/1 299 ± 25 295 ± 68 
10/1 442 ± 67 420 ± 52 
a Results represent the mean ± SD from three independent experiments. Data comparisons were 
performed between the hydrodynamic diameters of complex formulations measured at 25 and 37 °C 
(***p<0.001). 
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9.4.2 CYTOTOXICITY AND SILENCING EFFICIENCY 
The cytotoxicity and silencing efficiency of complexes (polyplexes) composed of siRNA 
targeting GFP and each of four PNIPAAMn-b-PAMPTMA(+)m block copolymers with 
different cloud points were evaluated in HT1080 cells, both in the absence and 
presence of 10% serum. 
In the absence of serum, the toxicity exerted by the polyplexes showed high 
dependence on the polymer/siRNA (+/-) charge ratio (Figure 9.2A). At the lowest 
(+/-) charge ratio tested (2/1), only the n:m 65:20 polymer-containing complexes 
exhibited some toxicity, inducing a decrease of 37% in cell viability. At the 
polymer/siRNA (+/-) charge ratios of 5/1 and 10/1 the complexes were toxic, causing 
a reduction of cell viability to values between 60% [n:m 48:20 at 10/1 (+/-) charge 
ratio] and 30% [n:m 65:20 at 10/1 (+/-) charge ratio], except for the n:m 48:20 
polymer-containing complexes at the 5/1 (+/-) charge ratio, which decreased the cell 
viability only to 84%. The n:m 48:20-based complexes were, therefore, the least toxic 
to the cells in the absence of serum. Comparatively, the cytotoxicity of the complexes in 
the presence of serum was in general less severe (Figure 9.2B). In this case, only for 
the highest (+/-) charge ratio tested (10/1), the complexes showed significant 
cytotoxicity. The most pronounced toxic effect was observed for the complexes 
containing the n:m 65:20 polymer, the cell viability reaching values of 46% and 32% in 
the presence of complexes at 5/1 and 10/1 (+/-) charge ratios, respectively.  
Regarding the silencing efficiency for cells incubated with the complexes in the 
absence of serum (Figure 9.2C), only the formulations that exhibited cytotoxicity 
displayed unspecific silencing. As observed, complexes prepared at the lowest (+/-) 
charge ratios (particularly at the 2/1 charge ratio), at which they exhibited low or no 
toxic effects, showed high ability to specifically silence the target gene (black columns). 
Remarkably, the n:m 48:6 polymer/siRNA complexes, prepared at the 2/1 (+/-) 
charge ratio, were able to suppress gene expression in 36% in a specific manner. In the 
presence of serum, the silencing specificity of the complexes decreased, as deduced 
from the knockdown effect observed when the complexes were formulated with the 
non-target siRNA (white bars in Figure 9.2D). Despite this being the general scenario, 
it is important to note that complexes of the n:m 48:20 polymer and siRNA, at the 
10/1 (+/-) charge ratio, presented a significantly lower unspecific silencing effect in 
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the presence of serum than in its absence. In this case, for complexes formulated with 
the non-target siRNA, GFP expression was reduced to 55% of the control in the 
absence of serum and to 67% in the presence of serum. On the other hand, as shown 
in Figure 9.2C and D, upon knockdown with the siRNA targeting GFP, protein 
expression was 34% and 32% of the control, in the presence and absence of serum, 
respectively, thus revealing an improvement of the performance of these complexes 
under conditions mimicking more closely those in vivo, regarding their specific effect 
on the target gene.  
 
Figure 9.2 Cell viability (A and B) and GFP expression (C and D) promoted by polyplexes of PNIPAAM-
b-PAMPTMA and siRNA in the absence (A and C) and in the presence of 10% serum (B and D) 
performed at 37 °C. Parallel experiments of GFP expression were performed with siRNA targeting GFP 
(■) and a non-target siRNA (□). The cell viability results are presented as a percentage of the control 
(non-treated cells, more than 98% of which are viable), taken as 100%. Results of GFP expression are 
presented with respect to GFP expression of a control (non-treated cells, 80% of which express GFP), 
taken as 1.0. The results represent the mean ± SD obtained from triplicates of three independent 
experiments. The following pairwise comparisons were performed: cell viability or GFP expression 
observed in cells treated with each complex formulation were compared to the same parameters 
obtained in non-treated control cells (*p<0.01, **p<0.005, ***p<0.0001, Dunnett’s multiple comparison 
test); each complex formulation was compared to the same complex formulation at the immediately 
precedent (+/−) charge ratio (#p<0.01, ##p<0.005, ###p<0.0001); GFP expression obtained with 
complexes containing siRNA targeting GFP was compared with that obtained with complexes containing 
the non-target siRNA (§p<0.01, §§p<0.005, §§§p<0.0001, ns, non significant). 
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9.4.3 SIRNA INTERNALIZATION AND INTRACELLULAR DISTRIBUTION 
Aiming at comparing the extent of cellular internalization and distribution of siRNA 
molecules mediated by polyplexes displaying different levels of specific silencing, 
complexes containing the polymers n:m 48:6 and 48:20 at polymer/siRNA (+/-) 
charge ratios of 2/1 and 10/1 were selected for confocal microscopy analysis. Figure 
9.3 displays the siRNA internalization patterns obtained in HT1080 cells, in the 
absence of serum, for the different conditions tested. Both untreated cells (data not 
shown) and cells treated with naked siRNA (Figure 9.3A) were used as negative 
controls. In these two cases, no siRNA red fluorescence was noticeable, which is in 
accordance with the inability of the siRNA per se to enter the cells. Lipofectamine 
siRNAmaxTM was used as a positive control (Figure 9.3B). As observed, this 
commercially available reagent was able to deliver siRNA to cells, which displayed some 
punctuated red fluorescence (round and intense red dots), most likely reflecting siRNA 
entrapment inside vesicles. However, some degree of siRNA dispersion throughout the 
cells could also be deduced from the observed diffuse red fluorescence. The n:m 48:20 
copolymer showed a poor ability to mediate the entry of siRNA into the cells after 4 h 
of cell incubation with the polyplexes, both at the 2/1 and 10/1 (+/-) charge ratios 
(Figure 9.3C and D). However, the pattern of distribution of siRNAs delivered by the 
10/1 (+/-) charge ratio complexes was more diffuse than that of siRNAs delivered by 
Lipofectamine siRNAmaxTM, indicating that siRNA internalization mediated by the 
polymer-based complexes was followed by its release from intracellular vesicles into 
the cytosol. On the other hand, complexes containing the n:m 48:6 copolymer were 
able to overload the cells with siRNA, at both charge ratios tested, as deduced from the 
intense and widely distributed red fluorescence observed throughout the cytoplasm 
(Figure 9.3E and F), thus showing their efficacy to promote both siRNA cellular 
uptake and cytoplasmic delivery. 
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Figure 9.3 siRNA internalization mediated by different polymer-based systems at 37 °C. HT1080 cells (green) were 
incubated with the different complexes containing 50 nM of non-target Cy3-labelled siRNA (red). Cell nuclei were 
labeled with Hoechst 33342 dye (blue). Representative confocal microscopy images of each experimental condition 
(630x), taken after 4 h of cell incubation with the complexes are presented (A-F). Representative results of siRNA 
internalization in cells treated with Lipofectamine siRNAmaxTM/Cy3-siRNA (B), 48:20 polymer/Cy3-siRNA (C-D) 
and 48:6 polymer/Cy3-siRNA (E-F) complexes, at the indicated charge ratios, are presented. Results for cells treated 
with Cy3-siRNA only (siRNA naked) are shown as a control (A). 
 
9.4.4 SIRNA PROTECTION CONFERRED BY THE POLYMERS 
The ability of the generated copolymers to confer protection to the siRNA was assessed by 
Picogreen fluorescence at 25 and 37 °C (Figure 9.4). This assay takes advantage of the probe 
fluorescence emission only occurring upon probe intercalation in the nucleic acid structure. 
Therefore, the fluorescence measured in this assay reflects the accessibility of the nucleic acid in 
solution.  
As observed, all the polymers studied herein were able to efficiently shield the siRNA molecules 
at 25 °C, with protection levels between 70 and 87%, over the range of the tested charge ratios. 
However, results obtained from parallel experiments performed at 37 °C showed that the 
copolymers essentially lost the capacity to protect the carried siRNAs. As observed, the 
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maximum protection (30%) was attained for complexes produced from the n:m 48:6 block 
copolymer and siRNA at the (+/-) charge ratio of 2/1. Surprisingly, at this temperature (37 °C), 
the polymers showed a tendency for decreased ability to protect the siRNA molecules with 
increasing (+/-) charge ratio. In fact, it should be expected that increasing the relative amount of 
the cationic molecule would increase the “wrapping” of the siRNAs, leading to a more efficient 
shielding of the carried nucleic acid molecules. That behavior was particularly noticed for 
polyplexes prepared from the copolymer n:m 48:20, while for the polyplexes based on n:m 48:6, 
48:10 and 65:20 copolymers, the degree of protection did not vary significantly with the (+/-) 
charge ratio. 
 
Figure 9.4 Effect of composition and (+/−) charge ratio of PNIPAAM-b-PAMPTMA-based polyplexes on siRNA 
protection, as assessed by measurement of the PicoGreen fluorescence at 25 °C (■) and at 37 °C (■). Polyplexes, 
prepared by incubating the copolymers n:m 48:6 (A), 48:10 (B), 48:20 (C) and 65:20 (D) with 14 pmol of siRNA, 
were added to a PicoGreen solution, as described in the Material and Methods section. The results represent the 
mean ± SD obtained from triplicates of three independent experiments. The degree of protection conferred by each 
polyplex formulation to siRNA at 37 °C was compared to that conferred by the same formulation at 25 °C 
(***p<0.001) and to that conferred by the same formulation at the immediately precedent polymer/siRNA (+/-) 
charge ratio (#p < 0.05, ###p < 0.001). 
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9.5 DISCUSSION 
 
The temperature dependence of the structural properties exhibited by PNIPAAM-based 
block copolymers has been extensively exploited in recent years, with the purpose of 
producing delivery systems with controlled release ability for pDNA and other 
therapeutic molecules (Ward & Georgiou 2011). 
In this study, four cationic diblock copolymers differing in terms of the length of the 
thermoresponsive and the charged blocks were used. In a previous work (Pamies et al. 
2009; Calejo et al. 2013b), it was shown that the length and ratio between these blocks 
are determinant of the structural changes taking place as the temperature is increased, 
influencing the transfection efficiency. For a constant length of the PNIPAAM block, 
increasing length of the PAMPTMA(+) block led to an increase in the hydrodynamic 
radius of the polyplexes at 25 °C (48:6 < 48:10 < 48:20, Table 9.2). This trend may be 
explained by the molecular weight increase and also by an enhancement of the 
repulsive electrostatic interactions leading to the complex expansion. However, the 
smaller hydrodynamic diameter of complexes formed with the highest molecular 
weight copolymer (65:20) as compared to  the complexes formed with 48:20 suggests 
that the temperature-responsive block also plays a role in that physical parameter. 
Furthermore, the fact that this temperature-responsive contraction is observed at 25 
°C suggests that the complexation of the polymer with the nucleic acids can shift the 
transition temperature of PNIPAAM to lower temperatures, in agreement with the 
charge neutralization of the copolymer. 
The increase of temperature from 25 to 37 °C apparently did not promote statistically 
significant differences in the hydrodynamic radii for the polyplexes prepared with 
48:6, 48:10 and 65:20 copolymers. However, the cloud point values and the 
thermoresponsive behavior of the copolymers suggest that structural changes take 
place as the temperature is increased. Interplay between temperature-induced 
contraction of the polyplexes (contributing to hydrodynamic diameter decrease) and 
an increased aggregation number (higher number of associating chains, contributing 
to hydrodynamic diameter increase) may explain the apparently unchanged 
hydrodynamic diameter of the polyplexes as the temperature is raised. Furthermore, 
with the exception of polyplexes based on 48:20 copolymers, the hydrodynamic 
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diameter of the polyplexes increased with the increase of (+/-) charge ratio, reflecting 
an increase of the aggregation number, caused by a higher number of polymer 
molecules in solution. Interestingly, at 37 °C the hydrodynamic diameter of the 
polyplexes prepared with 48:20 copolymers was found to be reduced as the charge 
ratio increased. This suggests a significant degree of electrostatic repulsion between the 
complexes formed with the long PAMPTMA(+) block. In the 65:20-containing 
complexes the electrostatic repulsions are minimized by an extremely long PNIPAAM 
block. 
In a therapeutic context, a siRNA delivery system must be able to carry the nucleic acid 
molecules to target cells, preventing their degradation by extracellular nucleases, and 
promote their cellular internalization and release into the cytosol. Because of the 
inhibitory effect exerted by serum on transfection mediated by non-viral systems, 
nucleic acid delivery is usually performed in the absence of serum. However, the 
presence of serum proteins is unavoidable under in vivo conditions. Therefore, in the 
present work, aiming at predicting the in vivo behavior of the generated PNIPAAMn-b-
PAMPTMA(+)m-based polyplexes towards their successful clinical application, the 
knockdown efficiency was evaluated in the presence of serum. 
The presence of serum during cell incubation with the complexes caused a mild 
decrease in their biological activity, as compared to that observed in the absence of 
serum. This may reflect an unspecific interaction between the cationic moiety of the 
PNIPAAM-b-PAMPTMA(+) copolymers and the negatively charged serum proteins, 
thus preventing some complexes to reach the cells, and thereby decreasing the 
knockdown levels. Moreover, the silencing efficiency achieved in the presence of serum 
was less specific than in its absence, indicating the occurrence of off-target effects. The 
unspecific silencing should be avoided as it can lead to gene mutations and cell 
transformation, with severe consequences, such as impairment of the cellular 
machinery responsible for the production of important cell survival proteins 
(Birmingham et al. 2006; Jackson et al. 2006). 
The cloud point of the polymers (Table 9.1) showed to influence both cytotoxicity and 
silencing efficiency. In this regard, at the highest polymer/siRNA charge ratios tested, 
the cytotoxicity induced by the complexes was inversely correlated with the cloud 
point of the polymers. Both in the absence and presence of 10% serum, the polymer 
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with the lowest cloud point (n:m 65:20) originated complexes that were highly toxic to 
the cells. Similar observations have been made when this polymer was used as a 
carrier for plasmid DNA, and this was then associated with the formation of a compact 
structure decorated with a highly charged corona (Calejo et al. 2013b). On the other 
hand, the knockdown efficiency of the polyplexes at the 10/1 (+/-) charge ratio in the 
absence of serum was found to be also inversely correlated with the polymer 
transition temperature. Indeed, the silencing activity was most effective for complexes 
formed by the polymer with the lowest cloud point, with a progressive increase in 
silencing efficiency according to the following order: 48:20 < 48:10 < 48:6 < 65:20 
(Figure 9.3). This can be explained by the effect of the siRNAs on the cloud point of 
the copolymers. Due to their negative charges, siRNA molecules may change the ionic 
strength of the environment or neutralize the charges of the cationic units of the 
copolymer (which are responsible for increasing the LCST), thus altering the thermal 
behavior of the complexes (Ward & Georgiou 2011), and eventually promoting their 
dissociation, by contraction of the polymer in a coil-to-globule transition (Volden et al. 
2012). 
Most cationic systems used to deliver nucleic acids to cells present a protection pattern 
to siRNA that is consistent with the amount of the cationic moiety employed to 
formulate the complexes, increasing from the lowest to the highest charge ratios 
(Crombez et al. 2009; Tsai et al. 2011). However, the thermoresponsive copolymers 
studied herein did not present such behavior. Apparently, the polymer/siRNA charge 
ratio did not affect the release of the siRNAs or showed an opposite effect to that 
described for non-thermoresponsive systems (Figure 9.4). In general, at 25 °C 
(temperature of complex preparation), a very efficient complexation was achieved and 
the siRNAs were highly shielded, similarly to what has been described for other 
cationic polymers used as delivery systems (Crombez et al. 2009). However, at 37 °C, 
the siRNA protection decreased, as the polymers collapsed and dissociated from the 
nucleic acids. This suggests that at this temperature the increase in polymer 
concentration mostly results in enhanced intra- and intermolecular hydrophobic 
associations between the PNIPAAM blocks, contributing to the formation of aggregated 
and compact structures. In other words, the thermoresponsive properties of the 
copolymers are dominant in the system, and an increase in charge ratio mostly 
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contributes to increase the associative behavior of PNIPAAM, rather than contributing 
to protect the siRNA. In this context, the polymer cloud point may also have guided the 
efficacy of siRNA release, as previously discussed. On the other hand, the polymer 
molecular weight and the number of charged PAMPTMA units determine the number 
of polymer molecules needed in each case to reach the desired complex charge ratio. 
Therefore, the organization of the polymeric moieties around the siRNAs was 
probably sufficiently diverse to lead to the observed differential behavior regarding 
the nucleic acid release.  
In spite of the much lower extent of internalization detected by confocal microscopy, 
the n:m 48:20 polyplexes, at 10/1 (+/-) charge ratio, showed a relatively high level of 
GFP knockdown (66%) as compared to that induced by n:m 48:6 complexes (85%), 
which should be attributed to their efficiency in promoting siRNA release. Parallel 
silencing experiments using Lipofectamine RNAi max revealed that the n:m 48:20 
copolymer is as efficient as this commercial reagent (65%) in promoting gene 
knockdown. Interestingly, the polyplexes formulated with the 48:20 copolymer, at the 
10/1 (+/-) charge ratio, were those presenting, at this charge ratio, the largest 
hydrodynamic diameter at 25 °C (>580 nm) and were the smallest (140 nm) at 37 °C. 
If, on the one hand, the large hydrodynamic diameter at 25 °C might be associated with 
a high siRNA load, the decay in size at 37 °C, on the other hand, can reflect a collapse of 
the structure upon heating, promoting the release of the entrapped nucleic acids, as 
described for other drugs (Ward & Georgiou 2011). Due to their small size, the siRNA 
molecules are exposed after contraction of the copolymers at high temperatures and 
their subsequent release by the temperature-induced contraction of the copolymers 
favors the gene silencing efficiency.  
The general picture that emerges from this work is that the silencing efficacy of the 
studied polyplexes depends on a delicate interplay between repulsive electrostatic 
forces and hydrophobic interactions, whose balance can be tuned by changing the 
length of the PNIPAAM or PAMPTMA blocks, which, in turn, defines polymer transition 
temperature and charge density. The cloud point of the polymer showed, as expected, 
high relevance for the biological activity achieved upon interaction of the complexes 
with the cells. It should be stressed that, in the present work, two promising siRNA 
delivery systems were generated with the n:m 48:6 and n:m 48:20 copolymers and 
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siRNA at the 10/1 (+/-) charge ratio, which revealed high efficiency in silencing a 
reporter gene in a fibrosarcoma cell line, even in the presence of serum. Under these 
conditions, the formulation containing n:m 48:20 combines the best relationship 
between a relatively low-toxic (65% of cell viability) and highly efficient gene silencing 
system, with 68% of GFP knockdown and only 33% of unspecific gene silencing. 
Although the size and nucleic acid protection levels of the complexes may limit their 
application for intravenous administration, the complexes under study can be useful 
for local delivery into target cells (Hruby et al. 2011). 
Overall, this study opens new trends for the engineering of innovative therapeutic 
delivery systems from the combination of materials whose properties can 
synergistically contribute to enhance the efficacy of nucleic acid delivery. With a 
growing understanding of polymeric drug delivery mechanisms, this approach may be 
therefore of great relevance to generate new and promising systems for gene 
therapies. 
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Concluding remarks and future perspectives 
 
The present work contributes to shed light on the relevance of the structural 
characteristics and ability of a variety of nucleic acid delivery systems to interact with 
lipid membranes for their efficiency in transfecting cells.  
In this context, some of the most significant conclusions drawn from the studies on 
the three main groups of nucleic acid delivery systems developed in the present work 
are mentioned below. 
The efficiency of transfection mediated by gemini surfactants depends on an intricate 
combination of unique features of these compounds regarding their headgroups, 
spacer, and hydrophobic tails. Therefore, the establishment of clear-cut structure–
activity relationships for these compounds is challenging. Structural characteristics, 
such as tail and spacer length and flexibility define the phases formed by gemini 
surfactants in aqueous medium and the supramolecular complexes they form with 
DNA. Conventional m-s-m gemini surfactants containing increasingly long tails 
formed vesicular complexes with DNA and helper lipids (12-2-12) and also 
irregularly-shaped aggregates of flocculated smaller vesicles (14-2-14 and 16-2-16). 
The variation of the headgroup-spacer linkage in serine-derived gemini surfactants, 
originating different spacer flexibility and different effective lengths between the two 
charged headgroups, resulted in complexes presenting different arrangements. The 
ester derivative, which presented the most flexible spacer, also formed the smallest 
complexes. The strength of gemini surfactant-DNA interactions and the extent of the 
interactions established by gemini surfactant-based complexes with cellular 
membranes determine, in turn, whether DNA is efficiently complexed and delivered 
into the cell or, in contrast, DNA is entrapped in the complex, being unable to reach its 
target organelle, or to be released from the endosomes, being degraded. Complexes of 
conventional gemini surfactants, internalized mostly by macropinocytosis and direct 
membrane translocation, benefited from a strong gemini surfactant-DNA interaction 
and a mild destabilization upon contact with lipid membranes, which lead to efficient 
transfection. Serine-derived gemini surfactants produced complexes that were shown 
to be internalized by a variety of endocytic mechanisms, as well as by direct 
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membrane translocation. The most efficient complexes in mediating transfection 
presented low propensity to be destabilized upon interactions with membranes, 
which most likely leads to a late disassembly of the complexes, allowing them to 
reach the proximities of the nucleus before nucleic acid release. 
On the other hand, the use of conventional and serine-derived gemini surfactants as 
nucleic acid carriers opens a window for the application of gene delivery to treat 
mitochondrial diseases. Thus, the ability of gemini surfactants (14-2-14, (14Ser)2N5 
and (16Ser)2N5)) to deliver a plasmid DNA that is selectively expressed by the 
mitochondrial machinery was demonstrated. Additionally, the most competent 
nucleic acid complexes in promoting gene delivery and expression in mitochondria 
were shown to be distinct from those able to induce expression of pDNA in the 
nucleus.  
Regarding CPPs, the ability to promote lipid domain segregation and to induce 
nonlamellar phases, thus destabilizing the membrane and increasing its permeability, 
has been correlated with the efficient DNA delivery mediated by S4(13)-PV. The 
inability of S4(13)-PV to efficiently deliver siRNAs was attributed to endosomal 
entrapment. Structural alteration of the delivery system, either by addition of the 
helper lipid DOPE or by the chemical modification of the peptide itself through the 
addition of a histidine tail, with the purpose of inducing endosomal destabilization 
and nucleic acid release, were shown to improve the transfection efficiency of the 
complexes.  
A temperature-induced phase transition of thermoresponsive polymers near the 
physiological temperature range was found to improve the silencing efficacy of the 
corresponding polyplexes. Structural alterations promoted by small changes in the 
relative proportions of the cationic (AMPTMA) and thermoresponsive (NIPAAM) 
blocks, which define polymer transition temperature and charge density, by 
modulating the delicate interplay between repulsive electrostatic forces and 
hydrophobic interactions, showed to be highly relevant for the biological activity 
achieved upon interaction of the complexes with the cells.  
Overall, these data provided deep insights into the mechanisms through which the 
composition, the physicochemical properties and the final architecture of a variety of 
nonviral delivery systems, whose structure was susceptible of systematic modulation, 
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influence their efficiency in mediating transfection. Table 10.1 summarizes the 
structural properties modulated in the delivery systems used in the present work and 
their influence on the success of transfection. 
 
Table 10.1 Structural characteristics of gene delivery systems suitable for modulation and their 
influence on the success of transfection. 
 
Delivery 
system 
Structural 
characteristic 
modulated 
Findings 
(correlations) 
Conclusions 
Gemini 
surfactant-
based 
 
 
 Tail length 
 Headgroup 
 
 
 Spacer length 
 
 Spacer-headgroup 
linkage 
 Surfactants with long tails 
and small headgroups 
(m-s-m) or with short tails 
and large headgroups (serine 
derivatives) produce the most 
efficient delivery systems. 
 Surfactants with long spacers 
produce  cytotoxic complexes 
 Surfactants with ester linkage 
produce the most efficient 
delivery systems. 
 Ability for gene delivery and 
cytotoxicity of gemini 
surfactants can be modulated 
by modifying structural 
properties that guide the 
strength of the interactions 
with DNA and the 
supramolecular structures 
adopted by DNA complexes. 
CPP-based 
 
 
 Sequence of 
aminoacids 
 
 
 NLS reversion 
 Histidine tail 
addition 
 S4(13)-PV promotes phase 
separation in model 
membranes and induces HII 
structures in cell membranes, 
whereas its scrambled 
analogue does not. 
 S4(13)-PVrev is highly 
cytotoxic. 
 H5-S4(13)-PV mediates gene 
silencing more efficiently than 
S4(13)-PV. 
 Transfection efficiency and 
cytotoxicity of complexes 
containing peptides from 
S4(13)-PV family showed to 
depend on: i) peptide aminoacid 
sequence, which drives peptide-
membrane interactions, 
membrane destabilization and  
formation of nonlamellar 
phases; ii) peptide His content, 
which impacts on nucleic acid 
endosomal escape 
Thermo-
responsive 
copolymer-
based 
 
 
 Relative 
proportions of 
cationic and 
thermoresponsive 
blocks 
 
 
 Complexes formed with the 
copolymer with LCST at 37 °C 
are the most efficient in 
mediating gene silencing. 
 Transfection efficiency of 
polyplexes can be enhanced by 
modulating structural 
properties of the 
thermoresponsive polymer in 
order to obtain efficient nucleic 
acid complexation at room 
temperature and high 
dissociation at physiological 
temperatures. 
 
These studies also allowed defining critical aspects that should be taken into 
consideration in the formulation of gene delivery systems, such as their capacity to 
interact with membranes, thus providing data to reinforce the importance of 
membrane interactions in determining the mechanisms by which delivery systems 
are taken up by cells and reach their target organelle. 
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In fact, a variety of pathways may be used by cells to internalize nucleic acid 
complexes, leading to more or less efficient transfection depending on an intricate set 
of circumstances, which ensure or avoid the intracellular trafficking of complexes or 
their cargo to the target organelle. Our results clearly showed that several 
mechanisms are available in the same type of cells to internalize different nucleic acid 
delivery systems and complexes with similar composition but different transfection 
efficiency are taken up through different pathways in the same cell type. These 
results pointed to the possibility of manipulating formulations in order to optimize 
intracellular delivery under a specific set of in vitro conditions, which, however, may 
not work equally well for different cells or cells integrated in the living organism, thus 
significantly hindering clinical applications. Therefore, a long way can be anticipated 
for developing new gene delivery systems endowed with properties that ensure their 
efficiency in transfection, such as those allowing to a precise and universal control of 
the endocytosis pathway, which may involve functionalizing the delivery systems 
with receptor-specific ligand moieties. Our results suggested that the 
physicochemical characteristics of the complexes, namely size and surface charge, are 
important parameters that dictate their cellular processing. On the other hand, it is 
expectable that the presence of chemical groups recognized by membrane receptors 
and intracellular transporters have an increased impact on the fate of nucleic acid 
complexes inside the cell (Georgieva et al., 2011). An alternative means of addressing 
gene delivery systems to the target cells or the target intracellular organelle consists 
of developing complexes with certain surface characteristics that make them able to 
interact selectively with lipid membranes of specific composition. Cardiolipin, the 
mitochondria lipid trademark, has been used as target for drugs and nanoparticles 
intended to enter mitochondria. Consistently, we have observed that gemini-based 
gene carriers that strongly interact with cardiolipin-containing membrane models 
succeeded in delivering mtpDNA into mitochondria. The differential lipid 
composition of diseased vs. healthy cells could also contribute to the design of gene 
delivery systems towards specific targets. In particular, cancer cells and tissues 
present several characteristics that suit specific targeting. Besides the particular lipid 
and protein composition of the cytoplasmic membranes, the lack of lymphatic 
drainage and the enhanced permeation and retention (EPR) effect, which 
characterizes the highly permeable tumor vasculature (pore sizes 400–800 vs. 5–10 
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nm), allow colloidal systems to extravasate across tumor vasculature while being 
unable to enter healthy tissue (Abulateefeh et al. 2011). Together, these 
characteristics make cancer cells particularly susceptible to gene delivery strategies, 
allowing to reducing the doses of complexes to be administered and, consequently, 
cytotoxicity. 
After cellular internalization, nucleic acids or the corresponding complexes are 
actively transported through the cytoplasm, a process mediated by the microtubule 
network (Won et al. 2009). However, the small functional size of the nuclear pore 
complex (≈ 10 nm) of a non-dividing (“postmitotic”) cell poses an important barrier 
to the nuclear import of complexes (or DNA) (Won et al. 2009). Complexes favor DNA 
nuclear import presumably due to the reduced size of DNA upon complexation with 
polycations. In this regard, it would be interesting to study in detail the stages of 
intracellular trafficking and the process of complex dissociation, since premature 
decompression of DNA can result in a less efficient nuclear uptake. In addition, 
tracking the fate of the components resulting from complex dissociation and their 
metabolites, which can be kept inside the cells or secreted to the extracellular 
medium, would enable the determination of the nature of the cytotoxicity 
mechanisms.  
Overall, an important driving force behind all types of nonviral gene delivery systems 
(gemini surfactant-based, cell-penetrating peptide-based and thermoresponsive 
polymer-based systems, included) seems to reside in their ability to undergo a 
structural or conformational change in physiological conditions. This alteration can 
occur upon selective interaction with cell membranes, or in response to a stimulus, 
such as pH, oxidative/reductive environment or temperature. The conformational 
change should be triggered in order to allow nucleic acid release near the appropriate 
target. 
Considering that humans have over 220 distinct cell types and the success of nucleic 
acid delivery varies from one cell type to another, ingenious approaches should be 
needed to devise synthetic, highly efficient materials with tunable selectivity for the 
different types of cells. In conclusion, there is still much work to be done towards a 
future precise molecular therapy for life-threatening diseases, but we believe that 
great strides are being made in this direction based on the development of nonviral 
delivery systems. 
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credit card upon receipt of the invoice for this transaction. Please follow instructions
provided at that time. 
To pay for this transaction now; please remit a copy of this document along with your
payment. Payment should be in the form of a check or money order referencing your
account number and this invoice number RLNK501382019.
Make payments to "COPYRIGHT CLEARANCE CENTER" and send to: 
Copyright Clearance Center
Dept 001
P.O. Box 843006
Boston, MA 02284-3006
Please disregard electronic and mailed copies if you remit payment in advance.
Questions? customercare@copyright.com or +1-855-239-3415 (toll free in the US) or
+1-978-646-2777.
Gratis licenses (referencing $0 in the Total field) are free. Please retain this printable
license for your reference. No payment is required.
